Digital PET compliance to EARL accreditation specifications

NARCIS (Netherlands)

Koopman, Daniëlle; Groot Koerkamp, Maureen; Jager, Pieter L.; Arkies, Hester; Knollema, Siert; Slump, Cornelis H.; Sanches, Pedro G.; van Dalen, Jorn A.

2017-01-01

Background: Our aim was to evaluate if a recently introduced TOF PET system with digital photon counting technology (Philips Healthcare), potentially providing an improved image quality over analogue systems, can fulfil EANM research Ltd (EARL) accreditation specifications for tumour imaging with

Preliminary experience of a three-dimensional, large-field-of-view PET scanner for the localization of partial epilepsy

International Nuclear Information System (INIS)

Binns, D.S.; O'Brien, T.J.; Murphy, M.; Cook, M.J.; Hicks, R.J.

1999-01-01

Full text: PET scanning is a useful ancillary technique in the localization of intractable partial epilepsy, but its widespread use has been limited by the high cost of traditional PET equipment and radioisotopes. The use of 3D-scanning mode with a large-field of-view PET scanner involves lower equipment costs and requires significantly lower doses of radioisotope. Our aim was to report our preliminary experience of the use of a 3-D, large-field-of-view scanner for FDG-PET studies in the localization of partial epilepsy. 31 patients (pts) with partial epilepsy were studied. The FDG-PET scans were reviewed blindly by a single reviewer without knowledge of seizure localization on structural imaging or ictal electroencephalographic (EEG) monitoring. The PET results were correlated with the localization by more traditional techniques and the results on surgery when available. A localized region of hypometabolism on FDG-PET scanning was reported in 26/31 (84%) patients (21 temporal, 5 extratemporal). This compared favourably with volumetric MRI on which 19/31 (61%) had a focal potentially epileptogenic abnormality, all of which were concordant with the PET localization. PET was concordant with ictal EEG onset in all 22 patients with localizing studies, including 5 pts with normal MRI. PET demonstrated localized hypometabolism in 4/5 pts with non-localizing ictal EEG and was concordant in both pts with abnormal MRI in this group. PET was considered normal in 4 pts, including 3 pts with normal MRI but localizing EEG and 1 pt without EEG or MRI abnormality. One pt with a localizing EEG and normal MRI was felt to have bitemporal hypometabolism. Five patients have subsequently had resective epilepsy surgery with 4 currently seizure-free and 1 significantly improved. Four patients are planned for surgery in the near future. In conclusion, FDG-PET using a 3-D, large-field-of view PET scanner provides sensitive and specific localization in partial epilepsy, and may provide a

Radioisotope instruments

CERN Document Server

Cameron, J F; Silverleaf, D J

1971-01-01

International Series of Monographs in Nuclear Energy, Volume 107: Radioisotope Instruments, Part 1 focuses on the design and applications of instruments based on the radiation released by radioactive substances. The book first offers information on the physical basis of radioisotope instruments; technical and economic advantages of radioisotope instruments; and radiation hazard. The manuscript then discusses commercial radioisotope instruments, including radiation sources and detectors, computing and control units, and measuring heads. The text describes the applications of radioisotop

Specific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites

Energy Technology Data Exchange (ETDEWEB)

Thomas, C. M., E-mail: christopher.thomas@gstt.nhs.uk; Convery, D. J.; Greener, A. G. [Guy' s and St. Thomas’ NHS Foundation Trust, Medical Physics Department, St. Thomas’ Hospital, London SE1 7EH (United Kingdom); Pike, L. C.; Baker, S.; Woods, E. [Division of Imaging Sciences and Biomedical Engineering, King' s College London, King' s Health Partners, St. Thomas’ Hospital, London SE1 7EH (United Kingdom); Hartill, C. E. [Guy' s and St. Thomas’ NHS Foundation Trust, Radiotherapy, Clinical Outpatients Clinic, St. Thomas’ Hospital, London SE1 7EH (United Kingdom)

2014-04-15

Purpose: To provide specific experience-based guidance and recommendations for centers wishing to develop, validate, and implement an accurate and efficient process for directly using positron emission tomography-computed tomography (PET-CT) for the radiotherapy planning of head and neck cancer patients. Methods: A PET-CT system was modified with hard-top couch, external lasers and radiotherapy immobilization and indexing devices and was subject to a commissioning and quality assurance program. PET-CT imaging protocols were developed specifically for radiotherapy planning and the image quality and pathway tested using phantoms and five patients recruited into an in-house study. Security and accuracy of data transfer was tested throughout the whole data pathway. The patient pathway was fully established and tested ready for implementation in a PET-guided dose-escalation trial for head and neck cancer patients. Results: Couch deflection was greater than for departmental CT simulator machines. An area of high attenuation in the couch generated image artifacts and adjustments were made accordingly. Using newly developed protocols CT image quality was suitable to maintain delineation and treatment accuracy. Upon transfer of data to the treatment planning system a half pixel offset between PET and CT was observed and corrected. By taking this into account, PET to CT alignment accuracy was maintained below 1 mm in all systems in the data pathway. Transfer of structures delineated in the PET fusion software to the radiotherapy treatment planning system was validated. Conclusions: A method to perform direct PET-guided radiotherapy planning was successfully validated and specific recommendations were developed to assist other centers. Of major concern is ensuring that the quality of PET and CT data is appropriate for radiotherapy treatment planning and on-treatment verification. Couch movements can be compromised, bore-size can be a limitation for certain immobilization

Specific recommendations for accurate and direct use of PET-CT in PET guided radiotherapy for head and neck sites

International Nuclear Information System (INIS)

Thomas, C. M.; Convery, D. J.; Greener, A. G.; Pike, L. C.; Baker, S.; Woods, E.; Hartill, C. E.

2014-01-01

Purpose: To provide specific experience-based guidance and recommendations for centers wishing to develop, validate, and implement an accurate and efficient process for directly using positron emission tomography-computed tomography (PET-CT) for the radiotherapy planning of head and neck cancer patients. Methods: A PET-CT system was modified with hard-top couch, external lasers and radiotherapy immobilization and indexing devices and was subject to a commissioning and quality assurance program. PET-CT imaging protocols were developed specifically for radiotherapy planning and the image quality and pathway tested using phantoms and five patients recruited into an in-house study. Security and accuracy of data transfer was tested throughout the whole data pathway. The patient pathway was fully established and tested ready for implementation in a PET-guided dose-escalation trial for head and neck cancer patients. Results: Couch deflection was greater than for departmental CT simulator machines. An area of high attenuation in the couch generated image artifacts and adjustments were made accordingly. Using newly developed protocols CT image quality was suitable to maintain delineation and treatment accuracy. Upon transfer of data to the treatment planning system a half pixel offset between PET and CT was observed and corrected. By taking this into account, PET to CT alignment accuracy was maintained below 1 mm in all systems in the data pathway. Transfer of structures delineated in the PET fusion software to the radiotherapy treatment planning system was validated. Conclusions: A method to perform direct PET-guided radiotherapy planning was successfully validated and specific recommendations were developed to assist other centers. Of major concern is ensuring that the quality of PET and CT data is appropriate for radiotherapy treatment planning and on-treatment verification. Couch movements can be compromised, bore-size can be a limitation for certain immobilization

Modular Stirling Radioisotope Generator

Science.gov (United States)

Schmitz, Paul C.; Mason, Lee S.; Schifer, Nicholas A.

2016-01-01

High-efficiency radioisotope power generators will play an important role in future NASA space exploration missions. Stirling Radioisotope Generators (SRGs) have been identified as a candidate generator technology capable of providing mission designers with an efficient, high-specific-power electrical generator. SRGs high conversion efficiency has the potential to extend the limited Pu-238 supply when compared with current Radioisotope Thermoelectric Generators (RTGs). Due to budgetary constraints, the Advanced Stirling Radioisotope Generator (ASRG) was canceled in the fall of 2013. Over the past year a joint study by NASA and the Department of Energy (DOE) called the Nuclear Power Assessment Study (NPAS) recommended that Stirling technologies continue to be explored. During the mission studies of the NPAS, spare SRGs were sometimes required to meet mission power system reliability requirements. This led to an additional mass penalty and increased isotope consumption levied on certain SRG-based missions. In an attempt to remove the spare power system, a new generator architecture is considered, which could increase the reliability of a Stirling generator and provide a more fault-tolerant power system. This new generator called the Modular Stirling Radioisotope Generator (MSRG) employs multiple parallel Stirling convertor/controller strings, all of which share the heat from the General Purpose Heat Source (GPHS) modules. For this design, generators utilizing one to eight GPHS modules were analyzed, which provided about 50 to 450 W of direct current (DC) to the spacecraft, respectively. Four Stirling convertors are arranged around each GPHS module resulting in from 4 to 32 Stirling/controller strings. The convertors are balanced either individually or in pairs, and are radiatively coupled to the GPHS modules. Heat is rejected through the housing/radiator, which is similar in construction to the ASRG. Mass and power analysis for these systems indicate that specific

Radioisotope clocks in archaeology

Energy Technology Data Exchange (ETDEWEB)

Hedges, R E.M. [Oxford Univ. (UK). Research Lab. for Archaeology

1979-09-06

Methods of absolute dating which use the rate of disintegration of a radioactive nucleus as the clock, are reviewed. The use of the abundant radioisotopes (/sup 40/K, Th and U) and of the rare radioisotopes (/sup 14/C, /sup 10/Be, /sup 26/Al, /sup 32/Si, /sup 36/Cl, /sup 41/Ca, /sup 53/Mn) is discussed and radiation integration techniques (fission track dating, thermoluminescence and related techniques) are considered. Specific fields of use of the various methods and their accuracy are examined.

Markets for reactor-produced non-fission radioisotopes

International Nuclear Information System (INIS)

Bennett, R.G.

1995-01-01

Current market segments for reactor produced radioisotopes are developed and reported from a review of current literature. Specific radioisotopes studied in is report are the primarily selected from those with major medical or industrial markets, or those expected to have strongly emerging markets. Relative market sizes are indicated. Special emphasis is given to those radioisotopes that are best matched to production in high flux reactors such as the Advanced Test Reactor (ATR) at the Idaho National Engineering Laboratory or the High Flux Isotope Reactor (HFIR) at the Oak Ridge National Laboratory. A general bibliography of medical and industrial radioisotope applications, trends, and historical notes is included

Statistical dynamic imaging of RI-labeled tracer from list-mode PET data

International Nuclear Information System (INIS)

Tanimoto, Michiaki; Kuroda, Yoshihiro; Oshiro, Osamu; Watabe, Hiroshi; Kuroda, Tomohiro

2009-01-01

Positron emission tomography (PET) can be used in physiological analysis to illustrate physiological states by visualizing the accumulation of radioisotope (RI)-labeled tracer in specific organs or tissues. PET obtains spatio-temporal statistics in the form of list-mode data. However, conventional imaging techniques, which sum up list-mode data over a given time period, cannot depict detailed temporal dynamics of the RI-labeled tracer. In this study, a spatio-temporal analysis approach was employed to visualize the temporal flow dynamics of RI-labeled tracer from the obtained list-mode data. Experiments to assess the visualization of simulated RI-labeled tracer dynamics as well as RI-labeled tracer dynamics in a vascular phantom showed that the proposed method successfully depicted detailed temporal flow dynamics that could not be visualized using conventional methods. (author)

Health physics and quality control management of a cyclotron-based PET facility

International Nuclear Information System (INIS)

Jerabek, P.A.

1995-01-01

This paper provides an overview of the operation and management of a Positron Emission Tomography (PET) facility at the University of Texas. The facility components are discussed from an operations perspective with an emphasis on devices, and on practices and procedures which are implemented to ensure that personnel exposures are as low as reasonably achievable. The cyclotron-based PET facility uses in-house production of PET radioisotopes for preparation of radiopharmaceuticals. A combination of specially designed cyclotron equipped devices, radiopharmaceutical preparation devices, and shielded devices along with health physics practices have helped to make PET operations become routine

Utilization of radioisotopes in medical field

Energy Technology Data Exchange (ETDEWEB)

Sasaki, Yasuhito [National Inst. of Radiological Sciences, Chiba (Japan)

2000-03-01

The establishment and advance of nuclear medicine was briefly described here and the present situations and recent topics on clinical nuclear medicine were summarized as well as its prospects for the future. A labeling method to monitor dynamic changes of living substances using radioisotope (RI) was established by Hevesy using radionuclides. The radiotracing method has been applied to chemical field. The numbers of yearly application in 1982, 1987, 1992 and 1997 were reported in respects of in vivo assays (scintigram, SPECT, PET), the treatments with unsealed RI, PET and in vitro examination (RIA, IRMA). The data show that the application of in vivo examination greatly increased for the last 5 years. Bone scintigram was most frequent (26.9%) followed by myocardial scintigram (19.6%). On the other hand, application of in vitro radioassay is gradually decreasing now after the peak in 1992 (241,000 cases per day). The determination of blood concentrations of various tumor markers such as CEA, CA19-9, CA15-3 ar3, etc. became able using radioimmunodetection (RID). Positron emission computed tomography (PET) is valuable for detection of malignant tumor especially for postoperative recurrence or metastasis, evaluation of myocardial viability and identification of epileptic focus. PET using {sup 15}O labeled H{sub 2}O is thought useful for the study on higher functions of human brain such as language, thinking, and prognostic evaluation of damages in the brain. Nuclear medicinal examination, which has been used for diagnosis would be utilized for designing of clinical therapy and evaluation of its effects and prognosis. (M.N.)

Radioisotope thermoelectric generators for implanted pacemakers

Energy Technology Data Exchange (ETDEWEB)

Pustovalov, A.A.; Bovin, A.V.; Fedorets, V.I.; Shapovalov, V.P.

1986-08-01

This paper discusses the development and application of long-life lithium batteries and the problems associated with miniature radioisotope thermoelectric generators (RITEG) with service lives of 10 years or longer. On eof the main problems encountered when devising a radioisotope heat source (RHS) for an RITEG is to obtain biomedical /sup 238/PuO/sub 2/ with a specific neutron yield of 3.10/sup 3/-4.10/sup 3/ (g /SUP ./ sec)/sup -1/, equivalent to metallic Pu 238, and with a content of gamma impurities sufficient to ensure a permissible exposure a permissible exposure does rate (EDR) of a mixture of neutron and gamma radiation. After carrying out the isotope exchange and purifying the initial sample of its gamma impurity elements, the authors obtain biomedical Pu 238 satisfying the indicated requirements king suitable for use in the power packs of medical devices. Taking the indicated specifications into account, the Ritm-1o and gamma radioisotope heat sources were designed, built, tested in models and under natural conditions, and then into production as radioisotope thermoelectric generators designed to power the electronic circuits of implanted pacemakers. The Ritm-MT and Gemma radioisotope thermoelectric generators described are basic units, which can be used as self-contained power supplies for electronic equipment with power requirements in the micromilliwatt range.

Advanced Radioisotope Power Systems Segmented Thermoelectric Research

Science.gov (United States)

Caillat, Thierry

2004-01-01

Flight times are long; - Need power systems with >15 years life. Mass is at an absolute premium; - Need power systems with high specific power and scalability. 3 orders of magnitude reduction in solar irradiance from Earth to Pluto. Nuclear power sources preferable. The Overall objective is to develop low mass, high efficiency, low-cost Advanced Radioisotope Power System with double the Specific Power and Efficiency over state-of-the-art Radioisotope Thermoelectric Generators (RTGs).

Procedures for evaluating technical specifications (PETS)

International Nuclear Information System (INIS)

Samanta, P.K.; Boccio, J.L.; Vesely, W.E.

1987-01-01

In this paper, aspects of technical specifications relating to Generic Issues B-56 and B-61 are discussed from a risk-standpoint. These primarily deal with the risk issues associated with (1) adaptive diesel test requirements/surveillance test intervals, and (2) the effectiveness of cumulative outage time requirements for controlling downtime risk. Risk and reliability approaches are presented which (1) allow risk-acceptable test intervals to be determined for any diesel and (2) show the potential risk-control capability of prescribed allowed cumulative outage times. This work was conducted through NRC's Procedures for Evaluating Technical Specifications (PETS) Program. The overall objective of this program is to develop and demonstrate methodologies that utilize risk insights and reliability techniques for evaluating the scope, detailed requirements, and safety impact of plant technical specifications

Transport of radioisotopes

International Nuclear Information System (INIS)

Aoki, Shigefumi

1978-01-01

Presently the amount of radioisotopes increased very much and the application spread to wide fields in Japan. Since facilities using radioisotopes are distributed to every place in the country, every transport means such as airplanes, automobiles, railways, ships and mail are employed. The problems in the transport of radioisotopes include too much difference in the recognition of criticality among the persons concerning the transportation and treatment, knowledges of shielding and energy difference in the types of radiation and handling of sealed and unsealed sources and the casks for transport. IAEA established the latest regulation on the package of radioisotopes in 1973, and in Japan, the related regulations will be revised according to the IAEA's regulation in near future. The present status in the inspection at the time of shipment, supervision, and the measures to the accidents are described for the transport means of airplanes, ships and automobiles. Finally, concerning the insurance for cargo, the objects of the insurance for radioisotopes include either the radioisotopes contained in casks for transportation or radioisotopes only. Generally, radioisotopes are accepted in all-risk condition including casks and limited to the useful radioisotopes for peaceful use. (Wakatsuki, Y

Radioisotopic indicators in microbiology

International Nuclear Information System (INIS)

Isamov, N.N.

1976-01-01

The book comprises data obtained by the laboratory of radiobiology (Uzbek Research Veterinary Institute) for 15 years and sums up data of domestic and foreign scientists; it discusses problems of the utilization of radioactive isotopes of sulphur, cadmium, phosphorus and other chemical elements by microorganisms; indicates the specificity of the utilization of radioisotopes in microbiology. The influence is considered of external factors on the inclusion of radioisotopes into microorganisms, methods are discussed of obtaining labelled microorganisms and their antigens, radioactivity of bacteria is considered as affected by the consistency and composition of the nutritive medium and other problems

Manual for reactor produced radioisotopes

International Nuclear Information System (INIS)

2003-01-01

Radioisotopes find extensive applications in several fields including medicine, industry, agriculture and research. Radioisotope production to service different sectors of economic significance constitutes an important ongoing activity of many national nuclear programmes. Radioisotopes, formed by nuclear reactions on targets in a reactor or cyclotron, require further processing in almost all cases to obtain them in a form suitable for use. Specifications for final products and testing procedures for ensuring quality are also an essential part of a radioisotope production programme. The International Atomic Energy Agency (IAEA) has compiled and published such information before for the benefit of laboratories of Member States. The first compilation, entitled Manual of Radioisotope Production, was published in 1966 (Technical Reports Series No. 63). A more elaborate and comprehensive compilation, entitled Radioisotope Production and Quality Control, was published in 1971 (Technical Reports Series No. 128). Both served as useful reference sources for scientists working in radioisotope production worldwide. The 1971 publication has been out of print for quite some time. The IAEA convened a consultants meeting to consider the need for compiling an updated manual. The consultants recommended the publication of an updated manual taking the following into consideration: significant changes have taken place since 1971 in many aspects of radioisotope production; many radioisotopes have been newly introduced while many others have become gradually obsolete; considerable experience and knowledge have been gained in production of important radioisotopes over the years, which can be preserved through compilation of the manual; there is still a need for a comprehensive manual on radioisotope production methods for new entrants to the field, and as a reference. It was also felt that updating all the subjects covered in the 1971 manual at a time may not be practical considering the

The Installation of a P.E.T. Pharmacy at Washington University

International Nuclear Information System (INIS)

Gaehle, G.; Schwarz, S.; Mueller, M.; Margenau, B.; Welch, M.J.

2003-01-01

Washington University has produced radioisotopes for medical application since the early 1960s. In order to serve seven PET scanners and to meet more stringent government regulations we have installed a new PET pharmacy based on our past years of experiences. The new pharmacy was installed at the site of the 3.7 MeV tandem cascade accelerator that was decommissioned in April of 2001. The pharmacy consists of a production lab, quality control lab, reagent preparation lab, shipping and storage area and an office. Security and safety was a main consideration in the design of this PET pharmacy

Experimental validation of gallium production and isotope-dependent positron range correction in PET

Energy Technology Data Exchange (ETDEWEB)

Fraile, L.M., E-mail: lmfraile@ucm.es [Grupo de Física Nuclear, Dpto. Física Atómica, Molecular y Nuclear, Universidad Complutense de Madrid (Spain); Herraiz, J.L.; Udías, J.M.; Cal-González, J.; Corzo, P.M.G.; España, S.; Herranz, E.; Pérez-Liva, M.; Picado, E.; Vicente, E. [Grupo de Física Nuclear, Dpto. Física Atómica, Molecular y Nuclear, Universidad Complutense de Madrid (Spain); Muñoz-Martín, A. [Centro de Microanálisis de Materiales, Universidad Autónoma de Madrid, E-28049 Madrid (Spain); Vaquero, J.J. [Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid (Spain)

2016-04-01

Positron range (PR) is one of the important factors that limit the spatial resolution of positron emission tomography (PET) preclinical images. Its blurring effect can be corrected to a large extent if the appropriate method is used during the image reconstruction. Nevertheless, this correction requires an accurate modelling of the PR for the particular radionuclide and materials in the sample under study. In this work we investigate PET imaging with {sup 68}Ga and {sup 66}Ga radioisotopes, which have a large PR and are being used in many preclinical and clinical PET studies. We produced a {sup 68}Ga and {sup 66}Ga phantom on a natural zinc target through (p,n) reactions using the 9-MeV proton beam delivered by the 5-MV CMAM tandetron accelerator. The phantom was imaged in an ARGUS small animal PET/CT scanner and reconstructed with a fully 3D iterative algorithm, with and without PR corrections. The reconstructed images at different time frames show significant improvement in spatial resolution when the appropriate PR is applied for each frame, by taking into account the relative amount of each isotope in the sample. With these results we validate our previously proposed PR correction method for isotopes with large PR. Additionally, we explore the feasibility of PET imaging with {sup 68}Ga and {sup 66}Ga radioisotopes in proton therapy.

Three dimensional positron-CT: 3D-PET

International Nuclear Information System (INIS)

Ishii, K.

2000-01-01

Positron-CT, namely the positron emission tomograph (PET) provides us the metabolism images obtained by the administration of the drug labeled by the positron emission nuclide in the human body. For example, the carbohydrate metabolism image is obtained by the administration of glucose labelled by 18 F-radioisotopes, and it can be applied to early detection of the cancer and research of high-order function of the brain. As well as X-ray CT, the examine receives the exposure in the positron CT. 3D-PET is based on the solid measurement of γ-rays, therefore, the detection sensitivity of 3D-PET becomes very high and it is possible to drastically reduce the dose of the positron emission nuclide. Because the exposure is reduced to the utmost, the positron CT diagnosis would be possible for the child and the exposure of positron CT doctor in charge can be also reduced. This ideal functional diagnostic imaging equipment, namely, 3D-PET is introduced here. (author)

US Department of Energy radioisotope customers with summary of radioisotope shipments, FY 1988

International Nuclear Information System (INIS)

Van Houten, N.C.

1989-06-01

Pacific Northwest Laboratory (PNL) prepared this edition of the radioisotope customer list at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, US Department of Energy (DOE). This is the 25th report in a series dating from 1964. This report covers DOE radioisotope sales and distribution activities by its facilities to domestic, foreign and other DOE facilities for FY 1988. The report is divided into five sections: radioisotope suppliers, facility contacts, and radioisotopes or services supplied; a list of customers, suppliers, and radioisotopes purchased; a list of radioisotopes purchased cross-referenced to customer numbers; geographic locations of radioisotope customers; and radioisotope sales and transfers -- FY 1988. Radioisotopes not previously reported in this series of reports were argon-37, arsenic-72, arsenic-73, bismuth-207, gadolinium-151, rhenium-188, rhodium-101, selenium-72, xenon-123 and zirconium-88. The total value of DOE radioisotope sales for FY 1988 was $11.1 million, an increase of 3% from FY 1987

US Department of Energy radioisotope customers with summary of radioisotope shipments, FY 1988

Energy Technology Data Exchange (ETDEWEB)

Van Houten, N.C.

1989-06-01

Pacific Northwest Laboratory (PNL) prepared this edition of the radioisotope customer list at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, US Department of Energy (DOE). This is the 25th report in a series dating from 1964. This report covers DOE radioisotope sales and distribution activities by its facilities to domestic, foreign and other DOE facilities for FY 1988. The report is divided into five sections: radioisotope suppliers, facility contacts, and radioisotopes or services supplied; a list of customers, suppliers, and radioisotopes purchased; a list of radioisotopes purchased cross-referenced to customer numbers; geographic locations of radioisotope customers; and radioisotope sales and transfers -- FY 1988. Radioisotopes not previously reported in this series of reports were argon-37, arsenic-72, arsenic-73, bismuth-207, gadolinium-151, rhenium-188, rhodium-101, selenium-72, xenon-123 and zirconium-88. The total value of DOE radioisotope sales for FY 1988 was $11.1 million, an increase of 3% from FY 1987.

The Synthesis And Characterization Of Wolfram Phthalocyanine For The Target Material Of High Specific Activity Radioisotope Wolfram - 188 (188W)

International Nuclear Information System (INIS)

Setiawan, Duyeh

2000-01-01

The application of 188 Re radioisotope separation on aluminia column through elution solution has increased significantly since the last two decades. The 188 Re radioisotope has been done fram 188 Re beta-decay through a neutron capture radiation on wolfram -186 target. In trhe column separation, high specific activity of 188 W radioisotope is required to get sufficient activity in small quality 188 W radioisotope has been carried out in this research. Wolfram-phthalocyanine compound was prepared by refluxing a mixture of wolfram trioxyde, (WO 3 ) and phthalonitrile, (C 8 H 4 N 2 ) at 250 o C for two hours. The synthesis of wolfram phthalocyanine is 70% purity yield, the product are green crystals, have a 193,0-193,8 o C melting points, and has a molecular formula C 3 2H 1 6 N8 WO 2 . The infra red spectrum of wolfram-phthalocyanine was the absorption band at 964,3 cm - 1 was due to the vibration of W=O bond of the wolfram dioxy-phthalocyanine. The x-ray diffraction of the wolfram dioxy-phthalocyanine was similar with molybdenum dioxy-phthalocyanine compound. This fact showed that the product was wolfram dioxy-phthalocyanine

Radioisotope applications in industry and environment: Indian scenario

International Nuclear Information System (INIS)

Pant, H.J.

2016-01-01

Applications of radioisotopes and radiation technology in industry, medicine and agriculture form an important part of India's programme of using nuclear technology for societal benefits. Radioisotope production in India started on a modest scale soon after 1 MW APSARA reactor at Trombay, Mumbai became critical in 1956. The scope of activities expanded thereafter. With the commissioning of 40 MW CIRUS reactor in 1960, the setting up of modern radioisotope processing laboratories in late sixties and the production of cobalt-60 in power reactors in megacurie quantities in late seventies made India self-sufficient in radioisotope production. The radioisotope production received a major boost in 1985 with the commissioning of high flux 100 MW DHRUVA reactor, which provided opportunity to extend the range of radioisotopes available in the country both in quantity as well in specific activity. The CIRUS reactor has been shutdown in year 2010 and 1 MW APSARA reactor is presently being upgraded to 5 MW. Today, The DHRUVA reactor operating at its full capacity is being used for production of 100 different radioisotopes those are used in industry, agriculture and medicine. (author)

Advanced Radioisotope Power Conversion Technology Research and Development

Science.gov (United States)

Wong, Wayne A.

2004-01-01

NASA's Radioisotope Power Conversion Technology program is developing next generation power conversion technologies that will enable future missions that have requirements that cannot be met by either the ubiquitous photovoltaic systems or by current Radioisotope Power System (RPS) technology. Performance goals of advanced radioisotope power systems include improvement over the state-of-practice General Purpose Heat Source/Radioisotope Thermoelectric Generator by providing significantly higher efficiency to reduce the number of radioisotope fuel modules, and increase specific power (watts/kilogram). Other Advanced RPS goals include safety, long-life, reliability, scalability, multi-mission capability, resistance to radiation, and minimal interference with the scientific payload. NASA has awarded ten contracts in the technology areas of Brayton, Stirling, Thermoelectric, and Thermophotovoltaic power conversion including five development contracts that deal with more mature technologies and five research contracts. The Advanced RPS Systems Assessment Team includes members from NASA GRC, JPL, DOE and Orbital Sciences whose function is to review the technologies being developed under the ten Radioisotope Power Conversion Technology contracts and assess their relevance to NASA's future missions. Presented is an overview of the ten radioisotope power conversion technology contracts and NASA's Advanced RPS Systems Assessment Team.

Imaging and PET - PET/CT imaging

International Nuclear Information System (INIS)

Von Schulthess, G.K.; Hany, Th.F.

2008-01-01

PET/CT has grown because the lack of anatomic landmarks in PET makes 'hardware-fusion' to anatomic cross-sectional data extremely useful. Addition of CT to PET improves specificity, but also sensitivity, and adding PET to CT adds sensitivity and specificity in tumor imaging. The synergistic advantage of adding CT is that the attenuation correction needed for PET data can also be derived from the CT data. This makes PET-CT 25-30% faster than PET alone, leading to higher patient throughput and a more comfortable examination for patients typically lasting 20 minutes or less. FDG-PET-CT appears to provide relevant information in the staging and therapy monitoring of many tumors, such as lung carcinoma, colorectal cancer, lymphoma, gynaecological cancers, melanoma and many others, with the notable exception of prostatic cancer. for this cancer, choline derivatives may possibly become useful radiopharmaceuticals. The published literature on the applications of FDG-PET-CT in oncology is still limited but several designed studies have demonstrated the benefits of PET-CT. (authors)

A new PET tracer specific for vascular endothelial growth factor receptor

International Nuclear Information System (INIS)

Wang, Hui; Cai, Weibo; Chen, Kai; Li, Zi-Bo; Kashefi, Amir; He, Lina; Chen, Xiaoyuan

2007-01-01

Noninvasive positron emission tomography (PET) imaging of vascular endothelial growth factor receptor 2 (VEGFR-2) expression could be a valuable tool for evaluation of patients with a variety of malignancies, and particularly for monitoring those undergoing antiangiogenic therapies that block VEGF/VEGFR-2 function. The aim of this study was to develop a VEGFR-2-specific PET tracer. The D63AE64AE67A mutant of VEGF 121 (VEGF DEE ) was generated by recombinant DNA technology. VEGF 121 and VEGF DEE were purified and conjugated with DOTA for 64 Cu labeling. The DOTA conjugates were tested in vitro for VEGFR-2 specificity and functional activity. In vivo tumor targeting efficacy and pharmacokinetics of 64 Cu-labeled VEGF 121 and VEGF DEE were compared using an orthotopic 4T1 murine breast tumor model. Blocking experiments, biodistribution studies, and immunofluorescence staining were carried out to confirm the noninvasive imaging results. Cell binding assay demonstrated that VEGF DEE had about 20-fold lower VEGFR-1 binding affinity and only slightly lower VEGFR-2 binding affinity as compared with VEGF 121 . MicroPET imaging studies revealed that both 64 Cu-DOTA-VEGF 121 and 64 Cu-DOTA-VEGF DEE had rapid and prominent activity accumulation in VEGFR-2-expressing 4T1 tumors. The renal uptake of 64 Cu-DOTA-VEGF DEE was significantly lower than that of 64 Cu-DOTA-VEGF 121 as rodent kidneys expressed high levels of VEGFR-1 based on immunofluorescence staining. Blocking experiments and biodistribution studies confirmed the VEGFR specificity of 64 Cu-DOTA-VEGF DEE . We have developed a VEGFR-2-specific PET tracer, 64 Cu-DOTA-VEGF DEE . It has comparable tumor targeting efficacy to 64 Cu-DOTA-VEGF 121 but much reduced renal toxicity. This tracer may be translated into the clinic for imaging tumor angiogenesis and monitoring antiangiogenic treatment efficacy. (orig.)

Packaging and transport of radioisotopes

International Nuclear Information System (INIS)

Taylor, C.B.G.

1976-01-01

The importance of radioisotope traffic is emphasized. More than a million packages are being transported each year, mostly for medical uses. The involvement of public transport services and the incidental dose to the public (which is very small) are appreciably greater than for movements connected with the nuclear fuel cycle. Modern isotope packages are described, and an outline given of the problems of a large radioisotope manufacturer who has to package many different types of product. Difficulties caused by recent uncoordinated restrictions on the use of passenger aircraft are mentioned. Some specific problems relating to radioisotope packaging are discussed. These include the crush resistance of Type A packages, the closure of steel drums, the design of secure closures for large containers, the Type A packaging of liquids, leak tightness criteria of Type B packages, and the use of 'unit load' overpacks to consign a group of individually approved packages together as a single shipment. Reference is made to recent studies of the impact of radioisotope shipments on the environment. Cost/benefit analysis is important in this field - an important public debate is only just beginning. (author)

Radiation protection programme for a radioisotope production facility

International Nuclear Information System (INIS)

Makgato, Thutu Nelson

2015-02-01

The present project reviews reactor based radioisotope production facilities. An overview of techniques and methodologies used as well as laboratory facilities necessary for the production process are discussed. Specific details of reactor based production and processing of more commonly used industrial and pharmaceutical radioisotopes are provided. Ultimately, based on facilities and techniques utilized as well as the associated hazard assessment, a proposed radiation protection programme is discussed. Elements of the radiation protection programme will also consider lessons from recent incidents and accidents encountered in radioisotope production facilities. (au)

Radioisotope production by reactors and cyclotrons in Japan

International Nuclear Information System (INIS)

Murakami, Yukio

1978-01-01

Present status of radioisotope production in Japan and the increasing demand from various fields are generally reviewed. Future problems associated with the shortage of economical supply are also discussed. The first half of this report is devoted to general review of the increasing demand for various radioisotopes from increasing number of users. The present status and future trends of the distribution of users of specific radioisotopes and their demands are shown. The remaining half of this report reviews the production with reactors and cyclotrons. The Japanese reactors producing radioisotopes are limited to low flux (10 13 ) research reactors at JAERI. Some problems associated with the improvement of availability and with the organizational structure are discussed. As for the production with cyclotrons, available facilities and the method of production are explained in detail. For clinical use, especially for the production of short lived radioisotopes, the advantage of a small special purpose cyclotron at each medical organization is emphasized. (Aoki, K.)

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1986

International Nuclear Information System (INIS)

Lamar, D.A.

1988-01-01

Data were collected and compiled on radioisotopes produced and sold by Department of Energy (DOE) facilities, and on services rendered by DOE facilities. Compiled data were published and distributed in the document list of DOE Radioisotope Customers with Summary of Radioisotope Shipments, FY 1986, PNL-6361, October 1987. The DOE facilities that supplied information for the compilation were Argonne National Laboratory, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho National Engineering Laboratory, Los Alamos National Laboratory, Oak Ridge National Laboratory, Pacific Northwest Laboratory, Savannah River Plant, and UNC Nuclear Industries, Inc. (Hanford). The data provided were reported in several different ways: (1) a list of radioisotopes and services provided by each facility; (2) a list of radioisotope customers, the supplying DOE facility, and the radioisotope or service provided to each customer; and (3) a list of the quantity and value of each radioisotope or service sold by each DOE facility. The sales information covered foreign customers, domestic private customers, and domestic DOE customers

The use of radioisotope tracers in the metallurgical industries

International Nuclear Information System (INIS)

Easey, J.F.

1987-01-01

Radioisotope techniques have been widely used in the metallurgical industries for many years. They have been shown to be very suitable for studying large scale plant and, in many cases, they are the most suitable techniques for such investigations. Applications of radioisotope tracers to some specific metallurgical problems are discussed. (author)

Production of radioisotopes with BR2 facilities

International Nuclear Information System (INIS)

Fallais, C.J.; Morel de Westfaver, A.; Heeren, L.; Baugnet, J.M.; Gandolfo, J.M.; Boeykens, W.

1978-01-01

After a brief account on the isotopes production evolution in the industrialized countries the irradiation devices and the types of standardized capsules used in the BR2 reactor are described as well as the thermal neutron flux. Production of most important radioisotopes like 131 Iodine, 60 Cobalt, 192 Iridium and 99 Molybdenum and their main utilizations (uses)are described. The mean specific activities and the limit of use for different radioisotopes are reported. (A.F.)

Contribution of radioisotopic techniques to identify sentinel lymph-nodes (SLN) in breast cancer

International Nuclear Information System (INIS)

Zarlenga, Ana C.; Katz, Lidia; Armesto, Amparo; Noblia, Cristina; Gorostidi, Susana; Perez, Juan; Parma, Patricia

2009-01-01

The SLN (one or several) is the first to receive lymph from a tumor. When a cancer cell comes off the tumor and circulates along the outgoing lymph, it meets a barrier, the SLN that intercepts and destroys it. If not, the cancer cell can stay and reproduce in the SLN making a metastasis which can affect other nodes in the same way. It has been shown that if the original tumor is small there is little chance that the SLN could be invaded and therefore little chance of dissemination to other lymph-nodes. Nowadays due to early detection, breast tumors are smaller than one cm, therefore with such size there is little chance of axillary lymph-nodes being affected. If it is confirmed by histological study that the SLN is free of metastasis, it is not necessary to perform a axillary emptying. This identification of SLNs has been achieved because of the advances of Radioisotopic Techniques, which has been carried out in our Hospital since 1997. We have been adapting this technique to the national supply of equipment and radio compounds always under a reliable and secure way. The aim of this presentation is to highlight the radioisotopic identification of SLNs in clinical investigation in 'Angel H. Roffo Institute', and its daily practice compare with Positron Emission Tomography (PET). By combining Radioisotopic Lymphography, Lymphochromography and intra surgical detection of the SN with Gamma Probe, we have obtained a true negative value of 95% of the SN, with 5% false negative. Due to this method we have included SN study in daily practice breast tumor patients with tumor up to 5 cm of diameter. Comparing this methods result (5% false negative), with the PET results, using 18 F-FDG, that has 33% false negatives, we conclude that a negative result can not replace this method of SN detection. (author)

A Survey on the Usage and Demand of Medical Radioisotope and Radiopharmaceuticals in Malaysia

International Nuclear Information System (INIS)

Muhammad Fakhrurazi Ahmad Fadzil; Siti Selina Abdul Hamid; Siti Najila Mohd Janib; Azahari Kasbollah; Syed Asraf Fahlawi Wafa

2016-01-01

Medical radioisotope is a small quantity of radioactive substance used for the purpose of diagnostic and therapy of various diseases. In Malaysia, the emerging of new nuclear medicine centers or institutions in both government and private sectors rose abruptly for the past few years. Currently, there are no data available on the usage and demand of these medical radioisotope or radiopharmaceuticals. The aim of this study is to assess current medical radioisotopes and radiopharmaceuticals usage and also to provide data on current medical radioisotope and radiopharmaceuticals demand for both private and government hospitals or institutions in Malaysia. A survey for a period of 3 months was conducted across Malaysia. The survey was divided into five (5) main parts and it was distributed among health care professionals involved working with medical radioisotope and radiopharmaceuticals in private, government and university based hospitals or institutions and was distributed manually either by hand, mail or e-mail. Data is presented in either pie chart or bar chart. Survey results found out that the highest demand and the highest usage among all radioisotopes are Technetium-99m and radioiodine isotopes such as the iodine-131, iodine-131 MIBG, iodine-123 and iodine-123 MIBG. Technetium-99m is the backbone of nuclear medicine whereby more than 80 % of Nuclear Medicine services utilize this radioisotope. Technetium-99m supply chain is unstable globally and in coming future, two main reactors that produce 60 % of world Molybdenum-99 will shut down and the supply of molybdenum-99 will be disrupted. In radioiodine services, currently, Iodine-123 cannot be obtained in Malaysia and neighboring countries due to its short half-life. Iodine-123 is useful in diagnostic of thyroid related diseases. As for PET services, the highest demands are F-18 FDG and gallium-68 Generator. It is important for Malaysia to self-produced medical radioisotope and radiopharmaceuticals to meet the

Detection of Cancer with PET and PET/CT in Asymptomatic Volunteers

International Nuclear Information System (INIS)

Chung, Ji In; Choi, Joon Young; Lee, Kyung Han; Kim, Byung Tae; Choi, Yoon Ho; Cho, Han Byoul; Shim, Jae Yong

2009-01-01

We retrospectively investigated the diagnostic performance of 18 F-fluorodeoxyglucose positron emission tomography (PET) and PET/CT for cancer detection in asymptomatic health-check examinees. This study consisted of 5091 PET or PET/CT conducted as part of annual health examination at one hospital from March 1998 to February 2008. To find the incidence of cancers, medical records of the subjects were thoroughly reviewed for a follow-up period of one year. The patterns of formal readings of PET and PET/CT were analyzed to assess the sensitivity and specificity for cancer detection. The histopathology and stage of the cancers were evaluated in relation to the results of PET. Eighty-six cancers (1.7%) were diagnosed within one year after PET or PET/CT. When PET and PET/CT results were combined, the sensitivity was 48.8% and specificity was 81.1% for cancer detection. PET only had a sensitivity of 46.2% and a specificity of 81.4%, and PET/CT only had a sensitivity of 75.0% and a specificity of 78.5% respectively. There were no significant differences in cancer site, stage and histopathology between PET positive and PET negative cancers. In 19.3% of formal readings of PET and PET/CT, further evaluation to exclude malignancy or significant disease was recommended. Head and neck area and upper gastrointestinal tract were commonly recommended sites for further evaluation. PET and PET/CT showed moderate performance for detecting cancers in asymptomatic adults in this study. More experience and further investigation are needed to overcome limitations of PET and PET/CT for cancer screening

Five Years of Cyclotron Radioisotope Production Experiences at the First PET-CT in Venezuela

International Nuclear Information System (INIS)

Colmenter, L.; Coelho, D.; Esteves, L. M.; Ruiz, N.; Morales, L.; Lugo, I.; Sajo-Bohus, L.; Liendo, J. A.; Greaves, E. D.; Barros, H.; Castillo, J.

2007-01-01

Five years operation of a compact cyclotron installed at PET-CT facility in Caracas, Venezuela is given. Production rate of 18 F labeled FDG, operation and radiation monitoring experience are included. We conclude that 18 FDG CT-PET is the most effective technique for patient diagnosis

Radioisotope electric propulsion of sciencecraft to the outer Solar System and near-interstellar space

International Nuclear Information System (INIS)

Noble, R.J.

1999-01-01

Radioisotopes have been used successfully for more than 25 years to supply the heat for thermoelectric generators on various deep-space probes. Radioisotope electric propulsion (REP) systems have been proposed as low-thrust ion propulsion units based on radioisotope electric generators and ion thrusters. The perceived liability of radioisotope electric generators for ion propulsion is their high mass. Conventional radioisotope thermoelectric generators have a specific mass of about 200 kg/kW of electric power. Many development efforts have been undertaken with the aim of reducing the specific mass of radioisotope electric systems. Recent performance estimates suggest that specific masses of 50 kg/kW may be achievable with thermophotovoltaic and alkali metal thermal-to-electric conversion generators. Powerplants constructed from these near-term radioisotope electric generators and long-life ion thrusters will likely have specific masses in the range of 100 to 200 kg/kW of thrust power if development continues over the next decade. In earlier studies, it was concluded that flight times within the Solar System are indeed insensitive to reductions in the powerplant specific mass, and that a timely scientific program of robotic planetary rendezvous and near-interstellar space missions is enabled by primary electric propulsion once the powerplant specific mass is in the range of 100 to 200 kg/kW. Flight times can be substantially reduced by using hybrid propulsion schemes that combine chemical propulsion, gravity assist, and electric propulsion. Hybrid schemes are further explored in this article to illustrate how the performance of REP is enhanced for Pluto rendezvous, heliopause orbiter, and gravitational lens missions

A systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?

Directory of Open Access Journals (Sweden)

Langer Astrid

2010-10-01

Full Text Available Abstract Background A number of diagnostic tests are required for the detection and management of cancer. Most imaging modalities such as computerized tomography (CT are anatomical. However, positron emission tomography (PET is a functional diagnostic imaging technique using compounds labelled with positron-emitting radioisotopes to measure cell metabolism. It has been a useful tool in studying soft tissues such as the brain, cardiovascular system, and cancer. The aim of this systematic review is to critically summarize the health economic evidence of oncologic PET in the literature. Methods Eight electronic databases were searched from 2005 until February 2010 to identify economic evaluation studies not included in previous Health Technology Assessment (HTA reports. Only full health economic evaluations in English, French, or German were considered for inclusion. Economic evaluations were appraised using published quality criteria for assessing the quality of decision-analytic models. Given the variety of methods used in the health economic evaluations, the economic evidence has been summarized in qualitative form. Results From this new search, 14 publications were identified that met the inclusion criteria. All publications were decision-analytic models and evaluated PET using Fluorodeoxyglucose F18 (FDG-PET. Eight publications were cost-effectiveness analyses; six were cost-utility analyses. The studies were from Australia, Belgium, Canada, France, Italy, Taiwan, Japan, the Netherlands, the United Kingdom, and the United States. In the base case analyses of these studies, cost-effectiveness results ranged from dominated to dominant. The methodology of the economic evaluations was of varying quality. Cost-effectiveness was primarily influenced by the cost of PET, the specificity of PET, and the risk of malignancy. Conclusions Owing to improved care and less exposure to ineffective treatments, personalized medicine using PET may be cost

A useful PET probe [11C]BU99008 with ultra-high specific radioactivity for small animal PET imaging of I2-imidazoline receptors in the hypothalamus

International Nuclear Information System (INIS)

Kawamura, Kazunori; Shimoda, Yoko; Yui, Joji; Zhang, Yiding; Yamasaki, Tomoteru; Wakizaka, Hidekatsu; Hatori, Akiko; Xie, Lin; Kumata, Katsushi; Fujinaga, Masayuki; Ogawa, Masanao; Kurihara, Yusuke; Nengaki, Nobuki; Zhang, Ming-Rong

2017-01-01

Introduction: A positron emission tomography (PET) probe with ultra-high specific radioactivity (SA) enables measuring high receptor specific binding in brain regions by avoiding mass effect of the PET probe itself. It has been reported that PET probe with ultra-high SA can detect small change caused by endogenous or exogenous ligand. Recently, Kealey et al. developed [ 11 C]BU99008, a more potent PET probe for I 2 -imidazoline receptors (I 2 Rs) imaging, with a conventional SA (mean 76 GBq/μmol) showed higher specific binding in the brain. Here, to detect small change of specific binding for I 2 Rs caused by endogenous or exogenous ligand in an extremely small region, such as hypothalamus in the brain, we synthesized and evaluated [ 11 C]BU99008 with ultra-high SA as a useful PET probe for small-animal PET imaging of I 2 Rs. Methods: [ 11 C]BU99008 was prepared by [ 11 C]methylation of N-desmethyl precursor with [ 11 C]methyl iodide. Biodistribution, metabolite analysis, and brain PET studies were conducted in rats. Results: [ 11 C]BU99008 with ultra-high SA in the range of 5400–16,600 GBq/μmol were successfully synthesized (n = 7), and had appropriate radioactivity for in vivo study. In the biodistribution study, the mean radioactivity levels in all investigated tissues except for the kidney did not show significant difference between [ 11 C]BU99008 with ultra-high SA and that with conventional SA. In the metabolite analysis, the percentage of unchanged [ 11 C]BU99008 at 30 min after the injection of probes with ultra-high and conventional SA was similar in rat brain and plasma. In the PET study of rats' brain, radioactivity level (AUC 30–60 min ) in the hypothalamus of rats injected with [ 11 C]BU99008 with ultra-high SA (64 [SUV ∙ min]) was significantly higher than that observed for that with conventional SA (50 [SUV ∙ min]). The specific binding of [ 11 C]BU99008 with ultra-high SA (86% of total binding) for I 2 R was higher than that of

Development of Kabila rocket: A radioisotope heated thermionic plasma rocket engine

Directory of Open Access Journals (Sweden)

Kalomba Mboyi

2015-04-01

Full Text Available A new type of plasma rocket engine, the Kabila rocket, using a radioisotope heated thermionic heating chamber instead of a conventional combustion chamber or catalyst bed is introduced and it achieves specific impulses similar to the ones of conventional solid and bipropellant rockets. Curium-244 is chosen as a radioisotope heat source and a thermal reductive layer is also used to obtain precise thermionic emissions. The self-sufficiency principle is applied by simultaneously heating up the emitting material with the radioisotope decay heat and by powering the different valves of the plasma rocket engine with the same radioisotope decay heat using a radioisotope thermoelectric generator. This rocket engine is then benchmarked against a 1 N hydrazine thruster configuration operated on one of the Pleiades-HR-1 constellation spacecraft. A maximal specific impulse and power saving of respectively 529 s and 32% are achieved with helium as propellant. Its advantages are its power saving capability, high specific impulses and simultaneous ease of storage and restart. It can however be extremely voluminous and potentially hazardous. The Kabila rocket is found to bring great benefits to the existing spacecraft and further research should optimize its geometric characteristics and investigate the physical principals of its operation.

Progress update on the development of the 3He linac for PET isotope production

International Nuclear Information System (INIS)

Young, P.; Sun, D.; Larson, D.; Pasquinelli, R.; Anderson, K.; Bieniosek, F.; Schmidt, C.W.; Popovic, M.; McCrory, E.; Webber, R.; Link, J.; Krohn, K.; Bida, J.

1996-01-01

In 1995, Fermilab and SAIC formed a collaboration with partners from the University of Washington (UW) and the Biomedical Research Foundation of Northwest Louisiana (BRF) to explore an innovative approach to the production of radioisotopes. The accelerator system that is being developed accelerates 3 He to 10.5 MeV and then delivers this beam to the target to produce the short lived radioisotopes of interest to the PET community ( 18 F, 15 0, 13 N, 11 C). Research is being conducted to investigate the contribution that this promising approach can make to clinical and research PET. The accelerator system has several very interesting aspects. These innovations include multiple RFQ accelerators configured in series, a gas stripper jet to doubly charge the low energy (1 MeV) 3 He beam, and an isochronous matching section to manipulate the transverse and maintain the longitudinal profile of the beam (without the use of an RF buncher) in the charge doubler transition section between RFQ's. This paper updates the progress of the PET 3 He RFQ accelerator, the current status of the design, and some of the interesting ongoing research. (author)

Progress update on the development of the 3He linac for PET isotope production

International Nuclear Information System (INIS)

1996-09-01

In 1995, Fermilab and SAIC formed a collaboration with partners from the University of Washington (UW) and the Biomedical Research Foundation of Northwest Louisiana (BRF) to explore an innovative approach to the production radioisotopes. The accelerator system that is being developed accelerates 3 He to 10.5 MeV and then delivers this beam to the target to produce the short lived radioisotopes of interest to the PET community ( 18 F, 15 0, 13 N, 11 C). Research is being conducted to investigate the contribution that this promising approach can make to clinical and research PET. The accelerator system has several very interesting aspects. These innovations include multiple RFQ accelerators configured in series, a gas stripper jet to doubly charge the low energy (I MeV) 3 He beam, and an isochronous matching section to manipulate the transverse and maintain the longitudinal profile of the beam (without the use of an RF buncher) in the charge doubler transition section between RFQ'S. This paper updates the progress of the PET 3 He RFQ accelerator, the current status of the design, and some of the interesting ongoing research

Fast and simple preparation of 68Ga-citrate for routine clinical PET

DEFF Research Database (Denmark)

Nielsen, Karin M; Kaufmann, Jens; Mewis, Dennis

2013-01-01

The imaging of infectious and inflammatory diseases using gallium-67 (⁶⁷Ga) citrate scintigraphy has been a well-established diagnostic tool for decades. In recent times, interest has focused on PET using the short-lived positron emitting radioisotope ⁶⁸Ga. ⁶⁸Ga is not only more readily available...

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1984

International Nuclear Information System (INIS)

Baker, D.A.

1985-08-01

This edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, Department of Energy (DOE). This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers - FY 1984

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1984

Energy Technology Data Exchange (ETDEWEB)

Baker, D.A.

1985-08-01

This edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research (ER-73), Office of Energy Research, Department of Energy (DOE). This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers - FY 1984.

Acquiring additional delayed PET images improves sensitivity and specificity in oncology cases

International Nuclear Information System (INIS)

Lamki, L.M.; Barron, B.J.; Mullani, N.; Joseph, U.; Ehert, E.

2002-01-01

Aim: This study looked into utility of acquiring PET images at 2-3 hours in addition to the standard whole body PET done at 1-hour after FDG injection in certain oncology cases. The objective is to evaluate whether the delayed additional images can decipher equivocal foci of FDG accumulation commonly seen in oncology patients. Typical example is the bowel activity that moves with time. Materials and Methods: PET protocol at our Institution in patients with colon Cancer, Pancreas Ca, Ovarian Ca and Breast Ca include a whole body PET (6-7 bed positions) done at 1-hour after 15 mCi F-18-FDG followed by select limited area PET scan (typically 2 bed stops over the area of interest) at 2-3 hours. Acquisition was undertaken on Siemens ECAT-EXACT Camera - 2-D acquisition and 8 mins. per bed position (5 mins. Emission and 3 mins. Transmission), 16.3 cm FOV and then Iterative Reconstruction. Results: Analysis of the first 115 patients who had additional delayed images resulted in 80% of patients where delayed images helped in interpretation. In 70% of these, delayed images helped in identifying physiological structures, e.g., ureters, bowel, blood vessels and muscles versus pathology. In 25%, they actually helped in identifying malignancy, e.g. more definite FDG accumulation. Almost all helped to boost the confidence of the reader. The contribution was mainly in differentiating bowel and ureter activity from cancer in the abdomen, as these change position with time. In case of pancreas and breast cancer, delayed images contributed in clarifying tumor metabolic activity as well. Inflammation and motion artifacts could also be better defined and so was muscle uptake. Conclusion: (1) Additional delayed PET imaging is very helpful in certain cancers in identifying more lesions and avoiding pitfalls. (2) They can yield higher sensitivity and specificity for colon, ovarian, breast and pancreas cancers. (3) Identification of physiologic structures and differentiation of these from

Radioisotope detection with accelerators

International Nuclear Information System (INIS)

Mast, T.S.; Muller, R.A.; Tans, P.P.

1979-12-01

High energy mass spectrometry is a new and very sensitive technique of measuring rare radioisotopes. This paper describes the techniques used to select and identify the individual radioisotope atoms in a sample and the status of the radioisotope measurements and their applications

Reactor-produced therapeutic radioisotopes

International Nuclear Information System (INIS)

Knapp, F.F. Jr.

2002-01-01

The significant worldwide increase in therapeutic radioisotope applications in nuclear medicine, oncology and interventional cardiology requires the dependable production of sufficient levels of radioisotopes for these applications (Reba, 2000; J. Nucl. Med., 1998; Nuclear News, 1999; Adelstein and Manning, 1994). The issues associated with both accelerator- and reactor-production of therapeutic radioisotopes is important. Clinical applications of therapeutic radioisotopes include the use of both sealed sources and unsealed radiopharmaceutical sources. Targeted radiopharmaceutical agents include those for cancer therapy and palliation of bone pain from metastatic disease, ablation of bone marrow prior to stem cell transplantation, treatment modalities for mono and oligo- and polyarthritis, for cancer therapy (including brachytherapy) and for the inhibition of the hyperplastic response following coronary angioplasty and other interventional procedures (For example, see Volkert and Hoffman, 1999). Sealed sources involve the use of radiolabeled devices for cancer therapy (brachytherapy) and also for the inhibition of the hyperplasia which is often encountered after angioplasty, especially with the exponential increase in the use of coronary stents and stents for the peripheral vasculature and other anatomical applications. Since neutron-rich radioisotopes often decay by beta decay or decay to beta-emitting daughter radioisotopes which serve as the basis for radionuclide generator systems, reactors are expected to play an increasingly important role for the production of a large variety of therapeutic radioisotopes required for these and other developing therapeutic applications. Because of the importance of the availability of reactor-produced radioisotopes for these applications, an understanding of the contribution of neutron spectra for radioisotope production and determination of those cross sections which have not yet been established is important. This

Specification and estimation of sources of bias affecting neurological studies in PET/MR with an anatomical brain phantom

Energy Technology Data Exchange (ETDEWEB)

Teuho, J., E-mail: jarmo.teuho@tyks.fi [Turku PET Centre, Turku (Finland); Johansson, J. [Turku PET Centre, Turku (Finland); Linden, J. [Turku PET Centre, Turku (Finland); Department of Mathematics and Statistics, University of Turku, Turku (Finland); Saunavaara, V.; Tolvanen, T.; Teräs, M. [Turku PET Centre, Turku (Finland)

2014-01-11

Selection of reconstruction parameters has an effect on the image quantification in PET, with an additional contribution from a scanner-specific attenuation correction method. For achieving comparable results in inter- and intra-center comparisons, any existing quantitative differences should be identified and compensated for. In this study, a comparison between PET, PET/CT and PET/MR is performed by using an anatomical brain phantom, to identify and measure the amount of bias caused due to differences in reconstruction and attenuation correction methods especially in PET/MR. Differences were estimated by using visual, qualitative and quantitative analysis. The qualitative analysis consisted of a line profile analysis for measuring the reproduction of anatomical structures and the contribution of the amount of iterations to image contrast. The quantitative analysis consisted of measurement and comparison of 10 anatomical VOIs, where the HRRT was considered as the reference. All scanners reproduced the main anatomical structures of the phantom adequately, although the image contrast on the PET/MR was inferior when using a default clinical brain protocol. Image contrast was improved by increasing the amount of iterations from 2 to 5 while using 33 subsets. Furthermore, a PET/MR-specific bias was detected, which resulted in underestimation of the activity values in anatomical structures closest to the skull, due to the MR-derived attenuation map that ignores the bone. Thus, further improvements for the PET/MR reconstruction and attenuation correction could be achieved by optimization of RAMLA-specific reconstruction parameters and implementation of bone to the attenuation template. -- Highlights: • Comparison between PET, PET/CT and PET/MR was performed with a novel brain phantom. • The performance of reconstruction and attenuation correction in PET/MR was studied. • A recently developed brain phantom was found feasible for PET/MR imaging. • Contrast reduction

Improvement of radioisotope production technology

International Nuclear Information System (INIS)

Li Yongjian

1987-01-01

The widespreading and deepgoing applications of radioisotopes results the increasing demands on both quality and quantity. This in turn stimulating the production technology to be improved unceasingly to meet the different requirements on availability, variety, facility, purity, specific activity and specificity. The major approaches of achieving these improvements including: optimizing mode of production; enhancing irradiation conditions; amelioration target arrangement; adapting nuclear process and inventing chemical processing. (author)

Project of a PET center at IEN-Rio de Janeiro

International Nuclear Information System (INIS)

Santos, G.R.; Suita, J.C.

2001-01-01

Full text: The Institute of Nuclear Engineering plans to establish a cyclotron-PET facility for production of positron emitting radionuclide for nuclear medicine. Indeed, this facility is part of a bigger project: the first PET Center in Brazil. It is envisioned that this Center would play a central role in the introduction to the region modern technologies in nuclear medicine based on PET radiopharmaceuticals. The problem to be addressed is to gather sufficient conditions to setting up the PET Center. Specifically, the IAEA's assistance would be indispensable to financing the proper equipment's for positron emitter radioisotopes' production, synthesis, labeling, and quality control. The IAEA's assistance would be also valuable in personnel training, as well as researcher's interchange and technical cooperation. With the IAEA's assistance, the PET Center project, already started, would gain a considerable impulse to its conclusion. The IAEA would be of greatly contributing to the improvement of the Brazilians' health care. This contribution takes account that the lEN's PET Center would be offering last generation exams and diagnosis, based on nuclear techniques. Therefore, the IEN is requesting the co-operation of the IAEA to set-up such a facility. The way of that requesting is strictly ordinary, and follows the logical framework structure for project elaboration. The first version of that project is now presented in its original form. From that is possible to extract a resumed table with the fundamental of logical framework, as well as consistence verification by a characteristic check list. Obviously some improvements must be done, and it will be performed before deadline. This way, by the end of 2004, the IEN hopes to be contributing in many application areas, and with Brazilian's health care system, by making available last generation techniques of diagnosis, becoming a center of reference in Latin America. (author)

TU-H-206-02: Novel Linearly-Filled Derenzo PET Phantom Design

International Nuclear Information System (INIS)

Graves, S; Cox, B; Valdovinos, H; Jeffery, J; Eliceiri, K; Barnhart, T; Nickles, R; Farhoud, M

2016-01-01

Purpose: To design a linearly-filled Derenzo positron emission tomography (PET) phantom, eliminating the extraneous radioisotope volumes in a conventional reservoir-type design. This activity reduction combined with the elimination of bubbles in smaller phantom channels would significantly reduce personnel dose, radioisotope cost, and would improve image quality by reducing out-of-slice activity scatter. Methods: A computer-aided design (CAD) was created of a modular Derenzo phantom consisting of three phantom layers with gaskets between the layers. The central piece contains the active pattern volume and channels connecting adjacent rods in a serpentine pattern. The two end-pieces contained an inlet and an outlet for filling purposes. Phantom prototypes were 3D printed on a Viper Si2 stereolithography machine. The two gaskets were fabricated from silicon sheets using a PLS 6.75 laser cutter. Phantoms were held together by pass-through glass-filled nylon bolts and nuts. Phantoms were filled with "5"2Mn, "6"4Cu, "7"4Br, and "1"2"4I for testing, and were imaged on a Siemens Inveon MicroPET scanner. Results: Four phantom prototypes were constructed using male Leur Lock fittings for inlet/outlet ports. 3D printed layers were sanded to ensure proper coupling to the silicon gaskets. The filling volume for each prototype was approximately 2.4 mL. The filling process was found to be rapid, leak-tight, and with minimal back-pressure. PET images were reconstructed by OSEM3D, and axial slices along the phantom pattern length were averaged to provide final images. Image distortion was isotope dependent with "5"2Mn and "6"4Cu having the least distortion and "1"2"4I having the most distortion. Conclusion: These results indicate that the linearlyfilled Derenzo design improves on conventional reservoir-type designs by eliminating potential bubbles in small channels and by reducing activity level, radioisotope volume, radioisotope cost, personnel dose, filling time, and out

Radioisotope laboratory in Turkey

International Nuclear Information System (INIS)

1961-01-01

The Turkish Government formally requested that the Agency provide for one year the services of an expert in the agricultural applications of radioisotopes. Specifically, they wanted this expert first of all to assist in setting up and equipping a pioneer laboratory for the utilization of radioisotopes in agricultural research. Once the laboratory was in operation, the expert was to initiate various research projects using isotope techniques, and to train personnel to carry on this work. The Agency was also asked to supply various specialized equipment for the laboratory, including some radioisotopes. On 10 December 1960 the first phase was complete - the new laboratory was formally opened. It is foreseen that the research projects which will be initiated at the laboratory will include the following: determination of the effect of fertilizers upon yield and quality of field crops and fruit trees, soil fertility studies, studies of mineral element uptake and localization of nutrients in plant body, studies of the folar application of mineral nutrients, especially in fruit trees, investigation of microelements in field crops and fruit trees, investigation of pollination problems, study of the distribution of mineral elements in different fruit seedlings, study of the uptake of nutrients by fruit trees during the rest period, dispersal studies on insects, insecticide studies

Radioisotope laboratory in Turkey

Energy Technology Data Exchange (ETDEWEB)

NONE

1961-04-15

The Turkish Government formally requested that the Agency provide for one year the services of an expert in the agricultural applications of radioisotopes. Specifically, they wanted this expert first of all to assist in setting up and equipping a pioneer laboratory for the utilization of radioisotopes in agricultural research. Once the laboratory was in operation, the expert was to initiate various research projects using isotope techniques, and to train personnel to carry on this work. The Agency was also asked to supply various specialized equipment for the laboratory, including some radioisotopes. On 10 December 1960 the first phase was complete - the new laboratory was formally opened. It is foreseen that the research projects which will be initiated at the laboratory will include the following: determination of the effect of fertilizers upon yield and quality of field crops and fruit trees, soil fertility studies, studies of mineral element uptake and localization of nutrients in plant body, studies of the folar application of mineral nutrients, especially in fruit trees, investigation of microelements in field crops and fruit trees, investigation of pollination problems, study of the distribution of mineral elements in different fruit seedlings, study of the uptake of nutrients by fruit trees during the rest period, dispersal studies on insects, insecticide studies.

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1985

Energy Technology Data Exchange (ETDEWEB)

Baker, D.A.

1986-08-01

This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfer - FY 1985.

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1985

International Nuclear Information System (INIS)

Baker, D.A.

1986-08-01

This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1) isotope suppliers, facility contacts, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfer - FY 1985

Fast and simple one-step preparation of Ga-68 citrate for routine clinical PET

DEFF Research Database (Denmark)

Jensen, Svend B.; Nielsen, Karin M.; Mewis, Dennis

2013-01-01

The imaging of infectious and inflammatory diseases using gallium-67 (Ga-67) citrate scintigraphy has been a well-established diagnostic tool for decades. In recent times, interest has focused on PET using the short-lived positron emitting radioisotope Ga-68. Ga-68 is not only more readily...

Production and utilization of radioisotopes

International Nuclear Information System (INIS)

Sekine, Toshiaki; Matsuoka, Hiromitsu

1999-01-01

A plan of developing radioisotopes with a high power proton accelerator of the Neutron Science Project is presented. The status of production and utilization of radioisotopes in Japan is briefly discussed. The radioisotopes to be produced for biomedical use are discussed together with the facility for production of those radioisotopes and for research with the products. (author)

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1986

International Nuclear Information System (INIS)

Lamar, D.A.

1987-10-01

This document describes radioisotope distribution from DOE facilities to private firms including foreign and other DOE facilities. The information is divided into five sections: (1)isotope suppliers, facility contact, and isotopes or services supplied; (2) customers, suppliers, and isotopes purchased; (3) isotopes purchased cross-referenced with customer numbers; (4) geographic locations of radioisotope customers; and (5) radioisotope sales and transfers for fiscal year 1986

Applications of radioisotopes in medicine

International Nuclear Information System (INIS)

Sivaprasad, N.

2012-01-01

The application of radioisotopes in medicine is many folds. They can be classified into two main groups. (a) The radioisotope tagged labeled compounds suitable for safe administration in the body for diagnosis of various diseases of vital organs such as brain, kidney, thyroid etc and for treatment known as radiotherapy (b) The sealed source of radioisotopes for utilizing the radiation emitted from the radioisotope for treatment, particularly for radiation therapy of cancer. The former application of radioisotope in the field of medicine has led to the formation of special branch of medicine termed Nuclear Medicine - the branch of medicine deals with the use of radioisotope in the from of radiopharmaceuticals for investigation, diagnosis and treatment of diseases. Radioisotopes in the form of radiolabelled compound and bio-chemicals that are pharmaceutically and radiologically safe for administration in the body for diagnosis and treatment are called radiopharmaceuticals. The radiopharmaceuticals are the results of world-wide effort to bring nuclear energy in a tangible form for diagnosis and treatment. Radioisotopes as radiopharmaceuticals thus constitute one of the key requirements for nuclear medicine investigation and radiotherapy. In the case of sealed radioisotope source the radiation emitted by the radioactive source is utilized for the treatment and this mode of treatment is called radiation therapy where no radioactive substance is administrated into the body. This does not form the part of nuclear medicine

Specification and estimation of sources of bias affecting neurological studies in PET/MR with an anatomical brain phantom

Science.gov (United States)

Teuho, J.; Johansson, J.; Linden, J.; Saunavaara, V.; Tolvanen, T.; Teräs, M.

2014-01-01

Selection of reconstruction parameters has an effect on the image quantification in PET, with an additional contribution from a scanner-specific attenuation correction method. For achieving comparable results in inter- and intra-center comparisons, any existing quantitative differences should be identified and compensated for. In this study, a comparison between PET, PET/CT and PET/MR is performed by using an anatomical brain phantom, to identify and measure the amount of bias caused due to differences in reconstruction and attenuation correction methods especially in PET/MR. Differences were estimated by using visual, qualitative and quantitative analysis. The qualitative analysis consisted of a line profile analysis for measuring the reproduction of anatomical structures and the contribution of the amount of iterations to image contrast. The quantitative analysis consisted of measurement and comparison of 10 anatomical VOIs, where the HRRT was considered as the reference. All scanners reproduced the main anatomical structures of the phantom adequately, although the image contrast on the PET/MR was inferior when using a default clinical brain protocol. Image contrast was improved by increasing the amount of iterations from 2 to 5 while using 33 subsets. Furthermore, a PET/MR-specific bias was detected, which resulted in underestimation of the activity values in anatomical structures closest to the skull, due to the MR-derived attenuation map that ignores the bone. Thus, further improvements for the PET/MR reconstruction and attenuation correction could be achieved by optimization of RAMLA-specific reconstruction parameters and implementation of bone to the attenuation template.

Isotope specific resolution recovery image reconstruction in high resolution PET imaging

NARCIS (Netherlands)

Kotasidis, Fotis A.; Angelis, Georgios I.; Anton-Rodriguez, Jose; Matthews, Julian C.; Reader, Andrew J.; Zaidi, Habib

Purpose: Measuring and incorporating a scanner-specific point spread function (PSF) within image reconstruction has been shown to improve spatial resolution in PET. However, due to the short half-life of clinically used isotopes, other long-lived isotopes not used in clinical practice are used to

Radioisotope battery for particular application

International Nuclear Information System (INIS)

Shen Tianjian; Liang Daihua; Cai Jianhua; Dai Zhimin; Xia Huihao; Wang Jianhua; Sun Sen; Yu Guojun; Wang Xiao; Wang Dongxing; Liu Xin

2010-01-01

Radioisotope battery, as a new type of power source, was developed in 1960s. It is advantageous in terms of long working life, high reliability, flexibility to rugged environment, maintenance free, and high capacity rate, hence its unique applications in space, isolated terrestrial or ocean spots, deep waters, and medicine. In this paper, we analysz the primary performances and classification of radioisotope thermoelectric generator, as well as characteristic, basic principle,and structure of radioisotope thermoelectric generator (RTG), which is the most popular in application of radioisotope battery in space, undersea, terrestrial and medicine. A prospect for development and application of radioisotope battery in the 21 st century is given, too. (authors)

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1979

International Nuclear Information System (INIS)

Burlison, J.S.

1980-06-01

The fifteenth edition of the radioisotope customer list was prepared at the request of the Division of Financial Services, Office of the Assistant Secretary for Environment, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Rocky Flats Area Office; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: Isotope suppliers, facility, contracts and isotopes or services supplied; alphabetical list of customers, and isotopes purchased; alphabetical list of isotopes cross-referenced to customer numbers; geographical location of radioisotope customers; and radioisotope sales and transfers-FY 1979

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1981

International Nuclear Information System (INIS)

Burlison, J.S.

1982-09-01

The seventeenth edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research, Office of Energy Research, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory: Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: (1) isotope suppliers, facility, contracts and isotopes or services supplied; (2) alphabetical list of customers, and isotopes purchased; (3) alphabetical list of isotopes cross-referenced to customer numbers; (4) geographical location of radioisotope customers; and (5) radioisotope sales and transfers-FY 1980

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1980

International Nuclear Information System (INIS)

Burlison, J.S.

1981-08-01

The sixteenth edition of the radioisotope customer list was prepared at the request of the Office of Health and Environmental Research, Office of energy Research, Department of Energy (DOE). This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboraory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc. The information is divided into five sections: (1) isotope suppliers, facility, contracts and isotopes or services supplied; (2) alphabetical list of customers, and isotopes purchased; (3) alphabetical list of isotopes cross-referenced to customer numbers; (4) geographical location of radioisotope customers; and (5) radioisotope sales and transfers-FY 1980

Immuno PET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo

DEFF Research Database (Denmark)

Rolle, Anna-Maria; Hasenberg, Mike; Thornton, Christopher R.

2016-01-01

-infected mice allowed specific localization of lung infection when combined with PET. Optical imaging with a fluorochrome-labeled version of the mAb showed colocalization with invasive hyphae. The mAb-based newly developed PET tracer [64Cu]DOTA-JF5 distinguishedIPA from bacterial lung infections and...

Radioisotope measurement system

International Nuclear Information System (INIS)

Villanueva Ruibal, Jose

2007-01-01

A radioisotope measurement system installed at L.M.R. (Ezeiza Atomic Center of CNEA) allows the measurement of nuclear activity from a wide range of radioisotopes. It permits to characterize a broad range of radioisotopes at several activity levels. The measurement hardware as well as the driving software have been developed and constructed at the Dept. of Instrumentation and Control. The work outlines the system's conformation and its operating concept, describes design characteristics, construction and the error treatment, comments assay results and supplies use advices. Measuring tests carried out employing different radionuclides confirmed the system performing satisfactorily and with friendly operation. (author) [es

Routes for the production of isotopes for PET with high intensity deuteron accelerators

Science.gov (United States)

Arias de Saavedra, F.; Porras, I.; Praena, J.

2018-04-01

Recent advances in accelerator science are opening new possibilities in different fields of physics. In particular, the development of compact linear accelerators that can provide charged particles of low-medium energy (few MeV) with high current (above mA) allows for the study of new possibilities in neutron production and for new routes for the production of radioisotopes. Keeping in mind how radioisotopes are actually produced in dedicated facilities, we have performed a study of alternative reactions to produce PET isotopes induced by low-energy deuterons. We have fitted the EXFOR cross sections data, used the fitted values of the stopping power by Andersen and Ziegler and calculated by numerical integration the production rate of isotopes for charged particles up to 20 MeV. The results for deuterons up to 3 MeV are compared with the ones from cyclotrons, which are able to provide higher energies to the charged projectiles but with lower intensities. Our results indicate that using linear accelerators may be a good alternative for producing PET isotopes, reducing the problem of neutron activation.

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1983

International Nuclear Information System (INIS)

Baker, D.A.

1984-08-01

This document lists DOE's radioisotope production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Idaho Operations Office; Los Alamos National Laboratory; Oak Ridge National Laboratory; Savannah River Plant; and UNC Nuclear Industries, Inc. The information is divided into five sections: isotope suppliers, facility contacts, and isotopes or services supplied; lists of customers, suppliers and isotopes purchased; list of isotopes purchased cross-referenced to customer codes; geographic locations of radioisotope customers; and radioisotope sales and transfers - FY 1983

Radioisotope Sources of Electric Power

Science.gov (United States)

1973-09-20

u) watt/cm-3 O) specific activity f) curia/watt (curie/a) a) half-life c) specific power output h) years (capacity) 1) days d) watt/p Polonium - 210 ...AD/A-001 210 RADIOISOTOPE SOURCES OF ELECTRIC POWER G. M. Fradkin, et al Army Foreign Science and Technology Center Charlottesville, Virginia 20...narticularlv for nurninn and irocess~ino of wastg.Sheatinc food , conversion of liruld oxtoner to des, and also for removal of imnurities and reula:tion

Transmission factors for neutrons produced by radioisotopes production used in PET

International Nuclear Information System (INIS)

Hernandez G, D.; Cruzate, J.A.

1996-01-01

The dose transmission factor for normal concrete and the neutrons produced in the 18 O(p,n) 18 F and 13 C(p,n) 13 N reactions are presented in this paper. These transmission factors permit to simplify the calculation of the necessary accelerator shielding to be used in the radioisotope production for positron emission tomography. The energy distributions of the neutrons resulting from the irradiation of thick targets, with 10 to 13 MeV protons, were determined using the thin target cross sections, the energy loss per path length and the energy balance of the reaction (Q-equation). The one dimensional discrete ordinate transport code ANISN and the conversion coefficients from fluence to dose, presented in the ICRP Publication 51 were employed to obtain the transmission factors. (authors). 12 refs., 3 figs., 2 tabs

Radioisotope labelling of several major insect pest

International Nuclear Information System (INIS)

Sutrisno, Singgih

1981-01-01

Radioisotope uptake by insects could take place through various parts i.e. mouth, cuticula, intersegmental, secretion and excretion organs. Usually insects are labelled internally by feeding them on an artificial diet containing radioisotope solution. Labelling of several insect pests of cabbage (Crocidolomia binotalis) Zell and Plutella maculipennis Curt and rice (Chilo suppressalis Walker) by dipping of the pupae in 32 P solution showed a promising result. Pupae of Crocidolomia binotalis Zell dipped in 3 ml solution of 32 P with specific activities of 1, 3, 5 and 7 μCi/ml had developed labelled adults of sufficiently high radioactivity levels for ecological studies. Similar results were also obtained with Plutella maculipennis Curt and Chilo suppressalis Walker with doses of 1, 3, 5, 7 and 9 μCi/ml 32 P solution. The best doses for radioisotope labelling by dipping of the insects Crocidolomia binotalis Zell, Plutella maculipennis Curt, and Chilo suppressalis Walker were 1, 9, and 7 μCi/ml respectivelly. (author)

EXPLORER: Changing the molecular imaging paradigm with total-body PET/CT (Conference Presentation)

Science.gov (United States)

Cherry, Simon R.; Badawi, Ramsey D.; Jones, Terry

2016-04-01

Positron emission tomography (PET) is the highest sensitivity technique for human whole-body imaging studies. However, current clinical PET scanners do not make full use of the available signal, as they only permit imaging of a 15-25 cm segment of the body at one time. Given the limited sensitive region, whole-body imaging with clinical PET scanners requires relatively long scan times and subjects the patient to higher than necessary radiation doses. The EXPLORER initiative aims to build a 2-meter axial length PET scanner to allow imaging the entire subject at once, capturing nearly the entire available PET signal. EXPLORER will acquire data with ~40-fold greater sensitivity leading to a six-fold increase in reconstructed signal-to-noise ratio for imaging the total body. Alternatively, total-body images with the EXPLORER scanner will be able to be acquired in ~30 seconds or with ~0.15 mSv injected dose, while maintaining current PET image quality. The superior sensitivity will open many new avenues for biomedical research. Specifically for cancer applications, high sensitivity PET will enable detection of smaller lesions. Additionally, greater sensitivity will allow imaging out to 10 half-lives of positron emitting radiotracers. This will enable 1) metabolic ultra-staging with FDG by extending the uptake and clearance time to 3-5 hours to significantly improve contrast and 2) improved kinetic imaging with short-lived radioisotopes such as C-11, crucial for drug development studies. Frequent imaging studies of the same subject to study disease progression or to track response to therapy will be possible with the low dose capabilities of the EXPLORER scanner. The low dose capabilities will also open up new imaging possibilities in pediatrics and adolescents to better study developmental disorders. This talk will review the basis for developing total-body PET, potential applications, and review progress to date in developing EXPLORER, the first total-body PET scanner.

List of DOE radioisotope customers with summary of radioisotope shipments, FY 1982

International Nuclear Information System (INIS)

Richards, M.P.

1983-08-01

The radioisotope production and distribution activities by facilities at Argonne National Laboratory, Pacific Northwest Laboratory, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho Operations Office, Los Alamos Scientific Laboratory, Oak Ridge National Laboratory, Savannah River Laboratory, and UNC Nuclear Industries, Inc. are listed. The information is divided into five sections: isotope suppliers, facility, contacts, and isotopes or services supplied; alphabetical list of customers, and isotopes purchased; alphabetical list of isotopes cross-referenced to customs numbers; geographical location of radioisotope customers; and radioisotope sales and transfers-FY 1982

Diagnostic accuracy and cost-effectiveness of FDG-PET in recurrent colorectal carcinoma. An analysis based on the results of questionnaire

International Nuclear Information System (INIS)

Ito, Kengo; Kato, Takashi; Inagaki, Hiroshi

2000-01-01

This study was done by the PET working group under Japan Radioisotope Association. The usefulness of [ 18 F]fluorodeoxyglucose (FDG)-PET in detecting local recurrence of colorectal carcinoma was investigated retrospectively, by the results of questionnaire. Six institutions participated in this study. One hundred and four cases were analyzed to calculate the diagnostic accuracy. The accuracy of FDG-PET in detecting local recurrence of colorectal carcinoma was 96.2%, with two false positive and two false negative cases. We also evaluated the cost-effectiveness of FDG-PET in staging recurrent colorectal carcinoma based on the results of questionnaire. FDG-PET reduced unnecessary radical surgery by 50% in comparison with that in the conventional protocol without PET, and the net savings were about 6.6 billion yen per year in Japan. (author)

Persistent non-specific FDG uptake on PET imaging following hip arthroplasty

Energy Technology Data Exchange (ETDEWEB)

Zhuang, Hongming; Chacko, Thomas K.; Hickeson, Marc; Stevenson, Karen; Feng, Qi; Ponzo, Fabio; Alavi, Abass [Division of Nuclear Medicine, Department of Radiology, The Hospital of University of Pennsylvania, 110 Donner Building, 3400 Spruce Street, Philadelphia, PA 19104 (United States); Garino, Jonathan P. [Department of Orthopedic Surgery, The Hospital of University of Pennsylvania, Philadelphia, PA 19802 (United States)

2002-10-01

prosthesis. The average time interval between arthroplasty and FDG-PET scan in these patients was 71.3 months. In only four prostheses (19%, 4 of 21) was no abnormally increased FDG uptake seen around the prostheses or adjacent sites. The average time interval in these patients was 114.8 months. It is concluded that following hip arthroplasty, non-specifically increased FDG uptake around the head or neck of the prosthesis persists for many years, even in patients without any complications. Therefore, to minimize the number of false-positive results for infection with PET studies obtained to evaluate a painful hip prosthesis, caution should be exercised when interpreting FDG uptake around the head or neck portion of the prosthesis. (orig.)

Stirling Radioisotope Power System as an Alternative for NASAs Deep Space Missions

Science.gov (United States)

Shaltens, R. K.; Mason, L. S.; Schreiber, J. G.

2001-01-01

The NASA Glenn Research Center (GRC) and the Department of Energy (DOE) are developing a free-piston Stirling convertor for a Stirling Radioisotope Power System (SRPS) to provide on-board electric power for future NASA deep space missions. The SRPS currently being developed provides about 100 watts and reduces the amount of radioisotope fuel by a factor of four over conventional Radioisotope Thermoelectric Generators (RTG). The present SRPS design has a specific power of approximately 4 W/kg which is comparable to an RTG. GRC estimates for advanced versions of the SRPS with improved heat source integration, lightweight Stirling convertors, composite radiators, and chip-packaged controllers improves the specific mass to about 8 W/kg. Additional information is contained in the original extended abstract.

Radioisotope Power Sources

International Nuclear Information System (INIS)

Culwell, J. P.

1963-01-01

The radioisotope power programme of the US Atomic Energy Commission has brought forth a whole new technology of the use of radioisotopes as energy sources in electric power generators. Radioisotope power systems are particularly suited for remote applications where long-lived, compact, reliable power is needed. Able to perform satisfactorily under extreme environmental conditions of temperature, sunlight and electromagnetic radiations, these ''atomic batteries'' are attractive power sources for remote data collecting devices, monitoring systems, satellites and other space missions. Radioisotopes used as fuels generally are either alpha or beta emitters. Alpha emitters are the preferable fuels but are more expensive and less available than beta fuels and are generally reserved for space applications. Beta fuels separated from reactor fission wastes are being used exclusively in land and sea applications at the present. It can be expected, however, that beta emitters such as stiontium-90 eventually will be used in space. Development work is being carried out on generators which will use mixed fission products as fuel. This fuel will be less expensive than the pure radioisotopes since the costs of isotope separation and purification are eliminated. Prototype thermoelectric generators, fuelled with strontium-90 and caesium-137, are now in operation or being developed for use in weather stations, marine navigation aids and deep sea monitoring devices. A plutonium-238 thermoelectric generator is in orbit operating as electric power source in a US Navy TRANSIT satellite. Generators are under development for use on US National Aeronautics and Space Administration missions. The large quantities of radioactivity involved in radioisotope power sources require that special attention be given to safety aspects of the units. Rigid safety requirements have been established and extensive tests have been conducted to insure that these systems can be employed without creating undue

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in 11C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence

Science.gov (United States)

Dusing, Reginald W.; Peng, Warner; Lai, Sue-Min; Grado, Gordon L.; Holzbeierlein, Jeffrey M.; Thrasher, J. Brantley; Hill, Jacqueline; Van Veldhuizen, Peter J.

2014-01-01

Purpose The aim of this study was to identify which patient characteristics are associated with the highest likelihood of positive findings on 11C-acetate PET/computed tomography attenuation correction (CTAC) (PET/CTAC) scan when imaging for recurrent prostate cancer. Methods From 2007 to 2011, 250 11C-acetate PET/CTAC scans were performed at a single institution on patients with prostate cancer recurrence after surgery, brachytherapy, or external beam radiation. Of these patients, 120 met our inclusion criteria. Logistic regression analysis was used to examine the relationship between predictability of positive findings and patients’ characteristics, such as prostate-specific antigen (PSA) level at the time of scan, PSA kinetics, Gleason score, staging, and type of treatment before scan. Results In total, 68.3% of the 120 11C-acetate PET/CTAC scans were positive. The percentage of positive scans and PSA at the time of scanning and PSA velocity (PSAV) had positive correlations. The putative sensitivity and specificity were 86.6% and 65.8%, respectively, when a PSA level greater than 1.24 ng/mL was used as the threshold for scanning. The putative sensitivity and specificity were 74% and 75%, respectively, when a PSAV level greater than 1.32 ng/mL/y was used as the threshold. No significant associations were found between scan positivity and age, PSA doubling time, Gleason score, staging, or type of treatment before scanning. Conclusions This retrospective study suggests that threshold models of PSA greater than 1.24 ng/mL or PSAV greater than 1.32 ng/mL per year are independent predictors of positive findings in 11C-acetate PET/CTAC imaging of recurrent prostate cancer. PMID:25036021

Application of PET and PET/CT imaging for cancer screening

International Nuclear Information System (INIS)

Chen Yenkung; Hu Fenglan; Shen Yehyou; Liao, A.C.; Hung, T.Z.; Su, Chentau; Chen Liangkuang

2004-01-01

The aim of this study was to evaluate the potential application of 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) and PET/CT for cancer screening in asymptomatic individuals. Methods: The subjects consisted of 3631 physical check up examinees (1947 men, 1684 women; mean age ±SD, 52.1±8.2 y) with non-specific medical histories. Whole-body FDG PET (or PET/CT), ultrasound and tumor markers were performed on all patients. Focal hypermetabolic areas with intensities equal to or exceeding the level of FDG uptake in the brain and bladder were considered abnormal and interpreted as neoplasia. Follow-up periods were longer than one year. Results: Among the 3631 FDG PET (including 1687 PET/CT), ultrasound and tumor markers examinations, malignant tumors were discovered in 47 examinees (1.29%). PET findings were true-positive in 38 of the 47 cancers (80.9%). In addition, 32 of the 47 cancers were performed with the PET-CT scan. PET detected cancer lesions in 28 of the 32 examinees. However, the CT detected cancer lesions in only 15 of 32 examinees. Conclusion: The sensitivity of FDG PET in the detection of a wide variety of cancers is high. Most cancer can be detected with FDG PET in a resectable stage. CT of the PET/CT for localization and characteristics of the lesion shows an increased specificity of the PET scan. Using ultrasound and tumor markers may complement the PET scan in cancer screening for hepatic and urologic neoplasms. (authors)

Present status of OAP radioisotope production

International Nuclear Information System (INIS)

Charoen, Sakda

2006-01-01

Radioisotope Production Program (RP), Office of Atoms for Peace (OAP) is a non-profit government organization which responsible for research development and service of radioisotopes. Several research works on radioisotope production have been carried on at OAP. The radioisotope products of successful R and D have been routinely produced to supply for medical, agriculture and research application. The main products are 131 I (solution and capsule), 131 I-MIBG, 131 I-Hippuran, 153 Sm-EDTMP, 153 Sm-HA, and 99m Tc-radiopharmaceutical kits to serve local users. Radioisotopes are very beneficial for science and human welfare so as almost of our products and services are mainly utilized for medical purpose for both diagnosis and therapy. OAP has a policy to serve and response to that community by providing radioisotopes and services with high quality but reasonable price. This policy will give the opportunity to the community to utilize these radioisotopes for their healthcare. (author)

A Japanese nationwide survey on the FDG-PET scans for dementia. Analysis on the predicted costs and benefits of FDG-PET for early diagnosis of Alzheimer

International Nuclear Information System (INIS)

Senda, Michio; Ouchi, Yasuomi; Ishii, Kazunari

2003-01-01

A nation-wide survey was carried out on the FDG-PET scans for the diagnosis of dementia by the FDG-PET Working Group organized by both the Japan Radioisotope Association and the Japanese Society of Nuclear Medicine. A total of 406 case reports were presented by 15 PET centers for one year. The purpose of the PET scans included early diagnosis of Alzheimer-type Dementia (154 cases, group A) and differential diagnosis of degenerative dementia (144 cases, group B), which was achieved by the PET scan in most cases. The PET scan turned out to allow omitting cerebral blood flow (CBF)-SPECT scans. Since donepezil treatment of the Alzheimer patients prevents the progress of the disease and reduces the care cost, an economic evaluation was performed on the two-year projected cost and benefit of FDG-PET. The reduction of the total cost by incorporating PET into the protocol was predicted to be 61500 yen (group A) and 13700 yen (group B) per person. The increase of the quality adjusted life year (QALY) was predicted to be 0.0442 (group A) and 0.0137 (group B). Therefore, incorporation of PET into the clinical pass was shown to be an economically dominant. As the number of potential subjects for early diagnosis of dementia is estimated to be 9000 across the country every year, PET is expected to increase their quality of life equivalent to 398 intact persons per year while reducing the cost of health care by 554 million yen. (author)

18F-FDG PET and PET/CT in Burkitt's lymphoma

International Nuclear Information System (INIS)

Karantanis, Dimitrios; Durski, Jolanta M.; Lowe, Val J.; Nathan, Mark A.; Mullan, Brian P.; Georgiou, Evangelos; Johnston, Patrick B.; Wiseman, Gregory A.

2010-01-01

Objective: To explore the value of 18 F fluorodeoxy-glucose (FDG) positron emission tomography (PET) in Burkitt's lymphoma. Methods: All Burkitt's lymphoma patients referred for FDG PET or FDG PET/computed tomography (CT) exams at our institution from June 2003 to June 2006 were included. Selected patients were followed and clinical information was reviewed retrospectively. Results from FDG PET-PET/CT, as blindly reviewed by a consensus of two experienced readers, were compared with the status of the disease as determined by other laboratory, clinical and imaging exams and clinical follow-up. FDG PET-PET/CT results were classified as true positive or negative and false positive or negative. The degree of FDG uptake in the positive lesions was semiquantified as maximum standard uptake value (SUVmax). Results: Fifty-seven FDG PET-PET/CT exams were done in 15 patients. Seven exams were done for initial staging, 8 during and 14 after the completion of therapy, and 28 for disease surveillance. For nodal disease FDG PET-PET/CT was true positive in 8, true negative in 47 and false positive in 2 exams (sensitivity 100%, specificity 96%). For extranodal disease FDG PET-PET/CT was true positive in 6, true negative in 48 and false positive in 3 exams (sensitivity 100%, specificity 94%). The mean SUVmax for the positive nodal lesions was 15.7 (range 6.9-21.7, median 18.5) and for extranodal lesions was 14.2 (range 6.2-24.3, median 12.4). Conclusions: FDG PET-PET/CT is sensitive for the detection of viable disease in Burkitt's lymphoma. Affected areas demonstrated high degree of uptake that was reversible upon successful implementation of treatment.

Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET

Energy Technology Data Exchange (ETDEWEB)

Faellmar, David; Larsson, Elna-Marie [Uppsala University, Department of Surgical Sciences, Radiology, Uppsala (Sweden); Haller, Sven [Uppsala University, Department of Surgical Sciences, Radiology, Uppsala (Sweden); University Medical Center Freiburg, Department of Neuroradiology, Freiburg (Germany); University of Geneva, Faculty of Medicine, Geneva (Switzerland); Affidea CDRC - Centre Diagnostique Radiologique de Carouge, Carouge (Switzerland); Lilja, Johan [Uppsala University, Department of Surgical Sciences, Nuclear Medicine and PET, Uppsala (Sweden); Hermes Medical Solutions, Stockholm (Sweden); Danfors, Torsten [Uppsala University, Department of Surgical Sciences, Nuclear Medicine and PET, Uppsala (Sweden); Kilander, Lena [Uppsala University, Department of Public Health and Caring Sciences, Geriatrics, Uppsala (Sweden); Tolboom, Nelleke; Croon, Philip M.; Berckel, Bart N.M. van [VU University Medical Center, Department of Radiology and Nuclear Medicine, Amsterdam (Netherlands); Egger, Karl [University Medical Center Freiburg, Department of Neuroradiology, Freiburg (Germany); Kellner, Elias [Medical Center University of Freiburg, Department of Radiology, Medical Physics, Faculty of Medicine, Freiburg (Germany); Verfaillie, Sander C.J.; Ossenkoppele, Rik [VU University Medical Center, Department of Neurology, Alzheimer Center Amsterdam, Amsterdam (Netherlands); Barkhof, Frederik [VU University Medical Center, Department of Radiology and Nuclear Medicine, Amsterdam (Netherlands); UCL, Institutes of Neurology and Healthcare Engineering, London (United Kingdom)

2017-10-15

Cerebral perfusion analysis based on arterial spin labeling (ASL) MRI has been proposed as an alternative to FDG-PET in patients with neurodegenerative disease. Z-maps show normal distribution values relating an image to a database of controls. They are routinely used for FDG-PET to demonstrate disease-specific patterns of hypometabolism at the individual level. This study aimed to compare the performance of Z-maps based on ASL to FDG-PET. Data were combined from two separate sites, each cohort consisting of patients with Alzheimer's disease (n = 18 + 7), frontotemporal dementia (n = 12 + 8) and controls (n = 9 + 29). Subjects underwent pseudocontinuous ASL and FDG-PET. Z-maps were created for each subject and modality. Four experienced physicians visually assessed the 166 Z-maps in random order, blinded to modality and diagnosis. Discrimination of patients versus controls using ASL-based Z-maps yielded high specificity (84%) and positive predictive value (80%), but significantly lower sensitivity compared to FDG-PET-based Z-maps (53% vs. 96%, p < 0.001). Among true-positive cases, correct diagnoses were made in 76% (ASL) and 84% (FDG-PET) (p = 0.168). ASL-based Z-maps can be used for visual assessment of neurodegenerative dementia with high specificity and positive predictive value, but with inferior sensitivity compared to FDG-PET. (orig.)

A Novel Kernel-Based Regularization Technique for PET Image Reconstruction

Directory of Open Access Journals (Sweden)

Abdelwahhab Boudjelal

2017-06-01

Full Text Available Positron emission tomography (PET is an imaging technique that generates 3D detail of physiological processes at the cellular level. The technique requires a radioactive tracer, which decays and releases a positron that collides with an electron; consequently, annihilation photons are emitted, which can be measured. The purpose of PET is to use the measurement of photons to reconstruct the distribution of radioisotopes in the body. Currently, PET is undergoing a revamp, with advancements in data measurement instruments and the computing methods used to create the images. These computer methods are required to solve the inverse problem of “image reconstruction from projection”. This paper proposes a novel kernel-based regularization technique for maximum-likelihood expectation-maximization ( κ -MLEM to reconstruct the image. Compared to standard MLEM, the proposed algorithm is more robust and is more effective in removing background noise, whilst preserving the edges; this suppresses image artifacts, such as out-of-focus slice blur.

PET imaging of adoptive progenitor cell therapies

International Nuclear Information System (INIS)

Gelovani, Juri G.

2008-01-01

is proposed to circumvent the major limitation of in vitro radiolabeling - the eventual radiolabel decay. Stable transduction of stem cells in vitro would allow for the selection of high quality stem cells with optimal functional parameters of the transduced reporter systems. The use of a long-lived radioisotope 124I to label a highly specific reporter gene probe will allow for ex vivo labeling of stem cells and their imaging immediately after injection and during the following next week. The use of short-lived radioisotopes (i.e., 18F) to label highly specific reporter gene probes will allow repetitive PET imaging for the assessment of to stem cell migration, targeting, differentiation, and long-term viability of stem cell-derived tissues. Qualifications of the research team and resources. An established research team of experts in various disciplines has been assembled at MD Anderson Cancer Center (MDACC) over the past two years including the PI, senior co-investigators and collaborators. The participants of this team are recognized internationally to be among the leaders in their corresponding fields of research and clinical medicine. The resources at MDACC are exceptionally well developed and have been recently reinforced by the installation of a microPET and microSPECT/CT cameras, and a 7T MRI system for high resolution animal imaging; and by integrating a synthetic chemistry core for the development and production of precursors for radiolabeling.

PET imaging of adoptive progenitor cell therapies.

Energy Technology Data Exchange (ETDEWEB)

Gelovani, Juri G.

2008-05-13

stem cell imaging is proposed to circumvent the major limitation of in vitro radiolabeling – the eventual radiolabel decay. Stable transduction of stem cells in vitro would allow for the selection of high quality stem cells with optimal functional parameters of the transduced reporter systems. The use of a long-lived radioisotope 124I to label a highly specific reporter gene probe will allow for ex vivo labeling of stem cells and their imaging immediately after injection and during the following next week. The use of short-lived radioisotopes (i.e., 18F) to label highly specific reporter gene probes will allow repetitive PET imaging for the assessment of to stem cell migration, targeting, differentiation, and long-term viability of stem cell-derived tissues. Qualifications of the research team and resources. An established research team of experts in various disciplines has been assembled at MD Anderson Cancer Center (MDACC) over the past two years including the PI, senior co-investigators and collaborators. The participants of this team are recognized internationally to be among the leaders in their corresponding fields of research and clinical medicine. The resources at MDACC are exceptionally well developed and have been recently reinforced by the installation of a microPET and microSPECT/CT cameras, and a 7T MRI system for high resolution animal imaging; and by integrating a synthetic chemistry core for the development and production of precursors for radiolabeling.

Application of radioisotopes in pharmaceutical research

International Nuclear Information System (INIS)

Khujaev, S.

2004-01-01

Full text: To use of radioisotopes in the processes of receiving radiopharmaceutical diagnostic means it is widely know [1]. Radioactivity labeled chemical compounds, pharmacological kinetics of which allows one solving a concrete diagnostic problem in an organism are used in radio pharmaceutics. In spite of this choice of the radioisotope, possessing the most favorable nuclei-physical characteristics for it to be detected and minimization of beam loadings, be of great importance. Development of a method of introduction of a radioisotope also has important value, as it is included into chemical structure of a radiopharmaceutical preparation. One more way of use of radioisotopes in pharmaceutics is their use as a radioactive mark at a stage of creation of a new medical product. And in this case, all those moments, which are listed above, take place. Preparations labeling by radioisotopes are used basically for their studying pharmacological kinetics. In Institute of nuclear physics AS RU, in recent years, works are done on studying pharmacological kinetics of some new medical products, which have been synthesized in the Tashkent pharmaceutical institute. These preparations are on the basis of microelements with a complex set of properties possessing expressed biological activity and have great value in pharmaceutical science of Republic of Uzbekistan. Reception of labeled compounds of all preparations was carried out by a method of introduction of a radioisotope at a stage of their synthesis. The work presents the results of researches on synthesis and study of pharmacological kinetics of radioactively labeled preparations - PIRACIN, labeled by radioisotope 69m Zn; FERAMED, labeled by radioisotope 59 Fe; COBAVIT, labeled by radioisotope 57 Co; VUC, labeled by radioisotope 57 Co

Suggestion for improvement of PET quality control tests in Brazil

International Nuclear Information System (INIS)

Ferreira, Fernanda C.L.; Magalhaes, Cinthia M.S.; Souza, Divanizia N.

2009-01-01

Nowadays nuclear medicine has a considerable importance among the other medical specialties. This medical specialty utilizes high-tech equipment for imaging in the diagnosis, obtaining information on the clinical functionality of organs and systems of the human body through the use of radioisotopes . In view of the importance of guaranteeing the image quality in SPECT and PET systems, enabling patients not repeat exams due to lack of quality control of equipment used in nuclear medicine, this paper aims to present a possible suggestion to update the quality control tests needed for quality assurance of nuclear medicine services. They were considered the requirements of the National Commission of Nuclear Energy (CNEN) and the National Health Surveillance Agency (ANVISA) in Brazil. The minimum requirements to be defined for inclusion of quality control tests on PET in the standard CNEN are extremely important because they will guide the evaluation of PET systems, determining the quality control tests to be performed. And those tests for PET will be a regulatory requirement by the CNEN and ANVISA. As the National Health Surveillance Agency has already publication of RDC 38 with recommendations for services of nuclear medicine. This study will continue with evaluation of PET systems and presenting the tests of quality control with additional objects and simulators to ensure safety in PET systems have not standardized in nuclear medicine services in Brazil. (author)

Economical and technical feasibility study of some radioisotopes production for medical application

International Nuclear Information System (INIS)

Souza, A.L.A.B. de.

1985-01-01

The economical and technical feasibility study of the production in reactors of some radioisotopes most used in medicine, are presented. The clinical applications of each radioisotope as well as its radioactive concentrations and specific activities are related. Irradiation procedures based in the foregoing data are given. Part of the study is dedicated to quality control. (M.A.C.) [pt

Status of NASA's Advanced Radioisotope Power Conversion Technology Research and Development

Science.gov (United States)

Wong, Wayne A.; Anderson, David J.; Tuttle, Karen L.; Tew, Roy C.

2006-01-01

NASA s Advanced Radioisotope Power Systems (RPS) development program is funding the advancement of next generation power conversion technologies that will enable future missions that have requirements that can not be met by either the ubiquitous photovoltaic systems or by current Radioisotope Power Systems (RPS). Requirements of advanced radioisotope power systems include high efficiency and high specific power (watts/kilogram) in order to meet mission requirements with less radioisotope fuel and lower mass. Other Advanced RPS development goals include long-life, reliability, and scalability so that these systems can meet requirements for a variety of future space applications including continual operation surface missions, outer-planetary missions, and solar probe. This paper provides an update on the Radioisotope Power Conversion Technology Project which awarded ten Phase I contracts for research and development of a variety of power conversion technologies consisting of Brayton, Stirling, thermoelectrics, and thermophotovoltaics. Three of the contracts continue during the current Phase II in the areas of thermoelectric and Stirling power conversion. The accomplishments to date of the contractors, project plans, and status will be summarized.

Production of radioisotopes using accelerators

International Nuclear Information System (INIS)

Qaim, S.M.

1990-01-01

Accelerator produced radioisotopes find applications in many fields. Most of them are ideally suited for in-vivo studies of physiological functions. A brief review of various types of accelerators used for radioisotope production is given. The 'state of art' technology relevant to the production of radioisotopes is briefly discussed. Some of the recent advances in nuclear data measurements, target development, chemical processing and quality control are described. There appears to be a definite shift from multipurpose accelerators to dedicated machines, and greater emphasis is placed now on the production of radioisotopes with high radionuclidic purity by choosing a suitable nuclear reaction in a proper energy range. (author)

Modern radioisotope production technologies for medicine

International Nuclear Information System (INIS)

Bechtold, V.; Schweickert, H.

1989-01-01

The advantages of the accelerator production of radioisotopes for medical purposes, are, above all, the high specific activity attainable as well as the possibility of the generation of nuclei with only a few neutrons which disintegrate due to β + emission or electron capture. It is, for example, possible to diagnostically utilize the developing long-range γ quanta by means of computerized tomography. The production of I-123 at the cyclotron of Karlsruhe (nuclear reaction, target, irradiation arrangement) as well as of ultra-pure I-123 with the help of compact cyclotrons, and the plant developed for this are described in brief. As another radioisotope which can be produced with the help of the compact cyclotron, Rb-81 is mentioned, the disintegration product Kr-81m of which is used in pulmonary diagnostics. (RB) [de

A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.

Science.gov (United States)

Adumeau, Pierre; Carnazza, Kathryn E; Brand, Christian; Carlin, Sean D; Reiner, Thomas; Agnew, Brian J; Lewis, Jason S; Zeglis, Brian M

2016-01-01

The complementary nature of positron emission tomography (PET) and near-infrared fluorescence (NIRF) imaging makes the development of strategies for the multimodal PET/NIRF imaging of cancer a very enticing prospect. Indeed, in the context of colorectal cancer, a single multimodal PET/NIRF imaging agent could be used to stage the disease, identify candidates for surgical intervention, and facilitate the image-guided resection of the disease. While antibodies have proven to be highly effective vectors for the delivery of radioisotopes and fluorophores to malignant tissues, the use of radioimmunoconjugates labeled with long-lived nuclides such as 89 Zr poses two important clinical complications: high radiation doses to the patient and the need for significant lag time between imaging and surgery. In vivo pretargeting strategies that decouple the targeting vector from the radioactivity at the time of injection have the potential to circumvent these issues by facilitating the use of positron-emitting radioisotopes with far shorter half-lives. Here, we report the synthesis, characterization, and in vivo validation of a pretargeted strategy for the multimodal PET and NIRF imaging of colorectal carcinoma. This approach is based on the rapid and bioorthogonal ligation between a trans -cyclooctene- and fluorophore-bearing immunoconjugate of the huA33 antibody (huA33-Dye800-TCO) and a 64 Cu-labeled tetrazine radioligand ( 64 Cu-Tz-SarAr). In vivo imaging experiments in mice bearing A33 antigen-expressing SW1222 colorectal cancer xenografts clearly demonstrate that this approach enables the non-invasive visualization of tumors and the image-guided resection of malignant tissue, all at only a fraction of the radiation dose created by a directly labeled radioimmunoconjugate. Additional in vivo experiments in peritoneal and patient-derived xenograft models of colorectal carcinoma reinforce the efficacy of this methodology and underscore its potential as an innovative and useful

Specific activities and the relevant gamma ray dose rates at 1 meter from radioisotopes and isomers following thermal neutron capture reaction

International Nuclear Information System (INIS)

Eissa, E.A.; Aly, R.A.; Gomaa, M.A.; Hassan, A.M.

1995-01-01

Calculations were performed for the specific activity of 245 gamma-ray emitting radioisotopes and isomers produced in 48, 72 and 96 hour irradiation periods of the natural isotopic mixture of their 77 elements with thermal neutron flux 1.0 E + 13 n/cm 2 .5, at the core of the (ET-R R-1) reactor. The relevant gamma-ray dose rate at a point 1 meter apart from each radioisotope or isomer was evaluated whenever the specific gamma-ray dose rate constant is available. The irradiation time factor (ITF) for the irradiation periods 24, 48, 72 and 96 hours are reported for each of the 248 gamma-ray emitters. The average of (ITF) over these 248 radionuclides for each irradiation period is taken as a measure of the feasibility of the irradiation time. The results favour the increase of the irradiation period from the conventional 48 to 72 hours but not to 96 hours. A programme was established in the VAX computer to carry out the above mentioned calculations. Tables of the present work are very useful for isotope production and reactor safety. 1 fig., 2 tabs

Activity calculation of radioisotopes in HFETR

International Nuclear Information System (INIS)

Liu Shuiqing

1996-12-01

The activity calculating method and formulas of seven kinds of radioisotopes for High Flux Engineering Test REactor (HFETR) are given. The perturbation of targets to neutron fluence rate is considered while targets are put into the neutron fluence rate field of reactor core. All perturbing factors of seven kinds of radioisotopes being used in HFETR are presented. After considering the perturbation, the calculating accuracy of radioisotope activity has been raised 10%. The given method and formulas have ended the history of all activities estimated by experiences, except for that of 60 Co, in the radioisotope production of HFETR. The conclusions are also useful and instructive for the production of radioisotopes in HFETR. (8 tabs.)

Gaseous radioactive effluent restrictions, measurement, and minimization at a PET/cyclotron facility

International Nuclear Information System (INIS)

Plascjak, P.S.; Kim, K.K.; Googins, S.W.; Meyer, W.C. Jr.

1993-01-01

In the US, restrictions on the release of radioactive effluents from PET (positron emission tomography)/cyclotron facilities are typically imposed by State regulatory agencies and may be based on various methodologies and limits published by numerous agencies. This work presents suitable effluent concentration limits for various chemical forms of radioisotopes routinely produced in PET/cyclotron facilities. They were determined by application of metabolic models defined by ICRP 53 and ICRP 26/30 which will result in compliance with effective dose equivalent limits of 100 mrem per year at the release point. The NIH Cyclotron Facility effluent air monitoring system, environmental dosimetry program, and simple, effective systems for radioactive effluent minimization are also described. (orig.)

Site-specifically {sup 89}Zr-labeled monoclonal antibodies for ImmunoPET

Energy Technology Data Exchange (ETDEWEB)

Tinianow, Jeff N.; Gill, Herman S.; Ogasawara, Annie; Flores, Judith E.; Vanderbilt, Alexander N.; Luis, Elizabeth; Vandlen, Richard; Darwish, Martine; Junutula, Jagath R.; Williams, Simon-P. [Genentech Research and Early Development, Genentech Inc., South San Francisco, CA 94080 (United States); Marik, Jan [Genentech Research and Early Development, Genentech Inc., South San Francisco, CA 94080 (United States)], E-mail: marik.jan@gene.com

2010-04-15

Three thiol reactive reagents were developed for the chemoselective conjugation of desferrioxamine (Df) to a monoclonal antibody via engineered cysteine residues (thio-trastuzumab). The in vitro stability and in vivo imaging properties of site-specifically radiolabeled {sup 89}Zr-Df-thio-trastuzumab conjugates were investigated. Methods: The amino group of desferrioxamine B was acylated by bromoacetyl bromide, N-hydroxysuccinimidyl iodoacetate, or N-hydroxysuccinimidyl 4-[N-maleimidomethyl]cyclohexane-1-carboxylate to obtain thiol reactive reagents bromoacetyl-desferrioxamine (Df-Bac), iodoacetyl-desferrioxamine (Df-Iac) and maleimidocyclohexyl-desferrioxamine (Df-Chx-Mal), respectively. Df-Bac and Df-Iac alkylated the free thiol groups of thio-trastuzumab by nucleophilic substitution forming Df-Ac-thio-trastuzumab, while the maleimide reagent Df-Chx-Mal reacted via Michael addition to provide Df-Chx-Mal-thio-trastuzumab. The conjugates were radiolabeled with {sup 89}Zr and evaluated for serum stability, and their positron emission tomography (PET) imaging properties were investigated in a BT474M1 (HER2-positive) breast tumor mouse model. Results: The chemoselective reagents were obtained in 14% (Df-Bac), 53% (Df-Iac) and 45% (Df-Chx-Mal) yields. Site-specific conjugation of Df-Chx-Mal to thio-trastuzumab was complete within 1 h at pH 7.5, while Df-Iac and Df-Bac respectively required 2 and 5 h at pH 9. Each Df modified thio-trastuzumab was chelated with {sup 89}Zr in yields exceeding 75%. {sup 89}Zr-Df-Ac-thio-trastuzumab and {sup 89}Zr-Df-Chx-Mal-thio-trastuzumab were stable in mouse serum and exhibited comparable PET imaging capabilities in a BT474M1 (HER2-positive) breast cancer model reaching 20-25 %ID/g of tumor uptake and a tumor to blood ratio of 6.1-7.1. Conclusions: The new reagents demonstrated good reactivity with engineered thiol groups of trastuzumab and very good chelation properties with {sup 89}Zr. The site-specifically {sup 89}Zr-labeled thio

Diagnostic performance of FDG PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis

International Nuclear Information System (INIS)

Jin, H.; Yuan, L.; Li, C.; Kan, Y.; Yang, J.; Hao, R.

2014-01-01

The purpose of this study was to systematically review and perform a meta-analysis of published data regarding the diagnostic performance of positron emission tomography (PET) or PET/computed tomography (PET/CT) in prosthetic infection after arthroplasty. A comprehensive computer literature search of studies published through May 31, 2012 regarding PET or PET/CT in patients suspicious of prosthetic infection was performed in PubMed/MEDLINE, Embase and Scopus databases. Pooled sensitivity and specificity of PET or PET/CT in patients suspicious of prosthetic infection on a per prosthesis-based analysis were calculated. The area under the receiver-operating characteristic (ROC) curve was calculated to measure the accuracy of PET or PET/CT in patients with suspicious of prosthetic infection. Fourteen studies comprising 838 prosthesis with suspicious of prosthetic infection after arthroplasty were included in this meta-analysis. The pooled sensitivity of PET or PET/CT in detecting prosthetic infection was 86% (95% confidence interval [CI] 82-90%) on a per prosthesis-based analysis. The pooled specificity of PET or PET/CT in detecting prosthetic infection was 86% (95% CI 83-89%) on a per prosthesis-based analysis. The area under the ROC curve was 0.93 on a per prosthesis-based analysis. In patients suspicious of prosthetic infection, FDG PET or PET/CT demonstrated high sensitivity and specificity. FDG PET or PET/CT are accurate methods in this setting. Nevertheless, possible sources of false positive results and influcing factors should kept in mind.

Diagnostic performance of FDG PET or PET/CT in prosthetic infection after arthroplasty: a meta-analysis.

Science.gov (United States)

Jin, H; Yuan, L; Li, C; Kan, Y; Hao, R; Yang, J

2014-03-01

The purpose of this study was to systematically review and perform a meta-analysis of published data regarding the diagnostic performance of positron emission tomography (PET) or PET/computed tomography (PET/CT) in prosthetic infection after arthroplasty. A comprehensive computer literature search of studies published through May 31, 2012 regarding PET or PET/CT in patients suspicious of prosthetic infection was performed in PubMed/MEDLINE, Embase and Scopus databases. Pooled sensitivity and specificity of PET or PET/CT in patients suspicious of prosthetic infection on a per prosthesis-based analysis were calculated. The area under the receiver-operating characteristic (ROC) curve was calculated to measure the accuracy of PET or PET/CT in patients with suspicious of prosthetic infection. Fourteen studies comprising 838 prosthesis with suspicious of prosthetic infection after arthroplasty were included in this meta-analysis. The pooled sensitivity of PET or PET/CT in detecting prosthetic infection was 86% (95% confidence interval [CI] 82-90%) on a per prosthesis-based analysis. The pooled specificity of PET or PET/CT in detecting prosthetic infection was 86% (95% CI 83-89%) on a per prosthesis-based analysis. The area under the ROC curve was 0.93 on a per prosthesis-based analysis. In patients suspicious of prosthetic infection, FDG PET or PET/CT demonstrated high sensitivity and specificity. FDG PET or PET/CT are accurate methods in this setting. Nevertheless, possible sources of false positive results and influcing factors should kept in mind.

Medical radioisotopes for the next century

International Nuclear Information System (INIS)

Carr, S.W.

1999-01-01

Radioisotopes are widely used in medicine (Nuclear Medicine) for diagnosis, palliation and therapy of heart disease, cancer, muscoskeletal and neurological conditions. The radioisotopes used are both reactor and cyclotron produced. The utilisation is currently growing and is expected to continue to grow over the next 10-20 years. The combination of radioisotope and delivery vehicle can be designed to meet the intended end use. This paper will deal with the main approaches to the use of radioisotopes for Nuclear medicine ad future prospects for the area

Development of radioisotope production in the Philippines

Energy Technology Data Exchange (ETDEWEB)

Cabalfin, E G [Philippine Nuclear Research Institute, Quezon (Philippines)

1998-10-01

The Philippine Nuclear Research Institute (PNRI) started its activities on radioisotope production more than three decades ago, when the Philippine Research Reactor (PRR-1) started operating at its full rated power of 1 MW. Since then, several radionuclides in different chemical forms, were routinely produced and supplied for use in nuclear medicine, industry, agriculture, research and training, until the conversion of the PRR-1 to a 3 MW TRIGA type reactor. After the criticality test of the upgraded reactor, a leak was discovered in the pool liner. With the repair of the reactor still ongoing, routine radioisotope production activities have been reduced to dispensing of imported bulk {sup 131}I. In the Philippines, radioisotopes are widely used in nuclear medicine, with {sup 131}I and {sup 99m}Tc as the major radionuclides of interest. Thus the present radioisotope production program of PNRI is directed to meet this demand. With the technical assistance of the International Atomic Energy Agency (IAEA), PNRI is setting up a new {sup 131}I production facility. The in-cell equipment have been installed and tested using both inactive and active target, obtained from BATAN, Indonesia. In order to meet the need of producing {sup 99}Mo-{sup 99m}Tc generators, based on low specific activity reactor-produced {sup 99}Mo, research and development work on the preparation of {sup 99m}Tc gel generators is ongoing. (author)

Role of radioisotopes in the study of insect pests

International Nuclear Information System (INIS)

Mansour, M.

2013-01-01

Although the use of nuclear techniques, particularly radioisotopes, in entomological research is less than a century old, the contribution of radioisotopes to the science of studying insects (Entomology) is indispensable. In fact, radioisotopes provided a very important and sometimes a unique tool for solving many research problems in entomology. This article discusses the most important and widely used applications of radioisotopes in studying insect pests. In particular, it concentrates on the subject of radioisotopes used in entomological research, methods of labeling insect with radioisotopes, half life of radioisotopes, and the role of radioisotopes in physiological, ecological, biological and behavioral studies of insects. (author)

Present and future of PET and PET/CT in gynaecologic malignancies

International Nuclear Information System (INIS)

Musto, Alessandra; Rampin, Lucia; Nanni, Cristina; Marzola, Maria Cristina; Fanti, Stefano; Rubello, Domenico

2011-01-01

Objectives: To review the published data in literature on patients affected by gynaecological malignancies to establish the role of 18 F-FDG positron emission tomography (PET) and PET/CT in comparison to conventional imaging (CI). Materials and methods: All papers specifically addressed to the role of 18 F-FDG PET and PET/CT in gynaecological malignancies published on PubMed/Medline, in abstracts from the principal international congresses, in the guidelines from national Societies that had appeared in literature until November 2009 were considered for the purpose of the present study. Results and conclusions: The use of 18 F-FDG PET, and even more of 18 F-FDG PET/CT, is increasing in the follow up of patients with gynaecologic malignancies and suspected recurrent disease: there is evidence in the literature that 18 F-FDG PET/CT has a higher sensitivity than CI in depicting occult metastatic spread. An interesting issue is represented by patients with ovarian cancer with an increase of the specific biomarker, CA-125, and negative/inconclusive findings at CI. The use of 18 F-FDG PET in differential diagnosis and staging is more controversial, but there is some evidence that a baseline PET examination performed before commencing therapy, for staging purpose, is also useful to evaluate the response to chemoradiation treatment. In several papers it has been suggested a relevant role of 18 F-FDG PET/CT in evaluating the entity of response to treatment and therefore to plan the subsequent therapeutic strategy.

Design of radioisotope power systems facility

International Nuclear Information System (INIS)

Eschenbaum, R.C.; Wiemers, M.J.

1991-01-01

Radioisotope power systems currently produced for the U.S. Department of Energy Office of Special Applications by the Mound Laboratory at Miamisburg, Ohio, have been used in a variety of configurations by the Department of Defense and the National Aeronautics and Space Administration. A forecast of fugure radioisotope power systems requirements showed a need for an increased production rate beyond the capability of the existing Mound Laboratory. Westinghouse Hanford Company is modifying the Fuels and Materials Examination Facility on the Hanford Site near Richland, Washington, to install the new Radioisotope Power Systems Facility for assembling future radioisotope power systems. The facility is currently being prepared to assemble the radioisotope thermoelectric generators required by the National Aeronautics and Space Administration missions for Comet Rendezvous Asteroid Flyby in 1995 and Cassini, an investigation of Saturn and its moons, in 1996

Radioisotope Power Supply, Phase I

Data.gov (United States)

National Aeronautics and Space Administration — Between 1998 and 2003, Hi-Z Technology developed and built a 40 mW radioisotope power supply (RPS) that used a 1 watt radioisotope heater unit (RHU) as the energy...

Transforming a Targeted Porphyrin Theranostic Agent into a PET Imaging Probe for Cancer

Directory of Open Access Journals (Sweden)

Jiyun Shi, Tracy W.B. Liu, Juan Chen, David Green, David Jaffray, Brian C. Wilson, Fan Wang, Gang Zheng

2011-01-01

Full Text Available Porphyrin based photosensitizers are useful agents for photodynamic therapy (PDT and fluorescence imaging of cancer. Porphyrins are also excellent metal chelators forming highly stable metallo-complexes making them efficient delivery vehicles for radioisotopes. Here we investigated the possibility of incorporating 64Cu into a porphyrin-peptide-folate (PPF probe developed previously as folate receptor (FR targeted fluorescent/PDT agent, and evaluated the potential of turning the resulting 64Cu-PPF into a positron emission tomography (PET probe for cancer imaging. Noninvasive PET imaging followed by radioassay evaluated the tumor accumulation, pharmacokinetics and biodistribution of 64Cu-PPF. 64Cu-PPF uptake in FR-positive tumors was visible on small-animal PET images with high tumor-to-muscle ratio (8.88 ± 3.60 observed after 24 h. Competitive blocking studies confirmed the FR-mediated tracer uptake by the tumor. The ease of efficient 64Cu-radiolabeling of PPF while retaining its favorable biodistribution, pharmacokinetics and selective tumor uptake, provides a robust strategy to transform tumor-targeted porphyrin-based photosensitizers into PET imaging probes.

Radioisotope detection and dating with accelerators

Energy Technology Data Exchange (ETDEWEB)

Mast, T S; Muller, R A [California Univ., Berkeley (USA). Lawrence Berkeley Lab.

1980-07-01

The status of the new technique of high energy mass spectrometry is reviewed. This sensitive method of measuring isotope concentrations has been applied to the detection of rare radioisotopes used for age estimation. The techniques used to select and identify the individual radioisotope atoms in a sample are described and then the status of the radioisotope measurements and their applications is reviewed.

Complementary roles of tumour specific PET tracer {sup 18}F-FAMT to {sup 18}F-FDG PET/CT for the assessment of bone metastasis

Energy Technology Data Exchange (ETDEWEB)

Morita, Motoho [Gunma University Hospital, Department of General Medicine, Maebashi, Gunma (Japan); Gunma University Graduate School of Medicine, Department of Diagnostic Radiology and Nuclear Medicine, Maebashi, Gunma (Japan); Higuchi, Tetsuya; Tokue, Azusa; Arisaka, Yukiko; Tsushima, Yoshito [Gunma University Graduate School of Medicine, Department of Diagnostic Radiology and Nuclear Medicine, Maebashi, Gunma (Japan); Achmad, Arifudin [Gunma University Graduate School of Medicine, Department of Diagnostic Radiology and Nuclear Medicine, Maebashi, Gunma (Japan); Gadjah Mada University, Department of Radiology, Faculty of Medicine, Yogyakarta (Indonesia)

2013-10-15

The usefulness of {sup 18}F-FDG PET/CT for bone metastasis evaluation has already been established. The amino acid PET tracer [{sup 18}F]-3-fluoro-alpha-methyl tyrosine ({sup 18}F-FAMT) has been reported to be highly specific for malignancy. We evaluated the additional value of {sup 18}F-FAMT PET/CT to complement {sup 18}F-FDG PET/CT in the evaluation of bone metastasis. This retrospective study included 21 patients with bone metastases of various cancers who had undergone both {sup 18}F-FDG and {sup 18}F-FAMT PET/CT within 1 month of each other. {sup 18}F-FDG-avid bone lesions suspicious for malignancy were carefully selected based on the cut-off value for malignancy, and the SUVmax of the {sup 18}F-FAMT in the corresponding lesions were evaluated. A total of 72 {sup 18}F-FDG-positive bone lesions suspected to be metastases in the 21 patients were used as the reference standard. {sup 18}F-FAMT uptake was found in 87.5 % of the lesions. In the lesions of lung cancer origin, the uptake of the two tracers showed a good correlation (40 lesions, r = 0.68, P < 0.01). Bone metastatic lesions of oesophageal cancer showed the highest average of {sup 18}F-FAMT uptake. Bone metastatic lesions of squamous cell carcinoma showed higher {sup 18}F-FAMT uptake than those of adenocarcinoma. No significant difference in {sup 18}F-FAMT uptake was seen between osteoblastic and osteolytic bone metastatic lesions. The usefulness of {sup 18}F-FAMT PET/CT for bone metastasis detection regardless of the lesion phenotype was demonstrated. The fact that {sup 18}F-FAMT uptake was confirmed by {sup 18}F-FDG uptake suggests that {sup 18}F-FAMT PET/CT has the potential to complement {sup 18}F-FDG PET/CT for the detection of bone metastases. (orig.)

Experience utilizing a 3.7 MeV tandem cascade accelerator (TCA) for PET radioisotope production

International Nuclear Information System (INIS)

Welch, M.J.; Gaehle, G.; Dence, C.S.

1994-01-01

A 3.7 MeV TCA was installed at Washington University in the Spring of 1993 for evaluation as a PET isotope production accelerator. The accelerator was installed in a specially designed suite consisting of the accelerator room, a open-quotes hot labclose quotes and a open-quotes cold labclose quotes. The accelerator has been utilized routinely for PET isotope production since it's installation. Although the major radionuclide produced utilizing the TCA is oxygen-15, techniques for the production of fluorine-18 and nitrogen-13 have been developed. The novel techniques used to produce usable quantities of these latter two isotopes will be discussed

Competitive advantage of PET/MRI

Energy Technology Data Exchange (ETDEWEB)

Jadvar, Hossein, E-mail: jadvar@usc.edu; Colletti, Patrick M.

2014-01-15

Multimodality imaging has made great strides in the imaging evaluation of patients with a variety of diseases. Positron emission tomography/computed tomography (PET/CT) is now established as the imaging modality of choice in many clinical conditions, particularly in oncology. While the initial development of combined PET/magnetic resonance imaging (PET/MRI) was in the preclinical arena, hybrid PET/MR scanners are now available for clinical use. PET/MRI combines the unique features of MRI including excellent soft tissue contrast, diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI and other specialized sequences as well as MR spectroscopy with the quantitative physiologic information that is provided by PET. Most evidence for the potential clinical utility of PET/MRI is based on studies performed with side-by-side comparison or software-fused MRI and PET images. Data on distinctive utility of hybrid PET/MRI are rapidly emerging. There are potential competitive advantages of PET/MRI over PET/CT. In general, PET/MRI may be preferred over PET/CT where the unique features of MRI provide more robust imaging evaluation in certain clinical settings. The exact role and potential utility of simultaneous data acquisition in specific research and clinical settings will need to be defined. It may be that simultaneous PET/MRI will be best suited for clinical situations that are disease-specific, organ-specific, related to diseases of the children or in those patients undergoing repeated imaging for whom cumulative radiation dose must be kept as low as reasonably achievable. PET/MRI also offers interesting opportunities for use of dual modality probes. Upon clear definition of clinical utility, other important and practical issues related to business operational model, clinical workflow and reimbursement will also be resolved.

Competitive advantage of PET/MRI.

Science.gov (United States)

Jadvar, Hossein; Colletti, Patrick M

2014-01-01

Multimodality imaging has made great strides in the imaging evaluation of patients with a variety of diseases. Positron emission tomography/computed tomography (PET/CT) is now established as the imaging modality of choice in many clinical conditions, particularly in oncology. While the initial development of combined PET/magnetic resonance imaging (PET/MRI) was in the preclinical arena, hybrid PET/MR scanners are now available for clinical use. PET/MRI combines the unique features of MRI including excellent soft tissue contrast, diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI and other specialized sequences as well as MR spectroscopy with the quantitative physiologic information that is provided by PET. Most evidence for the potential clinical utility of PET/MRI is based on studies performed with side-by-side comparison or software-fused MRI and PET images. Data on distinctive utility of hybrid PET/MRI are rapidly emerging. There are potential competitive advantages of PET/MRI over PET/CT. In general, PET/MRI may be preferred over PET/CT where the unique features of MRI provide more robust imaging evaluation in certain clinical settings. The exact role and potential utility of simultaneous data acquisition in specific research and clinical settings will need to be defined. It may be that simultaneous PET/MRI will be best suited for clinical situations that are disease-specific, organ-specific, related to diseases of the children or in those patients undergoing repeated imaging for whom cumulative radiation dose must be kept as low as reasonably achievable. PET/MRI also offers interesting opportunities for use of dual modality probes. Upon clear definition of clinical utility, other important and practical issues related to business operational model, clinical workflow and reimbursement will also be resolved. Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Competitive advantage of PET/MRI

International Nuclear Information System (INIS)

Jadvar, Hossein; Colletti, Patrick M.

2014-01-01

Multimodality imaging has made great strides in the imaging evaluation of patients with a variety of diseases. Positron emission tomography/computed tomography (PET/CT) is now established as the imaging modality of choice in many clinical conditions, particularly in oncology. While the initial development of combined PET/magnetic resonance imaging (PET/MRI) was in the preclinical arena, hybrid PET/MR scanners are now available for clinical use. PET/MRI combines the unique features of MRI including excellent soft tissue contrast, diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI and other specialized sequences as well as MR spectroscopy with the quantitative physiologic information that is provided by PET. Most evidence for the potential clinical utility of PET/MRI is based on studies performed with side-by-side comparison or software-fused MRI and PET images. Data on distinctive utility of hybrid PET/MRI are rapidly emerging. There are potential competitive advantages of PET/MRI over PET/CT. In general, PET/MRI may be preferred over PET/CT where the unique features of MRI provide more robust imaging evaluation in certain clinical settings. The exact role and potential utility of simultaneous data acquisition in specific research and clinical settings will need to be defined. It may be that simultaneous PET/MRI will be best suited for clinical situations that are disease-specific, organ-specific, related to diseases of the children or in those patients undergoing repeated imaging for whom cumulative radiation dose must be kept as low as reasonably achievable. PET/MRI also offers interesting opportunities for use of dual modality probes. Upon clear definition of clinical utility, other important and practical issues related to business operational model, clinical workflow and reimbursement will also be resolved

FDG PET and PET-CT for the detection of bone metastases in patients with head and neck cancer. A meta-analysis

International Nuclear Information System (INIS)

Yi, Xuelin; Zhang, Hongting; Liu, Shixi; Fan, Min; Liu, Yilin

2013-01-01

We performed a meta-analysis to evaluate 18FDG PET/PET-CT for the detection of bone metastases in patients with head and neck cancer. We calculated sensitivities, specificities, likelihood ratios, and constructed summary receiver operating characteristic curves for PET and PET-CT, respectively. We also compared the performance of PET/PET-CT with that of bone scintigraphy by analysing studies that had also used bone scintigraphy on the same patients. Across 9 PET studies (1621 patients) and 10 PET-CT studies (1291 patients), sensitivity and specificity of PET were 0.81 and 0.99, and of PET-CT were 0.89 and 0.99, respectively. In 5 comparative studies (1184 patients), sensitivity and specificity of PET/PET-CT were 0.85 and 0.98, and of bone scintigraphy were 0.55 and 0.98, respectively. 18FDG PET and PET-CT have high sensitivity and accuracy for the detection of bone metastasis in patients with head and neck cancer.

Present and future of PET and PET/CT in gynaecologic malignancies

Energy Technology Data Exchange (ETDEWEB)

Musto, Alessandra [Department of Nuclear Medicine, PET Center, Policlinico Sant' Orsola Malpighi, Bologna University, Bologna (Italy); Rampin, Lucia [Department of Nuclear Medicine, PET Center, Radiology, Medical Physics, Santa Maria della Misericordia Hospital, viale tre martiri 140, 45100 Rovigo (Italy); Nanni, Cristina [Department of Nuclear Medicine, PET Center, Policlinico Sant' Orsola Malpighi, Bologna University, Bologna (Italy); Marzola, Maria Cristina [Department of Nuclear Medicine, PET Center, Radiology, Medical Physics, Santa Maria della Misericordia Hospital, viale tre martiri 140, 45100 Rovigo (Italy); Fanti, Stefano [Department of Nuclear Medicine, PET Center, Policlinico Sant' Orsola Malpighi, Bologna University, Bologna (Italy); Rubello, Domenico, E-mail: domenico.rubello@libero.it [Department of Nuclear Medicine, PET Center, Radiology, Medical Physics, Santa Maria della Misericordia Hospital, viale tre martiri 140, 45100 Rovigo (Italy)

2011-04-15

Objectives: To review the published data in literature on patients affected by gynaecological malignancies to establish the role of {sup 18}F-FDG positron emission tomography (PET) and PET/CT in comparison to conventional imaging (CI). Materials and methods: All papers specifically addressed to the role of {sup 18}F-FDG PET and PET/CT in gynaecological malignancies published on PubMed/Medline, in abstracts from the principal international congresses, in the guidelines from national Societies that had appeared in literature until November 2009 were considered for the purpose of the present study. Results and conclusions: The use of {sup 18}F-FDG PET, and even more of {sup 18}F-FDG PET/CT, is increasing in the follow up of patients with gynaecologic malignancies and suspected recurrent disease: there is evidence in the literature that {sup 18}F-FDG PET/CT has a higher sensitivity than CI in depicting occult metastatic spread. An interesting issue is represented by patients with ovarian cancer with an increase of the specific biomarker, CA-125, and negative/inconclusive findings at CI. The use of {sup 18}F-FDG PET in differential diagnosis and staging is more controversial, but there is some evidence that a baseline PET examination performed before commencing therapy, for staging purpose, is also useful to evaluate the response to chemoradiation treatment. In several papers it has been suggested a relevant role of {sup 18}F-FDG PET/CT in evaluating the entity of response to treatment and therefore to plan the subsequent therapeutic strategy.

PET imaging of HSV1-tk mutants with acquired specificity toward pyrimidine- and acycloguanosine-based radiotracers

Energy Technology Data Exchange (ETDEWEB)

Likar, Yury; Dobrenkov, Konstantin; Olszewska, Malgorzata; Shenker, Larissa; Hricak, Hedvig; Ponomarev, Vladimir [Memorial Sloan-Kettering Cancer Center, Molecular Imaging Laboratory, Department of Radiology, New York, NY (United States); Cai, Shangde [Memorial Sloan-Kettering Cancer Center, Radiochemistry/Cyclotron Core Facility, New York, NY (United States)

2009-08-15

The aim of this study was to create an alternative mutant of the herpes simplex virus type 1 thymidine kinase (HSV1-tk) reporter gene with reduced phosphorylation capacity for acycloguanosine derivatives, but not pyrimidine-based compounds that will allow for successful PET imaging. A new mutant of HSV1-tk reporter gene, suitable for PET imaging using pyrimidine-based radiotracers, was developed. The HSV1-tk mutant contains an arginine-to-glutamine substitution at position 176 (HSV1-R176Qtk) of the nucleoside binding region of the enzyme. The mutant-gene product showed favorable enzymatic characteristics toward pyrimidine-based nucleosides, while exhibiting reduced activity with acycloguanosine derivatives. In order to enhance HSV1-R176Qtk reporter activity with pyrimidine-based radiotracers, we introduced the R176Q substitution into the more active HSV1-sr39tk mutant. U87 human glioma cells transduced with the HSV1-R176Qsr39tk double mutant reporter gene showed high {sup 3}H-FEAU pyrimidine nucleoside and low {sup 3}H-penciclovir acycloguanosine analog uptake in vitro. PET imaging also demonstrated high {sup 18}F-FEAU and low {sup 18}F-FHBG accumulation in HSV1-R176Qsr39tk+ xenografts. The feasibility of imaging two independent nucleoside-specific HSV1-tk mutants in the same animal with PET was demonstrated. Two opposite xenografts expressing the HSV1-R176Qsr39tk reporter gene and the previously described acycloguanosine-specific mutant of HSV1-tk, HSV1-A167Ysr39tk reporter gene, were imaged using a short-lived pyrimidine-based {sup 18}F-FEAU and an acycloguanosine-based {sup 18}F-FHBG radiotracer, respectively, administered on 2 consecutive days. We conclude that in combination with acycloguanosine-specific HSV1-A167Ysr39tk reporter gene, a HSV1-tk mutant containing the R176Q substitution could be used for PET imaging of two different cell populations or concurrent molecular biological processes in the same living subject. (orig.)

Support housing for radioisotope generation

International Nuclear Information System (INIS)

Fries, B.A.

1976-01-01

A support housing for on-site radioisotope generation is disclosed in which the formation of a short-lived daughter radioisotope from its longer-lived parent features countercurrent batch flow of the eluting reagent interior of the housing. 6 claims, 4 drawing figures

Isotope specific resolution recovery image reconstruction in high resolution PET imaging

OpenAIRE

Kotasidis Fotis A.; Kotasidis Fotis A.; Angelis Georgios I.; Anton-Rodriguez Jose; Matthews Julian C.; Reader Andrew J.; Reader Andrew J.; Zaidi Habib; Zaidi Habib; Zaidi Habib

2014-01-01

Purpose: Measuring and incorporating a scanner specific point spread function (PSF) within image reconstruction has been shown to improve spatial resolution in PET. However due to the short half life of clinically used isotopes other long lived isotopes not used in clinical practice are used to perform the PSF measurements. As such non optimal PSF models that do not correspond to those needed for the data to be reconstructed are used within resolution modeling (RM) image reconstruction usuall...

List of ERDA radioisotope (customers with summary of radioisotope shipments FY 1975

International Nuclear Information System (INIS)

Simmons, J.L.; Gano, S.R.

1976-01-01

The twelfth edition of the ERDA radioisotope customer list has been prepared at the request of the Division of Biomedical and Environmental Research. The purpose of this document is to list the FY 1975 commercial radioisotope production and distribution activities of USERDA facilities at Argonne National Laboratory, Battelle, Pacific Northwest Laboratories, Brookhaven National Laboratory, United Nuclear Inc., Idaho Operations Office, Hanford Engineering Development Laboratory, Mound Laboratory, Oak Ridge National Laboratory, and Savannah River Plant

Radioisotope conveyor ash meter

International Nuclear Information System (INIS)

Savelov, V.D.

1994-01-01

Radioisotope conveyor ash meter realizes persistent measuring of ashiness of coal and products of its enrichment on the belt conveyor without contact. The principle of ash meter acting is based on functional dependence of the gamma radiation flows backscattering intensity of radioisotope sources from the ash volume content in the controlled fuel. Facility consists from the ashiness transducer and the processing and control device

Prospect of radioisotopes and radiation utilization

International Nuclear Information System (INIS)

Tabata, Yoneho

1994-01-01

Radiation Utilization in Japan has been positioned, together with nuclear power generation, as one of the important cornerstones, and research and development and practical usage of it has been proceeded with steadily in the fields of industry, agriculture, medicine, and so on. In the field of medicine, SPECT and PET facilities, radio-immunoassay, radiotherapy has come widely to practical use. In the field of agriculture and fisheries, improvement of breed, sterile insect technique have been implemented, and eradication of melon fly has been achieved. In the field of industry, it is expected that the practical use of neutron radiography technique and research and development of synthesizing high performance, high function materials are progressed. In the environment preservation area, a pilot test using electron beam to treat the exhaust gases out of coal fired power plants, city garbages combustion facilities, city high way tunnels in order to establish de- sulphur/de-nitrogen technique is carried out. As the international contribution in the field of radiation utilization, the cooperation with developing countries and the cooperation among advanced countries are reported. In this paper, a prospect of radioisotopes and radiation utilization is described. (J.P.N.)

Subject-specific bone attenuation correction for brain PET/MR: can ZTE-MRI substitute CT scan accurately?

Science.gov (United States)

Khalifé, Maya; Fernandez, Brice; Jaubert, Olivier; Soussan, Michael; Brulon, Vincent; Buvat, Irène; Comtat, Claude

2017-10-01

In brain PET/MR applications, accurate attenuation maps are required for accurate PET image quantification. An implemented attenuation correction (AC) method for brain imaging is the single-atlas approach that estimates an AC map from an averaged CT template. As an alternative, we propose to use a zero echo time (ZTE) pulse sequence to segment bone, air and soft tissue. A linear relationship between histogram normalized ZTE intensity and measured CT density in Hounsfield units (HU ) in bone has been established thanks to a CT-MR database of 16 patients. Continuous AC maps were computed based on the segmented ZTE by setting a fixed linear attenuation coefficient (LAC) to air and soft tissue and by using the linear relationship to generate continuous μ values for the bone. Additionally, for the purpose of comparison, four other AC maps were generated: a ZTE derived AC map with a fixed LAC for the bone, an AC map based on the single-atlas approach as provided by the PET/MR manufacturer, a soft-tissue only AC map and, finally, the CT derived attenuation map used as the gold standard (CTAC). All these AC maps were used with different levels of smoothing for PET image reconstruction with and without time-of-flight (TOF). The subject-specific AC map generated by combining ZTE-based segmentation and linear scaling of the normalized ZTE signal into HU was found to be a good substitute for the measured CTAC map in brain PET/MR when used with a Gaussian smoothing kernel of 4~mm corresponding to the PET scanner intrinsic resolution. As expected TOF reduces AC error regardless of the AC method. The continuous ZTE-AC performed better than the other alternative MR derived AC methods, reducing the quantification error between the MRAC corrected PET image and the reference CTAC corrected PET image.

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

Energy Technology Data Exchange (ETDEWEB)

Sheikhbahaei, Sara; Solnes, Lilja B.; Javadi, Mehrbod S.; Pomper, Martin G.; Rowe, Steven P. [Johns Hopkins University School of Medicine, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD (United States); Afshar-Oromieh, Ali; Haberkorn, Uwe [Heidelberg University Hospital, Department of Nuclear Medicine, Heidelberg (Germany); Eiber, Matthias [David Geffen School of Medicine at UCLA, Department of Molecular and Medical Pharmacology, Los Angeles, CA (United States); Technical University of Munich, Department of Nuclear Medicine, Klinikum rechts der Isar, Munich (Germany); Ross, Ashley E.; Pienta, Kenneth J.; Allaf, Mohamad E.; Gorin, Michael A. [Johns Hopkins University School of Medicine, The James Buchanan Brady Urological Institute and Department of Urology, Baltimore, MD (United States)

2017-11-15

The rapidly expanding clinical adaptation of prostate-specific membrane antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has placed an increasing onus on understanding both the potential pearls of interpretation as well as limitations of this new technique. As with any new molecular imaging modality, accurate characterization of abnormalities on PSMA-targeted PET imaging can be accomplished only if one is aware of the normal distribution pattern, physiological variants of radiotracer uptake, and potential sources of false-positive and false-negative imaging findings. In recent years, a growing number of reports have come to light describing incidental non-prostatic benign or malignant pathologies with high uptake on PSMA-targeted PET imaging. In this review, we have summarized the published literature regarding the potential pearls and technical and interpretive pitfalls of this imaging modality. Knowledge of these limitations can increase the confidence of interpreting physicians and thus improve patient care. As PSMA-targeted PET is expected to be evaluated in larger prospective trials, the dissemination of potential diagnostic pitfalls and the biologic underpinning of those findings will be of increased importance. (orig.)

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

International Nuclear Information System (INIS)

Sheikhbahaei, Sara; Solnes, Lilja B.; Javadi, Mehrbod S.; Pomper, Martin G.; Rowe, Steven P.; Afshar-Oromieh, Ali; Haberkorn, Uwe; Eiber, Matthias; Ross, Ashley E.; Pienta, Kenneth J.; Allaf, Mohamad E.; Gorin, Michael A.

2017-01-01

The rapidly expanding clinical adaptation of prostate-specific membrane antigen (PSMA)-targeted PET imaging in the evaluation of patients with prostate cancer has placed an increasing onus on understanding both the potential pearls of interpretation as well as limitations of this new technique. As with any new molecular imaging modality, accurate characterization of abnormalities on PSMA-targeted PET imaging can be accomplished only if one is aware of the normal distribution pattern, physiological variants of radiotracer uptake, and potential sources of false-positive and false-negative imaging findings. In recent years, a growing number of reports have come to light describing incidental non-prostatic benign or malignant pathologies with high uptake on PSMA-targeted PET imaging. In this review, we have summarized the published literature regarding the potential pearls and technical and interpretive pitfalls of this imaging modality. Knowledge of these limitations can increase the confidence of interpreting physicians and thus improve patient care. As PSMA-targeted PET is expected to be evaluated in larger prospective trials, the dissemination of potential diagnostic pitfalls and the biologic underpinning of those findings will be of increased importance. (orig.)

Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-@]@a preliminary analysis

Energy Technology Data Exchange (ETDEWEB)

Klein Nulent, Thomas J.W.; Es, Robert J.J. van [Utrecht Cancer Center, University Medical Center Utrecht, Department of Head and Neck Surgical Oncology, P.O. Box 85500, Utrecht (Netherlands); University Medical Center Utrecht, Department of Oral and Maxillofacial Surgery, Utrecht (Netherlands); Krijger, Gerard C.; Keizer, Bart de [University Medical Center Utrecht, Department of Radiology and Nuclear Medicine, Utrecht (Netherlands); Bree, Remco de [Utrecht Cancer Center, University Medical Center Utrecht, Department of Head and Neck Surgical Oncology, P.O. Box 85500, Utrecht (Netherlands); Willems, Stefan M. [University Medical Center Utrecht, Department of Pathology, Utrecht (Netherlands)

2017-09-15

Adenoid cystic carcinoma (AdCC) of the head and neck is an uncommon malignant epithelial tumour of the secretory glands. Many patients develop slowly growing local recurrence and/or distant metastasis, for which treatment options are limited. A retrospective analysis of 9 AdCC patients was conducted to analyse the visualization of AdCC on PSMA PET/CT and to investigate the expression of PSMA on primary, recurrent and metastatic AdCC tumour tissue using immunohistochemistry. Local recurrence occurred in six patients and eight developed distant metastasis. All PET/CTs depicted PSMA-ligand uptake. Four PSMA PET/CTs showed suspected residual disease, eight scans depicted uptake in areas suspected of distant metastasis. Median Maximum Standardized Uptake Value (SUV{sub max}) in local recurrent and distant metastatic AdCC was 2.52 (IQR 2.41-5.95) and 4.01 (IQR 2.66-8.71), respectively. All primary tumours showed PSMA expression on immunohistochemistry (5-90% expression), as well as all available specimens of local recurrence and distant metastases. PSMA PET/CT is able to detect and visualize local recurrent and distant metastatic AdCC. PSMA-specific targeting is supported by PSMA expression on immunohistochemistry. (orig.)

Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot.

Science.gov (United States)

Veronese, Mattia; Zanotti-Fregonara, Paolo; Rizzo, Gaia; Bertoldo, Alessandra; Innis, Robert B; Turkheimer, Federico E

2016-04-15

PET studies allow in vivo imaging of the density of brain receptor species. The PET signal, however, is the sum of the fraction of radioligand that is specifically bound to the target receptor and the non-displaceable fraction (i.e. the non-specifically bound radioligand plus the free ligand in tissue). Therefore, measuring the non-displaceable fraction, which is generally assumed to be constant across the brain, is a necessary step to obtain regional estimates of the specific fractions. The nondisplaceable binding can be directly measured if a reference region, i.e. a region devoid of any specific binding, is available. Many receptors are however widely expressed across the brain, and a true reference region is rarely available. In these cases, the nonspecific binding can be obtained after competitive pharmacological blockade, which is often contraindicated in humans. In this work we introduce the genomic plot for estimating the nondisplaceable fraction using baseline scans only. The genomic plot is a transformation of the Lassen graphical method in which the brain maps of mRNA transcripts of the target receptor obtained from the Allen brain atlas are used as a surrogate measure of the specific binding. Thus, the genomic plot allows the calculation of the specific and nondisplaceable components of radioligand uptake without the need of pharmacological blockade. We first assessed the statistical properties of the method with computer simulations. Then we sought ground-truth validation using human PET datasets of seven different neuroreceptor radioligands, where nonspecific fractions were either obtained separately using drug displacement or available from a true reference region. The population nondisplaceable fractions estimated by the genomic plot were very close to those measured by actual human blocking studies (mean relative difference between 2% and 7%). However, these estimates were valid only when mRNA expressions were predictive of protein levels (i

{sup 18}F-FDG PET and PET/CT in Burkitt's lymphoma

Energy Technology Data Exchange (ETDEWEB)

Karantanis, Dimitrios, E-mail: dkarantanis@nuclmed.ne [Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN (United States); Durski, Jolanta M.; Lowe, Val J.; Nathan, Mark A.; Mullan, Brian P. [Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN (United States); Georgiou, Evangelos [Medical Physics Department, Medical School, University of Athens (Greece); Johnston, Patrick B. [Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN (United States); Wiseman, Gregory A. [Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN (United States)

2010-07-15

Objective: To explore the value of {sup 18}F fluorodeoxy-glucose (FDG) positron emission tomography (PET) in Burkitt's lymphoma. Methods: All Burkitt's lymphoma patients referred for FDG PET or FDG PET/computed tomography (CT) exams at our institution from June 2003 to June 2006 were included. Selected patients were followed and clinical information was reviewed retrospectively. Results from FDG PET-PET/CT, as blindly reviewed by a consensus of two experienced readers, were compared with the status of the disease as determined by other laboratory, clinical and imaging exams and clinical follow-up. FDG PET-PET/CT results were classified as true positive or negative and false positive or negative. The degree of FDG uptake in the positive lesions was semiquantified as maximum standard uptake value (SUVmax). Results: Fifty-seven FDG PET-PET/CT exams were done in 15 patients. Seven exams were done for initial staging, 8 during and 14 after the completion of therapy, and 28 for disease surveillance. For nodal disease FDG PET-PET/CT was true positive in 8, true negative in 47 and false positive in 2 exams (sensitivity 100%, specificity 96%). For extranodal disease FDG PET-PET/CT was true positive in 6, true negative in 48 and false positive in 3 exams (sensitivity 100%, specificity 94%). The mean SUVmax for the positive nodal lesions was 15.7 (range 6.9-21.7, median 18.5) and for extranodal lesions was 14.2 (range 6.2-24.3, median 12.4). Conclusions: FDG PET-PET/CT is sensitive for the detection of viable disease in Burkitt's lymphoma. Affected areas demonstrated high degree of uptake that was reversible upon successful implementation of treatment.

The efficient importation and distribution of radioisotopes. Suggestions for the most economic importation of radioisotopes

Energy Technology Data Exchange (ETDEWEB)

NONE

1963-08-01

In the course of their work in many Member States, IAEA technical assistance experts have sometimes encountered difficulties in connection with the importation of radioactive isotopes. In some countries they have been consulted as to the possible improvement of import procedures. The purpose of this publication is to summarize the experience that has been gained in the hope that it may be useful both to scientists who wish to import radioisotopes for their work and to public officials who are concerned with the administrative and financial aspects of the problem. This question is of considerable importance because many countries have only limited resources of scientific man-power and foreign exchange and hence it is essential, if these resources are to be utilized fully, that efficient importing procedures be established. Furthermore, the success or failure of technical assistance activities may depend on whether radioisotopes needed for the project can be efficiently imported. Although the data summarized in this publication are based mainly on the experience of medical users of radioisotopes, they are equally applicable to their uses in other fields such as agriculture and hydrology. This publication covers the subject of importation and distribution of radioisotopes, and concludes with a brief section on the domestic production of short-lived radioisotopes in research reactors.

The efficient importation and distribution of radioisotopes. Suggestions for the most economic importation of radioisotopes

International Nuclear Information System (INIS)

1963-01-01

In the course of their work in many Member States, IAEA technical assistance experts have sometimes encountered difficulties in connection with the importation of radioactive isotopes. In some countries they have been consulted as to the possible improvement of import procedures. The purpose of this publication is to summarize the experience that has been gained in the hope that it may be useful both to scientists who wish to import radioisotopes for their work and to public officials who are concerned with the administrative and financial aspects of the problem. This question is of considerable importance because many countries have only limited resources of scientific man-power and foreign exchange and hence it is essential, if these resources are to be utilized fully, that efficient importing procedures be established. Furthermore, the success or failure of technical assistance activities may depend on whether radioisotopes needed for the project can be efficiently imported. Although the data summarized in this publication are based mainly on the experience of medical users of radioisotopes, they are equally applicable to their uses in other fields such as agriculture and hydrology. This publication covers the subject of importation and distribution of radioisotopes, and concludes with a brief section on the domestic production of short-lived radioisotopes in research reactors

(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients.

Science.gov (United States)

Kurihara, Hiroaki; Hamada, Akinobu; Yoshida, Masayuki; Shimma, Schuichi; Hashimoto, Jun; Yonemori, Kan; Tani, Hitomi; Miyakita, Yasuji; Kanayama, Yousuke; Wada, Yasuhiro; Kodaira, Makoto; Yunokawa, Mayu; Yamamoto, Harukaze; Shimizu, Chikako; Takahashi, Kazuhiro; Watanabe, Yasuyoshi; Fujiwara, Yasuhiro; Tamura, Kenji

2015-01-01

The purpose of this study was to determine whether brain metastases from HER2-positive breast cancer could be detected noninvasively using positron emission tomography (PET) with (64)Cu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-trastuzumab. PET was performed on five patients with brain metastases from HER2-positive breast cancer, at 24 or 48 h after the injection of approximately 130 MBq of the probe (64)Cu-DOTA-trastuzumab. Radioactivity in metastatic brain tumors was evaluated based on PET images in five patients. Autoradiography, immunohistochemistry (IHC), and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis were performed in one surgical case to confirm HER2 specificity of (64)Cu-DOTA-trastuzumab. Metastatic brain lesions could be visualized by (64)Cu-DOTA-trastuzumab PET in all of five cases, which might indicated that trastuzumab passes through the blood-brain barrier (BBB). The HER2 specificity of (64)Cu-DOTA-trastuzumab was demonstrated in one patient by autoradiography, immunohistochemistry, and LC-MS/MS. Cu-DOTA-trastuzumab PET could be a potential noninvasive procedure for serial identification of metastatic brain lesions in patients with HER2-positive breast cancer. UMIN000004170.

Active Radiation Level Measurement on New Laboratory Instrument for Evaluating the Antibacterial Activity of Radioisotope

International Nuclear Information System (INIS)

Joh, Eunha; Park, Jang Guen

2014-01-01

A disc method has been widely used to measure the antibacterial effect of chemical agents. However, it is difficult to measure the antibacterial effect of radioisotopes using a disc method. A disc method is a method for diffusing a drug by placing the drug containing disc on the medium. In this method, radioisotopes are diffused on the medium and it is difficult to measure the exact effect by radiation. Thus, new laboratory equipment needs to evaluate the antibacterial activity by the radioisotopes. In this study, we measured the radiation level of radioisotopes on a new laboratory instrument using a MCNP. A disc method has been widely used to measure the antibacterial effect of chemical agents. This method uses a drug diffusion system for the measurement of anti-bacterial antibiotics. To measure the antimicrobial activity of a radioisotope, a new type of laboratory instrument is necessary to prevent the drug from spreading. The radioisotopes are used to diagnose and treat cancer. However, studies for anti-biotical use have not progressed. The radiation of radioisotopes has the effect of killing bacteria. Before this study proceeds further, it is necessary to be able to measure the antimicrobial activity of the radioisotope easily in the laboratory. However, in this study, it was possible to measure the antimicrobial activity of the radioisotope in the laboratory using a new laboratory instrument. We intend to start evaluation studies of the antibacterial activity of specific radioisotopes. In addition, it will be possible to develop research to overcome diseases caused by bacteria in the future

Active Radiation Level Measurement on New Laboratory Instrument for Evaluating the Antibacterial Activity of Radioisotope

Energy Technology Data Exchange (ETDEWEB)

Joh, Eunha; Park, Jang Guen [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

2014-05-15

A disc method has been widely used to measure the antibacterial effect of chemical agents. However, it is difficult to measure the antibacterial effect of radioisotopes using a disc method. A disc method is a method for diffusing a drug by placing the drug containing disc on the medium. In this method, radioisotopes are diffused on the medium and it is difficult to measure the exact effect by radiation. Thus, new laboratory equipment needs to evaluate the antibacterial activity by the radioisotopes. In this study, we measured the radiation level of radioisotopes on a new laboratory instrument using a MCNP. A disc method has been widely used to measure the antibacterial effect of chemical agents. This method uses a drug diffusion system for the measurement of anti-bacterial antibiotics. To measure the antimicrobial activity of a radioisotope, a new type of laboratory instrument is necessary to prevent the drug from spreading. The radioisotopes are used to diagnose and treat cancer. However, studies for anti-biotical use have not progressed. The radiation of radioisotopes has the effect of killing bacteria. Before this study proceeds further, it is necessary to be able to measure the antimicrobial activity of the radioisotope easily in the laboratory. However, in this study, it was possible to measure the antimicrobial activity of the radioisotope in the laboratory using a new laboratory instrument. We intend to start evaluation studies of the antibacterial activity of specific radioisotopes. In addition, it will be possible to develop research to overcome diseases caused by bacteria in the future.

Notification determining details of technical standards concerning transport of radioisotopes or goods contaminated by radioisotopes outside works or enterprises

International Nuclear Information System (INIS)

1981-01-01

This rule is established under the provisions of the regulation for the execution of the law on the prevention of radiation injuries by radioisotopes. Terms are used in this rule for the same meanings as in the regulation. The concentration of radioisotopes to which the technical standards for transport outside enterprises are not applied is 0.002 micro-curie per gram. The radioisotopes which can be transported as L type transported goods are defined in detail, excluding explosive or spontaneously igniting radioisotopes. The quantity limit of radioisotopes which can be transported as A type transported goods is the values A 1 and A 2 defined in this rule. The permissible surface density defined by the Director General of the Science and Technology Agency are 1/100,000 micro-curie per cm 2 for the radioisotopes emitting alpha-ray, and 1/10,000 micro-curie per cm 2 for the radioisotopes which do not emit alpha-ray. The leak quantity of radioisotopes specified by the Director General is 1/1,000,000 of A 2 value for BM type transported goods and 1/1,000 of A 2 value for BU type goods. The test conditions for each type of transported goods, dangerous goods, the limit of the number of transported goods and signs are stipulated, respectively. Permissible exposure dose is 1.5 rem a year for persons other than radiation workers. (Okada, K.)

Medical Radioisotopes Production Without A Nuclear Reactor

Energy Technology Data Exchange (ETDEWEB)

Van der Keur, H.

2010-05-15

This report is answering the key question: Is it possible to ban the use of research reactors for the production of medical radioisotopes? Chapter 2 offers a summarized overview on the history of nuclear medicine. Chapter 3 gives an overview of the basic principles and understandings of nuclear medicine. The production of radioisotopes and its use in radiopharmaceuticals as a tracer for imaging particular parts of the inside of the human body (diagnosis) or as an agent in radiotherapy. Chapter 4 lists the use of popular medical radioisotopes used in nuclear imaging techniques and radiotherapy. Chapter 5 analyses reactor-based radioisotopes that can be produced by particle accelerators on commercial scale, other alternatives and the advantages of the cyclotron. Chapter 6 gives an overview of recent developments and prospects in worldwide radioisotopes production. Chapter 7 presents discussion, conclusions and recommendations, and is answering the abovementioned key question of this report: Is it possible to ban the use of a nuclear reactor for the production of radiopharmaceuticals? Is a safe and secure production of radioisotopes possible?.

Radiation risk assessment for the transport of radioisotopes using KRI-BGM B(U) type container

International Nuclear Information System (INIS)

Cho, Woon-Kap

2008-01-01

The radiation risks were estimated for the transportation of radioisotopes using KRI-BGM transport container. KRI-BGM container was specially designed for transportation of large amount of radioisotopes for industrial or medical applications. The container can carry maximum 370 TBq of solid Ir-192, 29.6 TBq of liquid Mo-99 and 37 TBq of liquid I-131 respectively. For the radiation risk assessment, it was assumed that maximum design activity of those radioisotopes was transported. Transportation route is from Daejeon where radioisotopes are produced to Seoul where radioisotopes are consumed. Transport distance is 200 km including highway and downtown area from Daejeon to Seoul. As the transportation conveyance, an ordinary cargo truck is used exclusively. Radiation risks were estimated for incident free and accident condition of transportation and RADTRAN 5.6 was used as the risk assessment tool. For the risk assessment of radioisotopes transportation, various parameters such as population density around transport route, weather condition, probability of specific accidents such as impact, fire, etc. were considered. From the results of this study, the exclusive transportation of radioisotopes using KRI-BGM transport container by truck showed low radiological risks with manageable safety and health consequences. This paper discusses the methods and results of the radiation risks assessment for the radioisotopes transportation by an ordinary truck and presents the expected radiation risks in person-Sv and latent cancer fatalities. (author)

List of ERDA radioisotope customers with summary of radioisotope shipments, FY 1976

International Nuclear Information System (INIS)

Simmons, J.L.

1977-03-01

The thirteenth edition of the ERDA radioisotope customer list has been prepared at the request of the Office of Program Coordination, Office of the Assistant Administrator. The purpose of the document is to list the FY 1976 commercial radioisotope production and distribution activities of ERDA facilities at Argonne National Laboratory, Battelle, Pacific Northwest Laboratories, Brookhaven National Laboratory, Hanford Engineering Development Laboratory, Idaho Operations Office, Los Alamos Scientific Laboratory, Mound Laboratory, Oak Ridge National Laboratory, Savannah River Laboratory, and United Nuclear Industries, Inc

Investigation of Insulation Materials for Future Radioisotope Power Systems

Science.gov (United States)

Cornell, Peggy A.; Hurwitz, Frances I.; Ellis, David L.; Schmitz, Paul C.

2013-01-01

NASA's Radioisotope Power Systems (RPS) Technology Advancement Project is developing next generation high-temperature insulation materials that directly benefit thermal management and improve performance of RPS for future science missions. Preliminary studies on the use of multilayer insulation (MLI) for Stirling convertors used on the Advanced Stirling Radioisotope Generator (ASRG) have shown the potential benefits of MLI for space vacuum applications in reducing generator size and increasing specific power (W/kg) as compared to the baseline Microtherm HT (Microtherm, Inc.) insulation. Further studies are currently being conducted at NASA Glenn Research Center on candidate MLI foils and aerogel composite spacers. This paper presents the method of testing of foils and spacers and experimental results to date.

The safe handling of radioisotopes

Energy Technology Data Exchange (ETDEWEB)

NONE

1964-12-31

A narrative account of a minor contamination accident in a laboratory is used to demonstrate the important role of radiation protection measures in radioisotope work and the necessity of giving proper regard to such measures. It is primarily directed towards the research scientists and medical workers using radioisotopes on a relatively small scale

Radioisotope thermal photovoltaic application of the GaSb solar cell

Science.gov (United States)

Morgan, M. D.; Horne, W. E.; Day, A. C.

1991-01-01

An examination of a RTVP (radioisotopic thermophotovoltaic) conceptual design has shown a high potential for power densities well above those achievable with radioisotopic thermoelectric generator (RTG) systems. An efficiency of 14.4 percent and system specific power of 9.25 watts/kg were predicted for a system with sixteen GPHS (general purpose heat source) sources operating at 1100 C. The models also showed a 500 watt system power by the strontium-90 isotope at 1200 C at an efficiency of 17.0 percent and a system specific power of 11.8 watts/kg. The key to this level of performance is a high-quality photovoltaic cell with narrow bandgap and a reflective rear contact. Recent work at Boeing on GaSb cells and transparent back GaAs cells indicate that such a cell is well within reach.

Research reactor production of radioisotopes for medical use

International Nuclear Information System (INIS)

Mani, R.S.

1985-01-01

More than 70% of all radioisotopes applied in medical diagnosis and research are currently produced in research reactors. Research reactors are also an important source of certain radioisotopes, such as 60 Co, 90 Y, 137 Cs and 198 Au, which are employed in teletherapy and brachytherapy. For regular medical applications, mainly 29 radionuclides produced in research reactors are used. These are now produced on an 'industrial scale' by many leading commercial manufacturers in industrialized countries as well as by national atomic energy establishments in developing countries. Five main neutron-induced reactions have been employed for the regular production of these radionuclides, namely: (n,γ), (n,p), (n,α), (n,γ) followed by decay, and (n, fission). In addition, the Szilard-Chalmers process has been used in low- and medium-flux research reactors to enrich the specific activity of a few radionuclides (mainly 51 Cr) produced by the (n,γ) reaction. Extensive work done over the last three decades has resulted in the development of reliable and economic large-scale production methods for most of these radioisotopes and in the establishment of rigorous specifications and purity criteria for their manifold applications in medicine. A useful spectrum of other radionuclides with suitable half-lives and low to medium toxicity can be produced in research reactors, with the requisite purity and specific activity and at a reasonable cost, to be used as tracers. Thanks to the systematic work done in recent years by many radiopharmaceutical scientists, the radionuclides of several elements, such as arsenic, selenium, rhenium, ruthenium, palladium, cadmium, tellurium, antimony, platinum, lead and the rare earth elements, which until recently were considered 'exotic' in the biomedical field, are now gaining attention. (author)

Radioisotope electric propulsion of sciencecraft to the outer solar system and near-interstellar space

International Nuclear Information System (INIS)

Noble, R.J.

1998-08-01

Recent results are presented in the study of radioisotope electric propulsion as a near-term technology for sending small robotic sciencecraft to the outer Solar System and near-interstellar space. Radioisotope electric propulsion (REP) systems are low-thrust, ion propulsion units based on radioisotope electric generators and ion thrusters. Powerplant specific masses are expected to be in the range of 100 to 200 kg/kW of thrust power. Planetary rendezvous missions to Pluto, fast missions to the heliopause (100 AU) with the capability to decelerate an orbiter for an extended science program and prestellar missions to the first gravitational lens focus of the Sun (550 AU) are investigated

Manual of radioisotope production

International Nuclear Information System (INIS)

1966-01-01

The Manual of Radioisotope Production has been compiled primarily to help small reactor establishments which need a modest programme of radioisotope production for local requirements. It is not comprehensive, but gives guidance on essential preliminary considerations and problems that may be met in the early stages of production. References are included as an aid to the reader who wishes to seek further in the extensive literature on the subject. In preparing the Manual, which is in two parts, the Agency consulted several Member States which already have long experience in radioisotope production. An attempt has been made to condense this experience, firstly, by setting out the technical and economic considerations which govern the planning and execution of an isotope programme and, secondly, by providing experimental details of isotope production processes. Part I covers topics common to all radioisotope processing, namely, laboratory design, handling and dispensing of radioactive solutions, quality control, measurement and radiological safety. Part II contains information on the fifteen radioisotopes in most common use. These are bromine-82, cobalt-58, chromium-51, copper-64, fluorine-18, gold-198, iodine-131, iron-59, magnesium-28, potassium-42, sodium-24, phosphorus-32, sulphur-35, yttrium-90 and zinc-65. Their nuclear properties are described, references to typical applications are given and published methods of production are reviewed; also included are descriptions in detail of the production processes used at several national atomic energy organizations. No attempt has been made to distinguish the best values for nuclear data or to comment on the relative merits of production processes. Each process is presented essentially as it was described by the contributor on the understanding that critical comparisons are not necessary for processes which have been well tried in practical production for many years. The information is presented as a guide to enable

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.

Science.gov (United States)

Turkbey, Baris; Mena, Esther; Lindenberg, Liza; Adler, Stephen; Bednarova, Sandra; Berman, Rose; Ton, Anita T; McKinney, Yolanda; Eclarinal, Philip; Hill, Craig; Afari, George; Bhattacharyya, Sibaprasad; Mease, Ronnie C; Merino, Maria J; Jacobs, Paula M; Wood, Bradford J; Pinto, Peter A; Pomper, Martin G; Choyke, Peter L

2017-10-01

To assess the ability of (N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-F-fluorobenzyl-L-cysteine) (F-DCFBC), a prostate-specific membrane antigen-targeted PET agent, to detect localized prostate cancer lesions in correlation with multiparametric MRI (mpMRI) and histopathology. This Health Insurance Portability and Accountability Act of 1996-compliant, prospective, institutional review board-approved study included 13 evaluable patients with localized prostate cancer (median age, 62.8 years [range, 51-74 years]; median prostate-specific antigen, 37.5 ng/dL [range, 3.26-216 ng/dL]). Patients underwent mpMRI and F-DCFBC PET/CT within a 3 months' window. Lesions seen on mpMRI were biopsied under transrectal ultrasound/MRI fusion-guided biopsy, or a radical prostatectomy was performed. F-DCFBC PET/CT and mpMRI were evaluated blinded and separately for tumor detection on a lesion basis. For PET image analysis, MRI and F-DCFBC PET images were fused by using software registration; imaging findings were correlated with histology, and uptake of F-DCFBC in tumors was compared with uptake in benign prostatic hyperplasia nodules and normal peripheral zone tissue using the 80% threshold SUVmax. A total of 25 tumor foci (mean size, 1.8 cm; median size, 1.5 cm; range, 0.6-4.7 cm) were histopathologically identified in 13 patients. Sensitivity rates of F-DCFBC PET/CT and mpMRI were 36% and 96%, respectively, for all tumors. For index lesions, the largest tumor with highest Gleason score, sensitivity rates of F-DCFBC PET/CT and mpMRI were 61.5% and 92%, respectively. The average SUVmax for primary prostate cancer was higher (5.8 ± 4.4) than that of benign prostatic hyperplasia nodules (2.1 ± 0.3) or that of normal prostate tissue (2.1 ± 0.4) at 1 hour postinjection (P = 0.0033). The majority of index prostate cancers are detected with F-DCFBC PET/CT, and this may be a prognostic indicator based on uptake and staging. However, for detecting prostate cancer with high sensitivity, it

Industrial radioisotope economics. Findings of the study group

International Nuclear Information System (INIS)

1965-01-01

Within twenty years of the availability of radioisotopes in quantity the use of these as tracers has been widely applied in scientific research and in industrial process and product control. Industry spends millions of dollars on these new techniques. Since the overall attitude of industry is to favour methods that involve rapid financial returns the economic benefits must be considerable. In promoting the peaceful uses of atomic energy, the IAEA is actively interested in the international exchange of experience in all applications of radioisotopes. This has been demonstrated by a number of scientific conferences where new results of direct importance to the industrial use of radioisotopes have been presented. In 1963 the IAEA also published literature survey on radioisotope applications described in the scientific literature up to 1960, classified according to industry. However, the available scientific literature was found insufficient to determine the extent of the use of radioisotopes and the economic benefits derived from it. Therefore, further fact-finding efforts were necessary. The IAEA thus decided to carry out an International Survey on the Use of Radioisotopes in Industry. In 1962 the IAEA's highly industrialized Member States Were invited to participate in the Survey; 25 declared their willingness to do so and in due course submitted their national reports. These included information on how radioisotopes were used by industry in each country and indicated the size and form of the economic advantages, primarily in terms of savings made by industry. The findings from the Survey were discussed at a Study Group Meeting on Radioisotope Economics, held in Vienna in March 1964. Forty participants from 22 countries were nominated for this Study Group. The program of the meeting was divided in three parts: (1) experience of the International Survey on the use of radioisotopes in industry; (2) present use of radioisotopes, technical and economic aspects; (3

A dedicated tool for PET scanner simulations using FLUKA

International Nuclear Information System (INIS)

Ortega, P.G.; Boehlen, T.T.; Cerutti, F.; Chin, M.P.W.; Ferrari, A.; Mancini, C.; Vlachoudis, V.; Mairani, A.; Sala, Paola R.

2013-06-01

Positron emission tomography (PET) is a well-established medical imaging technique. It is based on the detection of pairs of annihilation gamma rays from a beta+-emitting radionuclide, usually inoculated in the body via a biologically active molecule. Apart from its wide-spread use for clinical diagnosis, new applications are proposed. This includes notably the usage of PET for treatment monitoring of radiation therapy with protons and ions. PET is currently the only available technique for non-invasive monitoring of ion beam dose delivery, which was tested in several clinical pilot studies. For hadrontherapy, the distribution of positron emitters, produced by the ion beam, can be analyzed to verify the correct treatment delivery. The adaptation of previous PET scanners to new environments and the necessity of more precise diagnostics by better image quality triggered the development of new PET scanner designs. The use of Monte Carlo (MC) codes is essential in the early stages of the scanner design to simulate the transport of particles and nuclear interactions from therapeutic ion beams or radioisotopes and to predict radiation fields in tissues and radiation emerging from the patient. In particular, range verification using PET is based on the comparison of detected and simulated activity distributions. The accuracy of the MC code for the relevant physics processes is obviously essential for such applications. In this work we present new developments of the physics models with importance for PET monitoring and integrated tools for PET scanner simulations for FLUKA, a fully-integrated MC particle-transport code, which is widely used for an extended range of applications (accelerator shielding, detector and target design, calorimetry, activation, dosimetry, medical physics, radiobiology, ...). The developed tools include a PET scanner geometry builder and a dedicated scoring routine for coincident event determination. The geometry builder allows the efficient

Can FDG PET predict verbal specific memory decline after surgery for left temporal lobe epilepsy when MRI is normal?

International Nuclear Information System (INIS)

Sagona, J.A.; Rowe, C.C.; Thomas, D.; Dickinson-Rowe, K.L.

2002-01-01

Full text: Temporal lobectomy gives excellent control of seizures in over 80% of patients with temporal lobe epilepsy. The left temporal lobe, particularly the left hippocampus, is primarily responsible for verbal memory. In most patients, the hippocampus which lies in the medial temporal lobe is abnormal and can be removed without loss of memory function. However, removal of the left hippocampus when it appears normal on MRI, often causes a significant decline in verbal specific memory (VSM) function. This paper explores the significance of pre-operative FDG-PET asymmetry in temporal lobe metabolism in predicting the VSM outcome after left temporal lobectomy when MRI demonstrates a normal hippocampus. Fifteen patients between 1993 and 2000, underwent left temporal lobectomy including left hippocampal resection, Pre-operatively all patients underwent 1.5T MRI, FDG PET and neuropsychological assessment. Neuropsychological assessment was repeated post-operatively. The left hippocampus was normal on MRI in nine and demonstrated mild T2 signal change without atrophy in six. FDG PET demonstrated temporal lobe hypometabolism in 12 patients. Post-operatively, neuropsychological evaluation documented a decline in verbal specific memory function in six patients, three with normal MRI and three with mild T2 change. We found that all patients with normal FDG PET studies (n=3) demonstrated significant verbal memory deterioration post-operatively. Nine of twelve patients (75%) with left temporal lobe hypometabolism did not show new verbal memory deficits. FDG PET improves the risk stratification for verbal specific memory decline with left temporal lobectomy in patients with normal hippocampi on MRI. Copyright (2002) The Australian and New Zealand Society of Nuclear Medicine Inc

Research trends in radioisotopes: a scientometric analysis

International Nuclear Information System (INIS)

Sagar, Anil; Kademani, B.S.; Bhanumurthy, K.; Ramamoorthy, N.

2014-01-01

Radioisotopes or radionuclides are radioactive forms of elements and are usually produced in research reactors and accelerators. They have wide ranging applications in healthcare, industry, food and agriculture, and environmental monitoring. Following over five decades of vast experience accumulated, radioisotope technology has developed to a high degree of sophistication and it is estimated that about 200 radioisotopes are in regular use. This paper attempts to highlight the publication status and growth of radioisotope research across the world and make quantitative and qualitative assessment by way of analyzing the following features of research output based on Web of Science database during the period 1993-2012. (author)

Radioisotope techniques for problem-solving on refineries

International Nuclear Information System (INIS)

Charlton, J.S.; Webb, M.

1994-01-01

Increasingly, refineries worldwide are recognizing the value of radioisotope technology in studying the operation of on-line plant. Using case studies, this paper illustrates the versatility of radioisotope techniques in a wide range of investigations: the density-profiling of distillation columns; the investigation of leaks on feed/effluent exchangers; on-line flowrate measurement; underground leakage detection. The economic benefits deriving from radioisotope applications are indicated

Clinical Application of F-18 FDG PET (PET/CT) in Malignancy of Unknown Origin

International Nuclear Information System (INIS)

Kim, Byung Il

2008-01-01

Diagnosis of primary origin site in the management of malignancy of unknown origin (MUO) is the most important issue. According to the histopathologic subtype of primary lesion, specialized treatment can be given and survival gain is expected. F-18 FDG PET (PET/CT) has been estimated as useful in detection of primary lesion with high sensitivity and moderate specificity. F-18 FDG PET (PET/CT) study before conventional studies is also recommended because it has high diagnostic performance compared to conventional studies. Although there has few data, F-18 FDG PET (PET/CT) is expected to be useful in diagnosis of recurrence, restaging, evaluation of treatment effect, considering that PET (PET/CT) has been reported as useful in other malignancies

Oncology PET imaging

International Nuclear Information System (INIS)

Inubushi, Masayuki

2014-01-01

At the beginning of this article, likening medical images to 'Where is Waldo?' I indicate the concept of diagnostic process of PET/CT imaging, so that medical physics specialists could understand the role of each imaging modality and infer our distress for image diagnosis. Then, I state the present situation of PET imaging and the basics (e.g. health insurance coverage, clinical significance, principle, protocol, and pitfall) of oncology FDG-PET imaging which accounts for more than 99% of all clinical PET examinations in Japan. Finally, I would like to give a wishful prospect of oncology PET that will expand to be more cancer-specific in order to assess therapeutic effects of emerging molecular targeted drugs targeting the 'hallmarks of cancer'. (author)

Medical Radioisotope Data Survey: 2002 Preliminary Results

Energy Technology Data Exchange (ETDEWEB)

Siciliano, Edward R.

2004-06-23

A limited, but accurate amount of detailed information about the radioactive isotopes used in the U.S. for medical procedures was collected from a local hospital and from a recent report on the U.S. Radiopharmaceutical Markets. These data included the total number of procedures, the specific types of procedures, the specific radioisotopes used in these procedures, and the dosage administered per procedure. The information from these sources was compiled, assessed, pruned, and then merged into a single, comprehensive and consistent set of results presented in this report. (PIET-43471-TM-197)

Research and development for the application of radioisotope technology in SINR

International Nuclear Information System (INIS)

Zhang Jiahua

1987-01-01

A brief systematic account on the research and development for the application of radioisotope technology in Shanghai Institute of Nuclear Research (SINR) is presented. It comprehensively covers the following categories: 1. Radioisotopes produced by cyclotron; 2. Radioisotope-labelled compounds; 3. Radioisotope as source of energy converter; 4. Induced-radioisotope generation as a means for elemental analysis--the activation analysis; 5. Radioisotope equipped with electronic instrument for various application; and 6. Special usage of some radioisotopes

Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.

Science.gov (United States)

Youland, Ryan S; Pafundi, Deanna H; Brinkmann, Debra H; Lowe, Val J; Morris, Jonathan M; Kemp, Bradley J; Hunt, Christopher H; Giannini, Caterina; Parney, Ian F; Laack, Nadia N

2018-05-01

Treatment-related changes can be difficult to differentiate from progressive glioma using MRI with contrast (CE). The purpose of this study is to compare the sensitivity and specificity of 18F-DOPA-PET and MRI in patients with recurrent glioma. Thirteen patients with MRI findings suspicious for recurrent glioma were prospectively enrolled and underwent 18F-DOPA-PET and MRI for neurosurgical planning. Stereotactic biopsies were obtained from regions of concordant and discordant PET and MRI CE, all within regions of T2/FLAIR signal hyperintensity. The sensitivity and specificity of 18F-DOPA-PET and CE were calculated based on histopathologic analysis. Receiver operating characteristic curve analysis revealed optimal tumor to normal (T/N) and SUVmax thresholds. In the 37 specimens obtained, 51% exhibited MRI contrast enhancement (M+) and 78% demonstrated 18F-DOPA-PET avidity (P+). Imaging characteristics included M-P- in 16%, M-P+ in 32%, M+P+ in 46% and M+P- in 5%. Histopathologic review of biopsies revealed grade II components in 16%, grade III in 43%, grade IV in 30% and no tumor in 11%. MRI CE sensitivity for recurrent tumor was 52% and specificity was 50%. PET sensitivity for tumor was 82% and specificity was 50%. A T/N threshold > 2.0 altered sensitivity to 76% and specificity to 100% and SUVmax > 1.36 improved sensitivity and specificity to 94 and 75%, respectively. 18F-DOPA-PET can provide increased sensitivity and specificity compared with MRI CE for visualizing the spatial distribution of recurrent gliomas. Future studies will incorporate 18F-DOPA-PET into re-irradiation target volume delineation for RT planning.

PET imaging in multiple sclerosis

NARCIS (Netherlands)

Faria, Daniele de Paula; Copray, Sjef; Buchpiguel, Carlos; Dierckx, Rudi; de Vries, Erik

Positron emission tomography (PET) is a non-invasive technique for quantitative imaging of biochemical and physiological processes in animals and humans. PET uses probes labeled with a radioactive isotope, called PET tracers, which can bind to or be converted by a specific biological target and thus

Rhenium radioisotopes for therapeutic radiopharmaceutical development

International Nuclear Information System (INIS)

Knapp, F.F. Jr.; Beets, A.L.; Pinkert, J.; Kropp, J.; Lin, W.Y.; Wang, S.Y.

2001-01-01

Rhenium-186 and rhenium-188 represent two important radioisotopes which are of interest for a variety of therapeutic applications in oncology, nuclear medicine and interventional cardiology. Rhenium-186 is directly produced in a nuclear reactor and the 90 hour half-life allows distribution to distant sites. The relatively low specific activity of rhenium-186 produced in most reactors, however, permits use of phosphonates, but limits use for labelled peptides and antibodies. Rhenium-188 has a much shorter 16.9 hour half-life which makes distribution from direct reactor production difficult. However, rhenium-188 can be obtained carrier-free from a tungsten-188/rhenium-188 generator, which has a long useful shelf-life of several months which is cost-effective, especially for developing regions. In this paper we discuss the issues associated with the production of rhenium-186- and rhenium-188 and the development and use of various radiopharmaceuticals and devices labelled with these radioisotopes for bone pain palliation, endoradiotherapy of tumours by selective catheterization and tumour therapy using radiolabelled peptides and antibodies, radionuclide synovectomy and the new field of vascular radiation therapy. (author)

68Ga-PSMA PET/CT in Patients with Rising Prostatic-Specific Antigen After Definitive Treatment of Prostate Cancer: Detection Efficacy and Diagnostic accuracy.

Science.gov (United States)

Hamed, Maged Abdel Galil; Basha, Mohammad Abd Alkhalik; Ahmed, Hussien; Obaya, Ahmed Ali; Afifi, Amira Hamed Mohamed; Abdelbary, Eman H

2018-06-20

68 Ga-prostate-specific membrane antigen-11 ( 68 Ga-PSMA-11) is a recently developed positron emission tomography (PET) tracer that can detect prostate cancer (PC) relapses and metastases with high contrast resolution. The aim of this study was to assess the detection efficacy and diagnostic accuracy of 68 Ga-PSMA PET/CT image in patients with rising prostatic-specific antigen (PSA) after treatment of PC. The present prospective study included 188 patients who exhibited rising of PSA level on a routine follow-up examination after definitive treatment of PC. All patients underwent a 68 Ga-PSMA PET/CT examination. For each patient, we determined the disease stage, the Gleason score, and the maximum standardized uptake value of the local recurrence and extraprostatic metastases. The detection efficacy and diagnostic accuracy of 68 Ga-PSMA PET/CT were established by histopathology and clinical and imaging follow-up as the reference standards. 68 Ga-PSMA PET/CT detected tumour relapse in 165 patients (35 patients had local recurrence, 106 patients had extraprostatic metastases, and 24 patients had combined lesions). The sensitivity, specificity, and accuracy values of 68 Ga-PSMA PET/CT examination in the detection of PC recurrence were 98.8%, 100%, and 98.8%, respectively. 68 Ga-PSMA PET/CT revealed an overall detection rate of 87.8% (165/188) in patients with rising PSA (median of 2.2 ng/mL, and range of 0.01-70 ng/mL). 68 Ga-PSMA PET/CT is a valuable tool for the detection of PC local recurrence or extraprostatic metastases following rising PSA levels after primary definitive therapy and should be incorporated during routine work-up. Copyright © 2018. Published by Elsevier Inc.

Regulations concerning the radionuclides uses in France; Reglementation de l'utilisation des radioisotopes en France

Energy Technology Data Exchange (ETDEWEB)

Vergne, J [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires; Bugnard, L [Institut national d' Hygiene (France)

1955-07-01

The progress in the uses of radioisotopes has been conditioned by increasing the number of trained workers and researchers and developing theoretical teaching in universities since 1950 in France as well as developing a national control of the distribution and uses of radioisotopes. With the large diffusion and development of radioisotopes uses and applications, new rules and regulations came to control the importation, exportation, transport and utilization of radioisotopes. In the first part, it described the different French laws since 1934 and their successive modifications which ruled on the production, manipulation and utilization of radioisotopes. An inter-ministerial committee was created in 1952 to advise and inform of all the questions related to the preparation, importation, exportation, possession and distribution of radioisotopes. The transport regulations are in constant evolution and has got to meet with international recommendations. It distinguished three different type of transport: road, river and railway transport, postal transport and finally air transport. All the different transports have their specific packaging, maximum transportable quantity, maximum material intensity and labelling requirements. The regulations about customs duties are specified as well as the administrative formalities for non natural radioisotopes importation. Since 1950, diseases caused by irradiation to natural or artificial radioactive materials are recognised as professional diseases and a table of the actual regulations is presented. (M.P.)

Uses of radioisotopes in Sudan

International Nuclear Information System (INIS)

Elradi, E. A. M.

2013-07-01

In this research project, an inventory for the different radioisotopes that were imported by public and private sectors of Sudan in the period between ( 2007-2011) has been set up. These organizations import the appropriates for different but in general we classify them into these applications: Medical, Industrial, Agricultural and Research. However, each broad discipline is subdivided into subgroups. This inventory will help those who are willing to establish research reactors in Sudan on the type and power of the reactors to be purchases according to the actual needs of Sudan with forecasting of the near and for future needs. Also the expenditure that has been spent by these organizations have been estimated for most of the radioisotopes. It was observed that almost 50% of the expenditure went for the fright charges as these radioisotopes need special handling and care by installing a research reactor in Sudan, the cost of purchasing will be cut down several folds. Also it will help in availability of the radioisotopes with very short half lives (hours to days). This will be reflected in the cut down the cost of tests and provision of new tests.(Author)

Radiopharmaceuticals in positron emission tomography: Radioisotope productions and radiolabelling procedures at the Austin and Repatriation Medical Centre

International Nuclear Information System (INIS)

Tochon-Danguy, H.J.; Sachinidis, J.I.; Chan, J.G.; Cook, M.

1997-01-01

Positron Emission Tomography (PET) is a technique that utilizes positron-emitting radiopharmaceuticals to map the physiology, biochemistry and pharmacology of the human body. Positron-emitting radioisotopes produced in a medical cyclotron are incorporated into compounds that are biologically active in the body. A scanner measures radioactivity emitted from a patient's body and provides cross-sectional images of the distribution of these radiolabelled compounds in the body. It is the purpose of this paper to review the variety of PET radiopharmaceuticals currently produced at the Austin and Repatriation Medical Centre in Melbourne. Radioisotope production, radiolabelling of molecules and quality control of radiopharmaceuticals will be discussed. A few examples of their clinical applications will be shown as well. During the last five years we achieved a reliable routine production of various radiopharmaceuticals labelled with the four most important positron-emitters: oxygen-15 (t, 1/2 =2min), nitrogen-13 (t 1/2 = 10 min), carbon-11 (t 1/2 =20 min) and fluorine-18 (t 1/2 = 110 min). These radiopharmaceuticals include [ 15 O]oxygen, [ 15 O]carbon monoxide, [ 15 O]carbon dioxide, [ 15 O]water, [ 13 N]ammonia, [ 11 C]flumazenil, [ 11 C]SCH23390, [ 18 F]fluoromisonidazole and [ 18 F]fluoro-deoxy-glucose ([ 18 F]FDG). In addition, since the half life of [ 18 F] is almost two hours, regional distribution can be done, and the Austin and Repatriation Medical Centre is currently supplying [ 18 F]FDG in routine to other hospitals. Future new radiopharmaceuticals development include a [ 18 F]thymidine analog to measure cell proliferation and a [ 11 C]pyrroloisoquinoline to visualize serotonergic neuron abnormalities. (authors)

PET/CT in lymphoma patients; PET-CT bei Lymphompatienten

Energy Technology Data Exchange (ETDEWEB)

Steinert, H.C. [Universitaetsspital Zuerich, Klinik und Poliklinik fuer Nuklearmedizin (Switzerland)

2004-11-01

First results of PET/CT in Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL) are reported. From March 2001 to August 2004 822 PET/CT were performed at our clinic in lymphoma patients for primary staging, restaging after therapy, and diagnosis of recurrence. For coregistration non contrast-enhanced low-dose CT were used. Due to the exact anatomic localization of {sup 18}F-FDG accumulating lesions equivocal or false positive PET findings are avoided. In comparison to contrast enhanced CT, PET/CT has a higher sensitivity and specificity in patients with HD and aggressive NHL. Integration of PET/CT in treatment planning of radiation therapy optimizes the field volume. Even in the initial phase of clinical evaluation, PET/CT has proven useful in staging and restaging of lymphoma. The exact anatomic localization of the PET findings is essential for a precise report, for treatment planning of radiation therapy, and for planning surgical biopsy. (orig.) [German] Erste Ergebnisse der PET-CT bei Morbus Hodgkin (HD) und den aggressiven Non-Hodgkin-Lymphomen (NHL) werden beschrieben. Von Maerz 2001 bis August 2004 wurden 822 PET-CT bei Lymphompatienten zum primaeren Staging, zum Restaging nach Therapie und zur Rezidivdiagnostik an unserer Klinik durchgefuehrt. Fuer die Koregistration wurde ein Low-dose-CT ohne i.v.-Kontrastmittel verwendet. Durch die exakte anatomische Zuordnung der {sup 18}F-FDG aufnehmenden Laesionen wurden unklare oder falsch-positive PET-Befunde vermieden. Die PET-CT erzielte im Vergleich zur KM-verstaerkten CT eine hoehere Sensitivitaet und Spezifitaet bei Patienten mit HD und aggressiven NHL. Die Integration der PET-CT in die Planung der Strahlentherapie fuehrte zu einer Optimierung der Feldgrenzen. Die PET-CT hat sich bereits in der Phase der initialen klinischen Evaluation als wertvoll beim Staging und Restaging von Lymphomen erwiesen. Die exakte anatomische Zuordnung der PET-Informationen ist fuer eine sichere Befundung

'Serial review on clinical PET tracers'. Manufacturing and quality control of positron emitting radiopharmaceuticals produced by in-house cyclotron

International Nuclear Information System (INIS)

Saji, Hideo

2009-01-01

In order to establish PET diagnosis as a routine clinical tool, manufacture's compliance with regulations under the Good Manufacturing Practice (GMP) principle for PET radiopharmaceuticals is necessary. For this purpose, the Sub-committee on Medical Application of Positron Emitting Radionuclides, Medical Science and Pharmaceutical Committee of Japan Radioisotopes Association has proposed 'Standards for Compounds Labeled with Emitting Radionuclides Approved as Established Techniques for Medical Use'. This guideline includes the general notices, general rules for preparations, general tests for the quality control, quality of each PET agents, guideline for manufacturing environment and manufacturing process at manufacturing facilities of PET agents. Each facility should have a committee and establish an internal system to account for manufacturing compounds labeled with positron emitting radionuclides produced in the facility, and compile standards by referring to the 'Established Standard Techniques of Labeling Compounds with Emitting Radionuclides for use as Radiopharmaceuticals: approved by the Subcommittee on Medical Application of Cyclotron-Produced Radionuclides (revised in 2009)', in order to maintain the quality of radiopharmaceuticals. (author)

Novel Radioisotope Applications in Industry Promoted by the IAEA

International Nuclear Information System (INIS)

Thereska, J.

2001-01-01

Presently, there is a lively activity in further development and use of radioisotope technology. Novel radioisotope applications in industry are promoted by the IAEA. Radioisotope technology is contributing significantly to improving and optimising process performance bringing an annual economic benefit to world-wide industry of several billion US$. Probably, an average benefit to cost ratio of 40:1 is reasonably representative of radioisotope applications in industry. There are few short-term investments, which will give a return of this magnitude. The cost effectiveness of radioisotope applications should be widely promulgated to encourage industrialists to take full advantage of the technology. (author)

Radioisotopes in soil science

International Nuclear Information System (INIS)

Kotur, S.C.

2004-01-01

Soils form a thin veneer of the Earth that sustain the entire flora and fauna of the terra firma. To that extent the soil as a natural resource is very precious and needs to be managed in a sustainable manner. The fate of degradation of pesticides in soil and build-up of heavy metals in the overall biosafety scenario is also studied gainfully using radioisotopes. Radioisotopes are a very potent tool in the hands of the Soil Scientists, perhaps, the most important among the peaceful applications in service of the mankind

Radioisotopes and their applications in highway testings

International Nuclear Information System (INIS)

Saxena, S.C.

1974-01-01

Applications of radioisotopes in highway testing are described. Radioisotopic methods have been used to determine : (1) moisture and density of soil and base materials for compaction control, (2) magnesium oxide content of cement, (3) permeability of bituminous coverings and (4) field density of freshly laid hot bituminous concrete surface. Possible uses of nuclear explosives for production of aggregates and of radioisotopes for determination of deflection in the design of flexible pavements are indicated. (M.G.B.)

PET/CT and radiotherapy

International Nuclear Information System (INIS)

Messa, C.; CNR, Milano; S. Gerardo Hospital, Monza; Di Muzio, N.; Picchio, M.; Bettinardi, V.; Gilardi, M.C.; CNR, Milano; San Raffaele Scientific Institute, Milano; Fazio, F.; CNR, Milano; San Raffaele Scientific Institute, Milano; San Raffaele Scientific Institute, Milano

2006-01-01

This article reviews the state of the art of PET/CT applications in radiotherapy, specifically its use in disease staging, patient selection, treatment planning and treatment evaluation. Diseases for which radiotherapy with radical intent is indicated will be considered, as well as those in which PET/CT may actually change the course of disease. The methodological and technological aspects of PET/CT in radiotherapy are discussed, focusing on the problem of target volume definition with CT and PET functional imaging and the problem of tumor motion with respect to imaging and dose delivery

Investigation of Insulation Materials for Future Radioisotope Power Systems (RPS)

Science.gov (United States)

Cornell, Peggy A.; Hurwitz, Frances I.; Ellis, David L.; Schmitz, Paul C.

2013-01-01

NASA's Radioisotope Power System (RPS) Technology Advancement Project is developing next generation high temperature insulation materials that directly benefit thermal management and improve performance of RPS for future science missions. Preliminary studies on the use of multilayer insulation (MLI) for Stirling convertors used on the Advanced Stirling Radioisotope Generator (ASRG) have shown the potential benefits of MLI for space vacuum applications in reducing generator size and increasing specific power (W/kg) as compared to the baseline Microtherm HT (Microtherm, Inc.) insulation. Further studies are currently being conducted at NASA Glenn Research Center (GRC) on candidate MLI foils and aerogel composite spacers. This paper presents the method of testing of foils and spacers and experimental results to date.

FDG-PET and FDG-PET/CT for therapy monitoring and restaging in malignant lymphoma

International Nuclear Information System (INIS)

Mottaghy, F.M.; Krause, B.J.

2003-01-01

F-18-fluorodeoxyglucose (FDG) PET allows to assess residual masses in patients with malignant lymphoma differentiating vital tumor from scar tissue. This approach is not applicable with conventional imaging methods (CDM) such as CT or MRI. On the other hand circumscribed results often cannot be definitely allocated in PET, therefore the combined morphological-biochemical approach using the now available PET/CT systems promises to be a pathbreaking technical progress. There is no doubt that stand alone PET is superior to CDM differentiating residual scar tissue from vital tumor as has been shown in 15 recently published studies. The median sensitivity for detecting active disease with FDG PET across the studies was 91%; the corresponding specificity was 89%. As a result FDG PET had a high negative predictive value of 94%. In contrast, specificity and positive predictive value (PPV) of CDM in the 9 studies were a direct comparison was available were low (31% and 46%, one study 82%). PET positive residual masses were associated with a progression-free survival of 0 - 55%. Only a few studies have included FDG-PET in therapy response monitoring studies, however also these results are promising. At the moment FDG-PET seems to be the best possibility to characterize and qualitatively visualize vitality of tumor masses and also hold promises for efficient therapy response monitoring in patients with malignant lymphoma. Therefore it should be included in standard diagnostic protocols in lymphoma patients. The combined PET/CT has to be ranked superior to conventional PET studies as in many cases the combined structural and functional imaging brings a clearer diagnostic statement. (orig.) [de

Medical Radioisotope Scanning, Vol. II. Proceedings of the Symposium on Medical Radioisotope Scanning

International Nuclear Information System (INIS)

1964-01-01

Medical applications of radioisotopes continue to grow in number and importance and medical centres in almost all countries of the world are now using radioactive materials both in the diagnosis and treatment of disease. An increasing proportion of these applications involves studies of the spatial distribution of radioactive material within the human body, for which purpose highly specialized scanning methods have been elaborated. By these methods it is possible to study the position, size and functional state of different organs, to detect tumours, cysts and other abnormalities and to obtain much useful information about regions of the body that are otherwise inaccessible, except by surgery. Progress in scanning methods in recent years has been very rapid and there have been many important advances in instrumentation and technique. The development of new forms of the gamma camera and of colour-scanning techniques are but two examples of recent improvements. The production of new radioisotopes and new labelled compounds has further extended the scope of these methods. To survey these new advances the International Atomic Energy Agency held a Symposium on Medical Radioisotope Scanning in Athens from 20-24 April 1964. The scientific programme of the meeting covered all aspects of scanning methods including theoretical principles, instrumentation, techniques and clinical applications. The World Health Organization assisted in the selection of papers by providing a consultant to the selection committee. The meeting followed the earlier IAEA/WHO Seminar on Medical Radioisotope Scanning in Vienna in 1959, which was attended by 36 participants and at which 14 papers were presented. Some idea of the growth of interest in the subject may be gained from the fact that the Symposium was attended by 160 participants from 26 countries and 4 international organizations, and that 58 papers were presented. The published proceedings, comprising two volumes, contain all the

Imaging corn plants with PhytoPET, a modular PET system for plant biology

Energy Technology Data Exchange (ETDEWEB)

Lee, S.; Kross, B.; McKisson, J.; McKisson, J. E.; Weisenberger, A. G.; Xi, W.; Zorn, C.; Bonito, G.; Howell, C. R.; Reid, C. D.; Crowell, A.; Cumberbatch, L. C.; Topp, C.; Smith, M. F.

2013-11-01

PhytoPET is a modular positron emission tomography (PET) system designed specifically for plant imaging. The PhytoPET design allows flexible arrangements of PET detectors based on individual standalone detector modules built from single Hamamatsu H8500 position sensitive photomultiplier tubes and pixelated LYSO arrays. We have used the PhytoPET system to perform preliminary corn plant imaging studies at the Duke University Biology Department Phytotron. Initial evaluation of the PhytoPET system to image the biodistribution of the positron emitting tracer {sup 11}C in corn plants is presented. {sup 11}CO{sub 2} is loaded into corn seedlings by a leaf-labeling cuvette and translocation of {sup 11}C-sugars is imaged by a flexible arrangement of PhytoPET modules on each side. The PhytoPET system successfully images {sup 11}C within corn plants and allows for the dynamic measurement of {sup 11}C-sugar translocation from the leaf to the roots.

Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis

Energy Technology Data Exchange (ETDEWEB)

Zerizer, Imene; Tan, Kathryn; Khan, Sameer; Barwick, Tara [Department of Nuclear Medicine, Imperial College Healthcare, Hammersmith Hospital, Du Cane Road, London (United Kingdom); Marzola, Maria Cristina [Department of Nuclear Medicine, PET/CT Centre, Radiology and Medical Physics, ' Santa Maria della Misericordia' Hospital, Rovigo (Italy); Rubello, Domenico [Department of Nuclear Medicine, PET/CT Centre, Radiology and Medical Physics, ' Santa Maria della Misericordia' Hospital, Rovigo (Italy)], E-mail: domenico.rubello@libero.it; Al-Nahhas, Adil [Department of Nuclear Medicine, Imperial College Healthcare, Hammersmith Hospital, Du Cane Road, London (United Kingdom)

2010-03-15

Purpose: to investigate the role of FDG-PET and PET/CT in the evaluation of vasculitis. Materials and methods: a systematic revision of the papers published in PubMed/Medline until December 2009 was done. Results: FDG-PET and PET/CT have been proven to be valuable in the diagnosis of large-vessel vasculitis, especially giant cells arteritis with sensitivity values ranging 77% to 92%, and specificity values ranging 89% to 100%. In particular, FDG-PET/CT has demonstrated the potential to non-invasively diagnose the onset of the vasculitis earlier than traditional anatomical imaging techniques, thus enabling prompt treatment. False positive results mainly occur in the differential diagnosis between vasculitis and atherosclerotic vessels in elderly patients. Another area where FDG-PET/CT is gaining wider acceptance is in monitoring response to therapy; it can reliably detect the earliest changes of disease improvement post-therapy, and persistent activity is an indicator of non-responders to therapy. A few data have been reported about medium/small vessel vasculitis. Discussion: FDG-PET and PET/CT have proven utility: (a) in the initial diagnosis of patients suspected of having vasculitis particularly in those who present with non-specific symptoms; (b) in the identification of areas of increased FDG uptake in which a biopsy should be done for obtaining a diagnosis; (c) in evaluating the extent of the disease; (d) in assessing response to treatment.

Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis

International Nuclear Information System (INIS)

Zerizer, Imene; Tan, Kathryn; Khan, Sameer; Barwick, Tara; Marzola, Maria Cristina; Rubello, Domenico; Al-Nahhas, Adil

2010-01-01

Purpose: to investigate the role of FDG-PET and PET/CT in the evaluation of vasculitis. Materials and methods: a systematic revision of the papers published in PubMed/Medline until December 2009 was done. Results: FDG-PET and PET/CT have been proven to be valuable in the diagnosis of large-vessel vasculitis, especially giant cells arteritis with sensitivity values ranging 77% to 92%, and specificity values ranging 89% to 100%. In particular, FDG-PET/CT has demonstrated the potential to non-invasively diagnose the onset of the vasculitis earlier than traditional anatomical imaging techniques, thus enabling prompt treatment. False positive results mainly occur in the differential diagnosis between vasculitis and atherosclerotic vessels in elderly patients. Another area where FDG-PET/CT is gaining wider acceptance is in monitoring response to therapy; it can reliably detect the earliest changes of disease improvement post-therapy, and persistent activity is an indicator of non-responders to therapy. A few data have been reported about medium/small vessel vasculitis. Discussion: FDG-PET and PET/CT have proven utility: (a) in the initial diagnosis of patients suspected of having vasculitis particularly in those who present with non-specific symptoms; (b) in the identification of areas of increased FDG uptake in which a biopsy should be done for obtaining a diagnosis; (c) in evaluating the extent of the disease; (d) in assessing response to treatment.

Economical Radioisotope Power

Data.gov (United States)

National Aeronautics and Space Administration — Almost all robotic space exploration missions and all Apollo missions to the moon used Radioisotopic Thermoelectric Generators (RTGs) to provide electrical power to...

Diagnostic value of [18F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.

Science.gov (United States)

Zhang, Huojun; Xing, Wei; Kang, Qinqin; Chen, Chao; Wang, Linhui; Lu, Jianping

2015-05-01

An early diagnosis of urinary bladder cancer is crucial for early treatment and management. The objective of this systematic review was to assess the overall diagnostic accuracy of 18 F FDG-PET and PET/CT in urinary bladder cancer with meta-analysis. The PubMed and CNKI databases were searched for the eligible studies published up to June 01, 2014. The sensitivity, specificity, and other measures of accuracy of 18 F FDG-PET and PET/CT in the diagnosis of urinary bladder cancer were pooled along with 95 % confidence intervals (CI). Summary receiver operating characteristic (ROC) curves were used to summarize overall test performance. Ten studies met our inclusion criteria. The summary estimates for 18 F FDG-PET and PET/CT in the diagnosis of urinary bladder cancer in meta-analysis were as follows: a pooled sensitivity, 0.82 (95 % confidence interval [CI], 0.75 to 0.88); a pooled specificity, 0.92 (95 % CI, 0.87 to 0.95); positive likelihood ratio, 6.80 (95 % CI, 4.31 to 10.74); negative likelihood ratio, 0.27 (95 % CI, 0.19 to 0.36); and diagnostic odds ratio, 25.18 (95 % CI, 17.58 to 70.4). The results indicate that 18 F FDG-PET and PET/CT are relatively high sensitive and specific for the diagnosis of urinary bladder cancer.

Charged particle cross-section database for medical radioisotope production: diagnostic radioisotopes and monitor reactions. Final report of a co-ordinated research project

International Nuclear Information System (INIS)

2001-05-01

Medical applications of nuclear radiation are of considerable interest to the IAEA. Cyclotrons and accelerators, available in recent years in an increasing number of countries, are being used for the production of radioisotopes for both diagnostic and therapeutic purposes. The physical basis of this production is described through interaction of charged particles, such as protons, deuterons and alphas, with matter. These processes have to be well understood in order to produce radioisotopes in an efficient and clean manner. In addition to medical radioisotope production, reactions with low energy charged particles are of primary importance for two major applications. Techniques of ion beam analysis use many specific reactions to identify material properties, and in nuclear astrophysics there is interest in numerous reaction rates to understand nucleosynthesis in the Universe. A large number of medically oriented cyclotrons have been running in North America, western Europe and Japan for more than two decades. In recent years, 30-40 MeV cyclotrons and smaller cyclotrons (E p < 20 MeV) have been installed in several countries. Although the production methods are well established, there are no evaluated and recommended nuclear data sets available. The need for standardization was thus imminent. This was pointed out at three IAEA meetings. Based on the recommendations made at these meetings, the IAEA decided to undertake and organize the Co-ordinated Research Project (CRP) on Development of Reference Charged Particle Cross-Section Database for Medical Radioisotope Production. The project was initiated in 1995. It focused on radioisotopes for diagnostic purposes and on the related beam monitor reactions in order to meet current needs. It constituted the first major international effort dedicated to standardization of nuclear data for radioisotope production. It covered the following areas: Compilation of data on the most important reactions for monitoring light ion

Comprehensive Approach for Monitoring and Analyzing the Activity Concentration Level of PET Isotopes

International Nuclear Information System (INIS)

Osovizky, A.; Paran, J.; Ankry, N.; Vulasky, E.; Ashkenazi, B.; Tal, N.; Dolev, E.; Gonen, E.

2004-01-01

A comprehensive approach for measuring and analyzing low concentration levels of positron emitter isotopes is introduced. The solution is based on a Continuous Air Monitoring Sampler (CAMS), Stack Monitoring System (SMS) and software package. Positron Emission Tomography (PET) is a major tool for both, biochemical research and non-invasive diagnostics for medicine imaging. The PET method utilizes short half life β + radioisotopes that are produced in cyclotron sites built especially for this purpose. The growing need for β + isotopes brought about a commonly wide use of cyclotrons next to populated areas. Isotopes production involves two possible radiation hazards deriving from the activity concentration; one refers to the nearby population by the activity released through the ventilation system and the other refers to the personnel working in the nuclear facility. A comprehensive system providing solution for both radiation hazards is introduced in this work

Radioisotope production linac

International Nuclear Information System (INIS)

Stovall, J.E.; Hansborough, L.D.; O'Brien, H.A.

1981-01-01

A 70-MeV proton beam would open a new family of medical radioisotopes (including the important 123 I) to wide application. A 70-MeV, 500-μA linac is described, based on recent innovations in accelerator technology. It would be 27.3 m long, cost approx. $6 million, and the cost of power deposited in the radioisotope-production target is comparable to existing cyclotrons. By operating the rf-power system to its full capability, the same accelerator is capable of producing a 1140-μA beam, and the cost per beam watt on the target is less than half that of comparable cyclotrons. The technology to build such a linac is in a mature stage of developmnt, ready for use by industry

Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.

Science.gov (United States)

Parida, Girish Kumar; Tripathy, Sarthak; Datta Gupta, Shreya; Singhal, Abhinav; Kumar, Rakesh; Bal, Chandrasekhar; Shamim, Shamim Ahmed

2018-04-01

Ga-PSMA PET/CT is the upcoming imaging modality for staging, restaging and response assessment of prostate cancer. However, due to neuroendocrine differentiation in some of patients with prostate cancer, they express somatostatin receptors instead of prostate specific membrane antigen. This can be exploited and other modalities like Ga-DOTANOC PET/CT and F-FDG PET/CT should be used in such cases for guiding management. We hereby discuss a similar case of 67-year-old man of adenocarcinoma prostate with neuroendocrine differentiation, which shows the potential pitfall of Ga-PSMA PET/CT imaging and benefit of Ga-DOTANOC PET/CT and F-FDG PET/CT in such cases.

Industrial applications of radioisotope tracers

International Nuclear Information System (INIS)

Easey, J.F.

1985-01-01

Radioisotope tracing techniques are powerful tools for analysing the behaviour of large systems and investigating industrially or economically important processes. The results of radioisotope experiments can yield important information, for example, on parameters such as flow rates, mixing phenomena, flow abnormalities and leaks. Some examples of current AAEC research are described, covering studies on hearth drainage in blast furnaces, flow behaviour in waste-water treatment ponds, and sediment transport in marine environments

Regulations concerning the radionuclides uses in France; Reglementation de l'utilisation des radioisotopes en France

Energy Technology Data Exchange (ETDEWEB)

Vergne, J. [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires; Bugnard, L. [Institut national d' Hygiene (France)

1955-07-01

The progress in the uses of radioisotopes has been conditioned by increasing the number of trained workers and researchers and developing theoretical teaching in universities since 1950 in France as well as developing a national control of the distribution and uses of radioisotopes. With the large diffusion and development of radioisotopes uses and applications, new rules and regulations came to control the importation, exportation, transport and utilization of radioisotopes. In the first part, it described the different French laws since 1934 and their successive modifications which ruled on the production, manipulation and utilization of radioisotopes. An inter-ministerial committee was created in 1952 to advise and inform of all the questions related to the preparation, importation, exportation, possession and distribution of radioisotopes. The transport regulations are in constant evolution and has got to meet with international recommendations. It distinguished three different type of transport: road, river and railway transport, postal transport and finally air transport. All the different transports have their specific packaging, maximum transportable quantity, maximum material intensity and labelling requirements. The regulations about customs duties are specified as well as the administrative formalities for non natural radioisotopes importation. Since 1950, diseases caused by irradiation to natural or artificial radioactive materials are recognised as professional diseases and a table of the actual regulations is presented. (M.P.)

Assessment of radioisotope heaters for remote terrestrial applications

International Nuclear Information System (INIS)

Uherka, K.L.

1987-05-01

This paper examines the feasibility of using radioisotope byproducts for special heating applications at remote sites in Alaska and other cold regions. The investigation included assessment of candidate radioisotope materials for heater applications, identification of the most promising cold region applications, evaluation of key technical issues and implementation constraints, and development of conceptual heater designs for candidate applications. Strontium-90 (Sr-90) was selected as the most viable fuel for radioisotopic heaters used in terrestrial applications. Opportunities for the application of radioisotopic heaters were determined through site visits to representative Alaska installations. Candidate heater applications included water storage tanks, sludge digesters, sewage lagoons, water piping systems, well-head pumping stations, emergency shelters, and fuel storage tank deicers. Radioisotopic heaters for water storage tank freeze-up protection and for enhancement of biological waste treatment processes at remote sites were selected as the most promising applications

Usefulness of {sup 18}F-FDG PET, combined FDG-PET/CT and EUS in diagnosing primary pancreatic carcinoma: A meta-analysis

Energy Technology Data Exchange (ETDEWEB)

Tang Shuang [Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127 (China); Huang Gang, E-mail: huang2802@163.com [Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127 (China); Liu Jianjun [Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127 (China); Liu Tao [Department of Orthopedics, Soochow University, Suzhou (China); Treven, Lyndal [Faculty of Public Health, University of Sydney, Sydney (Australia); Song Saoli; Zhang Chenpeng; Pan Lingling [Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127 (China); Zhang Ting [Department of Anesthesiology, Renji Hospital, Shanghai (China)

2011-04-15

The aim was to evaluate the diagnostic value of {sup 18}F-fluorodeoxyglucose-positron emission tomography ({sup 18}F-FDG PET), combined {sup 18}F-fluorodeoxyglucose-positron emission tomography/computed tomography ({sup 18}F-FDG PET/CT) and endoscopic ultrasonography (EUS) in diagnosing patients with pancreatic carcinoma. MEDLINE, EMBASE, Cochrane library and some other databases, from January 1966 to April 2009, were searched for initial studies. All the studies published in English or Chinese relating to the diagnostic value of {sup 18}F-FDG PET, PET/CT and EUS for patients with pancreatic cancer were collected. Methodological quality was assessed. The statistic software called 'Meta-Disc 1.4' was used for data analysis. Results: 51 studies were included in this meta-analysis. The pooled sensitivity estimate for combined PET/CT (90.1%) was significantly higher than PET (88.4%) and EUS (81.2%). The pooled specificity estimate for EUS (93.2%) was significantly higher than PET (83.1%) and PET/CT (80.1%). The pooled DOR estimate for EUS (49.774) was significantly higher than PET (32.778) and PET/CT (27.105). SROC curves for PET/CT and EUS showed a little better diagnostic accuracy than PET alone. For PET alone, when interpreted the results with knowledge of other imaging tests, its sensitivity (89.4%) and specificity (80.1%) were closer to PET/CT. For EUS, its diagnostic value decreased in differentiating pancreatic cancer for patients with chronic pancreatitis. In conclusion, PET/CT was a high sensitive and EUS was a high specific modality in diagnosing patients with pancreatic cancer. PET/CT and EUS could play different roles during different conditions in diagnosing pancreatic carcinoma.

A set of portable radioisotopic control and measuring instruments

International Nuclear Information System (INIS)

Pospeev, V.V.; Sidorov, V.N.; Tesnavs, Eh.R.; Uleksin, V.I.

1979-01-01

The problems and perspectives are examined of the portable radioisotope instruments application in agriculture, building industry, engeeniring and geological survay and in melioration. Principles are given of creation a series of radioisotopic instruments based on the principle of ganging. The series described consists of radioisotopic densimeters and moisture gages of the portable type, based on the ganging principle. The instruments differ in the measuring converters and have unified information processing and power supply devices. Criteria are stated for the ganging principle estimation, in particular, estimation of the technical means' compatibility. Four different types of compatibility are distinguished: an information compatibility; a metrological compatibility; structural and operational compatibility. Description is given of the unified information processing device - the unified pulse counter of the SIP-1M type and description of a row of radioisotopic measuring converters, which provides a possibility for completing the portable radioisotope densimeter of the RPP-2 type, intended for measuring densities of concrets and soils in the surface layer up to 30 cm and the density range from 1000 to 2500 kg/m 3 ; portable radioisotope densimeter of the RPP-1 type having measuring range from 600 to 1500 kg/m 3 ; surface-depth radioisotopic densimeter of the PPGR-1 type and surface-depth radioisotopic moisture gage of the VPGR-1 type [ru

Abstracts of the third conference on radioisotopes and their applications

International Nuclear Information System (INIS)

2002-10-01

The Third Uzbekistan Conference on radioisotopes and their applications was held on 8-10 October, 2002 in Tashkent, Uzbekistan. The specialists discussed various aspects of modern problems of radiochemistry, radioisotope production, technology of radioisotopes and compounds, activations analysis applications, radionuclides, radioimmunoassays, application of radioisotopes in industry, medicine, biology and agriculture. More than 80 talks were presented in the meeting

Computerized control system for administration of the radioisotope use

International Nuclear Information System (INIS)

Sago, Tsutomu; Ito, Shin; Isozumi, Yasuhito; Kurihara, Norio

1986-01-01

An on-line computer system for administration of the radioisotope use has been developed. This system consists of a multi-job type host computer and two sets of personal computers with identification card-readers. The personal computers are employed as terminal devices for radioisotope users. By the use of an identification card, entrance and leaving times are recorded automatically. Furthermore, an easy operation of the personal computer permits users to access to the information of their resistered radioisotopes, such as nuclides, chemical forms, updated activities, storage locations, and history of usage. A recording sheet on which those data are printed is provided from the personal computer. After the use of radioisotopes, users can record their data on the recording sheets. These records are used as the input data to this system to update the data of the used radioisotopes. Owing to the concise format of the recording sheet and various sorting programs developed in present work, this system enables us to grasp the exact flow of the radioisotopes from purchase to disposal. Out-put data from high-speed kanji printer can provide many important books which are legally requested to be kept for administration of the radioisotope use. (author)

The production and application of radioisotopes

International Nuclear Information System (INIS)

O'Neill, W.P.; Evans, D.J.R.

1987-01-01

This paper outlines the historical evolution of radioisotopes from first concepts and discoveries to significant milestones in their production and the development of applications throughout the world. Regarding production, it addresses the methods that have been used at various stages during this evolution outlining the important findings that have led to further developments. With respect to radioisotope applications, the paper addresses the development of markets in industry, medicine, and agriculture and comments on the size of these markets and their rate of growth. Throughout, the paper highlights the Canadian experience and it also presents a Canadian view of emerging prospects and a forecast of how the future for radioisotopes might develop. (author)

Positron emission tomography (PET) in psychiatry

International Nuclear Information System (INIS)

Buchsbaum, M.S.

1984-01-01

In the past the approach to the brain has been necessarily indirect, employing peripheral fluids to assess central and regional neurochemical processes. Blood, urine, skin and muscle biopsy, and cerebrospinal fluid are valuable reflectors of the neurochemical and neuropharmacological activity of the brain, but are removed in time and place from disordered thought processes and diluted by the products of both functional and dysfunctional brain systems. Biopsy studies have helped in studying the functional disorders of organs like the liver, but they are destructive to the brain and less useful because unlike these organs, the brain has a regional variation in its chemistry. The experimental insights from animal studies focusing on the pharmacology of individual cell groups - in striatum or locus coeruleus, for example - cannot easily or unambigiously be applied to clinical populations. Positron emission tomography (PET) is a versatile approach utilizing the mathematics of x-ray transmission scanning (CT scanning) to produce slice images of radioisotope distribution. PET makes possible a wide range of metabolic studies. Positron emitters such as carbon-11 or fluorine-18 can be used to label glucose, amino acids, drugs, neurotransmitter precursors, and many other molecules and examine their distribution and fate in discrete cell groups

Preparation of an annual report for a consolidated radioisotope licence

International Nuclear Information System (INIS)

1985-01-01

A consolidated radioisotope licence is a single license issued by the Atomic Energy Control Board (AECB) to an institution having many users of radioactive materials. The licence is issued when the institution has fulfilled the requirements set by the AECB and has implemented policies and procedures which will ensure the maintenance of an effective radiation safety program. The consolidated licence is retained only if the results of AECB inspections are satisfactory -- or remedial action is taken promptly -- and if the institution reports regularly about the status of its radiation safety program. One aspect of this reporting procedure is an annual report. This guide describes the information that the AECB requires in the annual report. The guide applies primarily to universities and research institutions where a wide variety of radioisotope uses take place. The guide does not affect most other institutions or facilities, either because the nature and extent of their operations with radioactive materials do not lend themselves to consolidated licensing or because they are not licensed by the Radioisotopes and Transportation Division. (For example, this guide does not apply to reactors, to accelerators, or to waste management or uranium mining or refining facilities.) The information in the annual report should be specific to the consolidated radioisotope licence. Incidents, staff exposures, and waste associated with accelerators, research reactors, and waste management facilities should be excluded from this report unless they affected activities under the consolidated licence

Twenty years of Korea radioisotope association history

International Nuclear Information System (INIS)

2005-09-01

This contents has two parts. The first part describes the present and post of Korea radioisotope association which are about the foundation of the association, organization, main projects and vision of the association. The second part is about the use and the prospect of radiation and radioisotope in Korea, which shows the plan of expansion of use of radiation and radioisotope, the prospect and present condition in fields such as medical, industry and farming, product and distribution, research and development of human resources, system and management of safety of radiation.

Diagnostic accuracy of 18F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis

International Nuclear Information System (INIS)

Treglia, Giorgio; Salsano, Marco; Stefanelli, Antonella; Mattoli, Maria Vittoria; Giordano, Alessandro; Bonomo, Lorenzo

2012-01-01

To systematically review and meta-analyse literature data on the diagnostic performance of fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) in patients with Ewing sarcoma family tumours (ESFT). PubMed/MEDLINE, Embase and Scopus databases were searched for articles that evaluated FDG-PET and PET/CT in patients with ESFT from inception to 31 May 2011. Studies that fulfilled the three following criteria were included in the systematic review: FDG-PET or PET/CT performed in patients with ESFT; articles about the diagnostic accuracy of FDG-PET and PET/CT; sample size of at least 10 patients with ESFT were included. Studies in which there were sufficient data to reassess sensitivity and specificity of FDG-PET or PET/CT in ESFT were included in the meta-analysis, excluding duplicate publications. Finally, pooled sensitivity, pooled specificity and area under the receiver operating characteristic (ROC) curve of FDG-PET or PET/CT in ESFT were calculated. We found 13 studies comprising a total of 342 patients with ESFT. The main findings of the studies included are presented. The meta-analysis of five selected studies provided these results about FDG-PET and PET/CT in ESFT: pooled sensitivity: 96% (95% confidence interval [CI] 91-99%); pooled specificity: 92% (95% CI 87-96%); area under the ROC curve: 0.97. With regard to the staging and restaging of patients with ESFT, the sensitivity, specificity and accuracy of FDG-PET and PET/CT are high; the combination of FDG-PET or PET/CT with conventional imaging is a valuable tool for the staging and restaging of ESFT and has a relevant impact on the treatment strategy plan. (orig.)

A PSMA Ligand Labeled with Cobalt-55 for PET Imaging of Prostate Cancer

DEFF Research Database (Denmark)

Dam, Johan Hygum; Olsen, Birgitte Brinkmann; Baun, Christina

2017-01-01

PURPOSE: Prostate-specific membrane antigen (PSMA) comprises a recognized target for molecular imaging of prostate cancer. As such, radiolabeled PSMA inhibitors are of great value for diagnosis and staging of this disease. Herein, we disclose the preclinical characterization of [(55)Co]PSMA-617...... for positron emission tomography (PET)/x-ray computed tomography (CT) imaging of prostate cancer lesions. PROCEDURES: By the application of microwave heating, PSMA-617 in acetate buffer (0.4 M, pH 4.4) was labeled with the radioisotopes cobalt-55/57. The extents of internalization and dissociation constants (K...... to the biodistribution in LNCaP xenograft mice, [(57)Co]PSMA-617 displayed a high and relatively constant uptake in the tumor (12.9 %IA/g at 1 h to 10.5 %IA/g at 24 h) with an initial but transient high uptake in the kidneys, adrenals, and spleen. Tumor-to-background ratios improved over time as normal tissue cleared...

Integro-differential equation analysis and radioisotope imaging systems. Research proposal. [Testing of radioisotope imaging system in phantoms

Energy Technology Data Exchange (ETDEWEB)

Hart, H.

1976-03-09

Design modifications of a five-probe focusing collimator coincidence radioisotope scanning system are described. Clinical applications of the system were tested in phantoms using radioisotopes with short biological half-lives, including /sup 75/Se, /sup 192/Ir, /sup 43/K, /sup 130/I, and /sup 82/Br. Data processing methods are also described. (CH)

Abstracts of the second conference on radioisotopes and their applications

Energy Technology Data Exchange (ETDEWEB)

NONE

2000-10-01

The Second Uzbekistan Conference on radioisotopes and their applications was held on 3-5 October, 2000 in Tashkent, Uzbekistan. The specialists discussed various aspects of modern problems of radiochemistry, radioisotope production, technology of radioisotopes and compounds, activations analysis applications, radionuclides, radioimmunoassays, application of radioisotopes in industry, medicine, biology and agriculture. More than 80 talks were presented in the meeting. (A.A.D.)

Radioisotope methodology course radioprotection aspects

International Nuclear Information System (INIS)

Bergoc, R.M.; Caro, R.A.; Menossi, C.A.

1996-01-01

The advancement knowledge in molecular and cell biology, biochemistry, medicine and pharmacology, which has taken place during the last 50 years, after World War II finalization, is really outstanding. It can be safely said that this fact is principally due to the application of radioisotope techniques. The research on metabolisms, biodistribution of pharmaceuticals, pharmacodynamics, etc., is mostly carried out by means of techniques employing radioactive materials. Radioisotopes and radiation are frequently used in medicine both as diagnostic and therapeutic tools. The radioimmunoanalysis is today a routine method in endocrinology and in general clinical medicine. The receptor determination and characterization is a steadily growing methodology used in clinical biochemistry, pharmacology and medicine. The use of radiopharmaceuticals and radiation of different origins, for therapeutic purposes, should not be overlooked. For these reasons, the importance to teach radioisotope methodology is steadily growing. This is principally the case for specialization at the post-graduate level but at the pre graduate curriculum it is worthwhile to give some elementary theoretical and practical notions on this subject. These observations are justified by a more than 30 years teaching experience at both levels at the School of Pharmacy and Biochemistry of the University of Buenos Aires, Argentina. In 1960 we began to teach Physics III, an obligatory pregraduate course for biochemistry students, in which some elementary notions of radioactivity and measurement techniques were given. Successive modifications of the biochemistry pregraduate curriculum incorporated radiochemistry as an elective subject and since 1978, radioisotope methodology, as obligatory subject for biochemistry students. This subject is given at the radioisotope laboratory during the first semester of each year and its objective is to provide theoretical and practical knowledge to the biochemistry students, even

A Review of the Production of ''Special'' Radioisotopes

International Nuclear Information System (INIS)

Stang, L.G. Jr.

1963-01-01

'special' radioisotopes and tagged beads available from Brookhaven are reviewed very briefly, including recent unpublished work concerned with the successful development of an Al 28 ''generator'', the production of Sc 47 , the increase in Mg 28 specific activity to 40 mc/g, and the use of Li 6 H 2 to effect (n, particle) reactions. (author) [fr

Contribution to the study of radioisotopic methods in pharmacokinetics. Application to specific determinations of drugs or their metabolites

International Nuclear Information System (INIS)

Khiat, Mouloud.

1977-01-01

The aim of this work was to refute one of the major criticisms expressed on the used of labelled molecules, that they give an overall result. Techniques were therefore developed to determine quantitatively and specifically the kinetics of the drug itself or its metabolites. Two methods turning to account the great sensitivity and facility offered by labelled molecules have been adopted: - reverse isotopic dilution and double isotopic dilution, applied to some medicinal molecules. In part one the glipentide labelled molecule was used to measure the unchanged product in rat plasma: the kinetics are established. In part two the plasma fraction curves of unchanged products and their metabolites were studied for two molecules of similar structure: cyclobutane carboxylic acid and propyl-3 cyclobutane carboxylic acid. Finally a radiocompetitive method to determine a sulfamido-benzoic diuretic, based on the interaction with carbonic anhydrase, was investigated. The sensitivity of these radioisotopic methods depends on the specific activity of the labelled molecule. For the glipentide for instance, where the specific activity is very high, as little as 2 ng/ml of plasma can be determined. The specific activities of cyclobutane carboxylic, propyl-3 cyclobutane carboxylic and sulfamido-3 chloro-4 benzoic acids are not high enough for measurements better than 1 μg/ml plasma to be obtained [fr

Recommendations for the use of PET and PET-CT for radiotherapy planning in research projects.

Science.gov (United States)

Somer, E J; Pike, L C; Marsden, P K

2012-08-01

With the increasing use of positron emission tomography (PET) for disease staging, follow-up and therapy monitoring in a number of oncological indications there is growing interest in the use of PET and PET-CT for radiation treatment planning. In order to create a strong clinical evidence base for this, it is important to ensure that research data are clinically relevant and of a high quality. Therefore the National Cancer Research Institute PET Research Network make these recommendations to assist investigators in the development of radiotherapy clinical trials involving the use of PET and PET-CT. These recommendations provide an overview of the current literature in this rapidly evolving field, including standards for PET in clinical trials, disease staging, volume delineation, intensity modulated radiotherapy and PET-augmented planning techniques, and are targeted at a general audience. We conclude with specific recommendations for the use of PET in radiotherapy planning in research projects.

Radiopharmaceuticals in positron emission tomography: Radioisotope productions and radiolabelling procedures at the Austin and Repatriation Medical Centre

Energy Technology Data Exchange (ETDEWEB)

Tochon-Danguy, H.J.; Sachinidis, J.I.; Chan, J.G.; Cook, M. [Austin and Repatriation Medical Centre, Melbourne, VIC (Australia). Centre for Positron Emission Tomography

1997-10-01

Positron Emission Tomography (PET) is a technique that utilizes positron-emitting radiopharmaceuticals to map the physiology, biochemistry and pharmacology of the human body. Positron-emitting radioisotopes produced in a medical cyclotron are incorporated into compounds that are biologically active in the body. A scanner measures radioactivity emitted from a patient`s body and provides cross-sectional images of the distribution of these radiolabelled compounds in the body. It is the purpose of this paper to review the variety of PET radiopharmaceuticals currently produced at the Austin and Repatriation Medical Centre in Melbourne. Radioisotope production, radiolabelling of molecules and quality control of radiopharmaceuticals will be discussed. A few examples of their clinical applications will be shown as well. During the last five years we achieved a reliable routine production of various radiopharmaceuticals labelled with the four most important positron-emitters: oxygen-15 (t,{sub 1/2}=2min), nitrogen-13 (t{sub 1/2}= 10 min), carbon-11 (t{sub 1/2}=20 min) and fluorine-18 (t{sub 1/2}= 110 min). These radiopharmaceuticals include [{sup 15}O]oxygen, [{sup 15}O]carbon monoxide, [{sup 15}O]carbon dioxide, [{sup 15}O]water, [{sup 13}N]ammonia, [{sup 11}C]flumazenil, [{sup 11}C]SCH23390, [{sup 18}F]fluoromisonidazole and [{sup 18}F]fluoro-deoxy-glucose ([{sup 18}F]FDG). In addition, since the half life of [{sup 18}F] is almost two hours, regional distribution can be done, and the Austin and Repatriation Medical Centre is currently supplying [{sup 18}F]FDG in routine to other hospitals. Future new radiopharmaceuticals development include a [{sup 18}F]thymidine analog to measure cell proliferation and a [{sup 11}C]pyrroloisoquinoline to visualize serotonergic neuron abnormalities. (authors) 23 refs., 2 tabs.

Design of a 1 MeV 3He+ RFQ for the SAIC PET accelerator facility

International Nuclear Information System (INIS)

Cornelius, W.D.; Young, P.E.

1993-01-01

The novel design of a 1 MeV 3 He + radiofrequency quadrupole (RFQ) accelerator is discussed. This RFQ is the first segment of an accelerator for the production of radioisotopes for positron emission tomography (PET) applications. This RFQ is unusual in that two specific innovations were incorporated into the design. The mechanical design is a hybrid of conventional four-vane and four-rod geometries. This hybridization reduces the physical dimensions of the accelerator without sacrificing too much in rf efficiency and has the added benefit of reducing the sensitivity to mechanical alignment errors. In addition, the beam dynamics of the last few cells was modified to tailor the output beam parameters to improve the beam transport through the next accelerator section. The details of the mechanical structure, the mechanical and electrical alignment experiences, and a comparison of the theoretical and experimental performance of this accelerator are also discussed. (orig.)

Establishment study of the in vivo imaging analysis with small animal imaging modalities (micro-PET and micro-SPECT/CT) for bio-drug development

Energy Technology Data Exchange (ETDEWEB)

Jang, Beomsu; Park, Sanghyeon; Park, Jeonghoon; Jo, Sungkee; Jung, Uhee; Kim, Seolwha; Lee, Yunjong; Choi, Daeseong

2011-01-15

In this study, we established the image acquisition and analysis procedures of micro-PET, SPECT/CT using the experimental animal (mouse) for the development of imaging assessment method for the bio-drug. We examined the micro-SPECT/CT, PET imaging study using the Siemens Inveon micro-multimodality system (SPECT/CT) and micro-PET with {sup 99m}Tc-MDP, DMSA, and {sup 18}F-FDG. SPECT imaging studies using 3 types of pinhole collimators. 5-MWB collimator was used for SPECT image study. To study whole-body distribution, {sup 99m}Tc-MDP SPECT image study was performed. We obtained the fine distribution image. And the CT images was obtained to provide the anatomical information. And then these two types images are fused. To study specific organ uptake, we examined {sup 99}mTc-DMSA SPECT/CT imaging study. We also performed the PET image study using U87MG tumor bearing mice and {sup 18}F-FDG. The overnight fasting, warming and anesthesia with 2% isoflurane pretreatment enhance the tumor image through reducing the background uptake including brown fat, harderian gland and skeletal muscles. Also we got the governmental approval for use of x-ray generator for CT and radioisotopes as sealed and open source. We prepared the draft of process procedure for the experimental animal imaging facility. These research results can be utilized as a basic image study protocols and data for the image assessment of drugs including biological drug.

Establishment study of the in vivo imaging analysis with small animal imaging modalities (micro-PET and micro-SPECT/CT) for bio-drug development

International Nuclear Information System (INIS)

Jang, Beomsu; Park, Sanghyeon; Park, Jeonghoon; Jo, Sungkee; Jung, Uhee; Kim, Seolwha; Lee, Yunjong; Choi, Daeseong

2011-01-01

In this study, we established the image acquisition and analysis procedures of micro-PET, SPECT/CT using the experimental animal (mouse) for the development of imaging assessment method for the bio-drug. We examined the micro-SPECT/CT, PET imaging study using the Siemens Inveon micro-multimodality system (SPECT/CT) and micro-PET with 99m Tc-MDP, DMSA, and 18 F-FDG. SPECT imaging studies using 3 types of pinhole collimators. 5-MWB collimator was used for SPECT image study. To study whole-body distribution, 99m Tc-MDP SPECT image study was performed. We obtained the fine distribution image. And the CT images was obtained to provide the anatomical information. And then these two types images are fused. To study specific organ uptake, we examined 99 mTc-DMSA SPECT/CT imaging study. We also performed the PET image study using U87MG tumor bearing mice and 18 F-FDG. The overnight fasting, warming and anesthesia with 2% isoflurane pretreatment enhance the tumor image through reducing the background uptake including brown fat, harderian gland and skeletal muscles. Also we got the governmental approval for use of x-ray generator for CT and radioisotopes as sealed and open source. We prepared the draft of process procedure for the experimental animal imaging facility. These research results can be utilized as a basic image study protocols and data for the image assessment of drugs including biological drug

Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: A systematic review and meta-analysis

International Nuclear Information System (INIS)

Chang, Ming-Che; Chen, Jin-Hua; Liang, Ji-An; Yang, Kuang-Tao; Cheng, Kai-Yuan; Kao, Chia-Hung

2013-01-01

Background: A meta-analysis was conducted to evaluate the accuracy of whole-body positron emission tomography (PET) or PET/CT in M staging of nasopharyngeal carcinoma (NPC). Methods: Through a search of relevant English language studies from October 1996 to September 2011, pooled estimated sensitivity, specificity, positive likelihood ratios, negative likelihood ratios, and summary receiver operating characteristic (SROC) curves of whole-body PET or PET/CT in M staging of NPC were calculated. Results: Three PET and 5 PET/CT studies were identified. The pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of FDG-PET or PET/CT were 0.83 (95% confidence interval [CI], 0.77–0.88), 0.97 (95% CI, 0.95–0.98), 23.38 (95% CI, 16.22–33.69), and 0.19 (95% CI, 0.13–0.25), respectively. The area under curve was 0.9764 and Q* index estimate was 0.9307 for FDG-PET or PET/CT. Conclusion: Current evidence confirms the good diagnostic performance of the whole-body FDG-PET or PET/CT in M staging of NPC

Technical and economical availability of radioisotopes production in Brazil

International Nuclear Information System (INIS)

Lima, J.O.V.

1981-10-01

The technical and economical availability of radioisotopes production in Brazil by a low power research reactor, are done. The importance of radioisotope utilization and controled radiations, in areas such as medicine, industry and cost evaluation for the production in nuclear reactors. In the cost evaluation of a radioisotope production reactor, the studies developed by the Department of Nuclear Engineering of Universidade Federal de Minas Gerais - DEN/UFMG were used. The information analysis justify the technical and economical availability and the necessity of the radioisotopes production in Brazil. (E.G.) [pt

PET with a dual-head coincidence gamma camera in head and neck cancer: A comparison with computed tomography and dedicated PET

International Nuclear Information System (INIS)

Zimny, M.

2001-01-01

Positron emission tomography with 18 F-fluoro-deoxyglucose (FDG PET) is a promising imaging tool for detecting and staging of primary or recurrent head and neck cancer. The aim of this study was to evaluate a dual-head gamma camera modified for coincidence detection (KGK-PET) in comparison to computed tomography (CT) and dedicated PET (dPET). 50 patients with known or suspected primary or recurrent head and neck cancer were enrolled. 32 patients underwent KGK-PET and dPET using a one-day protocol. The sensitivity for the detection of primary/ recurrent head and neck cancer for KGK-PET and CT was 80% and 54%, respectively, specificity was 73% and 82%, respectively. The sensitivity and specificity for the detection of lymph node metastases based on neck sides with KGK-PET was 71% (CT: 65%) and 88% (CT: 89%) respectively. In comparison to dPET, KGK-PET revealed concordant results in 32/32 patients with respect to primary tumor/recurrent disease and in 55/60 evaluated neck sides. All involved neck sides that were missed by KGK-PET were also negative with dPET. These results indicate that in patients with head and neck cancer KGK-PET reveals information, that are similar to dPET and complementary to CT. (orig.) [de

Elementary concepts of the radioisotopes uses

International Nuclear Information System (INIS)

Pisarev, Mario A.

2004-01-01

Endocrinology has been one of the specialties earlier benefited for the radioisotopes uses in the diagnosis and treatment of different affections. These applications are based on the radioisotopes property of biochemical behaving as non- radioactive molecules, and at the same time, radiations emitting that can be detected by suitable means (diagnostic utility) or that have effects on biological systems (therapeutic action). (author) [es

Development and application of industrial radioisotope instruments in China

International Nuclear Information System (INIS)

Lu Yanxiao

1994-09-01

Industrial radioisotope instruments are emerging as advanced monitoring, controlling and automation tools for industries in China. Especially the on-line analysis systems based on radioisotope instruments, referred to as nucleonic control systems (NCS), have more and more important role in the modernization and optimization of industrial processes. Over nearly four decades significant progress has been made in the development and application of radioisotope instruments in China. After a brief review of the history of radioisotope instruments, the state of the art of this kind of instruments and recent examples of their applications are given. Technical and economic benefits have resulted from the industrial applications of radioisotope instruments and the sales of products of their own in marketing. It is expected that along with the high speed growth of national economy, there will be greater demand for radioisotope instruments and nucleonic control systems in Chinese industry to promote the technological transformation and progress of traditional industries and to establish high-tech industries with technology-intensive products. Sustained efforts for the research and development of radioisotope instrument should be made to up-grade domestic instruments and to satisfy the needs of the smaller scale industries more common in China for low cost systems. (1 fig., 2 tabs.)

Radioisotope-powered photovoltaic generator

International Nuclear Information System (INIS)

McKlveen, J.W.; Uselman, J.

1979-01-01

Disposing of radioactive wastes from nuclear power plants has become one of the most important issues facing the nuclear industry. In a new concept, called a radioisotope photovoltaic generator, a portion of this waste would be used in conjunction with a scintillation material to produce light, with subsequent conversion into electricity via photovoltaic cells. Three types of scintillators and two types of silicon cells were tested in six combinations using 32 P as the radioisotope. The highest system efficiency, determined to be 0.5% when the light intensity was normalized to 100 mW/cm 2 , was obtained using a CsI crystal scintillator and a Helios photovoltaic cell

Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.

Science.gov (United States)

Ryvlin, P; Bouvard, S; Le Bars, D; De Lamérie, G; Grégoire, M C; Kahane, P; Froment, J C; Mauguière, F

1998-11-01

We assessed the clinical utility of [11C]flumazenil-PET (FMZ-PET) prospectively in 100 epileptic patients undergoing a pre-surgical evaluation, and defined the specific contribution of this neuro-imaging technique with respect to those of MRI and [18F]fluorodeoxyglucose-PET (FDG-PET). All patients benefited from a long term video-EEG monitoring, whereas an intracranial EEG investigation was performed in 40 cases. Most of our patients (73%) demonstrated a FMZ-PET abnormality; this hit rate was significantly higher in temporal lobe epilepsy (94%) than in other types of epilepsy (50%) (P lobe epilepsy associated with MRI signs of hippocampal sclerosis, FMZ-PET abnormalities delineated the site of seizure onset precisely, whenever they were coextensive with FDG-PET abnormalities; (ii) in bi-temporal epilepsy, FMZ-PET helped to confirm the bilateral origin of seizures by showing a specific pattern of decreased FMZ binding in both temporal lobes in 33% of cases; (iii) in patients with a unilateral cryptogenic frontal lobe epilepsy, FMZ-PET provided further evidence of the side and site of seizure onset in 55% of cases. Thus, FMZ-PET deserves to be included in the pre-surgical evaluation of these specific categories of epileptic patients, representing approximately half of the population considered for epilepsy surgery.

Diagnostic accuracy of {sup 18}F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis

Energy Technology Data Exchange (ETDEWEB)

Treglia, Giorgio [Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Department of Bioimaging and Radiological Sciences, Rome (Italy); Institute of Nuclear Medicine, Positron Emission Tomography Centre, Catholic University of the Sacred Heart, Department of Bioimaging and Radiological Sciences, Rome (Italy); Salsano, Marco; Stefanelli, Antonella; Mattoli, Maria Vittoria; Giordano, Alessandro [Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Department of Bioimaging and Radiological Sciences, Rome (Italy); Bonomo, Lorenzo [Institute of Radiology, Catholic University of the Sacred Heart, Department of Bioimaging and Radiological Sciences, Rome (Italy)

2012-03-15

To systematically review and meta-analyse literature data on the diagnostic performance of fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) in patients with Ewing sarcoma family tumours (ESFT). PubMed/MEDLINE, Embase and Scopus databases were searched for articles that evaluated FDG-PET and PET/CT in patients with ESFT from inception to 31 May 2011. Studies that fulfilled the three following criteria were included in the systematic review: FDG-PET or PET/CT performed in patients with ESFT; articles about the diagnostic accuracy of FDG-PET and PET/CT; sample size of at least 10 patients with ESFT were included. Studies in which there were sufficient data to reassess sensitivity and specificity of FDG-PET or PET/CT in ESFT were included in the meta-analysis, excluding duplicate publications. Finally, pooled sensitivity, pooled specificity and area under the receiver operating characteristic (ROC) curve of FDG-PET or PET/CT in ESFT were calculated. We found 13 studies comprising a total of 342 patients with ESFT. The main findings of the studies included are presented. The meta-analysis of five selected studies provided these results about FDG-PET and PET/CT in ESFT: pooled sensitivity: 96% (95% confidence interval [CI] 91-99%); pooled specificity: 92% (95% CI 87-96%); area under the ROC curve: 0.97. With regard to the staging and restaging of patients with ESFT, the sensitivity, specificity and accuracy of FDG-PET and PET/CT are high; the combination of FDG-PET or PET/CT with conventional imaging is a valuable tool for the staging and restaging of ESFT and has a relevant impact on the treatment strategy plan. (orig.)

RADIOISOTOPE INVENTORY FOR TSPA-SR

International Nuclear Information System (INIS)

Leigh, C.; Rechard, R.

2001-01-01

The total system performance assessment for site recommendation (TSPA-SR), on Yucca Mountain, as a site (if suitable) for disposal of radioactive waste, consists of several models. The Waste Form Degradation Model (i.e, source term) of the TSPA-SR, in turn, consists of several components. The Inventory Component, discussed here, defines the inventory of 26 radioisotopes for three representative waste categories: (1) commercial spent nuclear fuel (CSNF), (2) US Department of Energy (DOE) spent nuclear fuel (DSNF), and (3) high-level waste (HLW). These three categories are contained and disposed of in two types of waste packages (WPs)--CSNF WPs and co-disposal WPs, with the latter containing both DSNF and HLW. Three topics are summarized in this paper: first, the transport of radioisotopes evaluated in the past; second, the development of the inventory for the two WP types; and third, the selection of the most important radioisotopes to track in TSPA-SR

Design considerations for foil windows for PET radioisotope targets

International Nuclear Information System (INIS)

Hughey, B.J.; Shefer, R.E.; Klinkowstein, R.E.; Welch, M.J.

1992-01-01

This paper describes the results of a study performed at SRL to develop analytical and computational techniques for optimizing the design of conduction-cooled foil windows for PET targets. Single foil conduction cooled windows have been found to be good target entrance windows for both low energy accelerators and medium energy cyclotrons. Detailed thermal analysis has given an approximate analytical expression for the maximum temperature reached in a foil window under conditions of realistic ion beam bombardment. The effects of 'hot spots' in the beam density profile were investigated. It was shown that a factor of two safety margin in window design should be adequate to compensate for any possible beam hot spots. In addition, the reduction of foil stress by slack mounting was verified by experiments. The properties of conventional and novel foil materials were investigated for use in conduction cooled windows. Novel foil materials include two-component Al/Ti and Al/Havar foil. Results on the testing of candidate foil materials for thermal conductivity and mechanical strength at elevated temperature were presented. Two optimum foil window geometries were analyzed: a high aspect ratio window and a multiply slotted window. The multiply slotted window combines the advantages of a high aspect ratio foil window with a circular beam strike and is a promising window design for both TCA and cyclotron targets. A multiply slotted window for a N 2 gas target for 15 O production was designed using the methodologies discussed above. This prototype target was successfully tested using the TCA beam at SRL. (author) 6 figs., 3 tabs., 10 refs

Site specific measurements of bone formation using [18F] sodium fluoride PET/CT.

Science.gov (United States)

Blake, Glen M; Puri, Tanuj; Siddique, Musib; Frost, Michelle L; Moore, Amelia E B; Fogelman, Ignac

2018-02-01

Dynamic positron emission tomography (PET) imaging with fluorine-18 labelled sodium fluoride ([ 18 F]NaF) allows the quantitative assessment of regional bone formation by measuring the plasma clearance of fluoride to bone at any site in the skeleton. Today, hybrid PET and computed tomography (CT) dual-modality systems (PET/CT) are widely available, and [ 18 F]NaF PET/CT offers a convenient non-invasive method of studying bone formation at the important osteoporotic fracture sites at the hip and spine, as well as sites of pure cortical or trabecular bone. The technique complements conventional measurements of bone turnover using biochemical markers or bone biopsy as a tool to investigate new therapies for osteoporosis, and has a potential role as an early biomarker of treatment efficacy in clinical trials. This article reviews methods of acquiring and analyzing dynamic [ 18 F]NaF PET/CT scan data, and outlines a simplified approach combining venous blood sampling with a series of short (3- to 5-minute) static PET/CT scans acquired at different bed positions to estimate [ 18 F]NaF plasma clearance at multiple sites in the skeleton with just a single injection of tracer.

Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review

International Nuclear Information System (INIS)

Ciliberto, Mario; Maggi, Fabio; Treglia, Giorgio; Padovano, Federico; Calandriello, Lucio; Giordano, Alessandro; Bonomo, Lorenzo

2013-01-01

The aim of the article is to systematically review published data about the comparison between positron emission tomography (PET) or PET/computed tomography (PET/CT) using Fluorine-18-Fluorodeoxyglucose (FDG) and whole-body magnetic resonance imaging (WB-MRI) in patients with different tumours. A comprehensive literature search of studies published in PubMed/MEDLINE, Scopus and Embase databases through April 2012 and regarding the comparison between FDG-PET or PET/CT and WB-MRI in patients with various tumours was carried out. Forty-four articles comprising 2287 patients were retrieved in full-text version, included and discussed in this systematic review. Several articles evaluated mixed tumours with both diagnostic methods. Concerning the specific tumour types, more evidence exists for lymphomas, bone tumours, head and neck tumours and lung tumours, whereas there is less evidence for other tumour types. Overall, based on the literature findings, WB-MRI seems to be a valid alternative method compared to PET/CT in oncology. Further larger prospective studies and in particular cost-effectiveness analysis comparing these two whole-body imaging techniques are needed to better assess the role of WB-MRI compared to FDG-PET or PET/CT in specific tumour types

Miniaturized radioisotope solid state power sources

Science.gov (United States)

Fleurial, J.-P.; Snyder, G. J.; Patel, J.; Herman, J. A.; Caillat, T.; Nesmith, B.; Kolawa, E. A.

2000-01-01

Electrical power requirements for the next generation of deep space missions cover a wide range from the kilowatt to the milliwatt. Several of these missions call for the development of compact, low weight, long life, rugged power sources capable of delivering a few milliwatts up to a couple of watts while operating in harsh environments. Advanced solid state thermoelectric microdevices combined with radioisotope heat sources and energy storage devices such as capacitors are ideally suited for these applications. By making use of macroscopic film technology, microgenrators operating across relatively small temperature differences can be conceptualized for a variety of high heat flux or low heat flux heat source configurations. Moreover, by shrinking the size of the thermoelements and increasing their number to several thousands in a single structure, these devices can generate high voltages even at low power outputs that are more compatible with electronic components. Because the miniaturization of state-of-the-art thermoelectric module technology based on Bi2Te3 alloys is limited due to mechanical and manufacturing constraints, we are developing novel microdevices using integrated-circuit type fabrication processes, electrochemical deposition techniques and high thermal conductivity substrate materials. One power source concept is based on several thermoelectric microgenerator modules that are tightly integrated with a 1.1W Radioisotope Heater Unit. Such a system could deliver up to 50mW of electrical power in a small lightweight package of approximately 50 to 60g and 30cm3. An even higher degree of miniaturization and high specific power values (mW/mm3) can be obtained when considering the potential use of radioisotope materials for an alpha-voltaic or a hybrid thermoelectric/alpha-voltaic power source. Some of the technical challenges associated with these concepts are discussed in this paper. .

Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy

International Nuclear Information System (INIS)

Ishikita, Tomohiro; Oriuchi, Noboru; Higuchi, Tetsuya

2010-01-01

Clinical application of fluorodeoxyglucose (FDG)-positron emission tomography (PET) in head and neck cancer includes identification of metastases, unknown primary head and neck malignancy, or second primary carcinoma, and also recurrent tumor after treatment. In this study, the additional value of PET/CT fusion images over PET images alone was evaluated in patients with initial staging and follow up of head and neck malignancy. Forty patients with suspected primary head and neck malignancy and 129 patients with suspected relapse after treatment of head and neck malignancy were included. FDG-PET/CT study was performed after the intravenous administration of FDG (5 MBq/kg). Target of evaluation was set at primary tumor, cervical lymph node, and whole body. PET images and PET with CT fusion images were compared. Sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) were calculated. Results of PET and PET/CT were compared with postoperative histopathological examination, and case by case comparison of PET and PET/CT results for each region was performed. The additional value of CT images over PET only images was assessed. Statistical differences in sensitivity and specificity were evaluated. In the comparative evaluation of 507 targets by PET alone and PET/CT, 401 targets showed agreement of the results. Of the 106 discordant targets, 103 showed a positive result on PET alone and negative result on PET/CT. These results showed a significant difference (p<0.01). Sensitivity of PET/CT was slightly higher than that of PET without statistical significance, while specificity of PET/CT was significantly higher than that of PET alone (Initial Staging: 90.5% vs. 62.2%, p<0.01; Follow up: 97.2% vs. 74.4%, p<0.01). In Fisher's direct probability test, a significant difference was noted in the sensitivity (Initial staging: 91.3% vs. 87.0%, p<0.01; Follow up: 93.9% vs. 91.4%, p<0.01). Combined PET/CT showed improved diagnostic

Aspects of radioisotopes utilization in clinical medicine

International Nuclear Information System (INIS)

Rocha, A.F.G.; Lima e Forti, C.A. de; Cunha, M. da C.; Souza Maciel, O. de

1973-01-01

A revision concerning radioisotope use in Medicine have been dow. Harmless and effeciency of radioisotopes are shown. Techniques and advantages of tracers used for brain scintiscanning, lung scintiscanning, liver scintinscanning, spleen scintiscanning, bone scintiscanning and thyroid scintiscanning are described and images of them are presented [pt

Structure and manual of radioisotope-production data base, ISOP

International Nuclear Information System (INIS)

Hata, Kentaro; Terunuma, Kusuo

1994-02-01

We planned on collecting the information of radioisotope production which was obtained from research works and tasks at the Department of Radioisotopes in JAERI, and constructed a proto-type data base ISOP after discussion of the kinds and properties of the information available for radioisotope production. In this report the structure and the manual of ISOP are described. (author)

Radioisotopes in non-destructive testing

International Nuclear Information System (INIS)

Domanus, J.C.

1976-12-01

After defining nondestructive testing (NDT) and comparing this concept with destructive testing, a short description is given of NDT methods other than radiologic. The basic concepts of radiologic methods are discussed and the principles of radiography are explained. Radiation sources and gamma radiography machines are next reviewed and radiographic inspection of weldings and castings is described. A brief description is given of the radiographic darkroom and accessories. Other radioisotope methods, such as neutron radiography, are shortly reviewed. Cost estimations for radioisotopic equipment conclude the report. (author)

Radioisotope production at PUSPATI - five year programme

International Nuclear Information System (INIS)

Yusof Azuddin Ali; Abdul Rahman Mohamad Ali.

1983-01-01

Most of the basic laboratory facilities for radioisotopes production at PUSPATI will be commissioned by September 1983. Work on setting up of production and dispensing facilities is in progress as the nuclides being worked on are those that are commonly used in medical applications, such as Tc-99m, I-131, P-32 and other nuclides such as Na-24 and K-42. Kits for compounds labelled with Tc-99m such as Stannous Pyrophosphate, Sulfur Colloid and Stannous Glucoheptonate are being prepared. The irradiation facilities available now for radioisotope production at the PUSPATI TRIGA Reactor include a central thimble (flux density 1 x 10 13 n.cm -2 S -1 ) and a rotary specimen rack (flux density 0.2 x 10 13 n.cm -1 S -1 ). Irradiation schedules and target handling techniqes are discussed. Plans for radioisotope production at PUSPATI over the period of 1983-1987, based on present demand for radioisotope, are also explained. (author)

Radioisotopes: problems of responsibility arising from medicine

International Nuclear Information System (INIS)

Dupon, Michel.

1978-09-01

Radioisotopes have brought about great progress in the battle against illnesses of mainly tumoral origin, whether in diagnosis (nuclear medicine) or in treatment (medical radiotherapy). They are important enough therefore to warrant investigation. Such a study is attempted here, with special emphasis, at a time when medical responsibility proceedings are being taken more and more often on the medicolegal problems arising from their medical use. It is hoped that this study on medical responsibility in the use of radioisotopes will have shown: that the use of radioisotopes for either diagnosis or therapy constitutes a major banch of medicine; that this importance implies an awareness by the practitioner of a vast responsibility, especially in law where legislation to ensure protection as strict as in the field of ionizing radiations is lacking. The civil responsibility of doctors who use radioisotopes remains to be defined, since for want of adequate jurisprudence we are reduced to hypotheses based on general principles [fr

Evaluation of ambient radiation levels in positron emission tomography/computed tomography in microPET/CT laboratory

International Nuclear Information System (INIS)

Sarmento, Daniele Martins

2016-01-01

Micro PET/CT scanner is an essential tool generally used for small animal molecular imaging. Fluorine-18-labeled fluorodeoxyglucose is the most widely used radioisotope in this technique. The present study aimed to evaluate the radiation levels in a micro PET/CT research laboratory of the Radiopharmacy Center at IPEN-CNEN / SP, in order to accomplish both national standards and international recommendations. The radioprotection team has classified the laboratory as supervised area; even this laboratory does not require the adoption of specific measures for protection and safety, should be done regular re-evaluation of the conditions of occupational exposures. Workplace monitoring and individual control assessment were carried out to ensure the radiological protection of all workers directly involved in handling the scanner. Initially, there was conducted a radiometric survey, as well as measurements of the external radiation level in the workplace and its surroundings. To achieve this goal, there were placed nine thermoluminescent dosimeters of CaSO 4 :Dy in preselected locations. Monthly evaluations of the occupationally exposed individuals were carried out through the use of TL dosimeters, ported in the workers' chest. Moreover, whole body measurements were performed every six months. The study period was about two-years which started in April 2014. All tests to evaluate micro PET/CT performance were based on the standard protocol of the equipment in accordance with the standard developed by the Animal PET Standard Task Force. Present study's results demonstrated that the ambient radiation levels (ambient and effective estimated radiation dose), as well as the effective shielding equipment are both adequate. This study emphasizes that it is essential to strictly follow the principles of radioprotection in workplace, whenever researches involve radioactive unsealed sources. (author)

Radioisotope Production for Medical and Physics Applications

Science.gov (United States)

Mausner, Leonard

2012-10-01

Radioisotopes are critical to the science and technology base of the US. Discoveries and applications made as a result of the availability of radioisotopes span widely from medicine, biology, physics, chemistry and homeland security. The clinical use of radioisotopes for medical diagnosis is the largest sector of use, with about 16 million procedures a year in the US. The use of ^99Mo/^99mTc generator and ^18F make up the majority, but ^201Tl, ^123I, ^111In, and ^67Ga are also used routinely to perform imaging of organ function. Application of radioisotopes for therapy is dominated by use of ^131I for thyroid malignancies, ^90Y for some solid tumors, and ^89Sr for bone cancer, but production of several more exotic species such as ^225Ac and ^211At are of significant current research interest. In physics ^225Ra is of interest for CP violation studies, and the actinides ^242Am, ^249Bk, and ^254Es are needed as targets for experiments to create superheavy elements. Large amounts of ^252Cf are needed as a fission source for the CARIBU experiment at ANL. The process of radioisotope production is multidisciplinary. Nuclear physics input based on nuclear reaction excitation function data is needed to choose an optimum target/projectile in order to maximize desired isotope production and minimize unwanted byproducts. Mechanical engineering is needed to address issues of target heating, induced mechanical stress and material compatibility of target and claddings. Radiochemists are involved as well since chemical separation to purify the desired final radioisotope product from the bulk target and impurities is also usually necessary. Most neutron rich species are produced at a few government and university reactors. Other radioisotopes are produced in cyclotrons in the commercial sector, university/hospital based facilities, and larger devices at the DOE labs. The landscape of US facilities, the techniques involved, and current supply challenges will be reviewed.

Antibody-radioisotope conjugates for tumor localization and treatment

International Nuclear Information System (INIS)

Larson, S.M.; Carrasquillo, J.A.

1985-01-01

In principle, anti-tumor antibodies can be used to carry radioactivity to tumors for in-vivo diagnosis and treatment of cancer. First, for diagnostic purposes, an antibody that targets a specific antigen (for example, the p97 antigen of human melanoma tumor), is labeled with a tracer amount of radioactivity. When this antibody-radioisotope conjugate is injected into the blood stream, the antibody carries the radioactivity throughout the body and in time, percolates through all the tissues of the body. Because the tumor has specific antigens to which the antibody can bind, the antibody conjugate progressively accumulates in the tumor. Using conventional nuclear medicine imaging equipment, the body of the patient is scanned for radioactivity content, and a map of the distribution of the radioactivity is displayed on photographic film. The tumor shows up as a dense area of radio-activity. These same antibody-radioisotope conjugates may be used for therapy of tumors, except that in this case large amounts of radioactivity are loaded on the antibody. After localization of the conjugate there is sufficient radiation deposited in the tumor of radiotherapy. The success of this approach in the clinic is determined in large measure by the concentration gradient that can be achieved between tissue antibody conjugate in tumor versus normal tissue

PET in management of breast cancer

International Nuclear Information System (INIS)

Lee, Myung-Chul

2004-01-01

Full text: PET provides useful information about tumor metabolism enabling accurate visualization of malignant lesions. Approximately 60-80% suspicious lesions on mammography have benign histology and about 10% of breast cancers with palpable mass are not identified in mammography. The key roles of PET technology in breast cancer are in: primary diagnosis, staging, recurrent diseases monitoring and prediction of therapy response. The sensitivity and specificity of FDG-PET for the diagnosis of breast cancer has been reported to be 68-100% and 83-100%, respectively. Considering the increasing number of small breast tumors detected by mammography and false negative results, the clinical relevance of FDG-PET for the primary diagnosis is limited. In selected patients, however, for example with dense breasts, breasts implants, augmented breast or after breast surgery, which can affect the accuracy of mammography, and in cases with equivocal mammography, FDG-PET can provide clinically relevant information. PET accurately determines the extent of disease, including the loco-regional lymph node status. Furthermore, whole-body PET imaging promises a high diagnostic accuracy for detecting recurrent or metastatic breast carcinoma with a high positive predictive value. We studied the usefulness of the FDG-PET in 42 preoperative patients with suspected breast cancer in differentiation of lesions. The diagnostic value of FDG-PET in terms of sensitivity and specificity was 95% and 77% respectively in primary mass while it was 73% and 100% for axillary lymph nodes. PET is much more accurate than other conventional modalities. The sensitivity of FDG-PET for correct staging of axillary nodal status is 84-100%. It has the potential to replace conventional procedures for the staging of distant metastases. We observed the sensitivity and the specificity of FDG-PET to be 96% and 85% to detect distant metastases. FDG-PET may become the method of choice for the early assessment of

Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18 F]AMG 580 in non-human primates

International Nuclear Information System (INIS)

Hwang, Dah-Ren; Hu, Essa; Allen, Jennifer R.; Davis, Carl; Treanor, James; Miller, Silke; Chen, Hang; Shi, Bingzhi; Narayanan, Tanjorie K.; Barret, Olivier; Alagille, David; Yu, Zhigang; Slifstein, Mark

2015-01-01

Introduction: Phosphodiesterase 10A (PDE10A) is an intracellular enzyme responsible for the breakdown of cyclic nucleotides which are important second messengers for neurotransmission. Inhibition of PDE10A has been identified as a potential target for treatment of various neuropsychiatric disorders. To assist drug development, we have identified a selective PDE10A positron emission tomography (PET) tracer, AMG 580. We describe here the radiosynthesis of [ 18 F]AMG 580 and in vitro and in vivo characterization results. Methods: The potency and selectivity were determined by in vitro assay using [ 3 H]AMG 580 and baboon brain tissues. [ 18 F]AMG 580 was prepared by a 1-step [ 18 F]fluorination procedure. Dynamic brain PET scans were performed in non-human primates. Regions-of-interest were defined on individuals’ MRIs and transferred to the co-registered PET images. Data were analyzed using two tissue compartment analysis (2TC), Logan graphical (Logan) analysis with metabolite-corrected input function and the simplified reference tissue model (SRTM) method. A PDE10A inhibitor and unlabeled AMG 580 were used to demonstrate the PDE10A specificity. K D was estimated by Scatchard analysis of high and low affinity PET scans. Results: AMG 580 has an in vitro K D of 71.9 pM. Autoradiography showed specific uptake in striatum. Mean activity of 121 ± 18 MBq was used in PET studies. In Rhesus, the baseline BP ND for putamen and caudate was 3.38 and 2.34, respectively, via 2TC, and 3.16, 2.34 via Logan, and 2.92, and 2.01 via SRTM. A dose dependent decrease of BP ND was observed by the pre-treatment with a PDE10A inhibitor. In baboons, 0.24 mg/kg dose of AMG 580 resulted in about 70% decrease of BP ND . The in vivo K D of [ 18 F]AMG 580 was estimated to be around 0.44 nM in baboons. Conclusion: [ 18 F]AMG 580 is a selective and potent PDE10A PET tracer with excellent specific striatal binding in non-human primates. It warrants further evaluation in humans

Study of solid target preparation for developing I-124, Pd-103, Cu-64 radioisotopes based cyclotron

Energy Technology Data Exchange (ETDEWEB)

Kim, Jae Hong; Park, Hyun; Lee, Ji Sub; Lee, Dong Hoon; Chun, Kwon Soo [Korea Institute of Radiological and Medical Sciences, Seoul (Korea, Republic of); Choi, Hee Dong [Seoul National Univ., Seoul (Korea, Republic of)

2005-07-01

The decay characteristics of I-124, Pd-103 and Cu-64 radioisotopes produced by cyclotron have considered useful agents for diagnostic imaging or therapy. Numbers of radioisotopes used in medical applications or promised for development are produced with solid targets. The aims of developing solid targets are to obtain large quantities of radionuclides from accelerators. The scope of the study is to develop optimized target system and chemical procedures of these radioisotopes. In order to increase the availability of the radionuclides, the investigation for the design of the solid target and different procedures yielding efficient production of high specific activity will be carrying. In this work, we will present the issue of the primary target design concept.

Supercritical CO2 fluid radiochromatography system used to purify [11C]toluene for PET

International Nuclear Information System (INIS)

Muller, Ryan D.; Ferrieri, Richard A.; Gerasimov, Madina; Garza, Victor

2002-01-01

Abuse of inhalants in today's society has become such a widespread problem among today's adolescents that in many parts of the world their use exceeds that of many other illicit drugs or alcohol. Even so, little is known how such inhalants affect brain function to an extent that can lead to an abuse liability. While methodologies exist for radiolabeling certain inhalants of interest with short-lived positron emitting radioisotopes that would allow their investigation in human subjects using positron emission tomography (PET), the purification methodologies necessary to separate these volatile substances from the organic starting materials have not been developed. We've adapted supercritical fluid technology to this specific PET application by building a preparative-scale supercritical CO 2 fluid radiochromatograph, and applied it to the purification of [ 11 C]toluene. We've demonstrated that [ 11 C]toluene can be separated from the starting materials using a conventional C 18 HPLC column and pure supercritical CO 2 fluid as the mobile phase operating at 2000 psi and 40 deg. C. We've also shown that the purified radiotracer can be quantitatively captured on Tenax GR, a solid support material, as it exits the supercritical fluid stream, thus allowing for later desorption into a 1.5% cyclodextrin solution that is suitable for human injection, or into a breathing tube for direct inhalation

Neutron transport calculation for Activation Evaluation for Decommissioning of PET cyclotron Facility

Science.gov (United States)

Nobuhara, Fumiyoshi; Kuroyanagi, Makoto; Masumoto, Kazuyoshi; Nakamura, Hajime; Toyoda, Akihiro; Takahashi, Katsuhiko

2017-09-01

In order to evaluate the state of activation in a cyclotron facility used for the radioisotope production of PET diagnostics, we measured the neutron flux by using gold foils and TLDs. Then, the spatial distribution of neutrons and induced activity inside the cyclotron vault were simulated with the Monte Calro calculation code for neutron transport and DCHAIN-SP for activation calculation. The calculated results are in good agreement with measured values within factor 3. Therefore, the adaption of the advanced evaluation procedure for activation level is proved to be important for the planning of decommissioning of these facilities.

Summary, the 20th quality control survey for radioisotopes in vitro tests in Japan, 1998

Energy Technology Data Exchange (ETDEWEB)

NONE

1999-11-01

For advancement of radioisotope in vitro tests such as radioimmunoassay and immunoradiometric assay, the Subcommittee for Radioisotope in vitro Test in Medical and Pharmaceutical Committee of Japan Radioisotope Association has conducted the yearly quality control survey for the test facilities in Japan since 1978. This is the summary of the 20th survey in 1998 where non-radioisotope tests like enzyme-immunoassay were involved as well. The survey was done for 143 facilities: 20 national and public university hospitals, 18 private university hospitals, 8 national hospitals, 13 public hospitals, 21 private hospitals, 41 hygienic laboratories and 22 manufacturers of reagents. Facilities examined intra- and between day-reproducibility, freeze-thaw effect and time change of the measured values on the same samples. Assays were for: growth hormone (h), somatomedin C, follicle stimulating h, luteinizing h, prolactin, thyroid stimulating h, triiodothyronines, thyroxines, thyroxine binding protein, calcitonin, insulin, C-peptide, glucagons, gastrin, testosterones, estradiol, progesterone, gonadotropin, 17{alpha}-hydroxyprogesterone, aldosterone, cortisol, dehydroepiandorosterone sulfate, renin, IgE, digoxin, {alpha}-fetoprotein, carcinoembryonic antigen, tissue polypeptide antigen, CA (125, 19-9 and 15-3), prostatic acid phosphatase, prostate specific antigen, {beta}2-microglobulin, ferritin, and neuron specific enolase. There was no great difference between this and last survey results although tendency of improvement was recognized. There were problems to be solved from the standpoint of clinical practice. (K.H.)

Comparison of the production of medical radioisotopes on reactor and cyclotron

International Nuclear Information System (INIS)

Vucina, J.; Vuksanovic, Lj.; Dobrijevic, R.; Karanfilov, E.

1997-01-01

The production of radioisotopes for nuclear-medical applications can be performed either on nuclear reactor or on cyclotron. According to the nuclear reactions applied the radioisotopes of different physical characteristics can be produced. In the paper a comparison of the radioisotopes production given. Compared are the main steps in the production: choice of the nuclear reaction, targetry, irradiation and radiochemical separations performed on the irradiated target to isolate the desired radioisotope. The main characteristics of the produced radioisotopes are given and discussed. (author)

Evaluation of ambient radiation levels in positron emission tomography/computed tomography in microPET/CT laboratory; Avaliacao dos niveis de radiacao ambiental no laboratorio de tomografia por emissao de positrons acoplada a tomografia computadorizada, microPET/CT

Energy Technology Data Exchange (ETDEWEB)

Sarmento, Daniele Martins

2016-11-01

Micro PET/CT scanner is an essential tool generally used for small animal molecular imaging. Fluorine-18-labeled fluorodeoxyglucose is the most widely used radioisotope in this technique. The present study aimed to evaluate the radiation levels in a micro PET/CT research laboratory of the Radiopharmacy Center at IPEN-CNEN / SP, in order to accomplish both national standards and international recommendations. The radioprotection team has classified the laboratory as supervised area; even this laboratory does not require the adoption of specific measures for protection and safety, should be done regular re-evaluation of the conditions of occupational exposures. Workplace monitoring and individual control assessment were carried out to ensure the radiological protection of all workers directly involved in handling the scanner. Initially, there was conducted a radiometric survey, as well as measurements of the external radiation level in the workplace and its surroundings. To achieve this goal, there were placed nine thermoluminescent dosimeters of CaSO{sub 4}:Dy in preselected locations. Monthly evaluations of the occupationally exposed individuals were carried out through the use of TL dosimeters, ported in the workers' chest. Moreover, whole body measurements were performed every six months. The study period was about two-years which started in April 2014. All tests to evaluate micro PET/CT performance were based on the standard protocol of the equipment in accordance with the standard developed by the Animal PET Standard Task Force. Present study's results demonstrated that the ambient radiation levels (ambient and effective estimated radiation dose), as well as the effective shielding equipment are both adequate. This study emphasizes that it is essential to strictly follow the principles of radioprotection in workplace, whenever researches involve radioactive unsealed sources. (author)

Use of radioisotopes and nuclear methods in metallurgy

International Nuclear Information System (INIS)

Trehber, K.

1976-01-01

Some kinds of using radioisotope methods and instruments for regulation and control of metallurgical processes are reviewed. Computized data processing is described as well. The efficiency of industrial application of radioisotopes is remarked

Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer.

Science.gov (United States)

Bates, Anthony; Miles, Kenneth

2017-12-01

To validate MR textural analysis (MRTA) for detection of transition zone (TZ) prostate cancer through comparison with co-registered prostate-specific membrane antigen (PSMA) PET-MR. Retrospective analysis was performed for 30 men who underwent simultaneous PSMA PET-MR imaging for staging of prostate cancer. Thirty texture features were derived from each manually contoured T2-weighted, transaxial, prostatic TZ using texture analysis software that applies a spatial band-pass filter and quantifies texture through histogram analysis. Texture features of the TZ were compared to PSMA expression on the corresponding PET images. The Benjamini-Hochberg correction controlled the false discovery rate at prostate cancer. • Prostate transition zone (TZ) MR texture analysis may assist in prostate cancer detection. • Abnormal transition zone PSMA expression correlates with altered texture on T2-weighted MR. • TZ with abnormal PSMA expression demonstrates significantly reduced MI, SD and MPP.

Radio-isotope generator

International Nuclear Information System (INIS)

Benjamins, H.M.

1983-01-01

A device is claimed for interrupting an elution process in a radioisotope generator before an elution vial is entirely filled. The generator is simultaneously exposed to sterile air both in the direction of the generator column and of the elution vial

Utilization of Pets in a Hospice Program.

Science.gov (United States)

Doyle, Kathleen; Kukowski, Thomas

1989-01-01

The therapeutic use of animals with specific populations has gained increased attention and interest. Pet placement in special settings such as prisons, mental institutions and hospices have shown beneficial results. Development of a pet visitation program requires specific planning and organization. (JD)

HAC and production of radioisotopes and labelled compounds

International Nuclear Information System (INIS)

Nozaki, T.

1984-01-01

In this paper, the author reviews different methods for the production of radioisotopes and labelled compounds that make use of hot atom reactions. Subsequently he discusses the production of radioisotopes for radiopharmaceuticals; enrichment of (n,γ) products, recoil labelling and related methods (neutron reaction products, cyclotron production, excitation labelling, radiation and discharge induced labelling). The final section offers a survey of radioisotope production using accelerators. Only a selection of the various conditions used in practical RI production is considered. (Auth.)

PET-CT and PET-MRI of the prostate. From {sup 18}F-FDG to {sup 68}Ga-PSMA; PET-CT/-MRT der Prostata. Von {sup 18}F-FDG zu {sup 68}Ga-PSMA

Energy Technology Data Exchange (ETDEWEB)

Knorr, K.; Eiber, M.; Scheidhauer, K. [Technische Universitaet Muenchen, Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Muenchen (Germany); Maurer, T. [Technische Universitaet Muenchen, Urologische Klinik und Poliklinik, Klinikum rechts der Isar, Muenchen (Germany); Wester, H.J. [Technische Universitaet Muenchen, Pharmazeutische Radiochemie, Garching (Germany)

2017-08-15

In the last few years nuclear medical diagnostics have experienced a unprecedented renaissance in the diagnostics of prostate cancer, due to the availability of hybrid imaging with positron emission tomography computed tomography (PET/CT), PET magnetic resonance imaging (PET/MRI) and single photon emission computed tomography (SPECT) CT as well as the development of prostate-specific radiopharmaceuticals. The use of fluorodeoxyglucose (FDG), which has been successfully implemented for many years in PET diagnostics, is only helpful in dedifferentiated tumors due to the biological characteristics of prostate cancer. New specific radiopharmaceuticals, such as choline-derivatives, which are incorporated into the prostate cancer cell and built into the cell membrane as well as the recently developed highly specific ligands for prostate-specific membrane antigen (PSMA) are revolutionizing prostate cancer imaging and (re-) staging. The {sup 68} Ga-labeled PSMA ligands for PET-CT and PET-MRI are highly specific tracers for primary diagnostics and detection of metastases of prostate carcinoma. In risk patients, which includes patients with intermediate and high-risk tumors, they have largely replaced choline-based PET-CT, especially in the case of very low PSA values <0.5 ng/ml in the diagnostics of recurrence. The use in the primary diagnostics as PET-MRI, also in combination with multiparametric MRI (mpMRI), is promising with respect to early diagnostics and image fusion-assisted biopsy as well as surgery and irradiation planning. (orig.) [German] Die nuklearmedizinische Diagnostik hat in den letzten Jahren bei der Bildgebung des Prostatakarzinoms eine rasante Entwicklung erlebt, sowohl aufgrund der verfuegbaren Hybridbildgebung mit der Positronenemissionstomographie(PET)-CT, PET-MRT sowie der Single-photon-emission-computed-tomography(SPECT)-CT als auch durch die Entwicklung prostataspezifischer Radiopharmaka. Die in der PET-Diagnostik seit Jahren erfolgreich eingesetzte

Radioisotopes for medical applications

International Nuclear Information System (INIS)

Carr, S.

1998-01-01

For more than 3 decades, the Australian Nuclear Science and Technology Organisation has been the country's main supplier of radioisotopes for medical applications. The use of radioisotopes in medicine has revolutionised the diagnosis, management and treatment of many serious diseases such as cancer, heart disease and stroke. It is also beginning to play a key role in neurological disorders such as Parkinson and Alzheimers disease and epilepsy. More recently there has been considerable growth in the application of nuclear medicine to treat sport-related injuries - especially wrist, ankle and knees where more common techniques do not always enable accurate diagnosis. Australia is a recognised leader in nuclear medicine. This can be partially attributed to the close relationship between ANSTO and the medical community in providing opportunities to develop and evaluate new agents to support more effective patient care. A list of commercial isotopes produced in the reactor or the cyclotron and used in medical applications is given. Nuclear medicine plays an important role in the clinical environment and the timely supply of radioisotopes is a key element. ANSTO will continue to be the premier supplier of currently available and developing isotopes to support the health and well being of the Australian community

Radioisotopes for medical applications

Energy Technology Data Exchange (ETDEWEB)

Carr, S. [Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW (Australia). Radiopharmaceuticals Division

1998-03-01

For more than 3 decades, the Australian Nuclear Science and Technology Organisation has been the country`s main supplier of radioisotopes for medical applications. The use of radioisotopes in medicine has revolutionised the diagnosis, management and treatment of many serious diseases such as cancer, heart disease and stroke. It is also beginning to play a key role in neurological disorders such as Parkinson and Alzheimers disease and epilepsy. More recently there has been considerable growth in the application of nuclear medicine to treat sport-related injuries - especially wrist, ankle and knees where more common techniques do not always enable accurate diagnosis. Australia is a recognised leader in nuclear medicine. This can be partially attributed to the close relationship between ANSTO and the medical community in providing opportunities to develop and evaluate new agents to support more effective patient care. A list of commercial isotopes produced in the reactor or the cyclotron and used in medical applications is given. Nuclear medicine plays an important role in the clinical environment and the timely supply of radioisotopes is a key element. ANSTO will continue to be the premier supplier of currently available and developing isotopes to support the health and well being of the Australian community 2 tabs., 1 fig.

Clinical Investigation of the Dopaminergic System with PET and FLUORINE-18-FLUORO-L-DOPA.

Science.gov (United States)

Oakes, Terrence Rayford

1995-01-01

Positron Emission Tomography (PET) is a tool that provides quantitative physiological information. It is valuable both in a clinical environment, where information is sought for an individual, and in a research environment, to answer more fundamental questions about physiology and disease states. PET is particularly attractive compared to other nuclear medicine imaging techniques in cases where the anatomical regions of interest are small or when true metabolic rate constants are required. One example with both of these requirements is the investigation of Parkinson's Disease, which is characterized as a presynaptic motor function deficit affecting the striatum. As dopaminergic neurons die, the ability of the striatum to affect motor function decreases. The extent of functional neuronal damage in the small sub-structures may be ascertained by measuring the ability of the caudate and putamen to trap and store dopamine, a neurotransmitter. PET is able to utilize a tracer of dopamine activity, ^ {18}F- scL-DOPA, to quantitate the viability of the striatum. This thesis work deals with implementing and optimizing the many different elements that compose a PET study of the dopaminergic system, including: radioisotope production; conversion of aqueous ^{18}F ^-into [^ {18}F]-F2; synthesis of ^{18}F- scL -DOPA; details of the PET scan itself; measurements to estimate the radiation dosimetry; accurate measurement of a plasma input function; and the quantitation of dopaminergic activity in normal human subjects as well as in Parkinson's Disease patients.

Vitrified chemically bonded phosphate ceramics for immobilization of radioisotopes

Science.gov (United States)

Wagh, Arun S.

2016-04-05

A method of immobilizing a radioisotope and vitrified chemically bonded phosphate ceramic (CBPC) articles formed by the method are described. The method comprises combining a radioisotope-containing material, MgO, a source of phosphate, and optionally, a reducing agent, in water at a temperature of less than 100.degree. C. to form a slurry; curing the slurry to form a solid intermediate CBPC article comprising the radioisotope therefrom; comminuting the intermediate CBPC article, mixing the comminuted material with glass frits, and heating the mixture at a temperature in the range of about 900 to about 1500.degree. C. to form a vitrified CBPC article comprising the radioisotope immobilized therein.

Radioisotope production for medical and non-medical application at the Nuclear Energy Unit (UTN)

International Nuclear Information System (INIS)

Mohamad Awang; Zulkifli Mohamad Hashim; Yusof Azuddin Ali

1986-01-01

Radioisotopes are produced by using a low power research reactor, TRIGA MARK II situated at UTN. Products intended for use as radiopharmaceuticals undergo a more stringent precaution. The solvent extraction technique used to separate 99 m TC from the radioactive solution of Potassium molybdate (K 2 99 Mo0 4 ) is explained in detail. The specific activity of 99Mo obtained at a neutron flux of 2.5 x 10 12 n/cm 2 , s ranges from 1.75 mCi 99 Mo/g MoO 3 to 6.25 mCi 99 Mo/g MoO 3 . However, the specific activity of 99 Mo obtained could be increased by a factor of 6 using the central thimble facility. There are 14 radioisotopes being currently produced. Commonly used cold kits for 99m TC labelling are also produced. Sn-MDP kit for bone scintigraphy is prepared under aseptic environment and freeze-drived. Products are terminally sterilized using γ-irradiation. Uptake studies done on laboratory animals indicate good bone uptake. A few radioisotopes and radiopharmaceuticals products to be produced by UTN in future are reviewed. (author)

Radioisotopes as Political Instruments, 1946-1953.

Science.gov (United States)

Creager, Angela N H

2009-01-01

The development of nuclear "piles," soon called reactors, in the Manhattan Project provided a new technology for manufacturing radioactive isotopes. Radioisotopes, unstable variants of chemical elements that give off detectable radiation upon decay, were available in small amounts for use in research and therapy before World War II. In 1946, the U.S. government began utilizing one of its first reactors, dubbed X-10 at Oak Ridge, as a production facility for radioisotopes available for purchase to civilian institutions. This program of the U.S. Atomic Energy Commission was meant to exemplify the peacetime dividends of atomic energy. The numerous requests from scientists outside the United States, however, sparked a political debate about whether the Commission should or even could export radioisotopes. This controversy manifested the tension in U.S. politics between scientific internationalism as a tool of diplomacy, associated with the aims of the Marshall Plan, and the desire to safeguard the country's atomic monopoly at all costs, linked to American anti-Communism. This essay examines the various ways in which radioisotopes were used as political instruments-both by the U.S. federal government in world affairs, and by critics of the civilian control of atomic energy-in the early Cold War.

Notification determining details of technical standards concerning transport of radioisotopes or goods contaminated by radioisotopes in works or enterprises

International Nuclear Information System (INIS)

1981-01-01

This rule is established under the provisions of the regulation for the execution of the law on the prevention of radiation injuries by radioisotopes. Terms are used in this rule for the same meanings as in the regulation. The limit of the concentration of radioisotopes in the goods contaminated by these isotopes which are not required to be sealed in containers defined by the Director General of the Science and Technology Agency is 1/10,000 of the value A 2 under the notification determining the details of technical standards concerning the transport of radioisotopes or the goods contaminated by radioisotopes outside works or enterprises. The application for the permission of transporting the goods which are highly difficult to be sealed in containers shall list names and addresses, the kinds, quantities, shapes and properties of the transported goods contaminated by radioisotopes, etc. The radiation dose rate of transported goods and vehicles under the regulation is 200 milli-rem an hour on the surfaces of these goods, vehicles and containers, and 10 milli-rem an hour at the distance of 1 meter from their surfaces. The permissible exposure dose of the persons engaging in transport is 1.5 rem a year. Dangerous goods, signs, and the application for the approval of special measures are specified, respectively. (Okada, K.)

Seven Things to Know about Radioisotopes

International Nuclear Information System (INIS)

Henriques, Sasha

2014-01-01

Each atomic element knows exactly how many protons and neutrons it needs at its centre (nucleus) in order to be stable (stay in its elemental form). Radioisotopes are atomic elements that do not have the correct proton to neutron ratio to remain stable. With an unbalanced number of protons and neutrons, energy is given off by the atom in an attempt to become stable. For example, a stable carbon atom has six protons and six neutrons. Whereas its unstable (and therefore radioactive) isotope carbon-14, has six protons and eight neutrons. Carbon-14 and all other unstable elements are called radioisotopes. This movement towards stability, which involves emitting energy from the atom in the form of radiation, is known as radioactive decay. This radiation can be tracked and measured, making radioisotopes very useful in industry, agriculture and medicine

The guideline for in-hospital manufactured FDG for PET examinations

International Nuclear Information System (INIS)

2001-01-01

The guideline made by the three working groups of Japan Society of Nuclear Medicine, of subcommittee on Medical Application of Cyclotron-Produced Radionuclides in Medical and Pharmaceutical Science Committee of Japan Radioisotope Association (JRA) and of Radiopharmaceuticals Committee of JRA, deals with working environment and management system of FDG ( 18 F-2-deoxy-2-fluoro-D-glucose) manufacturing, standards for FDG synthetic equipment and its installation, quality and methods of synthesis and assay, PET apparatus and clinical application, for the purpose of safe and effective use of the FDG made in-hospital for its future application into public health insurance. FDG is synthesized in-hospital from 18 F generated from either 20 Ne irradiated by deuteron or 18 O, by proton. For the confirmation in the quality standard, the peaks only at 511 and 1022 keV should be observed by gamma-spectrometry with the half life of 105-115 min. The PET apparatus usable must be a defined one in the Pharmaceutical Affairs Law like that for positron CT, positron camera and PET camera. In clinical application, FDG is formulated for injection and used for examinations of brain/myocardium and cerebral/myocardial glucose consumption, of tumor and tumor FDG uptake and so on. Precautions involve general contraindications and usage in pregnancy, aged people and infants. (K.H.)

Radioisotopes for therapy: an overview

International Nuclear Information System (INIS)

Venkatesh, Meera

2006-01-01

Radionuclides made great impact in the history of nuclear sciences both at the end of 19th century with the discoveries of Becquerel and madame Curie and later in 1934, when Frederic Joliet and Irene Curie demonstrated the production of the first artificial radioisotopes, 30 P, by bombardment of 27 Al by alpha particles. The subsequent invention of cyclotron and setting up of nuclear reactor opened the floodgate for production of artificial radionuclides. Currently, majority of radionuclides are made artificially by transforming a stable nuclide into an unstable state and thus far over 2500 radionuclides have been produced artificially. Use of radionuclides in various fields immediately followed their production and last century has witnessed tremendous growth in the applications of radiation and radioisotopes, in diverse fields such as medicine, industry, agriculture, food preservation, water resource management, environmental studies, etc. While radiation and radioisotopes are used both for diagnosis as well as for therapy in the field of medicine, therapeutic applications are among the earliest, which began as an empirical science in the beginning and developed into a well structured modality with time. (author)

Specific image characteristics influence attitudes about chimpanzee conservation and use as pets.

Directory of Open Access Journals (Sweden)

Stephen R Ross

Full Text Available Chimpanzees are endangered in their native Africa but in the United States, they are housed not only in zoos and research centers but owned privately as pets and performers. In 2008, survey data revealed that the public is less likely to think that chimpanzees are endangered compared to other great apes, and that this is likely the result of media misportrayals in movies, television and advertisements. Here, we use an experimental survey paradigm with composite images of chimpanzees to determine the effects of specific image characteristics. We found that those viewing a photograph of a chimpanzee with a human standing nearby were 35.5% more likely to consider wild populations to be stable/healthy compared to those seeing the exact same picture without a human. Likewise, the presence of a human in the photograph increases the likelihood that they consider chimpanzees as appealing as a pet. We also found that respondents seeing images in which chimpanzees are shown in typically human settings (such as an office space were more likely to perceive wild populations as being stable and healthy compared to those seeing chimpanzees in other contexts. These findings shed light on the way that media portrayals of chimpanzees influence public attitudes about this important and endangered species.

Specific image characteristics influence attitudes about chimpanzee conservation and use as pets.

Science.gov (United States)

Ross, Stephen R; Vreeman, Vivian M; Lonsdorf, Elizabeth V

2011-01-01

Chimpanzees are endangered in their native Africa but in the United States, they are housed not only in zoos and research centers but owned privately as pets and performers. In 2008, survey data revealed that the public is less likely to think that chimpanzees are endangered compared to other great apes, and that this is likely the result of media misportrayals in movies, television and advertisements. Here, we use an experimental survey paradigm with composite images of chimpanzees to determine the effects of specific image characteristics. We found that those viewing a photograph of a chimpanzee with a human standing nearby were 35.5% more likely to consider wild populations to be stable/healthy compared to those seeing the exact same picture without a human. Likewise, the presence of a human in the photograph increases the likelihood that they consider chimpanzees as appealing as a pet. We also found that respondents seeing images in which chimpanzees are shown in typically human settings (such as an office space) were more likely to perceive wild populations as being stable and healthy compared to those seeing chimpanzees in other contexts. These findings shed light on the way that media portrayals of chimpanzees influence public attitudes about this important and endangered species.

Radioisotopes in Industry

Energy Technology Data Exchange (ETDEWEB)

Baker, Philip S. [Oak Ridge National Laboratory; Fuccillo, Jr., Domenic A. [Oak Ridge National Laboratory; Gerrard, Martha W. [Oak Ridge National Laboratory; Lafferty, Jr., Robert H. [Oak Ridge National Laboratory

1967-05-01

Radioisotopes, man-made radioactive elements, are used in industry primarily for measuring, testing and processing. How and why they are useful is the subject of this booklet. The booklet discusses their origin, their properties, their uses, and how they may be used in the future.

The FDG-PET diagnosis of head and neck malignant tumor

International Nuclear Information System (INIS)

Kada, Shinpei; Hayashi, Masahiko; Okazawa, Hidehiko

2003-01-01

We investigated the utility of whole body FDG-PET in patients with head and neck malignant tumor, retrospectively. Fifty four FDG-PET studies were performed in 45 patients. Regarding the primary tumor and nodal metastasis, we compared the diagnosis of only FDG-PET with diagnosis using CT, MRI, and physical examination without FDG-PET (diagnosis without FDG-PET). These FDG-PET images were evaluated with visual interpretation qualitatively. At the primary tumor, sensitivity and specificity of FDG-PET diagnoses were 90% and 93%, and those of the diagnoses without FDG-PET were 95% and 100%, respectively; for nodal metastasis, sensitivity and specificity of FDG-PET diagnoses were 90% and 84%, and those of the diagnoses without FDG-PET were 72% and 80%, respectively. In nodal metastasis, the diagnosis of FDG-PET was superior to the diagnosis without FDG-PET. However, it is important to be careful of false positive findings of FDG-PET such as inflammatory lymph nodes, and false negative findings such as very thin tumors. By combining the FDG-PET diagnosis with other examinations, we could achieve almost perfect diagnosis. Farthermore, we perform FDG-PET repeatedly to improve diagnosis accuracy. (author)

Radioisotope research and development at Los Alamos National Laboratory

International Nuclear Information System (INIS)

Peterson, E.J.

1993-01-01

Throughout its fifty year history, Los Alamos National Laboratory has conducted research and development in the production, isolation, purification, and application of radioactive isotopes. Initially this work supported the weapons development mission of the Laboratory. Over the years the work has evolved to support basic and applied research in many diverse fields, including nuclear medicine, biomedical studies, materials science, environmental research and the physical sciences. In the early 1970s people in the Medical Radioisotope Research Program began irradiating targets at the Los Alamos Meson Physics Facility (LAMPF) to investigate the production and recovery of medically important radioisotopes. Since then spallation production using the high intensity beam at LAMPF has become a significant source of many important radioisotopes. Los Alamos posesses other facilities with isotope production capabilities. Examples are the Omega West Reactor (OWR) and the Van de Graaf Ion Beam Facility (IBF). Historically these facilities have had limited availability for radioisotope production, but recent developments portend a significant radioisotope production mission in the future

SU-E-I-86: Ultra-Low Dose Computed Tomography Attenuation Correction for Pediatric PET CT Using Adaptive Statistical Iterative Reconstruction (ASiR™)

Energy Technology Data Exchange (ETDEWEB)

Brady, S; Shulkin, B [St. Jude Children’s Research Hospital, Memphis, TN (United States)

2015-06-15

Purpose: To develop ultra-low dose computed tomography (CT) attenuation correction (CTAC) acquisition protocols for pediatric positron emission tomography CT (PET CT). Methods: A GE Discovery 690 PET CT hybrid scanner was used to investigate the change to quantitative PET and CT measurements when operated at ultra-low doses (10–35 mAs). CT quantitation: noise, low-contrast resolution, and CT numbers for eleven tissue substitutes were analyzed in-phantom. CT quantitation was analyzed to a reduction of 90% CTDIvol (0.39/3.64; mGy) radiation dose from baseline. To minimize noise infiltration, 100% adaptive statistical iterative reconstruction (ASiR) was used for CT reconstruction. PET images were reconstructed with the lower-dose CTAC iterations and analyzed for: maximum body weight standardized uptake value (SUVbw) of various diameter targets (range 8–37 mm), background uniformity, and spatial resolution. Radiation organ dose, as derived from patient exam size specific dose estimate (SSDE), was converted to effective dose using the standard ICRP report 103 method. Effective dose and CTAC noise magnitude were compared for 140 patient examinations (76 post-ASiR implementation) to determine relative patient population dose reduction and noise control. Results: CT numbers were constant to within 10% from the non-dose reduced CTAC image down to 90% dose reduction. No change in SUVbw, background percent uniformity, or spatial resolution for PET images reconstructed with CTAC protocols reconstructed with ASiR and down to 90% dose reduction. Patient population effective dose analysis demonstrated relative CTAC dose reductions between 62%–86% (3.2/8.3−0.9/6.2; mSv). Noise magnitude in dose-reduced patient images increased but was not statistically different from pre dose-reduced patient images. Conclusion: Using ASiR allowed for aggressive reduction in CTAC dose with no change in PET reconstructed images while maintaining sufficient image quality for co

A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin

International Nuclear Information System (INIS)

Dong Mengjie; Zhao Kui; Liu Zhenfeng; Wang Guolin; Yang Shuye; Zhou Guojun

2011-01-01

Background and purpose: The diagnosis of patients with fever of unknown origin (FUO) remains a challenging medical problem for internal medicine. A reliable estimate of the diagnostic performance of FDG-PET and FDG-PET/CT in the assessment of FUO unidentified by conventional workup has never been systematically assessed, and present systematic review was aimed at this issue. Methods: A systematic search for relevant studies was performed of the PubMed, Embase, and Cochrane databases. Methodological quality of each study was assessed. Sensitivity, specificity and area under the curve (AUC) were meta-analyzed. Subgroup analyses were performed if results of individual studies were heterogeneous. Results: The inclusion criteria were met by nine studies. Overall, the studies had good methodological quality. Pooled sensitivity and specificity of FDG-PET for the detection of FUO were 0.826 (95% CI; 0.729–0.899) and 0.578 (95% CI; 0.488–0.665), respectively, and the AUC was 0.810. Heterogeneity among the results of FDG PET studies was present (QSE = 12.40, I 2 = 67.7%; QSp = 35.98, I 2 = 88.9%). Pooled sensitivity and specificity of FDG-PET/CT were 0.982 (95% CI; 0.936–0.998) and 0.859 (95% CI; 0.750–0.934), respectively, and the AUC was 0.947. We did not find any statistical differences in the AUC and Q* index between FDG-PET and FDG-PET/CT (Z = 0.566, p > 0.05). Conclusions: Although the FDG-PET studies that we examined were heterogeneous, FDG-PET appears to be a sensitive and promising diagnostic tool for the detection of the causes of FUO. FDG-PET/CT should be considered among the first diagnostic tools for patients with FUO in whom conventional diagnostics have been unsuccessful.

Shielded radioisotope generator and method for using same

International Nuclear Information System (INIS)

Fries, B.A.

1976-01-01

A nuclide generator for on-site radioisotope generation is disclosed in which the formation of a short-lived daughter radioisotope from its longer-lived parent features batch flow of eluting reagent interior of the generator in a completely shielded environment

Radioisotopes and radiopharmaceuticals catalogue

International Nuclear Information System (INIS)

2002-01-01

The Chilean Nuclear Energy Commission (CCHEN) presents its radioisotopes and radiopharmaceuticals 2002 catalogue. In it we found physical characteristics of 9 different reactor produced radioisotopes ( Tc-99m, I-131, Sm-153, Ir-192, P-32, Na-24, K-42, Cu-64, Rb-86 ), 7 radiopharmaceuticals ( MDP, DTPA, DMSA, Disida, Phitate, S-Coloid, Red Blood Cells In-Vivo, Red Blood Cells In-Vitro) and 4 labelled compounds ( DMSA-Tc99m, DTPA-Tc99m, MIBG-I131, EDTMP-Sm153 ). In the near future the number of items will be increased with new reactor and cyclotron products. Our production system will be certified by ISO 9000 on March 2003. CCHEN is interested in being a national and an international supplier of these products (RS)

NTP Radioisotopes SOC Ltd

International Nuclear Information System (INIS)

Letule, T.

2017-01-01

NTP Radioisotopes SOC Ltd, a wholly owned subsidiary of the South African Nuclear Energy Corporation (NECSA). Supplies around 20% of the world's medical radioisotopes used. NTP is a pioneer in the introduction and growth of nuclear medicine as in South Africa. Nuclear medicine is the medical specialty that involves the use of radioactive isotopes in the diagnosis and treatment of diseases. Nuclear medicine contributes to enhancing the lives of the society. There is a compelling need for nuclear medicine to be promoted and utilized in the rest of Africa, due to the increasing prevalence of cancer. Cancer is rapidly becoming a public health crisis in low-income and middle-income countries. In sub-Saharan Africa, patients often present with advanced disease

Radio-Isotopes Section, radiation Safety Division, Ministry Of The Environment, Israel: A General Review, And Future Developments

International Nuclear Information System (INIS)

Ben-Zion, S.

1999-01-01

The section of radio-isotopes in the Ministry Of Environment, is responsible for preventing environmental hazards fi.om radio-isotopes ''from cradle to grave's'. The management and the supervision of radioactive materials, includes about 350 institutes in Israel. We are dealing with the implementation and the enforcement of the environmental regulations and safety standards, and licensing for each institution and installation. Among our tasks are the following: Follow-up of the import, transportation and distribution, usage and storage and disposal of radio-isotopes, as well as legislation, risk-assessments, inspection, , and ''education'. We are also participating in committees / working groups discussing specific topics: Radioactive stores, Low RW disposal, Y2K, GIS, penalties charging, transportation and more

The law concerning prevention from radiation hazards due to radioisotopes

International Nuclear Information System (INIS)

1984-01-01

The law regulates uses, sales and disposal of radioisotopes, uses of radiation generating apparatuses, disposal of materials contaminated with radioisotopes, and so on, in accordance with the Atomic Energy Fundamental Act, for public safety. Covered are the following: permission for and notification of the uses and permission for businesses selling and disposing of radioisotopes, and approval of designs concerning radiation hazard prevention mechanisms, obligations of the users and business enterprises selling and disposing of radioisotopes, the licensed engineers of radiation, organs, etc. for confirmation of the mechanisms, punitive provisions, and so on. (Mori, K.)

Radioisotope techniques in oil wells

International Nuclear Information System (INIS)

Jain, Prabuddha

1998-01-01

Radioisotope techniques are quite useful in oil exploration and exploitation. Nuclear logging offers a way of gathering information on porosity, permeability, fluid saturations, hydrocarbon types and lithology. Some of the interesting applications in well drilling are determining depth of filtrate invasion, detection of lost circulation, drill-bit erosion control; primary cement measurements and well completions such as permanent tubular markers, perforation position marking, detection of channeling behind casing and gravel pack operations. Radioisotopes have been successfully used in optimizing production processes such as production profiling injection profiling, corrosion measurements and well to well tracer tests. (author)

PET and endocrine tumors

International Nuclear Information System (INIS)

Rigo, P.; Belhocine, T.; Hustinx, R.; Foidart-Willems, J.

2000-01-01

The authors review the main indications of PET examination, and specifically of 18 FDG, in the assessment of endocrine tumors: of the thyroid, of the parathyroid, of the adrenal and of the pituitary glands. Neuroendocrine tumors, gastro-entero-pancreatic or carcinoid tumors are also under the scope. Usually, the most differentiated tumors show only poor uptake of the FDG as they have a weak metabolic and proliferative activity. In the assessment of endocrine tumors, FDG-PET should be used only after most specific nuclear examinations been performed. (author)

Cost-benefit aspects of radioisotope methods

International Nuclear Information System (INIS)

Jankowski, L.

1986-01-01

The cost-benefit relations in the complex application of radioisotpe techniques increased in the last years to up to 1/10 to 1/15. The most essential cause of this trend is the increase of the capacity of production processes, controlled and automatized by means of radioisotopes, and the solution of qualitatively new technological problems of a high economic relevance. A collection of statistical data about the expediture and benefit of different radioisotopes techniques is presented. (author)

Radioisotope tracers in industrial flow studies

International Nuclear Information System (INIS)

Easey, J.F.

1987-01-01

The scope of radioisotope tracer work carried out by ANSTO has involved most sectors of Australian industry including iron and steel coal, chemical, petrochemical, natural gas, metallurgical, mineral, power generation, liquified air plant, as well as port authorities, water and sewerage instrumentalities, and environmental agencies. A major class of such studies concerns itself with flow and wear studies involving industrial equipment. Some examples are discussed which illustrate the utility of radioisotope tracer techniques in these applications

Economic Contributions of Radioisotope Production Reactor in Korea

International Nuclear Information System (INIS)

Nam, Ji Hee; Kim, Seung Su; Moon, Kee Whan

2010-01-01

Radioisotopes (RIs) have been used extensively in the fields of industrial, the agricultural, and the medical applications. Especially the deficiency of radioisotopes such as Mo-99 and I-131 in the medical applications recently is becoming the main issue in our society. Radioisotope with the characteristics of public goods in some aspects is mainly playing as the intermediate inputs or goods in the process of the industrial production, with being expected to produce the economic benefits by creating the new demand in the market or enlarging the value added for the related goods and services. In this study, the contribution effects for Korean economy by the construction and operation of the reactor for radioisotope production would be evaluated the effects produced by the activities such as a RI supplies into domestic industry, the RI exports, the neutron transmutation doping services called NTD, and the exports of RI production reactors

Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases

Directory of Open Access Journals (Sweden)

Tetsuro Tago

2018-01-01

Full Text Available Epigenetic alterations of gene expression have emerged as a key factor in several neurodegenerative diseases. In particular, inhibitors targeting histone deacetylases (HDACs, which are enzymes responsible for deacetylation of histones and other proteins, show therapeutic effects in animal neurodegenerative disease models. However, the details of the interaction between changes in HDAC levels in the brain and disease progression remain unknown. In this review, we focus on recent advances in development of radioligands for HDAC imaging in the brain with positron emission tomography (PET. We summarize the results of radiosynthesis and biological evaluation of the HDAC ligands to identify their successful results and challenges. Since 2006, several small molecules that are radiolabeled with a radioisotope such as carbon-11 or fluorine-18 have been developed and evaluated using various assays including in vitro HDAC binding assays and PET imaging in rodents and non-human primates. Although most compounds do not readily cross the blood-brain barrier, adamantane-conjugated radioligands tend to show good brain uptake. Until now, only one HDAC radioligand has been tested clinically in a brain PET study. Further PET imaging studies to clarify age-related and disease-related changes in HDACs in disease models and humans will increase our understanding of the roles of HDACs in neurodegenerative diseases.

SPECT and PET imaging in epilepsia; SPECT und PET in der Diagnostik von Epilepsien

Energy Technology Data Exchange (ETDEWEB)

Landvogt, C. [Mainz Univ. (Germany). Klinik und Poliklinik fuer Nuklearmedizin

2007-09-15

In preoperative localisation of epileptogenic foci, nuclear medicine diagnostics plays a crucial role. FDG-PET is used as first line diagnostics. In case of inconsistent MRI, EEG and FDG-PET findings, {sup 11}C-Flumazenil-PET or ictal and interictal perfusion-SPECT should be performed. Other than FDG, Flumazenil can help to identify the extend of the region, which should be resected. To enhance sensitivity and specificity, further data analysis using voxelbased statistical analyses or SISCOM (substraction ictal SPECT coregistered MRI) should be performed.

Kinetic modeling in PET imaging of hypoxia

DEFF Research Database (Denmark)

Li, Fan; Jørgensen, Jesper Tranekjær; Hansen, Anders E

2014-01-01

be used for non-invasive mapping of tissue oxygenation in vivo and several hypoxia specific PET tracers have been developed. Evaluation of PET data in the clinic is commonly based on visual assessment together with semiquantitative measurements e.g. standard uptake value (SUV). However, dynamic PET......Tumor hypoxia is associated with increased therapeutic resistance leading to poor treatment outcome. Therefore the ability to detect and quantify intratumoral oxygenation could play an important role in future individual personalized treatment strategies. Positron Emission Tomography (PET) can...... analysis for PET imaging of hypoxia....

The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET

International Nuclear Information System (INIS)

Hsieh Hungjen; Lin Shenghsiang; Lin Kohan; Lee Chienying; Chang Chengpei; Wang Shyhjen

2008-01-01

The objective of this study was to differentiate between benign and malignant lesions of the lung, 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET) has limitations such as a lower specificity in cases of non-specific inflammation. The positive predictive value is unsatisfactory in countries where inflammatory lung disorders are prevalent. We present the preliminary results of the usefulness of combining 11 C-methionine-PET and 18 F-FDG-PET in this context. Fifteen patients with indeterminate solitary pulmonary nodules/masses (10 men, 5 women; average age 64.7±14.0 years, ranging from 25 to 87 years) were studied using 11 C-methionine- and 18 F-FDG-PET. Interpretations were primarily made on visual analysis with five-point scale and a consensus of two nuclear medicine physicians, using standardized uptake value as an accessory reference. Foci of abnormal radiotracer uptake were subsequently correlated with clinical follow-up, imaging modalities such as chest radiography, chest computed tomography (CT), serial PET studies, and pathology results from bronchoscopic biopsy and/or surgical specimen. Diagnoses were established in 14 patients. The 11 C-methionine-PET and 18 F-FDG-PET studies were both true positive in two cases of adenocarcinoma and true negative in two cases of clinical benign nodules. In one case of lymphoid hyperplasia both 11 C-methionine-PET and 18 F-FDG-PET showed false-positive findings. Discordant results were obtained in nine cases. In spite of the false-positive results of 18 F-FDG-PET, 11 C-methionine-PET was true negative in four cases with chronic inflammatory nodules and three cases of pulmonary tuberculosis. Furthermore, 11 C-methionine-PET was true positive in one case of lung metastasis of thyroid cancer, and in another with recurrence of gastric cancer, respectively, for which 18 F-FDG-PET imaging was false negative. Our experience indicates that 11 C-methionine-PET seems more specific and sensitive when compared with

Pseudo-random generator to allow to an electronic pulse simulator the ability to emulate radioisotopes spectra

International Nuclear Information System (INIS)

Lucianna F A; Carrillo M A; Mangussi M J

2012-01-01

The present work describes the development of a pseudo-random system to provide to a simulator pulse of radiation detectors the ability to emit pulses patterns similar to those recorded when measuring actual radioisotope. The idea is that the system can emulate characteristic spectral distributions of known radioisotopes, as well as creating individual spectra for specific purposes. This design is based on an improvement in terms of software from earlier development that only supplied predefined amplitude pulses at constant intervals (author)

Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma

International Nuclear Information System (INIS)

Fougere, Christian la; Broeckel, Nicole; Pfluger, Thomas; Haug, Alexander; Scher, Bernhard; Hacker, Marcus; Hahn, Klaus; Tiling, Reinhold; Hundt, Walter; Reiser, Maximilan

2006-01-01

The aim of this study was to assess the clinical benefit of combined [ 18 F]FDG PET/CT in patients with malignant lymphoma as compared to separately performed PET and CT. Overall, 100 patients with Hodgkin's disease (HD) or non-Hodgkin's lymphoma (NHL) were included in this study. Co-registered PET/CT with [ 18 F]FDG and contrast medium was performed in 50 consecutive patients with NHL (n=38) or HD (n=12) for initial staging (IS) (n=12) or re-treatment staging (RS) (n=38). Another 50 patients with NHL (n=32) or HD (n=18) underwent separate PET and CT investigations within a time frame of 10 days for IS (n=22) or RS (n=28). Lymphoma involvement was separately evaluated for seven different regions in each patient. Each patient had clinical follow-up evaluation for >6 months. PET and CT data were analysed separately as well as side-by-side or in fused mode. In the PET/CT group, region-based evaluation for lymphoma involvement suggested a sensitivity/specificity of 85%/91% for CT, 98%/99% for PET and 98%/99% for PET/CT. In the PET and CT group, region-based evaluation showed a sensitivity/specificity of 87%/80% for CT, 98%/99% for PET and 98%/100% for PET and CT read side by side. PET was superior to CT alone and was improved further by side-by-side reading of both examinations. However, no significant difference was observed between PET/CT and separate PET and CT imaging in patients with lymphoma. (orig.)

Trends in the development of radioisotope batteries

International Nuclear Information System (INIS)

Goeldner, R.; Leonhardt, J.W.; Radmaneche, R.; Schlegel, H.

1978-01-01

Improved methods for producing radioisotopes by nuclear fuel reprocessing and the rapid development of microelectronics offer new possibilities for utilizing radioisotope batteries. A review is given of the main principles of conversion of decay energy into electric power. The current state of such energy sources is evaluated. Finally, new fields of application and further trends in the development are indicated. (author)

Tailoring medium energy proton beam to induce low energy nuclear reactions in ⁸⁶SrCl₂ for production of PET radioisotope ⁸⁶Y.

Science.gov (United States)

Medvedev, Dmitri G; Mausner, Leonard F; Pile, Philip

2015-07-01

This paper reports results of experiments at Brookhaven Linac Isotope Producer (BLIP) aiming to investigate effective production of positron emitting radioisotope (86)Y by the low energy (86)Sr(p,n) reaction. BLIP is a facility at Brookhaven National Laboratory designed for the proton irradiation of the targets for isotope production at high and intermediate proton energies. The proton beam is delivered by the Linear Accelerator (LINAC) whose incident energy is tunable from 200 to 66 MeV in approximately 21 MeV increments. The array was designed to ensure energy degradation from 66 MeV down to less than 20 MeV. Aluminum slabs were used to degrade the proton energy down to the required range. The production yield of (86)Y (1.2+/-0.1 mCi (44.4+/-3.7) MBq/μAh) and ratio of radioisotopic impurities was determined by assaying an aliquot of the irradiated (86)SrCl2 solution by gamma spectroscopy. The analysis of energy dependence of the (86)Y production yield and the ratios of radioisotopic impurities has been used to adjust degrader thickness. Experimental data showed substantial discrepancies in actual energy propagation compared to energy loss calculations. Copyright © 2015 Elsevier Ltd. All rights reserved.

PET/MRI. Challenges, solutions and perspectives

Energy Technology Data Exchange (ETDEWEB)

Herzog, Hans [Forschungszentrum Juelich (Germany). Inst. of Neuroscience and Medicine - 4

2012-07-01

Already from the start of PET/CT integrating positron emission tomography (PET) and computed tomography (CT) in one instrument, there have been considerations how to combine PET and magnetic resonance imaging (MRI) so that their complementary abilities can be utilized in a single investigation. Since classical PET electronics fail in an even weak magnetic field and PET signal processing might disturb high-frequency signals of MRI, it soon became clear that new solutions had to be found to avoid mutual interferences. During the last fifteen years a number of different approaches towards PET/MRI for small animal imaging have been developed by research groups which together with their specific features are summarized in this review. Recently, PET/MRI for human imaging became available as well - this time by industrial initiatives. First some prototypes of BrainPET/MRI were developed followed by commercial products for simultaneous and non-simultaneous whole-body PET/MRI. Although only PET/MRI integrated in one scanner offers the full diversity of complementary multiparametric imaging, there are also promising applications of non-simultaneous sequential PET/MRI. While describing the present instrumentation for human PET/MRI, this review discusses the challenges and promises related to this new imaging technology. (orig.)

Bacteriophages safely reduce Salmonella contamination in pet food and raw pet food ingredients.

Science.gov (United States)

Soffer, Nitzan; Abuladze, Tamar; Woolston, Joelle; Li, Manrong; Hanna, Leigh Farris; Heyse, Serena; Charbonneau, Duane; Sulakvelidze, Alexander

2016-01-01

Contamination of pet food with Salmonella is a serious public health concern, and several disease outbreaks have recently occurred due to human exposure to Salmonella tainted pet food. The problem is especially challenging for raw pet foods (which include raw meats, seafood, fruits, and vegetables). These foods are becoming increasingly popular because of their nutritional qualities, but they are also more difficult to maintain Salmonella -free because they lack heat-treatment. Among various methods examined to improve the safety of pet foods (including raw pet food), one intriguing approach is to use bacteriophages to specifically kill Salmonella serotypes. At least 2 phage preparations (SalmoFresh® and Salmonelex™) targeting Salmonella are already FDA cleared for commercial applications to improve the safety of human foods. However, similar preparations are not yet available for pet food applications. Here, we report the results of evaluating one such preparation (SalmoLyse®) in reducing Salmonella levels in various raw pet food ingredients (chicken, tuna, turkey, cantaloupe, and lettuce). Application of SalmoLyse® in low (ca. 2-4×10 6 PFU/g) and standard (ca. 9×10 6 PFU/g) concentrations significantly ( P contamination in all raw foods examined compared to control treatments. When SalmoLyse®-treated (ca. 2×10 7 PFU/g) dry pet food was fed to cats and dogs, it did not trigger any deleterious side effects in the pets. Our data suggest that the bacteriophage cocktail lytic for Salmonella can significantly and safely reduce Salmonella contamination in various raw pet food ingredients.

Cost effectiveness of FDG-PET: rapid evaluation in recurrent colorectal cancer

International Nuclear Information System (INIS)

Kelley, B.B.; Miles, K.A.; Keith, C.J.; Wong, D.C.; Griffiths, M.R.

2002-01-01

Full text: Intensive patient follow-up in assessments of the cost-effectiveness of a new imaging modality is associated with time-delays, ethical difficulties and increased costs. This study aims to evaluate the cost-effectiveness of FDG-PET in recurrent colorectal cancer using Australian data whilst avoiding intensive patient follow-up. The study population comprised patients with recurrent colorectal under consideration for resection of apparently isolated hepatic metastasis in whom demonstration of extra-hepatic tumour would preclude surgery. The results of FDG-PET in a consecutive series of 75 such patients referred to the Wesley PET centre were used to determine the range of possible values for disease prevalence and specificity, assuming the value for PET sensitivity as reported in the federal government's PET review. These values, along with the diagnostic accuracy of CT and Australian costs for procedures (PET = $ 1200), were entered into decision trees modelling a diagnostic strategy comprising CT only and an alternative strategy where patients without extra-hepatic tumour on CT also undergo FDG-PET. The cost per patient, accuracy and Incremental Cost-Accuracy Ratio (ICAR) were determined for each strategy. The PET strategy is cheaper for all possible values of disease prevalence and PET specificity ($306-328/patient) and is more cost-effective for values of disease prevalence above 0.18 or PET specificity above 0.86. At a typical disease prevalence of 0.3 (PET specificity 0.92), the ICAR for the PET strategy is $9700 versus $11,200 for CT. PET remains cost saving even if the best reported values for sensitivity of CT and worse values for PET are used, FDG-PET for recurrent colorectal cancer in Australia would be cost-saving and most probably cost-effective. Copyright (2002) The Australian and New Zealand Society of Nuclear Medicine Inc

Generation of Pet1210-Cre Transgenic Mouse Line Reveals Non-Serotonergic Expression Domains of Pet1 Both in CNS and Periphery

Science.gov (United States)

Pelosi, Barbara; Migliarini, Sara; Pacini, Giulia; Pratelli, Marta; Pasqualetti, Massimo

2014-01-01

Neurons producing serotonin (5-hydroxytryptamine, 5-HT) constitute one of the most widely distributed neuronal networks in the mammalian central nervous system (CNS) and exhibit a profuse innervation throughout the CNS already at early stages of development. Serotonergic neuron specification is controlled by a combination of secreted molecules and transcription factors such as Shh, Fgf4/8, Nkx2.2, Lmx1b and Pet1. In the mouse, Pet1 mRNA expression appears between 10 and 11 days post coitum (dpc) in serotonergic post-mitotic precursors and persists in serotonergic neurons up to adulthood, where it promotes the expression of genes defining the mature serotonergic phenotype such as tryptophan hydroxylase 2 (Tph2) and serotonin transporter (SERT). Hence, the generation of genetic tools based on Pet1 specific expression represents a valuable approach to study the development and function of the serotonergic system. Here, we report the generation of a Pet1210-Cre transgenic mouse line in which the Cre recombinase is expressed under the control of a 210 kb fragment from the Pet1 genetic locus to ensure a reliable and faithful control of somatic recombination in Pet1 cell lineage. Besides Cre-mediated recombination accurately occurred in the serotonergic system as expected and according to previous studies, Pet1210-Cre transgenic mouse line allowed us to identify novel, so far uncharacterized, Pet1 expression domains. Indeed, we showed that in the raphe Pet1 is expressed also in a non-serotonergic neuronal population intermingled with Tph2-expressing cells and mostly localized in the B8 and B9 nuclei. Moreover, we detected Cre-mediated recombination also in the developing pancreas and in the ureteric bud derivatives of the kidney, where it reflected a specific Pet1 expression. Thus, Pet1210-Cre transgenic mouse line faithfully drives Cre-mediated recombination in all Pet1 expression domains representing a valuable tool to genetically manipulate serotonergic and non

PET/MRI: Technical challenges and recent advances

International Nuclear Information System (INIS)

Jung, Jin Ho; Choi, Yong; Im, Ki Chun

2016-01-01

Integrated positron emission tomography (PET)/magnetic resonance imaging (MRI), which can provide complementary functional and anatomical information about a specific organ or body system at the molecular level, has become a powerful imaging modality to understand the molecular biology details, disease mechanisms, and pharmacokinetics in animals and humans. Although the first experiment on the PET/MRI was performed in the early 1990s, its clinical application was accomplished in recent years because there were various technical challenges in integrating PET and MRI in a single system with minimum mutual interference between PET and MRI. This paper presents the technical challenges and recent advances in combining PET and MRI along with several approaches for improving PET image quality of the PET/MRI hybrid imaging system

Diffusion of Implanted Radioisotopes in Solids

CERN Multimedia

2002-01-01

Implantation of radioisotopes into metal and semiconductor samples is performed. The implanted isotope or its decay-product should have a half-life long enough for radiotracer diffusion experiments. Such radioisotopes are utilized to investigate basic diffusion properties in semiconductors and metals and to improve our understanding of the atomic mechanisms of diffusion. For suitably chosen systems the combination of on-line production and clean implantation of radioisotopes at the ISOLDE facility opens new possibilities for diffusion studies in solids. \\\\ \\\\ The investigations are concentrated on diffusion studies of $^{195}$Au in amorphous materials. The isotope $^{195}$Au was obtained from the mass 195 of the mercury beam. $^{195}$Hg decays into $^{195}$Au which is a very convenient isotope for diffusion experiments. \\\\ \\\\ It was found that $^{195}$Au is a slow diffusor in amorphous Co-Zr alloys, whereas Co is a fast diffusor in the same matrix. The ``asymmetry'' in the diffusion behaviour is of considerab...

Malignant lipogenesis defined by {sup 11}C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy

Energy Technology Data Exchange (ETDEWEB)

Regula, Naresh [Uppsala University, Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala (Sweden); Haeggman, Michael [Uppsala University, Section of Urology, Department of Surgical Sciences, Uppsala (Sweden); Johansson, Silvia [Uppsala University, Section of Oncology, Department of Immunology, Genetics and Pathology, Uppsala (Sweden); Soerensen, Jens [Uppsala University, Section of Nuclear Medicine and PET, Department of Surgical Sciences, Uppsala (Sweden); PET Center Research Department, Uppsala (Sweden)

2016-11-15

Malignant de novo lipogenesis is strongly linked to the aggressiveness of prostate cancer (PCa) under experimental conditions. {sup 11}C-Acetate PET/CT is a potential noninvasive biomarker of malignant lipogenesis in PCa, but its prognostic value is not known. The objective of this study was to analyse {sup 11}C-acetate PET/CT image metrics in relation to survival. All patients undergoing {sup 11}C-acetate PET/CT in one university hospital from 2005 to 2011 due to PSA relapse after previous prostatectomy were retrospectively evaluated. Two groups of patients were compared: those who died from PCa and those who were censored. All previously reported findings of local recurrence, regional or distal lymph node metastases and bone metastases were counted and evaluated regarding {sup 11}C-acetate uptake intensity (SUV{sub max}) and tumour volume. Total tumour volume and total lipogenic activity (TLA, summed SUV{sub max} x TV) were calculated. Survival analysis in the entire study population was followed by Cox proportional hazards ratio (HR) analysis. A total of 121 patients were included, and 22 PCa-specific deaths were recorded. The mean PSA level at the time of PET was 2.69 ± 4.35 ng/mL. The median follow-up of the study population was 79 ± 28 months. PET identified at least one PCa lesion in 53 % of patients. Five-year PCa-specific survival after PET was 80 % and 100 % in patients with a positive and a negative PET scan, respectively (p < 0.001). Time-to-death was linearly correlated with highest SUV{sub max} (r = -0.55, p = 0.01) and nonlinearly with TLA (r = -0.75, p < 0.001). Multivariate analysis showed statistical significance for number of bone metastases (HR 1.74, p = 0.01), tertile of TLA (HR 5.63, p = 0.029) and postoperative Gleason score (HR 1.84, p = 0.045). Malignant {sup 11}C-acetate accumulation measured with PET/CT is a strong predictor of survival in the setting of PSA relapse after prostatectomy. The study provides further evidence for a

Radioisotope production in fusion reactors

International Nuclear Information System (INIS)

Engholm, B.A.; Cheng, E.T.; Schultz, K.R.

1986-01-01

Radioisotope production in fusion reactors is being investigated as part of the Fusion Applications and Market Evaluation (FAME) study. /sup 60/Co is the most promising such product identified to date, since the /sup 60/Co demand for medical and food sterilization is strong and the potential output from a fusion reactor is high. Some of the other radioisotopes considered are /sup 99/Tc, /sup 131/l, several Eu isotopes, and /sup 210/Po. Among the stable isotopes of interest are /sup 197/Au, /sup 103/Rh and Os. In all cases, heat or electricity can be co-produced from the fusion reactor, with overall attractive economics

Radioisotopes production for applications on the health

International Nuclear Information System (INIS)

Monroy G, F.; Alanis M, J.

2010-01-01

In the Radioactive Materials Department of the Instituto Nacional de Investigaciones Nucleares (ININ) processes have been studied and developed for the radioisotopes production of interest in the medicine, research, industry and agriculture. In particular five new processes have been developed in the last 10 years by the group of the Radioactive Materials Research Laboratory to produce: 99 Mo/ 99m Tc and 188 W/ 188 Re generators, the radio lanthanides: 151 Pm, 147 Pm, 161 Tb, 166 Ho, 177 Lu, 131 I and the 32 P. All these radioisotopes are artificial and they can be produced in nuclear reactors and some of them in particle accelerators. The radioisotope generators are of particular interest, as those of 99 Mo/ 99m Tc and 188 W/ 188 Re presented in this work, because they are systems that allow to produce an artificial radioisotope of interest continually, in these cases the 99m Tc and the 188 Re, without the necessity of having a nuclear reactor or an particle accelerator. They are compact systems armored and sure perfectly of manipulating that, once the radioactive material has decayed, they do not present radiological risk some for the environment and the population. These systems are therefore of supreme utility in places where it is not had nuclear reactors or with a continuous radioisotope supply, due to their time of decaying, for its cost or for logistical problems in their supply, like it is the case of many hospital centers, of research or industries in our country. (Author)

Radioisotope applications in petroleum and gas industries

International Nuclear Information System (INIS)

Castagnet, A.C.; Agudo, E.G.; Duarte, U.

1974-01-01

The principal radioisotopic technique used for studying and /or controling the drilling, completion, treatment and oil well secondary recovery operations are described. In this cases the radioisotopes are employed almost exclusively as 'markers', in the form of localized and dispersed tracers. The growing acceptance of these techniques is essentially, a consequence of the confidence in the reliability of the data and conclusions derived from their application

Optimization of periodical interrogation of transducers of radioisotope measuring systems

International Nuclear Information System (INIS)

Ivashchenko, A.S.; Kaznakov, V.P.; Korolev, V.M.

1978-01-01

Certain methods are examined of optimizing periodic interrogation of sensors connected in a definite sequence to device for data processing in a system for controlling production processes. It is shown that in designing multiinput radioisotope measurement systems with a centralized data processing, the choice of the method of organizing periodic interrogation should be made with account for the conditions existing in each specific case

Clinical PET/CT imaging. Promises and misconceptions

International Nuclear Information System (INIS)

Czernin, J.; Auerbach, M.A.

2005-01-01

PET/CT is now established as the most important imaging tool in oncology. PET/CT stages and restages cancer with a higher accuracy than PET or CT alone. The sometimes irrational approach to combine state of the art PET with the highest end CT devices should give way to a more reasonable equipment design tailored towards the specific clinical indications in well-defined patient populations. The continuing success of molecular PET/CT now depends more upon advances in molecular imaging with the introduction of targeted imaging probes for individualized therapy approaches in cancer patients and less upon technological advances of imaging equipment. (orig.)

Production and application of radioisotopes - a Canadian perspective

International Nuclear Information System (INIS)

O'Neill, W.P.; Evans, D.J.R.

1988-01-01

This paper outlines the historical evolutions of radioisotopes from first concepts and discoveries to significant milestones in their production and the development of applications throughout the world. Regarding production, it addresses the methods that have been used at various stages during this evolution outlining the important findings that have led to further developments. With respect to radioisotope applications, the paper addresses the development of markets in industry, medicine, and agriculture and comments on the size of these markets and their rate of growth. Throughout, the paper highlights the Canadian experience and it also presents a Canadian view of emerging prospects and a forecast of how the future for radioisotopes might develop

Developing simplified Regional Potential Evapotranspiration (PET ...

African Journals Online (AJOL)

Regional Potential Evapotranspiration (PET) estimation method was developed to estimate the potential evapotranspiration (reference evapotranspiration) over Abbay Basin as a function of basin maximum and minimum temperature, and modulated by site specific elevation data. The method is intended to estimate PET in ...

Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests.

Science.gov (United States)

Demir, Mustafa; Toklu, Türkay; Abuqbeitah, Mohammad; Çetin, Hüseyin; Sezgin, H Sezer; Yeyin, Nami; Sönmezoğlu, Kerim

2018-02-01

The aim of the present study was to compare the performance of positron emission tomography (PET) component of PET/computed tomography (CT) with new emerging PET/magnetic resonance (MR) of the same vendor. According to National Electrical Manufacturers Association NU2-07, five separate experimental tests were performed to evaluate the performance of PET scanner of General Electric GE company; SIGNATM model PET/MR and GE Discovery 710 model PET/CT. The main investigated aspects were spatial resolution, sensitivity, scatter fraction, count rate performance, image quality, count loss and random events correction accuracy. The findings of this study demonstrated superior sensitivity (~ 4 folds) of PET scanner in PET/MR compared to PET/CT system. Image quality test exhibited higher contrast in PET/MR (~ 9%) compared with PET/CT. The scatter fraction of PET/MR was 43.4% at noise equivalent count rate (NECR) peak of 218 kcps and the corresponding activity concentration was 17.7 kBq/cc. Whereas the scatter fraction of PET/CT was found as 39.2% at NECR peak of 72 kcps and activity concentration of 24.3 kBq/cc. The percentage error of the random event correction accuracy was 3.4% and 3.1% in PET/MR and PET/CT, respectively. It was concluded that PET/MR system is about 4 times more sensitive than PET/CT, and the contrast of hot lesions in PET/MR was ~ 9% higher than PET/CT. These outcomes also emphasize the possibility to achieve excellent clinical PET images with low administered dose and/or a short acquisition time in PET/MR.

Performance characterization of the PET-CT tomograph at the PET-cyclotron-radiochemistry site of Messina University

OpenAIRE

Amato, Ernesto; Baldari, Sergio; Tomasello, Francesco

2015-01-01

A PET-cyclotron-radiochemistry plant was built at Messina University Hospital, whose diagnostics section was equipped with a PET-CT scanner composed by a time of flight PET and a 16-slice CT. The present note reports about the results of tomograph's acceptance tests, which had been planned and carried out in order to verify the correspondence of the specific scanner's performances declared by the firm and the fulfillment of Italian law's minimal criteria of acceptability. Acceptance tests...

Ultralow dose computed tomography attenuation correction for pediatric PET CT using adaptive statistical iterative reconstruction

International Nuclear Information System (INIS)

Brady, Samuel L.; Shulkin, Barry L.

2015-01-01

Purpose: To develop ultralow dose computed tomography (CT) attenuation correction (CTAC) acquisition protocols for pediatric positron emission tomography CT (PET CT). Methods: A GE Discovery 690 PET CT hybrid scanner was used to investigate the change to quantitative PET and CT measurements when operated at ultralow doses (10–35 mA s). CT quantitation: noise, low-contrast resolution, and CT numbers for 11 tissue substitutes were analyzed in-phantom. CT quantitation was analyzed to a reduction of 90% volume computed tomography dose index (0.39/3.64; mGy) from baseline. To minimize noise infiltration, 100% adaptive statistical iterative reconstruction (ASiR) was used for CT reconstruction. PET images were reconstructed with the lower-dose CTAC iterations and analyzed for: maximum body weight standardized uptake value (SUV bw ) of various diameter targets (range 8–37 mm), background uniformity, and spatial resolution. Radiation dose and CTAC noise magnitude were compared for 140 patient examinations (76 post-ASiR implementation) to determine relative dose reduction and noise control. Results: CT numbers were constant to within 10% from the nondose reduced CTAC image for 90% dose reduction. No change in SUV bw , background percent uniformity, or spatial resolution for PET images reconstructed with CTAC protocols was found down to 90% dose reduction. Patient population effective dose analysis demonstrated relative CTAC dose reductions between 62% and 86% (3.2/8.3–0.9/6.2). Noise magnitude in dose-reduced patient images increased but was not statistically different from predose-reduced patient images. Conclusions: Using ASiR allowed for aggressive reduction in CT dose with no change in PET reconstructed images while maintaining sufficient image quality for colocalization of hybrid CT anatomy and PET radioisotope uptake

Ultralow dose computed tomography attenuation correction for pediatric PET CT using adaptive statistical iterative reconstruction

Energy Technology Data Exchange (ETDEWEB)

Brady, Samuel L., E-mail: samuel.brady@stjude.org [Division of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105 (United States); Shulkin, Barry L. [Nuclear Medicine and Department of Radiological Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105 (United States)

2015-02-15

Purpose: To develop ultralow dose computed tomography (CT) attenuation correction (CTAC) acquisition protocols for pediatric positron emission tomography CT (PET CT). Methods: A GE Discovery 690 PET CT hybrid scanner was used to investigate the change to quantitative PET and CT measurements when operated at ultralow doses (10–35 mA s). CT quantitation: noise, low-contrast resolution, and CT numbers for 11 tissue substitutes were analyzed in-phantom. CT quantitation was analyzed to a reduction of 90% volume computed tomography dose index (0.39/3.64; mGy) from baseline. To minimize noise infiltration, 100% adaptive statistical iterative reconstruction (ASiR) was used for CT reconstruction. PET images were reconstructed with the lower-dose CTAC iterations and analyzed for: maximum body weight standardized uptake value (SUV{sub bw}) of various diameter targets (range 8–37 mm), background uniformity, and spatial resolution. Radiation dose and CTAC noise magnitude were compared for 140 patient examinations (76 post-ASiR implementation) to determine relative dose reduction and noise control. Results: CT numbers were constant to within 10% from the nondose reduced CTAC image for 90% dose reduction. No change in SUV{sub bw}, background percent uniformity, or spatial resolution for PET images reconstructed with CTAC protocols was found down to 90% dose reduction. Patient population effective dose analysis demonstrated relative CTAC dose reductions between 62% and 86% (3.2/8.3–0.9/6.2). Noise magnitude in dose-reduced patient images increased but was not statistically different from predose-reduced patient images. Conclusions: Using ASiR allowed for aggressive reduction in CT dose with no change in PET reconstructed images while maintaining sufficient image quality for colocalization of hybrid CT anatomy and PET radioisotope uptake.

PET/CT in the complex estimation of the patient after breast cancer therapy - case report

International Nuclear Information System (INIS)

Ziolkowska, E.; Lozynska-Podhrebelna, D.; Zarzycka, M.; Malkowski, B.

2007-01-01

The connection of positron emission tomography (PET) and computer tomography (CT) with the use of FDG is finding wider application to the diagnostics, monitoring and treatment of breast cancer. The use of PET/CT improves the effectiveness of recurrence, metastases to the bones and distant internal organs diagnostics, and in some patients outdistances the presence of lesions which in conventional diagnostic examinations are described considerably later. This work presents the case of a 50-year-old woman with diagnosed breast cancer, after surgery treatment and complementary chemotherapy and radiotherapy. There was a suspicion of local recurrence in postoperative scar (in 18 th month after finished radiotherapy) and the absence of oncocytes in cytological examination in this patient and PET/CT was performed. The recurrence in postoperative scar and signs of dissemination to the bones and the liver was shown in this examination despite the negative tumour marker profile. CT and scintigraphy were performed additionally and they confirmed only the existence of metastatic changes in S1 vertebra and VI rib on the left side. Thanks to PET/CT examination both palliative radiotherapy and chemotherapy were applied immediately. After 5 months the control PET/CT examination was performed which showed a partial response to the applied treatment. The result of the examination and further growth of CA 15-3 marker were reasons for the inclusion of the next two series of chemotherapy. Bone scintigraphy, which was performed after completion of chemotherapy, showed the progression of metastatic changes. The patient was referred for radioisotopic treatment. The introduced case confirms the suitability of PET/CT in the complex assessment of a patient with diagnosed breast cancer. The use of PET/CT is a valuable element of recurrence and dissemination in neoplasmic disease quick diagnostics and directs the ways of the optimum antineoplasmic treatment. (authors)

Evaluation of suspected local recurrence in head and neck cancer: A comparison between PET and PET/CT for biopsy proven lesions

International Nuclear Information System (INIS)

Halpern, Benjamin S.; Yeom, Kristen; Fueger, Barbara J.; Lufkin, Robert B.; Czernin, Johannes; Allen-Auerbach, Martin

2007-01-01

Background: 18 F-FDG PET has a high accuracy for re-staging of head and neck cancer. The purpose of this study was to determine whether the diagnostic accuracy can be further improved with integrated PET/CT. Materials and methods: Forty-nine patients with a mean age of 59 ± 18 years were studied retrospectively. Histo-pathological verification was available either from complete tumor resection with or without lymph node dissection (n = 27) or direct endoscopic biopsy (n = 16) or ultrasound guided biopsy (n = 6). Two reviewers blinded to the pathological findings read all PET images in consensus. An experienced radiologist was added for the interpretation of the PET/CT images. Results: Tissue verification was available for 110 lesions in 49 patients. Sixty-seven lesions (61%) were biopsy positive and 43 (39%) were negative for malignant disease. PET and PET/CT showed an overall accuracy for cancer detection of 84 and 88% (p = 0.06), respectively. Sensitivity and specificity for PET were 78 and 93% versus 84 (p = NS) and 95% (p = NS) with PET/CT. A patient-by-patient analysis yielded a sensitivity, specificity and accuracy for PET of 80, 56 and 76%, compared to 88% (p = NS), 78% (p = NS) and 86% (p = 0.06) for PET/CT. Conclusion: The results of this study indicate that PET/CT does not significantly improve the detection of recurrence of head and neck cancer. However, a trend towards improved accuracy was observed (p = 0.06)

FDG-PET/CT in oncology. German guideline

International Nuclear Information System (INIS)

Krause, B.J.; Beyer, T.; Bockisch, A.; Delbeke, D.; Kotzerke, J.; Minkov, V.; Reiser, M.; Willich, N.

2007-01-01

FDG-PET/CT examinations combine metabolic and morphologic imaging within an integrated procedure. Over the past decade PET/CT imaging has gained wide clinical acceptance in the field of oncology. This FDG-PET/CT guideline focuses on indications, data acquisition and processing as well as documentation of FDG-PET/CT examinations in oncologic patients within a clinical and social context specific to Germany. Background information and definitions are followed by examples of clinical and research applications of FDG-PET/CT. Furthermore, protocols for CT scanning (low dose and contrast-enhanced CT) and PET emission imaging are discussed. Documentation and reporting of examinations are specified. Image interpretation criteria and sources of errors are discussed. Quality control for FDG and PET/CT-systems, qualification requirements of personnel as well as legal aspects are presented. (orig.)

Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer

Energy Technology Data Exchange (ETDEWEB)

Bates, Anthony [Princess Alexandra Hospital, Brisbane (Australia); Miles, Kenneth [Princess Alexandra Hospital, Department of Diagnostic Radiology, Brisbane, QLD (Australia); University College London, Institute of Nuclear Medicine, London (United Kingdom)

2017-12-15

To validate MR textural analysis (MRTA) for detection of transition zone (TZ) prostate cancer through comparison with co-registered prostate-specific membrane antigen (PSMA) PET-MR. Retrospective analysis was performed for 30 men who underwent simultaneous PSMA PET-MR imaging for staging of prostate cancer. Thirty texture features were derived from each manually contoured T2-weighted, transaxial, prostatic TZ using texture analysis software that applies a spatial band-pass filter and quantifies texture through histogram analysis. Texture features of the TZ were compared to PSMA expression on the corresponding PET images. The Benjamini-Hochberg correction controlled the false discovery rate at <5%. Eighty-eight T2-weighted images in 18 patients demonstrated abnormal PSMA expression within the TZ on PET-MR. 123 images were PSMA negative. Based on the corrected p-value of 0.005, significant differences between PSMA positive and negative slices were found for 16 texture parameters: Standard deviation and mean of positive pixels for all spatial filters (p = <0.0001 for both at all spatial scaling factor (SSF) values) and mean intensity following filtration for SSF 3-6 mm (p = 0.0002-0.0018). Abnormal expression of PSMA within the TZ is associated with altered texture on T2-weighted MR, providing validation of MRTA for the detection of TZ prostate cancer. (orig.)

Prostate-specific membrane antigen PET/MRI validation of MR textural analysis for detection of transition zone prostate cancer

International Nuclear Information System (INIS)

Bates, Anthony; Miles, Kenneth

2017-01-01

To validate MR textural analysis (MRTA) for detection of transition zone (TZ) prostate cancer through comparison with co-registered prostate-specific membrane antigen (PSMA) PET-MR. Retrospective analysis was performed for 30 men who underwent simultaneous PSMA PET-MR imaging for staging of prostate cancer. Thirty texture features were derived from each manually contoured T2-weighted, transaxial, prostatic TZ using texture analysis software that applies a spatial band-pass filter and quantifies texture through histogram analysis. Texture features of the TZ were compared to PSMA expression on the corresponding PET images. The Benjamini-Hochberg correction controlled the false discovery rate at <5%. Eighty-eight T2-weighted images in 18 patients demonstrated abnormal PSMA expression within the TZ on PET-MR. 123 images were PSMA negative. Based on the corrected p-value of 0.005, significant differences between PSMA positive and negative slices were found for 16 texture parameters: Standard deviation and mean of positive pixels for all spatial filters (p = <0.0001 for both at all spatial scaling factor (SSF) values) and mean intensity following filtration for SSF 3-6 mm (p = 0.0002-0.0018). Abnormal expression of PSMA within the TZ is associated with altered texture on T2-weighted MR, providing validation of MRTA for the detection of TZ prostate cancer. (orig.)

Design of shipping packages to transport varying radioisotopic source materials for future space and terrestrial missions

International Nuclear Information System (INIS)

Barklay, C.D.

1995-01-01

The exploration of space will begin with manned missions to the moon and to Mars, first for scientific discoveries, then for mining and manufacturing. Because of the great financial costs of this type of exploration, it can only be accomplished through an international team effort. This unified effort must include the design, planning and, execution phases of future space missions, extending down to such activities as isotope processing, and shipping package design, fabrication, and certification. All aspects of this effort potentially involve the use of radioisotopes in some capacity, and the transportation of these radioisotopes will be impossible without a shipping package that is certified by the Nuclear Regulatory Commission or the U.S. Department of Energy for domestic shipments, and the U.S. Department of Transportation or the International Atomic Energy Agency for international shipments. To remain without the international regulatory constraints, and still support the needs of new and challenging space missions conducted within ever-shrinking budgets, shipping package concepts must be innovative. A shipping package must also be versatile enough to be reconfigured to transport the varying radioisotopic source materials that may be required to support future space and terrestrial missions. One such package is the Mound USA/9516/B(U)F. Taking into consideration the potential need to transport specific types of radioisotopes, approximations of dose rates at specific distances were determined taking into account the attenuation of dose rate with distance for varying radioisotopic source materials. As a result, it has been determined that the shipping package requirements that will be demanded by future space (and terrestrial) missions can be met by making minor modifications to the USA/9516/B(U)F. copyright 1995 American Institute of Physics

PET-MRI and multimodal cancer imaging

International Nuclear Information System (INIS)

Wang Taisong; Zhao Jinhua; Song Jianhua

2011-01-01

Multimodality imaging, specifically PET-CT, brought a new perspective into the fields of clinical imaging. Clinical cases have shown that PET-CT has great value in clinical diagnosis and experimental research. But PET-CT still bears some limitations. A major drawback is that CT provides only limited soft tissue contrast and exposes the patient to a significant radiation dose. MRI overcome these limitations, it has excellent soft tissue contrast, high temporal and spatial resolution and no radiation damage. Additionally, since MRI provides also functional information, PET-MRI will show a new direction of multimodality imaging in the future. (authors)

Future radioisotope power needs for missions to the solar system

International Nuclear Information System (INIS)

Mondt, J.F.; Underwood, M.L.; Nesmith, B.J.

1997-01-01

NASA and DOE plan a cooperative team effort with industry, government laboratories and universities to develop a near term, low cost, low power (100 watt electric class), low mass (<10 kg), advanced radioisotope space power source (ARPS) and in the process reduce the plutonium-related costs as well. The near term is focused on developing an advanced energy converter to use with the General Purpose Heat Source (GPHS). The GPHS was developed and used for the current radioisotope thermoelectric generators (RTGs). Advanced energy converter technologies are needed as a more efficient replacement for the existing thermoelectric converters so that the space radioisotope power source mass and cost can be reduced. a more advanced technology space radioisotope power system program is also planned that addresses a longer-term need. Twenty first century robotic scientific information missions to the outer planets and beyond are planned to be accomplished with microspacecraft which may demand safe, even more compact, lower-power, lower-mass radioisotope power sources than those which can be achieved as a result of the near term efforts. The longer-term program focuses not only on converter technology but also on lower power, more compact radioisotope heat source technology and smaller, lower mass radioisotope heater units for second generation microspacecraft. This more ambitious, longer time-horizon focus necessarily occurs at this time on the technology R and D level rather than at the system technology level

Random-process excursions in radioisotope instruments

International Nuclear Information System (INIS)

Galochkin, D.V.; Polovko, S.A.

1984-01-01

Approximate expressions are derived for the mathematical expectation, variance, and distribution of the durations of the excursions of the output signal from a ratemeter in a radioisotope relay instrument. The tabulated comparison of results from Monte Carlo simulation and analytical calculation shows good agreement over the mean value and the variance of the excursion duration for T 0.2 sec as calculated and as obtained by Monte Carlo simulation with a computer using 5000 realizations. It is suggested that the results should be used in choosing the optimum parameters of radioisotope relay instruments

Daily intakes of naturally occurring radioisotopes in typical Korean foods

International Nuclear Information System (INIS)

Choi, Min-Seok; Lin Xiujing; Lee, Sun Ah; Kim, Wan; Kang, Hee-Dong; Doh, Sih-Hong; Kim, Do-Sung; Lee, Dong-Myung

2008-01-01

The concentrations of naturally occurring radioisotopes ( 232 Th, 228 Th, 230 Th, 228 Ra, 226 Ra, and 40 K) in typical Korean foods were evaluated. The daily intakes of these radioisotopes were calculated by comparing concentrations in typical Korean foods and the daily consumption rates of these foods. Daily intakes were as follows: 232 Th, 0.00-0.23; 228 Th, 0.00-2.04; 230 Th, 0.00-0.26; 228 Ra, 0.02-2.73; 226 Ra, 0.01-4.37 mBq/day; and 40 K, 0.01-5.71 Bq/day. The total daily intake of the naturally occurring radioisotopes measured in this study from food was 39.46 Bq/day. The total annual internal dose resulting from ingestion of radioisotopes in food was 109.83 μSv/y, and the radioisotope with the highest daily intake was 40 K. These values were same level compiled in other countries

[F-18]FDG imaging of head and neck tumors: comparison of hybrid PET, dedicated PET and CT

International Nuclear Information System (INIS)

Dresel, S.; Brinkbaeumer, K.; Schmid, R.; Poepperl, G.; Hahn, K.; Szeimies, U.

2001-01-01

Aim: Aim of the study was to evaluate [F-18]FDG imaging of head and neck tumors using a Hybrid-PET device of the 2nd or 3rd generation. Examinations were compared to dedicated PET and Spiral-CT. Methods: 54 patients suffering from head and neck tumors were examined using dedicated PET and Hybrid-PET after injection of 185-350 MBq [F-18]FDG. Examinations were carried out on the dedicated PET first followed by a scan on the Hybrid-PET. Dedicated PET was acquired in 3D mode, Hybrid-PET was performed in list mode using an axial filter. Reconstruction of data was performed iteratively on both, dedicated PET and Hybrid-PET. All patients received a CT scan in multislice technique. All finding have been verified by the goldstandard histology or in case of negative histology by follow up. Results: Using dedicated PET the primary or recurrent lesion was correctly diagnosed in 47/48 patients, using Hybrid-PET in 46/48 patients and using CT in 25/48 patients. Metastatic disease in cervical lymph nodes was diagnosed in 17/18 patients with dedicated PET, in 16/18 patients with Hybrid-PET and in 15/18 with CT. False positive results with regard to lymph node metastasis were seen with one patient for dedicated PET and Hybrid-PET, respectively, and with 18 patients for CT. In a total of 11 patients unknown metastastic lesions were seen with dedicated PET and with Hybrid-PET elsewhere in the body. Additional malignant disease other than the head and neck tumor was found in 4 patients. Conclusion: Using Hybrid-PET for [F-18]FDG imaging reveals a loss of sensitivity and specificity of about 1-5% as compared to dedicated PET in head and neck tumors. [F-18]FDG PET with both, dedicated PET and Hybrid-PET is superior to CT in the diagnosis of primary or recurrent lesions as well as in the assessment of lymph node involvement. (orig.) [de

Radioisotopes as Political Instruments, 1946–1953

Science.gov (United States)

Creager, Angela N. H.

2009-01-01

The development of nuclear “piles,” soon called reactors, in the Manhattan Project provided a new technology for manufacturing radioactive isotopes. Radioisotopes, unstable variants of chemical elements that give off detectable radiation upon decay, were available in small amounts for use in research and therapy before World War II. In 1946, the U.S. government began utilizing one of its first reactors, dubbed X-10 at Oak Ridge, as a production facility for radioisotopes available for purchase to civilian institutions. This program of the U.S. Atomic Energy Commission was meant to exemplify the peacetime dividends of atomic energy. The numerous requests from scientists outside the United States, however, sparked a political debate about whether the Commission should or even could export radioisotopes. This controversy manifested the tension in U.S. politics between scientific internationalism as a tool of diplomacy, associated with the aims of the Marshall Plan, and the desire to safeguard the country’s atomic monopoly at all costs, linked to American anti-Communism. This essay examines the various ways in which radioisotopes were used as political instruments—both by the U.S. federal government in world affairs, and by critics of the civilian control of atomic energy—in the early Cold War. PMID:20725612

18F-FDG PET in children with lymphomas

International Nuclear Information System (INIS)

Depas, Gisele; Barsy, Caroline De; Foidart, Jacqueline; Rigo, Pierre; Hustinx, Roland; Jerusalem, Guy; Hoyoux, Claire; Dresse, Marie-Francoise; Fassotte, Marie-France; Paquet, Nancy

2005-01-01

The aim of this study was to retrospectively evaluate the performance of positron emission tomography (PET) with 18 F-fluorodeoxyglucose ( 18 F-FDG) in children with lymphomas, at various stages of their disease. Twenty-eight children (mean age 12.5 years, 14 girls, 14 boys) with Hodgkin's disease (HD, n=17) or non-Hodgkin's lymphoma (NHL, n=11) were evaluated. Patients were investigated at initial staging (n=19), early in the course of treatment (n=19), at the end of treatment (n=16) and during long-term follow-up (n=19). A total of 113 whole-body PET studies were performed on dedicated scanners. PET results were compared with the results of conventional methods (CMs) such as physical examination, laboratory studies, chest X-rays, computed tomography, magnetic resonance imaging, ultrasonography and bone scan when available. At initial evaluation (group 1), PET changed the disease stage and treatment in 10.5% of the cases. In early evaluation of the response to treatment (group 2), PET failed to predict two relapses and one incomplete response to treatment. In this group, however, PET did not show any false positive results. There were only 4/75 false positive results for PET among patients studied at the end of treatment (group 3, specificity 94%) or during the systematic follow-up (group 4, specificity 95%), as compared with 27/75 for CMs (specificity 54% and 66%, respectively). 18 F-FDG-PET is a useful tool for evaluating children with lymphomas. Large prospective studies are needed to appreciate its real impact on patient management. (orig.)

CyberPET: a PET service distributed over a wide area

International Nuclear Information System (INIS)

Pilloy, W.J.; Hellwig, D.; Schaeffer, A.; Hoffmann, P.; Lens, V.

2002-01-01

Aim: Demonstration of bi-directional PET data transmission, interactive display and co-registration, for the purpose of correlative imaging, treatment planning and teaching. Material and Method: In the year 2000, the initial problem to attend was to provide an effective PET service to a hospital (in Luxemburg) which lies 150 km away from a PET center (in another country). Once this solved, the procedure was expanded (in 2001) to co-registration with CT/MRI scans performed locally, and with radiotherapy simulation CT performed in another center 25 km away (in 2002). Equipment from various vendors was used (Siemens, Adac, GE, Hermes). With preliminary agreement of the national medical aid, patients are sent from the Nuclear Medicine Dept of the Centre Hospitalier in Luxemburg (CHL) to the Dept NM of the Saarland University Medical Center for PET examination. The digital data are then sent from the Siemens PET camera to a PC connected to the LAN, and then to a FTP server (Healthnet). The data are similarly collected by a PC of the hospital network in Luxemburg, and transferred to a Hermes NM station. The Dicom PET data are converted on the fly to Interfile, displayed interactively as any other tomographic data, printed and available on the NM image server. Since 2001, the PET data are co-registered with whole-body CT data recorded at CHL according to a specific protocol (see other paper of this group). Now in 2002, we are busy implementing the co-registration of PET data and simulation CT data obtained from the Centre Baclesse (CFB, 25 km from CHL) for the treatment planning of brain tumours (input into an ADAC system). Furthermore, we plan to send the data (after deletion of their digital ID) to a (South African) university which does not yet dispose of a PET camera, to allow the training of their registrars. Results: For the end-user clinician at CHL and CFB , the PET data have the quality of 'live data', which can be examined interactively, along with other imaging

Comparison of the diagnosis using FDG-PET and AC-PET with histopathological features in lung adenocarcinomas

International Nuclear Information System (INIS)

Koizumi, Satoko

2011-01-01

Fluorodeoxyglucose-positron emission tomography (FDG-PET) is a useful tool for lung cancer diagnosis because of its good sensitivity and specificity. However, FDG-PET is problematically causing the false negative in cases of well differentiated lung adenocarcinomas which are low grade malignancies. Acetate (AC)-PET using 11 C-acetate is thought to be a superior detection tool for low grade malignancies. In this study, comparison of each type of PET in relation with histopathological features of lung adenocarcinomas was conducted. Samples obtained from 81 lesions in 75 patients with a lung adenocarcinoma who were operated at various institutions of our collaborators between 2005 and 2009 following FDG-PET and AC-PET procedures were examined. These samples consisted of fifty-seven cases of a well differentiated adenocarcinoma and twenty-four cases of a moderately- or a poorly-differentiated adenocarcinoma. Relationships between the histopathological factors (ly, v, p) as well as the lymphatic microvessel and microvessel densities in a tumor and FDG- and AC-PET findings were evaluated. AC-PET was more sensitive than FDG-PET (0.58 vs 0.74, p=0.0001). FDG-PET showed a correlation with invasiveness of the tumor and intratumoral lymphatic microvessel density (p<0.05). Furthermore, AC-PET possessed a superior sensitivity for the detection of well differentiated adenocarcinomas, and tumors without ly, v, or p factors. In lung adenocarcinoma AC-PET showed better sensitivity than FDG-PET and true positive in all cases of stage I B or more. FDG-PET showed the correlation with the pathological invasiveness (ly, v, p) of a tumor and the intratumoral lymphatic microvessel density. (author)

Application of radiation and radioisotopes in life science

International Nuclear Information System (INIS)

Nakanishi, Tomoko M.

2005-01-01

Radiation and Radioisotopes have been played an important role in the wide range of life science, from the field study, such as fertilizer or pesticide development or production of new species, to gene engineering researches. Many mutants through radiation have been provided to the market and the usage of radioactive tracers was an effective tool to study plant physiology. It has been granted that the contribution of radioisotopes has been accelerated the development of the gene engineering technology, which is now overwhelming all the other usages of radiation or radioisotopes. However, because of the difficulty to get social acceptance for gene modified plants, the orientation of the life science is now changing towards, so called ''post genome era''. Therefore, from the point of radiation or radioisotope usage, new application methods are needed to develop new type of researches. We present how (1) neutron activation analysis, (2) neutron radiography and (3) positron emission tomography are promising to study living plant physiology. Some of these techniques are not necessarily new methods but with a little modification, they show new aspects of plant activity. (author)

Radioisotopes - where have we got to, where are we going ?

International Nuclear Information System (INIS)

Taylor, C.B.G.

1986-01-01

Rapid growth has been achieved and there are remarkable possibilities in various fields of radioisotopes and radiation. New applications in molecular biology, in nuclear medicine, and in biotechnology are opening further opportunities for the use of radioisotopes. In the industrial field too there is growth, as microprocessor techniques extend the usefulness of radioisotope methods. And radiation engineering is a success story of its own, as ever-increasing use is made of radiation processing and sterilization, and new horizons open for food irradiation. This paper begins by recalling how isotope technology developed from the research laboratory to become the industry-scale activity it is today. A section is devoted to describing the development of a new radioisotope industry during the period from the 1930s through 1960s, focusing on the growth in the areas of nuclear medicine, radiotherapy, isotope gauging and tracing, production control, industrial processing, and production of radioisotopes. After a brief review of the present it looks into the future to suggest the directions in which new developments may lie. In particular, remarkable growth is expected in such areas as molecular biology, biotechnology, radiography, gauging, process control, radiation processing, and radiation sterilization. A review is also made of the transport and disposal of radioisotopes. (Nogami, K.)

Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.

Science.gov (United States)

Bowen, S R; Nyflot, M J; Herrmann, C; Groh, C M; Meyer, J; Wollenweber, S D; Stearns, C W; Kinahan, P E; Sandison, G A

2015-05-07

Effective positron emission tomography / computed tomography (PET/CT) guidance in radiotherapy of lung cancer requires estimation and mitigation of errors due to respiratory motion. An end-to-end workflow was developed to measure patient-specific motion-induced uncertainties in imaging, treatment planning, and radiation delivery with respiratory motion phantoms and dosimeters. A custom torso phantom with inserts mimicking normal lung tissue and lung lesion was filled with [(18)F]FDG. The lung lesion insert was driven by six different patient-specific respiratory patterns or kept stationary. PET/CT images were acquired under motionless ground truth, tidal breathing motion-averaged (3D), and respiratory phase-correlated (4D) conditions. Target volumes were estimated by standardized uptake value (SUV) thresholds that accurately defined the ground-truth lesion volume. Non-uniform dose-painting plans using volumetrically modulated arc therapy were optimized for fixed normal lung and spinal cord objectives and variable PET-based target objectives. Resulting plans were delivered to a cylindrical diode array at rest, in motion on a platform driven by the same respiratory patterns (3D), or motion-compensated by a robotic couch with an infrared camera tracking system (4D). Errors were estimated relative to the static ground truth condition for mean target-to-background (T/Bmean) ratios, target volumes, planned equivalent uniform target doses, and 2%-2 mm gamma delivery passing rates. Relative to motionless ground truth conditions, PET/CT imaging errors were on the order of 10-20%, treatment planning errors were 5-10%, and treatment delivery errors were 5-30% without motion compensation. Errors from residual motion following compensation methods were reduced to 5-10% in PET/CT imaging, PET/CT imaging to RT planning, and RT delivery under a dose painting paradigm is feasible within an integrated respiratory motion phantom workflow. For a limited set of cases, the magnitude

Work Began on Contracts for Radioisotope Power Conversion Technology Research and Development

Science.gov (United States)

Wong, Wayne A.

2005-01-01

NASA has had a history of successful space flight missions that depended on radioisotope-fueled power systems. These Radioisotope Power Systems (RPSs) converted the heat generated from the decay of radioisotope material into useful electrical power. An RPS is most attractive in applications where photovoltaics are not optimal, such as deep-space applications where the solar flux is too low or extended applications on planets such as Mars where the day/night cycle, settling of dust, and life requirements limit the usefulness of photovoltaics. NASA s Radioisotope Power Conversion Technology (RPCT) Program is developing next-generation power-conversion technologies that will enable future missions that have requirements that cannot be met by the two RPS flight systems currently being developed by the Department of Energy for NASA: the Multi-Mission Radioisotope Thermoelectric Generator and the Stirling Radioisotope Generator (SRG).

Reactor production and processing of radioisotopes for therapeutic applications in nuclear medicine

International Nuclear Information System (INIS)

Knapp, F.F. Jr.; Mirzadeh, S.; Beets, A.L.

1995-01-01

Nuclear reactors continue to play an important role in providing radioisotopes for nuclear medicine. Many reactor-produced radioisotopes are ''neutron rich'' and decay by beta-emission and are thus of interest for therapeutic applications. This talk discusses the production and processing of a variety of reactor-produced radioisotopes of current interest, including those produced by the single neutron capture process, double neutron capture and those available from beta-decay of reactorproduced radioisotopes. Generators prepared from reactorproduced radioisotopes are of particular interest since repeated elution inexpensively provides many patient doses. The development of the alumina-based W-188/Re-188 generator system is discussed in detail

Radioisotope Sample Measurement Techniques in Medicine and Biology. Proceedings of the Symposium on Radioisotope Sample Measurement Techniques

International Nuclear Information System (INIS)

1965-01-01

The medical and biological applications of radioisotopes depend on two basically different types of measurements, those on living subjects in vivo and those on samples in vitro. The International Atomic Energy Agency has in the past held several meetings on in vivo measurement techniques, notably whole-body counting and radioisotope scanning. The present volume contains the Proceedings of the first Symposium the Agency has organized to discuss the various aspects of techniques for sample measurement in vitro. The range of these sample measurement techniques is very wide. The sample may weigh a few milligrams or several hundred grams, and may be in the gaseous, liquid or solid state. Its radioactive content may consist of a single, known radioisotope or several unknown ones. The concentration of radioactivity may be low, medium or high. The measurements may be made manually or automatically and any one of the many radiation detectors now available may be used. The 53 papers presented at the Symposium illustrate the great variety of methods now in use for radioactive- sample measurements. The first topic discussed is gamma-ray spectrometry, which finds an increasing number of applications in sample measurements. Other sections of the Proceedings deal with: the use of computers in gamma-ray spectrometry and multiple tracer techniques; recent developments in activation analysis where both gamma-ray spectrometry and computing techniques are applied; thin-layer and paper radio chromatographic techniques for use with low energy beta-ray emitters; various aspects of liquid scintillation counting techniques in the measurement of alpha- and beta-ray emitters, including chemical and colour quenching; autoradiographic techniques; calibration of equipment; and standardization of radioisotopes. Finally, some applications of solid-state detectors are presented; this section may be regarded as a preview of important future developments. The meeting was attended by 203 participants

Control of radioisotopes and radiation sources in Indonesia

International Nuclear Information System (INIS)

Ridwan, M.

2001-01-01

Radioisotopes and radiation sources are extensively used in Indonesia in medicine, industry, mining, agriculture and research. These materials are controlled by the regulatory authority, according to established legal procedures. The Nuclear Energy Control Board of Indonesia (BAPETEN), which was established in 1998 through the Nuclear Energy Act No. 10/1997, is entrusted with the control of any application of nuclear energy, including the application of radioisotopes and radiation sources, through regulation, licensing and inspection. The control is aimed to assure welfare, security and peace, the safety and health of workers and the public, and environmental protection. The number of licences issued to date is around 2400, consisting of 1600 licences for radioisotopes and radiation sources used in hospitals, 347 in radiography, 256 in industry, 53 in mining, and the rest in many other areas such as research and agriculture. A licence can cover one or more radioisotopes or radiation sources, depending on the location of the user institution. These radioisotopes and radiation sources are Co-60, Cs-137, Ir-192, Ra-226, Am-241, Sr-90, Kr-85, Pm-147, linear accelerator and X-ray, and short half-life radioisotopes such as I-125, I-131 and Tc-99m. There are 10 LINACs, 27 X-ray medicines, 61 radioisotope devices for Co-60 and Cs-137, and 10 mHDR Ir-192 for therapeutic purposes currently used in Indonesia and some Ra-226 in storage. Any activity related to the application of nuclear energy is required to be conducted in a manner which observes safety and security. According to the legal requirements, each user has to employ at least one radiation safety officer. To improve the control of the application of radiation sources and radioactive material in the country, BAPETEN introduced some new approaches to the users, including regular dialogues with radiation safety officers and the management of the users, requalification for radiation protection officers twice in five

Initial clinical results of simultaneous {sup 18}F-FDG PET/MRI in comparison to {sup 18}F-FDG PET/CT in patients with head and neck cancer

Energy Technology Data Exchange (ETDEWEB)

Kubiessa, K.; Gawlitza, M.; Kuehn, A.; Fuchs, J.; Kahn, T.; Stumpp, P. [University Hospital of Leipzig, Department of Diagnostic and Interventional Radiology, Leipzig (Germany); Purz, S.; Steinhoff, K.G.; Sabri, O.; Kluge, R. [University Hospital of Leipzig, Department of Nuclear Medicine, Leipzig (Germany); Boehm, A. [University Hospital of Leipzig, ENT Department, Leipzig (Germany)

2014-04-15

The aim of this study was to evaluate the diagnostic capability of simultaneous {sup 18}F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/MRI compared to {sup 18}F-FDG PET/CT as well as their single components in head and neck cancer patients. In a prospective study 17 patients underwent {sup 18}F-FDG PET/CT for staging or follow-up and an additional {sup 18}F-FDG PET/MRI scan with whole-body imaging and dedicated examination of the neck. MRI, CT and PET images as well as PET/MRI and PET/CT examinations were evaluated independently and in a blinded fashion by two reader groups. Results were compared with the reference standard (final diagnosis determined in consensus using all available data including histology and follow-up). Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated. A total of 23 malignant tumours were found with the reference standard. PET/CT showed a sensitivity of 82.7 %, a specificity of 87.3 %, a PPV of 73.2 % and a NPV of 92.4 %. Corresponding values for PET/MRI were 80.5, 88.2, 75.6 and 92.5 %. No statistically significant difference in diagnostic capability could be found between PET/CT and PET/MRI. Evaluation of the PET part from PET/CT revealed highest sensitivity of 95.7 %, and MRI showed best specificity of 96.4 %. There was a high inter-rater agreement in all modalities (Cohen's kappa 0.61-0.82). PET/MRI of patients with head and neck cancer yielded good diagnostic capability, similar to PET/CT. Further studies on larger cohorts to prove these first results seem justified. (orig.)

New Directions In Radioisotope Spectrum Identification

International Nuclear Information System (INIS)

Salaymeh, S.; Jeffcoat, R.

2010-01-01

Recent studies have found the performance of commercial handheld detectors with automatic RIID software to be less than acceptable. Previously, we have explored approaches rooted in speech processing such as cepstral features and information-theoretic measures. Scientific advances are often made when researchers identify mathematical or physical commonalities between different fields and are able to apply mature techniques or algorithms developed in one field to another field which shares some of the same challenges. The authors of this paper have identified similarities between the unsolved problems faced in gamma-spectroscopy for automated radioisotope identification and the challenges of the much larger body of research in speech processing. Our research has led to a probabilistic framework for describing and solving radioisotope identification problems. Many heuristic approaches to classification in current use, including for radioisotope classification, make implicit probabilistic assumptions which are not clear to the users and, if stated explicitly, might not be considered desirable. Our framework leads to a classification approach with demonstrable improvements using standard feature sets on proof-of-concept simulated and field-collected data.

Application of PET in breast cancer

International Nuclear Information System (INIS)

Noh, Dong Young

2002-01-01

Positron emission tomography (PET) is an imaging method that employs radionuclide and tomography techniques. Since 1995, we applied PET not only to the diagnosis of breast cancer but also to the detection of abnormalities in the augmented breast and to the detection of metastasis. Until 2001, we evaluated 242 breast cases by PET at PET center of Seoul National University Hospital. Our group has reported serially at the international journals. In the firtst report, PET showed high sensitivity for detecting breast cancer, both the primary and axillary node metastasis. A total of 27 patients underwent breast operations based on PET results at Seoul National University Hospital from 1995 to 1996. The diagnostic accuracy of PET were 97% for the primary tumor mass and 96% for axillary lymph node metastasis. In case of the breast augmented, PET also showed excellent diagnostic results for primary breast cancer and axillary lymph node metastasis where mammography and ultrasound could not diagnose properly. PET also had outstanding results in the detection of recurrent or metastatic breast cancer(sensitivity 94%, specificity 80%, accuracy 89%). In addition, our study gave some evidence that PET could be applied further to evaluate the growth rate of tumors by measuring SUV, and finally to prognosticated the disease. PET could also be applied to evaluate the response after chemotherapy to measure its metabolic rate and size. In conclsion, PET is a highly sensitive, accurate diagnostic tool for breast cancer of primary lesion in various conditions including metastasis

PET-Tool: a software suite for comprehensive processing and managing of Paired-End diTag (PET sequence data

Directory of Open Access Journals (Sweden)

Wei Chia-Lin

2006-08-01

Full Text Available Abstract Background We recently developed the Paired End diTag (PET strategy for efficient characterization of mammalian transcriptomes and genomes. The paired end nature of short PET sequences derived from long DNA fragments raised a new set of bioinformatics challenges, including how to extract PETs from raw sequence reads, and correctly yet efficiently map PETs to reference genome sequences. To accommodate and streamline data analysis of the large volume PET sequences generated from each PET experiment, an automated PET data process pipeline is desirable. Results We designed an integrated computation program package, PET-Tool, to automatically process PET sequences and map them to the genome sequences. The Tool was implemented as a web-based application composed of four modules: the Extractor module for PET extraction; the Examiner module for analytic evaluation of PET sequence quality; the Mapper module for locating PET sequences in the genome sequences; and the ProjectManager module for data organization. The performance of PET-Tool was evaluated through the analyses of 2.7 million PET sequences. It was demonstrated that PET-Tool is accurate and efficient in extracting PET sequences and removing artifacts from large volume dataset. Using optimized mapping criteria, over 70% of quality PET sequences were mapped specifically to the genome sequences. With a 2.4 GHz LINUX machine, it takes approximately six hours to process one million PETs from extraction to mapping. Conclusion The speed, accuracy, and comprehensiveness have proved that PET-Tool is an important and useful component in PET experiments, and can be extended to accommodate other related analyses of paired-end sequences. The Tool also provides user-friendly functions for data quality check and system for multi-layer data management.

Dynamic Studies with Radioisotopes in Medicine. Proceedings of the Symposium on Dynamics Studies with Radioisotopes in Clinical Medicine and Research

International Nuclear Information System (INIS)

1971-01-01

Observations on the temporal patterns of uptake, metabolism, clearance or excretion of administered radioactive materials form the basis of many important applications of radioisotopes in clinical medicine and research. Such applications include studies of organ function, of regional blood flow and of the turnover of various substances in the human body. Newly available radioisotopes, new instruments such as gamma came ras, new techniques and new methods of data analysis based on the use of analogue and digital computers are continually enlarging the scope of the applications. Progress in these matters was discussed at the Symposium on Dynamic Studies with Radioisotopes in Clinical Medicine and Research, organized by the lnternational Atomic Energy Agency and held in Rotterdam, The Netherlands, from 31 August to 4 September 1970. A total of 315 participants nominated by 39 countries and 4 international organizations attended, and the 70 papers presented cove r the theoretical aspects of dynamic studies, the development of techniques and instruments for such studies, and specific applications in studies of thyroid, renal, hepatic and splenic function, mineral metabolism, regional blood flow, and cardiac and pulmonary function. The proceedings include the full texts of all the papers presented together with the edited discussions. Invited review papers deal with the general aspects of the various main groups of applications covered. Many of the applications described have already reached the stage of routine use; others are still in the developmental stage. Of particular note in the latter connection are applications based on the quantitative analysis of scintillation camera data. The many papers presented on these topics and the ensuing discussions indicate the great interest now shown in this promising area of development. It is hoped that the proceedings will provide a valuable guide to the present status of the subject

KAERI's challenge to steady production of radioisotopes and radiopharmaceuticals

International Nuclear Information System (INIS)

Park, J.H.; Han, H.S.; Park, K.B.

2000-01-01

The Korea Atomic Energy Research Institute (KAERI) is a national organization in Korea, and has been doing many research and development works in radioisotope production and applications for more than 30 years. Now KAERI regularly produces radioisotopes (I-131, Tc-99m, Ho-166) for medical use and Ir-192 for industrial use. Various I-131 labeled compounds and more than 10 kinds of Tc-99m cold kits are also produced. Our multi-purpose reactor, named HANARO, has been operative since April of 1995. HANAKO is an open tank type reactor with 30 MW thermal capacity. This reactor was designed not only for research on neutron utilization but for production of radioisotopes. KAERI intended to maximize the radioisotope production capability. For this purpose, radioisotope production facilities (RIPF) have been constructed adjacent to the HANARO reactor building. There are four banks of hot cells equipped with manipulators and some of the hot cells were installed according to the KGMP standards and with clean rooms. In reviewing our RI production plan intensively, emphasis was placed on the development of new radiopharmaceuticals, development of new radiation sources for industrial and therapeutic use, and steady production of selected radioisotopes and radiopharmaceuticals. The selected items are Ho-166 based pharmaceuticals, fission Mo-99/Tc-99m generators. solution and capsules of I-131, and Ir-192 and Co-60 for industrial use. The status and future plan of KAERI's research and development program will be introduced, and will highlight programs for steady production. (author)

Dynamic neurotransmitter interactions measured with PET

International Nuclear Information System (INIS)

Schiffer, W.K.; Dewey, S.L.

2001-01-01

Positron emission tomography (PET) has become a valuable interdisciplinary tool for understanding physiological, biochemical and pharmacological functions at a molecular level in living humans, whether in a healthy or diseased state. The utility of tracing chemical activity through the body transcends the fields of cardiology, oncology, neurology and psychiatry. In this, PET techniques span radiochemistry and radiopharmaceutical development to instrumentation, image analysis, anatomy and modeling. PET has made substantial contributions in each of these fields by providing a,venue for mapping dynamic functions of healthy and unhealthy human anatomy. As diverse as the disciplines it bridges, PET has provided insight into an equally significant variety of psychiatric disorders. Using the unique quantitative ability of PET, researchers are now better able to non-invasively characterize normally occurring neurotransmitter interactions in the brain. With the knowledge that these interactions provide the fundamental basis for brain response, many investigators have recently focused their efforts on an examination of the communication between these chemicals in both healthy volunteers and individuals suffering from diseases classically defined as neurotransmitter specific in nature. In addition, PET can measure the biochemical dynamics of acute and sustained drug abuse. Thus, PET studies of neurotransmitter interactions enable investigators to describe a multitude of specific functional interactions in the human brain. This information can then be applied to understanding side effects that occur in response to acute and chronic drug therapy, and to designing new drugs that target multiple systems as opposed to single receptor types. Knowledge derived from PET studies can be applied to drug discovery, research and development (for review, see (Fowler et al., 1999) and (Burns et al., 1999)). Here, we will cover the most substantial contributions of PET to understanding

Dynamic neurotransmitter interactions measured with PET

Energy Technology Data Exchange (ETDEWEB)

Schiffer, W.K.; Dewey, S.L.

2001-04-02

Positron emission tomography (PET) has become a valuable interdisciplinary tool for understanding physiological, biochemical and pharmacological functions at a molecular level in living humans, whether in a healthy or diseased state. The utility of tracing chemical activity through the body transcends the fields of cardiology, oncology, neurology and psychiatry. In this, PET techniques span radiochemistry and radiopharmaceutical development to instrumentation, image analysis, anatomy and modeling. PET has made substantial contributions in each of these fields by providing a,venue for mapping dynamic functions of healthy and unhealthy human anatomy. As diverse as the disciplines it bridges, PET has provided insight into an equally significant variety of psychiatric disorders. Using the unique quantitative ability of PET, researchers are now better able to non-invasively characterize normally occurring neurotransmitter interactions in the brain. With the knowledge that these interactions provide the fundamental basis for brain response, many investigators have recently focused their efforts on an examination of the communication between these chemicals in both healthy volunteers and individuals suffering from diseases classically defined as neurotransmitter specific in nature. In addition, PET can measure the biochemical dynamics of acute and sustained drug abuse. Thus, PET studies of neurotransmitter interactions enable investigators to describe a multitude of specific functional interactions in the human brain. This information can then be applied to understanding side effects that occur in response to acute and chronic drug therapy, and to designing new drugs that target multiple systems as opposed to single receptor types. Knowledge derived from PET studies can be applied to drug discovery, research and development (for review, see (Fowler et al., 1999) and (Burns et al., 1999)). Here, we will cover the most substantial contributions of PET to understanding

Radioisotopes in Hydrology. Proceedings of a Symposium

Energy Technology Data Exchange (ETDEWEB)

NONE

1963-08-15

The increasing emphasis on the development of water resources poses problems which are of interest to all countries, both developing and advanced, where the demand for water is continuously rising. There is no doubt that greater efforts must be made to evaluate, control and develop water resources using all scientific means available and during recent years increasing attention has been directed to the supplementation of hydrological methods with radioisotope techniques. These techniques have already been applied to a number of problems and their potential usefulness demonstrated. Radioisotopes can be used for stream discharge measurements with an accuracy as good as that obtainable with conventional methods. They are also finding increasing application in the measurement of groundwater direction and velocity, the study of suspected interconnections between different sources of water, and the investigation of mixing processes in rivers and lakes. Radioisotope techniques have been used in different parts of the world for studying the transport of silt in rivers and harbours. Present research is directed towards making these investigations on a quantitative basis which, if successful, would be of great importance in the design of hydraulic structures. The method of finding out the age of groundwater by measuring its natural tritium content can be applied to the determination of the recharge rate of groundwater bodies, so enabling a more rational use of the groundwater reserves without fear of overexploitation. Current research is aimed at using carbon-14 for groundwater-dating to extend the age measurable by tritium. A Symposium on the use of radioisotopes in hydrology was organized by the Agency and held in March 1963 in Tokyo in co-operation with the Japanese Government, for whose material and other assistance and generous hospitality the Agency wishes to record its grateful appreciation. The Symposium was attended by about 100 participants from 14 countries and 5

Radioisotope labelling of several major insect pest. Dipping the pupae in /sup 32/P solution

Energy Technology Data Exchange (ETDEWEB)

Sutrisno, S. (National Atomic Energy Agency, Jakarta (Indonesia). Pasar Djumat Research Centre)

1981-12-01

Radioisotope uptake by insects could take place through various parts i.e. mouth, cuticula, intersegmental, secretion and excretion organs. Usually insects are labelled internally by feeding them on an artificial diet containing radioisotope solution. Labelling of several insect pests of cabbage (Crocidolomia binotalis) Zell and Plutella maculipennis Curt and rice (Chilo suppressalis Walker) by dipping of the pupae in /sup 32/P solution showed a promising result. Pupae of Crocidolomia binotalis Zell dipped in 3 ml solution of /sup 32/P with specific activities of 1, 3, 5 and 7 ..mu..Ci/ml had developed labelled adults of sufficiently high radioactivity levels for ecological studies. Similar results were also obtained with Plutella maculipennis Curt and Chilo suppressalis Walker with doses of 1, 3, 5, 7 and 9 ..mu..Ci/ml /sup 32/P solution. The best doses for radioisotope labelling by dipping of the insects Crocidolomia binotalis Zell, Plutella maculipennis Curt, and Chilo suppressalis Walker were 1, 9, and 7 ..mu..Ci/ml respectivelly.

Application of radioisotope technique for investigation of pumps seals

International Nuclear Information System (INIS)

Antoszewski, B.; Zorawska, A.

1988-01-01

Radioisotope method of measuring the wear of rings of the face mechanical seals, bush in soft seals, and leakage in double mechanical seals is described. The examples are given. It is found that radioisotope technique can be used for investigation of the seals. (author)

Studies on application of radiation and radioisotopes

International Nuclear Information System (INIS)

Kim, Jae Rok; Lee, Ji Bok; Lee, Yeong Iil; Jin, Joon Ha; Beon, Myeong Uh; Park, Kyeong Bae; Han, Heon Soo; Jeong, Yong Sam; Uh, Jong Seop; Kang, Kyeong Cheol; Cho, Han Ok; Song, Hui Seop; Yoon, Byeong Mok; Jeon, Byeong Jin; Park, Hong Sik; Kim, Jae Seong; Jeong, Un Soo; Baek, Sam Tae; Cho, Seong Won; Jeon, Yeong Keon; Kim, Joon Yeon; Kwon, Joong Ho; Kim, Ki Yeop; Yang, Jae Seung; No, Yeong Chang; Lee, Yeong Keun; Shin, Byeong Cheol; Park, Sang Joon; Hong, Kwang Pyo; Cho, Seung Yeon; Kang, Iil Joon; Cho, Seong Ki; Jeong, Yeong Joo; Park, Chun Deuk; Lee, Yeong Koo; Seo, Chun Ha; Han, Kwang Hui; Shin, Hyeon Young; Kim, Jong Kuk; Park, Soon Chul; Shin, In Cheol; Lee, Sang Jae; Lee, Ki Un; Lim, Yong Taek; Park, Eung Uh; Kim, Dong Soo; Jeon, Sang Soo

1993-05-01

With the completion of construction of KMRR, the facility and technology of radiation application will be greatly improved. This study was performed as follows; (1) Studies on the production and application of radioisotopes. (2) The development of radiation processing technology. (3) The application of Irradiation techniques for food preservation and process improvement. (4) Studies on the radiation application for the development of genetic resources (5) Development of the radioisotope (RI) production facilities for Korea Multipurpose Research Reactor (KMRR)

A comparative study on PET and SPECT image formation systems for a proper scanner choice in a considered PET center

International Nuclear Information System (INIS)

Santos, G.R. dos; Oliveira, A. de; Oliveira, C.L. de

2001-01-01

precocious discovery of males. Presently multi-ring commercial PET scanners can operate in either two or three-dimensional acquisition modes. Some special features like the retractable lead septa allows 3-D acquisition. In this mode the overall scanner sensitivity has a remarkable increasing compared with earlier scanners, in spite of an increase in both the scatter and random rate. As the emission and transmission data are fed into the computers, and the coincidence events are stored as sinograms, it is also necessary to keep up with computational area. Just to give an idea on the complexity level, the software should be able to provide a full 2-D or 3-D reconstruction algorithm, based on filtered back projection, incorporating an attenuation correction procedure. This is necessary to characterize sinograms, which correspond to sets of two-dimensional projections of the tracer distribution. Software tools should also have the capability for image manipulation and ultimately using various bio-mathematical models. This way, the PET data could be transformed into information with physiological, pathological significance. In a self-sustained project, like the PET Center's project in Rio de Janeiro intend to be, the most important parameters to be considered in the equipment's choice are the per capita's income and acquisition and maintenance costs. However, these factors by itself cannot predict which the best equipment should be acquired and some inherent characteristic of the product as resolution, sensitivity, time of resolution, time of scan and others capabilities should be considered. Out of the comparative scenario, there are also some legal complies. Specifically connected to project of PET Center in Brazil, is the fact that the production of radioactive substances are monopoly of the federal government. As a consequence, and also considering that most PET radioisotopes are short-lived, the availability is restricted to this Southeastern region of Brazil. This region

SPECT and PET imaging in epilepsia

International Nuclear Information System (INIS)

Landvogt, C.

2007-01-01

In preoperative localisation of epileptogenic foci, nuclear medicine diagnostics plays a crucial role. FDG-PET is used as first line diagnostics. In case of inconsistent MRI, EEG and FDG-PET findings, 11 C-Flumazenil-PET or ictal and interictal perfusion-SPECT should be performed. Other than FDG, Flumazenil can help to identify the extend of the region, which should be resected. To enhance sensitivity and specificity, further data analysis using voxelbased statistical analyses or SISCOM (substraction ictal SPECT coregistered MRI) should be performed

Safety regulations for radioisotopes, etc. (interim report)

International Nuclear Information System (INIS)

1980-01-01

An (interim) report by an ad hoc expert committee to the Nuclear Safety Commission, on the safety regulations for radioisotopes, etc., was presented. For the utilization of radioisotopes, etc., there is the Law Concerning Prevention of Radiation Injury Due to Radioisotopes, etc. with the advances in this field and the improvement in international standards, the regulations by the law have been examined. After explaining the basic ideas of the regulations, the problems and countermeasures in the current regulations are described: legal system, rationalization in permission procedures and others, inspection on RI management, the system of the persons in charge of radiation handling, RI transport, low-level radioactive wastes, consumer goods, definitions of RIs, radiation and sealed sources, regulations by group partitioning, RI facilities, system of personnel exposure registration, entrusting of inspection, etc. to private firms, and reduction in the works for permission among governmental offices. (author)

Rapid evaluation of the cost-effectiveness o FDG-PET in recurrent colorectal cancer

International Nuclear Information System (INIS)

Miles, K.A.; Keith, C.J.; Wong, D.C.; Griffiths, M.R.

2002-01-01

Full text: To evaluate the cost-effectiveness of FDG-PET in recurrent colorectal cancer using Australian data whilst avoiding the time delays, costs and ethical difficulties associated with intensive patient follow-up. A decision tree sensitivity analysis was used. The study population comprised patients with recurrent colorectal under consideration for resection of apparently isolated hepatic metastasis in whom demonstration of extra-hepatic tumour would preclude surgery.The results of FDG-PET in a consecutive series of 75 such patients referred to the Wesley PET centre were used to determine the range of possible values for disease prevalence and specificity, assuming the value for PET sensitivity as reported in the federal government's PET review. These values, along with the diagnostic accuracy of CT and Australian costs for procedures (PET = $1200), were entered into decision trees modelling a diagnostic strategy comprising CT only and an alternative strategy where patients without extrahepatic tumour on CT also undergo FDG-PET. The cost per patient, accuracy and Incremental Cost-Accuracy Ratio (ICAR) were determined for each strategy. The PET strategy is cheaper for all possible values of disease prevalence and PET specificity ($306-328 / patient) and is more cost-effective for values of disease prevalence above 0.18 or PET specificity above 0.86. At a typical disease prevalence of 0.3 (PET specificity 0.92), the ICAR for the PET strategy is $9700 versus $11,200 for CT. PET remains cost saving even if the best reported values for sensitivity of CT and worse values for PET are used. FDG-PET for recurrent colorectal cancer in Australia would be cost saving and most probably cost-effective. Copyright (2002) Blackwell Science Pty Ltd

Radioisotope Power Systems Technology Development

Data.gov (United States)

National Aeronautics and Space Administration — The goal of the RPS's technology portfolio is to advance performance of radioisotope power systems through new and novel innovations being developed and transitioned...

RSG-Gas Based Radioisotopes And Sharing Program For Regional Back Up Supply

International Nuclear Information System (INIS)

Soenardjo, Sunarhadijoso; Tamat, Swasono R.; Suparman, Ibon; Purwadi, Bambang

2003-01-01

As the owner of the reactors used for radioisotope production, BATAN needs to increase the effectiveness of the reactor operation cost that can be achieved by simultaneously exploiting all the existing irradiation facility, supported by full utilization of the radioisotopes produced. On the other hand, the domestic demand of radioisotopes is much lower than the production capability but sometimes the request is compulsory to be suspended due to reactor operation schedule. As this condition is mostly similar to that of several countries of RCA Member States, a sharing program for regional back up supply seems to be a positive thought to support expectation on the effectiveness of reactor operation cost and the continuity of radioisotope product services as well as the utilization of radioisotopes produced. Based on radioactivity achieved in each production batch at the present, 131 I, 99 Mo, 153 Sm, 125 I and 32 p radioisotopes may be offered for back up supply program. Due to consideration on conformity of user demands with reactor operation and radiochemical processing costs, the concept of back up supply program should performed first by means of full utilization of the available products and not by increasing reactor operation frequency. An information and communication network system, therefore, is absolutely needed to support information exchange between the radioisotope producer, members of back up supply program and radioisotope customers

Radioisotopic heat source

Science.gov (United States)

Jones, G.J.; Selle, J.E.; Teaney, P.E.

1975-09-30

Disclosed is a radioisotopic heat source and method for a long life electrical generator. The source includes plutonium dioxide shards and yttrium or hafnium in a container of tantalum-tungsten-hafnium alloy, all being in a nickel alloy outer container, and subjected to heat treatment of from about 1570$sup 0$F to about 1720$sup 0$F for about one h. (auth)

Diagnostic performance of PET/MR in the evaluation of active inflammation in Crohn disease.

Science.gov (United States)

Catalano, Onofrio Antonio; Wu, Vincent; Mahmood, Umar; Signore, Alberto; Vangel, Mark; Soricelli, Andrea; Salvatore, Marco; Gervais, Debra; Rosen, Bruce R

2018-01-01

This study investigates the performance of PET/MR versus each sub-modality alone in the assessment of active inflammation in patients with Crohn disease, when compared to surgery as standard of reference. Sensitivity for detecting active inflammation was 91.5% for PET, 80% for MR, and 88% for PET/MR. Specificity for active inflammation was 74% for PET, 87% for MR, and 93% for PET/MR. Diagnostic accuracy was 84% for PET, 83% for MR, and 91% for PET/MR. In conclusion, PET/MR is significantly more accurate than either sub-modality alone and more specific than PET alone in the detection of active inflammation in patients with Crohn disease.

The study on the adaptation for regulation - the permission of a radioisotope

Energy Technology Data Exchange (ETDEWEB)

Park, Byoung Il; Choi, Won Seok; Jung, Yong Moon [Gallup Korea, Seoul (Korea, Republic of)

2003-08-15

The restriction -the permission of a radioisotope keeps satisfaction with almost parts for example, awareness, observance and so on. Moreover two concepts are considered fully -too strict about certain specific control rules and needed more discriminated application standards to each organization related to KINS, it's preserved and controlled properly even if the penalties are downsized.

Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with 44Sc-Labeled Cetuximab Fab Fragment

Science.gov (United States)

2015-01-01

Scandium-44 (t1/2 = 3.9 h) is a relatively new radioisotope of potential interest for use in clinical positron emission tomography (PET). Herein, we report, for the first time, the room-temperature radiolabeling of proteins with 44Sc for in vivo PET imaging. For this purpose, the Fab fragment of Cetuximab, a monoclonal antibody that binds with high affinity to epidermal growth factor receptor (EGFR), was generated and conjugated with N-[(R)-2-amino-3-(para-isothiocyanato-phenyl)propyl]-trans-(S,S)-cyclohexane-1,2-diamine-N,N,N′,N″,N″-pentaacetic acid (CHX-A″-DTPA). The high purity of Cetuximab-Fab was confirmed by SDS-PAGE and mass spectrometry. The potential of the bioconjugate for PET imaging of EGFR expression in human glioblastoma (U87MG) tumor-bearing mice was investigated after 44Sc labeling. PET imaging revealed rapid tumor uptake (maximum uptake of ∼12% ID/g at 4 h postinjection) of 44Sc–CHX-A″-DTPA–Cetuximab-Fab with excellent tumor-to-background ratio, which might allow for same day PET imaging in future clinical studies. Immunofluorescence staining was conducted to correlate tracer uptake in the tumor and normal tissues with EGFR expression. This successful strategy for immunoPET imaging of EGFR expression using 44Sc–CHX-A″-DTPA–Cetuximab-Fab can make clinically translatable advances to select the right population of patients for EGFR-targeted therapy and also to monitor the therapeutic efficacy of anti-EGFR treatments. PMID:25389697

Study on the status of radiation/radioisotope utilization during the last 5 years

International Nuclear Information System (INIS)

Lee, Yun Jong; Park, Tae Jin; Kuk, Il Hiun

2007-01-01

The objectives of this study is derivation of important indices for establishing government policy to promote radiation and radioisotope utilization and for setting up effective strategy o develop related industries, on the basis of utilization data, and deduction of economic scale induced by using radiation and radioisotope, through the analysis of economic contribution by multi-variate model. Uses of radiation and radioisotopes are increasing annually in Korea, and the effect of utilization to economy and industry is continuously enlarged in accordance with technology development and expansion of radiation and radioisotope uses. Indices related to radiation nd radioisotope uses, which are useful for the promotion of utilization and establishment of development strategy, have to be derived and updated every year. Important indices related to radiation and radioisotope utilization are derived through the study. The indices are useful for planning establishing, and revising policies to promote radiation and radioisotope utilization, and re furthermore valuable for public acceptance nuclear energy

Biocompatible branched copolymer nanoparticles prepared by RAFT polymerization as MRI/PET bimodal tracers

Energy Technology Data Exchange (ETDEWEB)

Yang, Chang-Tong [Lee Kong Chian School of Medicine, Nanyang Technological University (Singapore); Tao, He; Jackson, Alexander W [Institute of Chemical and Engineering Sciences, Agency for Science Technology and Research (Singapore); Chandrasekharan, Prashant [Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, Agency for Science Technology and Research (Singapore); Padmanabhan, Parasuraman [Lee Kong Chian School of Medicine, Nanyang Technological University (Singapore); Gulyás, Balázs; Halldin, Christer [Lee Kong Chian School of Medicine, Nanyang Technological University (Singapore); Karolinska Institutet, Department of Clinical Neuroscience, Stockholm (Sweden)

2015-05-18

Stable branched copolymer nanoparticles of varying size (Dh = 20 – 35 nm) have been developed and employed as MRI nano-sized contrast agents. RAFT polymerization has been employed to prepare these novel nanoparticles possessing DO3A macrocycles within their cores and succinimidyl ester benzoate functionalities within their coronas. It has been demonstrated that these nanoparticles can chelate gadolinium and in vitro cytotoxicity studies using HK-2 cells established their negligible toxicity profile. In vivo MRI experiments showed that these nanoparticles have a high relaxivity and a long blood retention time. Xenograft experiments further illustrated the ability of these nanoparticles to perfuse and passively accumulate in tumor cells, presumably through the enhanced EPR effect. The presence of the succinimidyl ester benzoate functionalities within the nanoparticle coronas will permit future surface modification with fluorophores or targeting moieties to generate nanoparticles to study opportunities for bimodal imaging nano-probes or active cell targeting contrast agents. The chelation with PET radioisotopes (68Ga(III) or 64Cu(II)) can afford various PET tracers.

Biocompatible branched copolymer nanoparticles prepared by RAFT polymerization as MRI/PET bimodal tracers

International Nuclear Information System (INIS)

Yang, Chang-Tong; Tao, He; Jackson, Alexander W; Chandrasekharan, Prashant; Padmanabhan, Parasuraman; Gulyás, Balázs; Halldin, Christer

2015-01-01

Stable branched copolymer nanoparticles of varying size (Dh = 20 – 35 nm) have been developed and employed as MRI nano-sized contrast agents. RAFT polymerization has been employed to prepare these novel nanoparticles possessing DO3A macrocycles within their cores and succinimidyl ester benzoate functionalities within their coronas. It has been demonstrated that these nanoparticles can chelate gadolinium and in vitro cytotoxicity studies using HK-2 cells established their negligible toxicity profile. In vivo MRI experiments showed that these nanoparticles have a high relaxivity and a long blood retention time. Xenograft experiments further illustrated the ability of these nanoparticles to perfuse and passively accumulate in tumor cells, presumably through the enhanced EPR effect. The presence of the succinimidyl ester benzoate functionalities within the nanoparticle coronas will permit future surface modification with fluorophores or targeting moieties to generate nanoparticles to study opportunities for bimodal imaging nano-probes or active cell targeting contrast agents. The chelation with PET radioisotopes (68Ga(III) or 64Cu(II)) can afford various PET tracers.

Comparison of PET/CT with Sequential PET/MRI Using an MR-Compatible Mobile PET System.

Science.gov (United States)

Nakamoto, Ryusuke; Nakamoto, Yuji; Ishimori, Takayoshi; Fushimi, Yasutaka; Kido, Aki; Togashi, Kaori

2018-05-01

The current study tested a newly developed flexible PET (fxPET) scanner prototype. This fxPET system involves dual arc-shaped detectors based on silicon photomultipliers that are designed to fit existing MRI devices, allowing us to obtain fused PET and MR images by sequential PET and MR scanning. This prospective study sought to evaluate the image quality, lesion detection rate, and quantitative values of fxPET in comparison with conventional whole-body (WB) PET and to assess the accuracy of registration. Methods: Seventeen patients with suspected or known malignant tumors were analyzed. Approximately 1 h after intravenous injection of 18 F-FDG, WB PET/CT was performed, followed by fxPET and MRI. For reconstruction of fxPET images, MRI-based attenuation correction was applied. The quality of fxPET images was visually assessed, and the number of detected lesions was compared between the 2 imaging methods. SUV max and maximum average SUV within a 1 cm 3 spheric volume (SUV peak ) of lesions were also compared. In addition, the magnitude of misregistration between fxPET and MR images was evaluated. Results: The image quality of fxPET was acceptable for diagnosis of malignant tumors. There was no significant difference in detectability of malignant lesions between fxPET and WB PET ( P > 0.05). However, the fxPET system did not exhibit superior performance to the WB PET system. There were strong positive correlations between the 2 imaging modalities in SUV max (ρ = 0.88) and SUV peak (ρ = 0.81). SUV max and SUV peak measured with fxPET were approximately 1.1-fold greater than measured with WB PET. The average misregistration between fxPET and MR images was 5.5 ± 3.4 mm. Conclusion: Our preliminary data indicate that running an fxPET scanner near an existing MRI system provides visually and quantitatively acceptable fused PET/MR images for diagnosis of malignant lesions. © 2018 by the Society of Nuclear Medicine and Molecular Imaging.

Hygienic efficiency of radioisotope instruments application in motor-car industry

International Nuclear Information System (INIS)

Tolokonnikov, M.I.; Lev, M.Ya.; Liberman, A.N.; Chictov, E.D.

1978-01-01

At the Moscow Automobile Works named after I.A. Likhachev, an analysis was made of the hygienic and technologic-economic benefits from use of radioisotope instruments. Radioisotopic sources of radiation are used for research and measuring purposes in various automatic control and monitoring systems, and in evaluating the effectiveness of cleaning facilities. The application of radioisotopic instruments contributes to achieving the maximum possible efficiency of the equipment, to the improvement of working conditions, and to the prevention of environmental pollution

A report on the extent of radioisotope usage in Malaysia

International Nuclear Information System (INIS)

1983-04-01

A market survey was carried out to study the extent of radioisotope usage in Malaysia. From the survey, the radioisotopes and their activities/quantities that are used in Industry, Medicine and Research were identified. The radioisotopes that are frequently needed or routinely used were also determined and this formed the basis of the recommendations put forward in this report. It is proposed that PUSPATI adopt the concept of a Distribution Centre in order to provide a service to the Malaysian community. (author)

The Research and Development of the Radioisotope Energy Conversion System

International Nuclear Information System (INIS)

Steinfelds, E.V.; Ghosh, T.K.; Prelas, M.A.; Tompson, R.V.; Loyalka, S.K.

2001-01-01

The project of developing radioisotope energy conversion system (RECS) involves analytical computational assisted design and modeling and also laboratory research. The computational analysis consists of selecting various geometries and materials for the main RECS container and the internally located radioisotope, computing the fluxes of the beta (-) particles and of the visible (or ultraviolet) photons produced by the beta (-) s, computing the transport of these photons to the photovoltaic cells, and computing the overall efficiency of useful conversion of the radioisotope power

Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images*

Science.gov (United States)

Botta, F; Mairani, A; Hobbs, R F; Vergara Gil, A; Pacilio, M; Parodi, K; Cremonesi, M; Coca Pérez, M A; Di Dia, A; Ferrari, M; Guerriero, F; Battistoni, G; Pedroli, G; Paganelli, G; Torres Aroche, L A; Sgouros, G

2014-01-01

Patient-specific absorbed dose calculation for nuclear medicine therapy is a topic of increasing interest. 3D dosimetry at the voxel level is one of the major improvements for the development of more accurate calculation techniques, as compared to the standard dosimetry at the organ level. This study aims to use the FLUKA Monte Carlo code to perform patient-specific 3D dosimetry through direct Monte Carlo simulation on PET-CT and SPECT-CT images. To this aim, dedicated routines were developed in the FLUKA environment. Two sets of simulations were performed on model and phantom images. Firstly, the correct handling of PET and SPECT images was tested under the assumption of homogeneous water medium by comparing FLUKA results with those obtained with the voxel kernel convolution method and with other Monte Carlo-based tools developed to the same purpose (the EGS-based 3D-RD software and the MCNP5-based MCID). Afterwards, the correct integration of the PET/SPECT and CT information was tested, performing direct simulations on PET/CT images for both homogeneous (water) and non-homogeneous (water with air, lung and bone inserts) phantoms. Comparison was performed with the other Monte Carlo tools performing direct simulation as well. The absorbed dose maps were compared at the voxel level. In the case of homogeneous water, by simulating 108 primary particles a 2% average difference with respect to the kernel convolution method was achieved; such difference was lower than the statistical uncertainty affecting the FLUKA results. The agreement with the other tools was within 3–4%, partially ascribable to the differences among the simulation algorithms. Including the CT-based density map, the average difference was always within 4% irrespective of the medium (water, air, bone), except for a maximum 6% value when comparing FLUKA and 3D-RD in air. The results confirmed that the routines were properly developed, opening the way for the use of FLUKA for patient-specific, image

Clinical Application of 18F-FDG PET in Gastric Cancer

International Nuclear Information System (INIS)

Yun, Mi Jin; Kim, Tae Sung; Hwang, Hee Sung

2008-01-01

PET or PET/CT detects only less than 50% of early gastric cancer and 62-98% of advanced gastric cancer. Therefore, mass screening programs are recommended for all adults over the age of 40 for early detection and early treatment of gastric cancer through endoscopy or various radiological tests. The most important step after diagnosis of gastric cancer is accurate staging, which mainly evaluates tumor resectability to avoid unnecessary surgery. Important factors that affect tumor resectability are whether the tumor can be separated from adjacent organs or important blood vessels, the extent of lymph node metastasis, presence of peritoneal metastasis, or distant organ metastasis. To evaluate the extent of local tumor invasion, anatomical imaging that has superior spatial resolution is essential. There are a few studies on prognostic significance of FDG uptake with inconsistent results between them. In spite of lower sensitivity for lymph node staging, the specificity of CT and PET are very high, and the specificity for PET tends to be higher than that for CT. Limited data published so far show that PET seems less useful in the detection of lung and bone metastasis. In the evaluation of pleural or peritoneal metastasis, PET seems very specific but insensitive as well. When FDG uptake of primary tumor is low, distant metastasis also tends to show low FDG uptake reducing its detection on PET. There are only a few data available in the evaluation of recurrence detection and treatment response using FDG PET or PET/CT

Personal reflections on the highlights and changes in radiation and radioisotope measurement applications

International Nuclear Information System (INIS)

Gardner, Robin P.; Lee, Kyoung O.

2015-01-01

This paper describes the recent changes that the authors have perceived in the use of radiation and radioisotope measurement applications. The first change is that due to the increased use of Monte Carlo simulation which has occurred from a normal evolutionary process. This is due in large part to the increased accuracy that is being obtained by the use of detector response functions (DRFs) and the simultaneous increased computational efficiency that has become available with these DRFs, the availability of a greatly improved weight windows variance reduction method, and the availability of inexpensive computer clusters. This first change is a happy one. The other change that is occurring is in response to recent terrorist activities. That change is the replacement or major change in the use of long-lived radioisotopes in radioisotope measurement and other radioisotope source applications. In general this can be done by improving the security of these radioisotope sources or by replacing them altogether by using machine sources of radiation. In either case one would like to preclude altogether or at least minimize the possibility of terrorists being able to obtain radioisotopes and use them for clandestine purposes. - Highlights: • Recent changes in radioisotope measurement applications. • Improvements in Monte Carlo simulation for treating radioisotope measurement applications. • Replacement of radioisotope sources with machine sources of radiation.

Production of Radioisotopes in Pakistan Research Reactor: Past, Present and Future

International Nuclear Information System (INIS)

Mushtaq, A.

2013-01-01

Radioisotope production to service different sectors of economic significance constitutes an important ongoing activity of many national nuclear programs. Radioisotopes, formed by nuclear reactions on targets in a reactor or cyclotron, require further processing in almost all cases to obtain them in a form suitable for use. The availability of short-lived radionuclides from radionuclide generators provides an inexpensive and convenient alternative to in-house radioisotope production facilities such as cyclotrons and reactors. The reactor offers large volume for irradiation, simultaneous irradiation of several samples, economy of production and possibility to produce a wide variety of radioisotopes. The accelerator-produced isotopes relatively constitute a smaller percentage of total use. (author)

Technical diagnosis of industrial plants with radioisotopes

International Nuclear Information System (INIS)

Hartmann, G.

1984-01-01

A survey is given of the application of radioisotopes in technical diagnosis of industrial plants. Proceeding from the economic importance and the state of the art of radioisotope applications, the principles of tracer techniques are outlined including topical examples of application such as passage of coal through a steam generator, wear in impact crashing of coal, wear and corrosion in pipelines, testing the effective cross section of pipes, and investigations of microstructures. Limits and restrictions of applications are briefly discussed

Comparison between PET/MR and PET/CT in evaluation of oncological patients%PET/MR与PET/CT的对比研究

Institute of Scientific and Technical Information of China (English)

徐白萱; 富丽萍; 关志伟; 尹大一; 刘家金; 杨晖; 张锦明; 陈英茂; 安宁豫

2014-01-01

Objective To verify the feasibility of the integrated PET/MR for oncological applications by comparing PET/MR with PET/CT in terms of lesion detection and quantitative measurement.Methods A total of 277 patients (165 males,112 females,average age (52.9± 12.6) years) voluntarily participated in this same-day PET/CT and PET/MR comparative study.The time interval between the two studies was 15-35 min.PET/CT images were acquired and reconstructed following standard protocols.PET/MR covered the body trunk with a sequence combination of transverse T1 weighted imaging (WI) 3D-volumetric interpolated breath-hold,T2WI turbo spin echo with fat saturation,diffusion-weighted imaging,and simultaneous PET acquisition.PET images were reconstructed by vender-provided attenuation correction methods.The results of PET/CT and PET/MR were regarded as positive if any modality (CT,PET or MRI) was positive.SUVmax was obtained by the manually drawn ROI.Detection rates were compared with x2 test and SUVmax from the two modalities was analyzed with Spearman correlation analysis.Results A total of 353 lesions were detected in 220 patients.Compared to PET/CT,PET/MR revealed 30 additional true-positive lesions,while missed 6.The detection rates between PET/CT and PET/MR were significantly different (P＜0.05).The lesion-based and patient-based consistency was 89.8％ (317/353) and 85.9％ (189/220),respectively.There were significant correlations of SUVmax between PET/MR and PET/CT for lesions(rs =0.91,P＜0.01) and for normal tissues(rs =0.62-0.76,all P＜0.01).Conclusions With reference to PET/CT,integrated PET/MR may provide comparable semi-quantitative measurements of pathological lesions as well as normal tissues.Integrated PET/MR may be more effective to detect lesions in abdomen and pelvis.%目的 通过与PET/CT在病灶检测及定量分析方面的比较,论证PET/MR一体机应用于临床的可行性.方法 2012年5月至2013年2月共300例患者同天间隔15 ～ 35 min行PET/CT和PET

Diagnostic accuracy and impact on management of {sup 18}F-FDG PET and PET/CT in colorectal liver metastasis: a meta-analysis and systematic review

Energy Technology Data Exchange (ETDEWEB)

Maffione, Anna Margherita; Rubello, Domenico [S.M. della Misericordia Hospital, PET Unit, Nuclear Medicine Department, Rovigo (Italy); Lopci, Egesta [Humanitas Research Hospital, Department of Nuclear Medicine, Milano (Italy); Bluemel, Christina; Herrmann, Ken [University Hospital Wuerzburg, Department of Nuclear Medicine, Wuerzburg (Germany); Giammarile, Francesco [Centre Hospitalier Lyon Sud Biophysique, Department of Nuclear Medicine, Lyon (France)

2015-01-15

The first aim of the review (aim 1) was to obtain the diagnostic performance values of {sup 18}F-FDG PET for the detection and staging of liver metastases in patients with colorectal cancer (CRC), the second aim (aim 2) was to compare PET and conventional imaging modalities, and the third aim (aim 3) was to evaluate the impact of PET on patient management. The incidence of extrahepatic disease (EHD) detected by PET is also reviewed. A comprehensive search was performed on PubMed/MEDLINE for studies evaluating PET and PET/CT in CRC patients with liver metastases up to June 2014. For inclusion PET had to have been performed prior to surgery, there had to be at least 18 patients in the study, and the reported data had to allow calculation of 2 x 2 contingency tables (for aim 1). A total of 18 studies were eligible for at least one of the three intended subanalyses including a total of 1,059 patients. Pooled sensitivity, specificity and accuracy and the corresponding 95 % confidence intervals were derived from the contingency tables on a patient basis (patient-based analysis, PBA) and a lesion basis (lesion-based analysis, LBA) for eight studies. Pooled sensitivity and specificity of PET on PBA were both 93 %. Corresponding values for LBA were 60 % and 79 %, respectively. Areas under the summary ROC were 0.97 for PBA and 0.67 for LBA. Regarding aim 2, PET had a slightly lower sensitivity than MRI and CT on PBA (93 %, 100 % and 98 %, respectively) and LBA (66 %, 89 % and 79 %, respectively) but appeared to be more specific than MRI and CT (86 %, 81 % and 67 %, respectively). PET findings resulted in changes in the management of a mean of 24 % of patients. The mean incidence of PET-based EHD was 32 %. This meta-analysis suggests that FDG PET/CT is highly accurate for the detection of liver metastases on a patient basis but less accurate on a lesion basis. Compared to MRI, PET is less sensitive but more specific and affects the management of about one-quarter of patients

Studies on the production and application of radioisotopes

Energy Technology Data Exchange (ETDEWEB)

Han, Hyon Soo; Park, K. B.; Kim, J. R.; Yoon, B. M.; Bang, H. S.; Shin, B. C.; Cho, W. K.; Park, U. J.; Park, C. D.; Lee, Y. G.; Suh, C. H.; Shin, H. Y.; Kim, D. S.; Hong, S. B.; Jun, S. S.; Min, E. S.; Jang, K. D.; Kim, J. K.; Kim, S. J.; Yang, S. Y.; Yang, S. H.; Chun, K. J.; Kang, H. Y.; Suh, K. S.; Goo, J. H.; Chung, S. H.; Lee, J. C.; Choi, J. L.; Lee, H. Y.; Bang, K. S.

1997-09-01

To produce radioisotopes utilizing the research reactor `HANARO`, development of RI production process, target fabrication, preparation of devices and tools for RI process, preparation of production facility for radiopharmaceuticals, test production for the established process, etc. have been carried out, respectively. Production processes for various kinds of radionuclides were developed and the settled methods were applied to test production using `HANARO`. The results of developed process are as follows: (1) I-131 dry distillation method. (2) Large scale production of Ir-192 sources (3) P-32 production process by distillation under reduced pressure (4) Cr-51 production process using enriched target. To irradiate the target for RI production in `HANARO`, target for neutron irradiation, loading/unloading devices, working table in service pool, remote handling tools, shield cask for irradiated target transfer, etc. were designed and fabricated. The function test of prepared targets and the safety analysis of shielding casks were carried out. License for practical use of the prepared casks were obtained from Ministry of Science and Technology. For production of medical radioisotopes, their production facilities were designed in detail and were installed in RIPF (Radioisotope Production Facility), with full reflection of the basic concept of the good manufacturing practice for radiopharmaceuticals. The constructed GMP facilities have started to be operated after authorization since Jun., 1997. Results of this study will be applied to mass production of radioisotopes in `HANARO` and are to contribute the advance of domestic medicine and industry related to radioisotopes. (author). 7 refs., 7 tabs., 4 figs.

Studies on the production and application of radioisotopes

International Nuclear Information System (INIS)

Han, Hyon Soo; Park, K. B.; Kim, J. R.; Yoon, B. M.; Bang, H. S.; Shin, B. C.; Cho, W. K.; Park, U. J.; Park, C. D.; Lee, Y. G.; Suh, C. H.; Shin, H. Y.; Kim, D. S.; Hong, S. B.; Jun, S. S.; Min, E. S.; Jang, K. D.; Kim, J. K.; Kim, S. J.; Yang, S. Y.; Yang, S. H.; Chun, K. J.; Kang, H. Y.; Suh, K. S.; Goo, J. H.; Chung, S. H.; Lee, J. C.; Choi, J. L.; Lee, H. Y.; Bang, K. S.

1997-09-01

To produce radioisotopes utilizing the research reactor 'HANARO', development of RI production process, target fabrication, preparation of devices and tools for RI process, preparation of production facility for radiopharmaceuticals, test production for the established process, etc. have been carried out, respectively. Production processes for various kinds of radionuclides were developed and the settled methods were applied to test production using 'HANARO'. The results of developed process are as follows: 1) I-131 dry distillation method. 2) Large scale production of Ir-192 sources 3) P-32 production process by distillation under reduced pressure 4) Cr-51 production process using enriched target. To irradiate the target for RI production in 'HANARO', target for neutron irradiation, loading/unloading devices, working table in service pool, remote handling tools, shield cask for irradiated target transfer, etc. were designed and fabricated. The function test of prepared targets and the safety analysis of shielding casks were carried out. License for practical use of the prepared casks were obtained from Ministry of Science and Technology. For production of medical radioisotopes, their production facilities were designed in detail and were installed in RIPF (Radioisotope Production Facility), with full reflection of the basic concept of the good manufacturing practice for radiopharmaceuticals. The constructed GMP facilities have started to be operated after authorization since Jun., 1997. Results of this study will be applied to mass production of radioisotopes in 'HANARO' and are to contribute the advance of domestic medicine and industry related to radioisotopes. (author). 7 refs., 7 tabs., 4 figs

List of DOE radioisotope customers with summary of radioisotope shipments FY 1978

International Nuclear Information System (INIS)

Burlison, J.S.; Laidler, R.I.

1979-05-01

The purpose of the document is to list DOE's radioisotopes production and distribution activities by its facilities at Argonne National Laboratory; Pacific Northwest Laboratory; Brookhaven National Laboratory; Hanford Engineering Development Laboratory; Idaho Operations Office; Los Alamos Scientific Laboratory; Mound Facility; Oak Ridge National Laboratory; Savannah River Laboratory; and UNC Nuclear Industries, Inc

Radioisotopes and radiation technology

International Nuclear Information System (INIS)

Ramamoorthy, N.

2011-01-01

The field of radioisotopes and radiation processing has grown enormously all over the world with India being no exception. The chemistry and radiochemistry related inputs to the overall technology development and achievements have been, and will continue to be, of considerable value and importance in this multi-disciplinary and multi-specialty field. Harnessing further benefits as well as sustaining proven applications should be the goal in planning for the future. An objective analysis of the socio-economic impact and benefits from this field to the society at large will undoubtedly justify assigning continued high priority, and providing adequate resources and support, to relevant new projects and programmes on the anvil in the area of radioisotopes and radiation technology. It is necessary to nurture and strengthen inter-disciplinary and multi-specialty collaborations and cooperation - at both national and international level as a rule (not as exception) - for greater efficiency, cost-effectiveness and success of ongoing endeavors and future developments in this important field

Prediction of standard-dose brain PET image by using MRI and low-dose brain [{sup 18}F]FDG PET images

Energy Technology Data Exchange (ETDEWEB)

Kang, Jiayin [School of Electronics Engineering, Huaihai Institute of Technology, Lianyungang, Jiangsu 222005, China and IDEA Laboratory, Department of Radiology and BRIC, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 (United States); Gao, Yaozong [IDEA Laboratory, Department of Radiology and BRIC, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 and Department of Computer Science, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 (United States); Shi, Feng [IDEA Laboratory, Department of Radiology and BRIC, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 (United States); Lalush, David S. [Joint UNC-NCSU Department of Biomedical Engineering, North Carolina State University, Raleigh, North Carolina 27695 (United States); Lin, Weili [MRI Laboratory, Department of Radiology and BRIC, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 (United States); Shen, Dinggang, E-mail: dgshen@med.unc.edu [IDEA Laboratory, Department of Radiology and BRIC, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 and Department of Brain and Cognitive Engineering, Korea University, Seoul 136-713 (Korea, Republic of)

2015-09-15

Purpose: Positron emission tomography (PET) is a nuclear medical imaging technology that produces 3D images reflecting tissue metabolic activity in human body. PET has been widely used in various clinical applications, such as in diagnosis of brain disorders. High-quality PET images play an essential role in diagnosing brain diseases/disorders. In practice, in order to obtain high-quality PET images, a standard-dose radionuclide (tracer) needs to be used and injected into a living body. As a result, it will inevitably increase the patient’s exposure to radiation. One solution to solve this problem is predicting standard-dose PET images using low-dose PET images. As yet, no previous studies with this approach have been reported. Accordingly, in this paper, the authors propose a regression forest based framework for predicting a standard-dose brain [{sup 18}F]FDG PET image by using a low-dose brain [{sup 18}F]FDG PET image and its corresponding magnetic resonance imaging (MRI) image. Methods: The authors employ a regression forest for predicting the standard-dose brain [{sup 18}F]FDG PET image by low-dose brain [{sup 18}F]FDG PET and MRI images. Specifically, the proposed method consists of two main steps. First, based on the segmented brain tissues (i.e., cerebrospinal fluid, gray matter, and white matter) in the MRI image, the authors extract features for each patch in the brain image from both low-dose PET and MRI images to build tissue-specific models that can be used to initially predict standard-dose brain [{sup 18}F]FDG PET images. Second, an iterative refinement strategy, via estimating the predicted image difference, is used to further improve the prediction accuracy. Results: The authors evaluated their algorithm on a brain dataset, consisting of 11 subjects with MRI, low-dose PET, and standard-dose PET images, using leave-one-out cross-validations. The proposed algorithm gives promising results with well-estimated standard-dose brain [{sup 18}F]FDG PET

Prediction of standard-dose brain PET image by using MRI and low-dose brain ["1"8F]FDG PET images

International Nuclear Information System (INIS)

Kang, Jiayin; Gao, Yaozong; Shi, Feng; Lalush, David S.; Lin, Weili; Shen, Dinggang

2015-01-01

Purpose: Positron emission tomography (PET) is a nuclear medical imaging technology that produces 3D images reflecting tissue metabolic activity in human body. PET has been widely used in various clinical applications, such as in diagnosis of brain disorders. High-quality PET images play an essential role in diagnosing brain diseases/disorders. In practice, in order to obtain high-quality PET images, a standard-dose radionuclide (tracer) needs to be used and injected into a living body. As a result, it will inevitably increase the patient’s exposure to radiation. One solution to solve this problem is predicting standard-dose PET images using low-dose PET images. As yet, no previous studies with this approach have been reported. Accordingly, in this paper, the authors propose a regression forest based framework for predicting a standard-dose brain ["1"8F]FDG PET image by using a low-dose brain ["1"8F]FDG PET image and its corresponding magnetic resonance imaging (MRI) image. Methods: The authors employ a regression forest for predicting the standard-dose brain ["1"8F]FDG PET image by low-dose brain ["1"8F]FDG PET and MRI images. Specifically, the proposed method consists of two main steps. First, based on the segmented brain tissues (i.e., cerebrospinal fluid, gray matter, and white matter) in the MRI image, the authors extract features for each patch in the brain image from both low-dose PET and MRI images to build tissue-specific models that can be used to initially predict standard-dose brain ["1"8F]FDG PET images. Second, an iterative refinement strategy, via estimating the predicted image difference, is used to further improve the prediction accuracy. Results: The authors evaluated their algorithm on a brain dataset, consisting of 11 subjects with MRI, low-dose PET, and standard-dose PET images, using leave-one-out cross-validations. The proposed algorithm gives promising results with well-estimated standard-dose brain ["1"8F]FDG PET image and substantially

Early lesion-specific 18F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer

DEFF Research Database (Denmark)

Nygård, Lotte; Vogelius, Ivan Richter; Fischer, Barbara M

2016-01-01

BACKGROUND AND PURPOSE: We hypothesize that the lesion-to-lesion variability in FDG-PET response after one cycle of chemotherapy for NSCLC in an individual patient may inform radiation dose redistribution. To test this hypothesis, we investigate if time to lesion-progression in patients with mult...... patient response involves a loss of biological information on heterogeneity between lesions. Poor lesion-specific response after one cycle chemotherapy may identify lesions that would benefit from an individualized radiotherapy strategy.......BACKGROUND AND PURPOSE: We hypothesize that the lesion-to-lesion variability in FDG-PET response after one cycle of chemotherapy for NSCLC in an individual patient may inform radiation dose redistribution. To test this hypothesis, we investigate if time to lesion-progression in patients...... with multiple lesions is dependent on lesion-specific response to chemotherapy. MATERIALS AND METHODS: We analyzed 81 patients with 184 lesions referred to curative chemo-radiotherapy for NSCLC 2010-2012. (18)F-FDG PET scans were performed at diagnosis and after one series of chemotherapy. Response of each...

Modeling of the Renal Kinetics of the AT1 Receptor Specific PET Radioligand [11C]KR31173

Directory of Open Access Journals (Sweden)

Nedim C. M. Gulaldi

2013-01-01

Full Text Available Purpose. The radioligand [11C]KR31173 has been introduced for PET imaging of the angiotensin II subtype 1 receptor (AT1R. The purpose of the present project was to employ and validate a compartmental model for quantification of the kinetics of this radioligand in a porcine model of renal ischemia followed by reperfusion (IR. Procedures. Ten domestic pigs were included in the study: five controls and five experimental animals with IR of the left kidney. To achieve IR, acute ischemia was created with a balloon inserted into the left renal artery and inflated for 60 minutes. Reperfusion was achieved by deflation and removal of the balloon. Blood chemistries, urine specific gravity and PH values, and circulating hormones of the renin angiotensin system were measured and PET imaging was performed one week after IR. Cortical time-activity curves obtained from a 90 min [11C]KR31173 dynamic PET study were processed with a compartmental model that included two tissue compartments connected in parallel. Radioligand binding quantified by radioligand retention (80 min value to maximum value ratio was compared to the binding parameters derived from the compartmental model. A binding ratio was calculated as DVR=DVS/DVNS, where DVS and DVNS represented the distribution volumes of specific binding and nonspecific binding. Receptor binding was also determined by autoradiography in vitro. Results. Correlations between rate constants and binding parameters derived by the convolution and deconvolution curve fittings were significant (r>0.9. Also significant was the correlation between the retention parameter derived from the tissue activity curve (Yret and the retention parameter derived from the impulse response function (fret. Furthermore, significant correlations were found between these two retention parameters and DVR. Measurements with PET showed no significant changes in the radioligand binding parameters caused by IR, and these in vivo findings were

Pet Problems at Home: Pet Problems in the Community.

Science.gov (United States)

Soltow, Willow

1984-01-01

Discusses problems of pets in the community, examining the community's role related to disruptive pets and pet overpopulation. Also discusses pet problems at home, offering advice on selecting a pet, meeting a pet's needs, and disciplining pets. Includes a list of books, films/filmstrips, teaching materials, and various instructional strategies.…

Utilization of radioisotopes and irradiation in crop protection research

International Nuclear Information System (INIS)

Ong, S.H.

1981-01-01

There is a growing realization of the benefits which may be derived from the application of radioisotopes and radiation sources in the different disciplines of crop protection research. Many investigations which might only be carried out with extreme difficulty or not all by conventional methods, could be pursued with relative ease. Radioisotopes and irradiation have been utilized in understanding the physiology and behaviour of pests and their biochemical processes and in consequence, have contributed beneficially to the development of better control techniques and more effective pesticides. On the environmental aspects, radioisotopic techniques have provided a useful tool in understanding the behaviour, metabolism and residues of pesticides in the environment. (author)

Survey of industrial radioisotope savings

International Nuclear Information System (INIS)

1965-01-01

Only three decades after the discovery of artificial radioactivity and two after radioisotopes became available in quantity, methods employing these as sources or tracers have found widespread use, not only in scientific research, but also in industrial process and product control. The sums spent by industry on these new techniques amount to millions of dollars a year. Realizing the overall attitude of industry to scientific progress - to accept only methods that pay relatively quickly - one can assume that the economic benefits must be of a still larger order of magnitude. In order to determine the extent to which radioisotopes are in daily use and to evaluate the economic benefits derived from such use, IAEA decided to make an 'International Survey on the Use of Radioisotopes in Industry'. In 1962, the Agency invited a number of its highly industrialized Member States to participate in this Survey. Similar surveys had been performed in various countries in the 1950's. However, the approaches and also the definition of the economic benefits differed greatly from one survey to another. Hence, the Agency's approach was to try to persuade all countries to conduct surveys at the same time, concerning the same categories of industries and using the same terms of costs, savings, etc. In total, 24 Member States of the Agency agreed to participate in the survey and in due course they submitted contributions. The national reports were discussed at a 'Study Group Meeting on Radioisotope Economics', convened in Vienna in March 1964. Based upon these discussions, the national reports have been edited and summarized. A publication showing the administration of the Survey and providing all details is now published by the Agency. From the publication it is evident that in general the return of technical information was quite high, of the order of 90%, but, unfortunately the economic response was much lower. However, most of the reports had some bearing on the economic aspects

PET/CT imaging in head and neck tumors

International Nuclear Information System (INIS)

Roedel, R.; Palmedo, H.; Reichmann, K.; Reinhardt, M.J.; Biersack, H.J.; Straehler-Pohl, H.J.; Jaeger, U.

2004-01-01

To evaluate the usefulness of combined PET/CT examinations for detection of malignant tumors and their metastases in head and neck oncology. 51 patients received whole body scans on a dual modality PET/CT system. CT was performed without i.v. contrast. The results were compared concerning the diagnostic impact of native CT scan on FDG-PET images and the additional value of fused imaging. From 153 lesions were 97 classified as malignant on CT and 136 on FDG/PET images, as suspicious for malignancy in 33 on CT and 7 on FDG-PET and as benign in 23 on CT and 10 on FDG-PET. With combined PET/CT all primary and recurrent tumors could be found, the detection rate in patients with unknown primary tumors was 45%. Compared to PET or CT alone the sensitivity, specifity and accuracy could be significantly improved by means of combined PET/CT. Fused PET/CT imaging with [F18]-FDG and native CT-scanning enables accurate diagnosis in 93% of lesions and 90% of patients with head and neck oncology. (orig.) [de

Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study

International Nuclear Information System (INIS)

Bowen, S R; Nyflot, M J; Meyer, J; Sandison, G A; Herrmann, C; Groh, C M; Wollenweber, S D; Stearns, C W; Kinahan, P E

2015-01-01

Effective positron emission tomography / computed tomography (PET/CT) guidance in radiotherapy of lung cancer requires estimation and mitigation of errors due to respiratory motion. An end-to-end workflow was developed to measure patient-specific motion-induced uncertainties in imaging, treatment planning, and radiation delivery with respiratory motion phantoms and dosimeters. A custom torso phantom with inserts mimicking normal lung tissue and lung lesion was filled with [ 18 F]FDG. The lung lesion insert was driven by six different patient-specific respiratory patterns or kept stationary. PET/CT images were acquired under motionless ground truth, tidal breathing motion-averaged (3D), and respiratory phase-correlated (4D) conditions. Target volumes were estimated by standardized uptake value (SUV) thresholds that accurately defined the ground-truth lesion volume. Non-uniform dose-painting plans using volumetrically modulated arc therapy were optimized for fixed normal lung and spinal cord objectives and variable PET-based target objectives. Resulting plans were delivered to a cylindrical diode array at rest, in motion on a platform driven by the same respiratory patterns (3D), or motion-compensated by a robotic couch with an infrared camera tracking system (4D). Errors were estimated relative to the static ground truth condition for mean target-to-background (T/B mean ) ratios, target volumes, planned equivalent uniform target doses, and 2%-2 mm gamma delivery passing rates. Relative to motionless ground truth conditions, PET/CT imaging errors were on the order of 10–20%, treatment planning errors were 5–10%, and treatment delivery errors were 5–30% without motion compensation. Errors from residual motion following compensation methods were reduced to 5–10% in PET/CT imaging, <5% in treatment planning, and <2% in treatment delivery. We have demonstrated that estimation of respiratory motion uncertainty and its propagation from PET/CT imaging to RT

Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study

Science.gov (United States)

Bowen, S R; Nyflot, M J; Hermann, C; Groh, C; Meyer, J; Wollenweber, S D; Stearns, C W; Kinahan, P E; Sandison, G A

2015-01-01

Effective positron emission tomography/computed tomography (PET/CT) guidance in radiotherapy of lung cancer requires estimation and mitigation of errors due to respiratory motion. An end-to-end workflow was developed to measure patient-specific motion-induced uncertainties in imaging, treatment planning, and radiation delivery with respiratory motion phantoms and dosimeters. A custom torso phantom with inserts mimicking normal lung tissue and lung lesion was filled with [18F]FDG. The lung lesion insert was driven by 6 different patient-specific respiratory patterns or kept stationary. PET/CT images were acquired under motionless ground truth, tidal breathing motion-averaged (3D), and respiratory phase-correlated (4D) conditions. Target volumes were estimated by standardized uptake value (SUV) thresholds that accurately defined the ground-truth lesion volume. Non-uniform dose-painting plans using volumetrically modulated arc therapy (VMAT) were optimized for fixed normal lung and spinal cord objectives and variable PET-based target objectives. Resulting plans were delivered to a cylindrical diode array at rest, in motion on a platform driven by the same respiratory patterns (3D), or motion-compensated by a robotic couch with an infrared camera tracking system (4D). Errors were estimated relative to the static ground truth condition for mean target-to-background (T/Bmean) ratios, target volumes, planned equivalent uniform target doses (EUD), and 2%-2mm gamma delivery passing rates. Relative to motionless ground truth conditions, PET/CT imaging errors were on the order of 10–20%, treatment planning errors were 5–10%, and treatment delivery errors were 5–30% without motion compensation. Errors from residual motion following compensation methods were reduced to 5–10% in PET/CT imaging, PET/CT imaging to RT planning, and RT delivery under a dose painting paradigm is feasible within an integrated respiratory motion phantom workflow. For a limited set of cases, the

List of ERDA radioisotope customers with summary of radioisotope shipments, FY-1974

International Nuclear Information System (INIS)

Simmons, J.L.; Mandell, S.

1974-01-01

The eleventh edition of the AEC radioisotope customer list has been prepared at the request of the Division of Biomedical and Environmental Research. The purpose of this document is to list the FY 1974 commercial radioisotope production and distribution activities of USAEC facilities at Argonne National Laboratory, Battelle, Pacific Northwest Laboratories, Brookhaven National Laboratory, United Nuclear Inc., Idaho Operations Office, Hanford Engineering Development Laboratory, Mound Laboratory, Oak Ridge National Laboratory, and Savannah River Plant. The information is divided into four sections. Section I is an alphabetical list of domestic and foreign customers and their addresses. Each customer has been designated a number according to its alphabetical position which provides a means of cross-referencing in the following sections. The isotopes purchased are listed after the address of the customer and the laboratory supplying each isotope is indicated by a letter set off by parentheses. Section II is an alphabetical list of isotopes, cross-referenced to customer numbers and again divided into the domestic and foreign categories. This section provides a quick idea of the amount of companies purchasing a particular isotope. If more information is needed, the reader can locate the customer by number and determine the laboratory supplying the isotope. The third section is an alphabetical list of states and countries, also cross-referenced to customer numbers, indicating geographical concentrations of isotope users. Section IV summarizes the FY 1974 radioisotope shipment activities of USAEC laboratories in a comprehensive table providing an alphabetical listing of the isotopes and their suppliers. The shipments, quantities and dollars are broken down for each isotope under the Domestic, Foreign, and Project (AEC facilities) categories, and the total figures for each isotope are also provided. (U.S.)

Radioisotope sources for X-ray fluorescence analysis

International Nuclear Information System (INIS)

Leonowich, J.; Pandian, S.; Preiss, I.L.

1977-01-01

Problems involved in developing radioisotope sources and the characteristics of potentially useful radioisotopes for X-ray fluorescence analysis are presented. These include the following. The isotope must be evaluated for the physical and chemical forms available, purity, half-life, specific activity, toxicity, and cost. The radiation hazards of the source must be considered. The type and amount of radiation output of the source must be evaluated. The source construction must be planned. The source should also present an advance over those currently available in order to justify its development. Some of the isotopes, which are not in use but look very promising, are indicated, and their data are tabulated. A more or less ''perfect'' source within a given range of interest would exhibit the following characteristics. (1) Decay by an isometric transition with little or no internal conversion, (2) Have an intense gamma transition near the absorption edge of the element(s) of interest with no high energy gammas, (3) Have a sufficiently long half-life (in the order of years) for both economic and calibration reasons, (4) Have a sufficiently large cross-section for production in a reasonable amount of time. If there are competing reactions the interfering isotopes should be reasonably short-lived, or if not, be apt to be separated from the isotope chemically with a minimum of difficulty. (T.G.)

Supercritical CO{sub 2} fluid radiochromatography system used to purify [{sup 11}C]toluene for PET

Energy Technology Data Exchange (ETDEWEB)

Muller, Ryan D.; Ferrieri, Richard A. E-mail: rferrieri@bnl.gov; Gerasimov, Madina; Garza, Victor

2002-04-01

Abuse of inhalants in today's society has become such a widespread problem among today's adolescents that in many parts of the world their use exceeds that of many other illicit drugs or alcohol. Even so, little is known how such inhalants affect brain function to an extent that can lead to an abuse liability. While methodologies exist for radiolabeling certain inhalants of interest with short-lived positron emitting radioisotopes that would allow their investigation in human subjects using positron emission tomography (PET), the purification methodologies necessary to separate these volatile substances from the organic starting materials have not been developed. We've adapted supercritical fluid technology to this specific PET application by building a preparative-scale supercritical CO{sub 2} fluid radiochromatograph, and applied it to the purification of [{sup 11}C]toluene. We've demonstrated that [{sup 11}C]toluene can be separated from the starting materials using a conventional C{sub 18} HPLC column and pure supercritical CO{sub 2} fluid as the mobile phase operating at 2000 psi and 40 deg. C. We've also shown that the purified radiotracer can be quantitatively captured on Tenax GR, a solid support material, as it exits the supercritical fluid stream, thus allowing for later desorption into a 1.5% cyclodextrin solution that is suitable for human injection, or into a breathing tube for direct inhalation.

Industrial applications of radioisotope techniques in Poland

International Nuclear Information System (INIS)

Michalik, J.St.

1985-01-01

A general review of applications of radioisotope techniques in the Polish industry for about 25 years is given. The radiotracer methods used in metallurgy, hydrometallurgy, glass industry, oil and petroleum industries, in material testing and in other industries are described. Neutron activation analysis methods as well as nuclear gauges for industry (thickness meters, density meters, conveyer belt weigher, acid concentration meters and others) are also presented. The economic advantages of industrial applications of radioisotope techniques are described too. 42 refs., 43 figs., 11 tabs. (author)

Clinical evaluation of radioisotope examination in oncology

Energy Technology Data Exchange (ETDEWEB)

Yasukochi, H [National Konodai Hospital (Japan)

1979-07-01

Although many approaches are tried for the diagnoses of malignant tumor, radiological examinations act surely main parts. Among the radiological examinations, radioisotope techniques are not well evaluated instead of their usefulness in this field. The reason may depend on the complexity and difficulty in legal limitations, however, the lack of knowledge in this field is also a main reason. In this paper, the present status of the evaluation of radioisotope techniques is discussed in selected region of the body and some characteristic cases are demonstrated.

Radioisotopes preparation with GA Siwabessy for application in health/medical

International Nuclear Information System (INIS)

Sunarhadijoso-Soenarjo

2003-01-01

The Center for Development of Radioisotopes and Radiopharmaceuticals (CDRR) has to improve its role and potency to comply domestic demand in radioisotope preparations. The radioisotopes are used as both primary radioisotopes and labeled compounds, especially for medical diagnosis and therapy as radiopharmaceutical preparations. The implementation of capability in production of radioisotopes and radiopharmaceuticals is fully affected by the readiness of operational function of supporting facilities in regard to maintain safety system, process and personnel as well. For those reasons, activities program has been carried out with the aims of : (a). To faithful capability in production of GA Siwabessy reactor based radioisotopes, labeled compounds and radiopharmaceutical kits, (b). To optimize normal operational function of supporting facilities and utilities, and (c). To perform invention and modification of heater and temperature control units on the air handling unit (AHU) system. Some kinds of radioactive products are dominant during the year of 2002, i.e. 153 SmCl 3 , Na 2 99 MoO 4 and Na 186 ReO 4 primary radioisotopes and 153 Sm-EDTMP labeled compound. The main utilization of the products is for research and development of processing technology and medical application as diagnostic or therapeutic agent. The operational function of supporting facilities and utilities was well performed meeting the requirement of the users. Some units of the systems partially showed degradation of working performance but it did not cause trouble in security and safety of the system, process and personnel. A heater device completed with control system has been installed as a modified part of AHU system and has been tested successfully. The operation of the heater device is significantly influential to the air temperature and humidity in working area. The required air condition, e.g. 22 - 25 o C of temperature and 40 - 50 % of humidity, can be complied on the blower motor

Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in {sup 68}Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI

Energy Technology Data Exchange (ETDEWEB)

Freitag, Martin T. [Department of Radiology, German Cancer Research Center, Heidelberg (Germany); Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg (Germany); Radtke, Jan P. [Department of Radiology, German Cancer Research Center, Heidelberg (Germany); University Hospital Heidelberg, Department of Urology, Heidelberg (Germany); Afshar-Oromieh, Ali; Flechsig, Paul; Giesel, Frederik; Haberkorn, Uwe [University Hospital Heidelberg, Department of Nuclear Medicine, Heidelberg (Germany); Roethke, Matthias C.; Bonekamp, David; Schlemmer, Heinz-Peter [Department of Radiology, German Cancer Research Center, Heidelberg (Germany); Hadaschik, Boris A.; Hohenfellner, Markus [University Hospital Heidelberg, Department of Urology, Heidelberg (Germany); Gleave, Martin [University of British Columbia, The Vancouver Prostate Centre, Vancouver (Canada); Kopka, Klaus; Eder, Matthias [Division of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg (Germany); Heusser, Thorsten; Kachelriess, Marc [Department of Medical Physics in Radiology, German Cancer Research Center, Heidelberg (Germany); Wieczorek, Kathrin [University Hospital Heidelberg, Institute of Pathology, Heidelberg (Germany); Sachpekidis, Christos; Dimitrakopoulou-Strauss, A. [Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg (Germany)

2017-05-15

The positron emission tomography (PET) tracer {sup 68}Ga-PSMA-11, targeting the prostate-specific membrane antigen (PSMA), is rapidly excreted into the urinary tract. This leads to significant radioactivity in the bladder, which may limit the PET-detection of local recurrence (LR) of prostate cancer (PC) after radical prostatectomy (RP), developing in close proximity to the bladder. Here, we analyze if there is additional value of multi-parametric magnetic resonance imaging (mpMRI) compared to the {sup 68}Ga-PSMA-11-PET-component of PET/CT or PET/MRI to detect LR. One hundred and nineteen patients with biochemical recurrence after prior RP underwent both hybrid {sup 68}Ga-PSMA-11-PET/CT{sub low-dose} (1 h p.i.) and -PET/MRI (2-3 h p.i.) including a mpMRI protocol of the prostatic bed. The comparison of both methods was restricted to the abdomen with focus on LR (McNemar). Bladder-LR distance and recurrence size were measured in axial T2w-TSE. A logistic regression was performed to determine the influence of these variables on detectability in {sup 68}Ga-PSMA-11-PET. Standardized-uptake-value (SUV{sub mean}) quantification of LR was performed. There were 93/119 patients that had at least one pathologic finding. In addition, 18/119 Patients (15.1%) were diagnosed with a LR in mpMRI of PET/MRI but only nine were PET-positive in PET/CT and PET/MRI. This mismatch was statistically significant (p = 0.004). Detection of LR using the PET-component was significantly influenced by proximity to the bladder (p = 0.028). The PET-pattern of LR-uptake was classified into three types (1): separated from bladder; (2): fuses with bladder, and (3): obliterated by bladder. The size of LRs did not affect PET-detectability (p = 0.84), mean size was 1.7 ± 0.69 cm long axis, 1.2 ± 0.46 cm short-axis. SUV{sub mean} in nine men was 8.7 ± 3.7 (PET/CT) and 7.0 ± 4.2 (PET/MRI) but could not be quantified in the remaining nine cases (obliterated by bladder). The present study demonstrates

Radioisotopes in Burmese agricultural research

Energy Technology Data Exchange (ETDEWEB)

NONE

1961-07-15

The Burmese authorities decided to start a laboratory for the use of radioisotope techniques in agricultural r e search. The laboratory was set up at the Agricultural Research Institute at Gyogon, on the outskirts of Rangoon. Under its technical assistance program, IAEA assigned an expert in the agricultural applications of radioisotopes for this project. Discussions were held with regional representatives of the Food and Agriculture Organization on the best lines of research to be adopted at the laboratory in its early stages. As the most important crop in Burma is rice, a series of experiments were planned for a study of the nutrition of rice, particularly its phosphorus uptake, with special reference to comparative responses on a range of typical paddy soils. The experiments began last year and are being continued.

Use of radioisotopes in Japan

International Nuclear Information System (INIS)

Foeldiak, G.

1974-01-01

A survey of the following general data on the use of radioisotopes in Japan is given (from the material of the 11th Japan Conference on Radioisotopes): 1. number of the organizations using radioactive isotopes, grouped according to special working fields and instruments; 2. amount of the unsealed sources (Ci) used in the different special working fields in 1971, 4. amount of the sealed sources (Ci) used between 1966 and 1971. 5. number of the institutions using sealed sources, grouped according to special working fields (March, 1972), 6. number of the accelerators applied, grouped according to special working fields (March, 1972), 7. number of the nuclear instruments in the education and research institutes (March, 1972), 8. amount of the collected radioactive waste material between 1960 and 1971 (number of containers). (K.A.)

Similarities between obesity in pets and children: the addiction model.

Science.gov (United States)

Pretlow, Robert A; Corbee, Ronald J

2016-09-01

Obesity in pets is a frustrating, major health problem. Obesity in human children is similar. Prevailing theories accounting for the rising obesity rates - for example, poor nutrition and sedentary activity - are being challenged. Obesity interventions in both pets and children have produced modest short-term but poor long-term results. New strategies are needed. A novel theory posits that obesity in pets and children is due to 'treats' and excessive meal amounts given by the 'pet-parent' and child-parent to obtain affection from the pet/child, which enables 'eating addiction' in the pet/child and results in parental 'co-dependence'. Pet-parents and child-parents may even become hostage to the treats/food to avoid the ire of the pet/child. Eating addiction in the pet/child also may be brought about by emotional factors such as stress, independent of parental co-dependence. An applicable treatment for child obesity has been trialled using classic addiction withdrawal/abstinence techniques, as well as behavioural addiction methods, with significant results. Both the child and the parent progress through withdrawal from specific 'problem foods', next from snacking (non-specific foods) and finally from excessive portions at meals (gradual reductions). This approach should adapt well for pets and pet-parents. Pet obesity is more 'pure' than child obesity, in that contributing factors and treatment points are essentially under the control of the pet-parent. Pet obesity might thus serve as an ideal test bed for the treatment and prevention of child obesity, with focus primarily on parental behaviours. Sharing information between the fields of pet and child obesity would be mutually beneficial.

Radioisotope diagnostics of neoplasms in children

International Nuclear Information System (INIS)

Mechev, D.S.; Sinyuta, B.T.; Borisyuk, T.B.

1982-01-01

On the basis of radioisotope studies of 111 children with neoplasms of locomotor system, retroperitoneal space, maxillofacial region and neck, the limits and possibilities of the method of positive radiodiagnostics with short-life radionuclides sup(99M)Tc pertechnetate and 99 Tc pyrophosphate have been analyzed. It is pointed out that sensitivity of the investigation method with sup(99M)Tc pyrophosphate is higher (91.6%) than that of the method with 99 Tc pertechnetate (84.5%). Specificity of the investigation method with 99 Tc p.ertechnetate is higher (71.5%) than that of the method with sup(99M)Tc pyrophosphate (30%). The method of positive radiodiagnostics is characterized by safety, atraumatism, low radiation burdens and possibility of its realization in ambulatory conditions

Positron emission tomography. Present status and Romanian perspectives

International Nuclear Information System (INIS)

Constantinescu, B.; Lungu, V.

1995-01-01

Basic principles of the positron emission tomography (PET) are summarised. The main PET methods using short-lived radioisotopes (i.e. 11 C, 13 N, 15 O, 18 F) are briefly reviewed. Three types of particle accelerators for radioisotopes production and medical uses (including radiotherapy), corresponding to the proton energy (E p p p < 200 MeV) are presented. PET imaging equipment and procedures are discussed. Main radiopharmaceuticals based on beta decay for PET studies and their role in medicine is also described. Finally, perspectives for a PET program in Romania (Cyclotron + Radiochemistry + Tomograph ) are discussed. (author)

Ability of 18F-DOPA PET/CT and fused 18F-DOPA PET/MRI to assess striatal involvement in paediatric glioma

International Nuclear Information System (INIS)

Morana, Giovanni; Severino, Mariasavina; Tortora, Domenico; Rossi, Andrea; Puntoni, Matteo; Garre, Maria Luisa; Massollo, Michela; Naseri, Merhdad; Piccardo, Arnoldo; Lopci, Egesta

2016-01-01

To assess the diagnostic performance of 18 F-DOPA PET/CT and fused 18 F-DOPA PET/MRI in detecting striatal involvement in children with gliomas. This retrospective study included 28 paediatric patients referred to our institution for the presence of primary, residual or recurrent glioma (12 boys, 16 girls; mean age 10.7 years) and investigated with 18 F-DOPA PET/CT and brain MRI. Fused 18 F-DOPA PET/MR images were obtained and compared with PET/CT and MRI images. Accuracy, sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) for striatal involvement were calculated for each diagnostic tool. Univariate and multivariate logistic analyses were applied to evaluate the associations between 18 F-DOPA PET/CT and fused 18 F-DOPA PET/MRI diagnostic results and tumour uptake outside the striatum, grade, dimension and site of striatal involvement (ventral and/or dorsal). Accuracy, sensitivity, specificity, PPV, and NPV were 100 % for MRI, 93 %, 89 %, 100 %, 100 % and 82 % for 18 F-DOPA PET/MRI, and 75 %, 74 %, 78 %, 88 % and 58 % for 18 F-DOPA PET/CT, respectively. 18 F-DOPA PET/MRI showed a trend towards higher accuracy compared with 18 F-DOPA PET/CT (p = 0.06). MRI showed significantly higher accuracy compared with 18 F-DOPA PET/CT (p = 0.01), but there was no significant difference between MRI and 18 F-DOPA PET/MRI. Both univariate and multivariate logistic analyses showed a significant association (OR 8.0 and 7.7, respectively) between the tumour-to-normal striatal uptake (T/S) ratio and the diagnostic ability of 18 F-DOPA PET/CT (p = 0.03). A strong significant association was also found between involvement of the dorsal striatum and the 18 F-DOPA PET/CT results (p = 0.001), with a perfect prediction of involvement of the dorsal striatum by 18 F-DOPA PET/MRI. Physiological striatal 18 F-DOPA uptake does not appear to be a main limitation in the evaluation of basal ganglia involvement. 18 F-DOPA PET/CT correctly detected

Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests

OpenAIRE

Mustafa Demir; Türkay Toklu; Mohammad Abuqbeitah; Hüseyin Çetin; H. Sezer Sezgin; Nami Yeyin; Kerim Sönmezoğlu

2018-01-01

Objective: The aim of the present study was to compare the performance of positron emission tomography (PET) component of PET/computed tomography (CT) with new emerging PET/magnetic resonance (MR) of the same vendor. Methods: According to National Electrical Manufacturers Association NU2-07, five separate experimental tests were performed to evaluate the performance of PET scanner of General Electric GE company; SIGNATM model PET/MR and GE Discovery 710 model PET/CT. The main investigated...

Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests

OpenAIRE

Demir, Mustafa; Toklu, Türkay; Abuqbeitah, Mohammad; Çetin, Hüseyin; Sezgin, H. Sezer; Yeyin, Nami; Sönmezoğlu, Kerim

2018-01-01

Objective: The aim of the present study was to compare the performance of positron emission tomography (PET) component of PET/computed tomography (CT) with new emerging PET/magnetic resonance (MR) of the same vendor. Methods: According to National Electrical Manufacturers Association NU2-07, five separate experimental tests were performed to evaluate the performance of PET scanner of General Electric GE company; SIGNATM model PET/MR and GE Discovery 710 model PET/CT. The main investigated asp...

Calculation correlations for radioisotope level gages with relay tracing systems

International Nuclear Information System (INIS)

Krejndlin, I.I.; Pakhunkov, Yu.I.

1978-01-01

The interrelationship was examined between the operational and instrumental parameters of radioisotope tracking level indicators. The relationships were obtained permitting to check the reliability of the tracking regime, and also of the equilibrium state of the radioisotope tracking level indicator

Determination of the radiological impact of radioisotope waste disposal

International Nuclear Information System (INIS)

1986-09-01

The Atomic Energy Control Board (AECB) controls the uses of radioisotopes and the management of wastes resulting from radioisotope use through licences. In most cases, wastes generated through the use of radioisotopes are required by licence condition to be sent to Chalk River Nuclear Laboratories for storage but if the amounts of radioisotope are very small, have a low activity or a very short half-life, the radioisotope is permitted to be released to regular waste management systems. The AECB commissioned this study to determine the doses to individuals working in municipal waste management systems and to populations of cities where small amounts of radioisotopes are disposed of through the municipal waste managment systems. The Hamilton-Burlington area surrounding Hamilton Harbour was selected as the study area. The pathways and dosimetry models were put into a computer spread sheet, to give the model flexibility so that it could be easily modified to model other cities. Within the occupational critical group, the maximum doses were calculated for the Hamilton sewage treatment plant aeration worker at 1.2E-6 Sv/a. If this individual were also a member of the critical group in the general population, the maximum dose would be 2.0E-6 Sv/a. Individual doses to the critical group within the general population were calculated as 7.7E-7 Sv/a for adults and 6.8E-8 Sv/a for infants. These compare to AECB regulatory limits of 5.0E-2 Sv/a per person for atomic radiation workers and 5.0E-3 Sv/a per person for the general public. The collective population dose for the study area was 1.37E-1 person-Sv/a or an average dose of 2.6E-7 Sv/a per person for the 525,000 population

Actual and future situations of the use of radioisotopes

International Nuclear Information System (INIS)

Paredes G, L.C.

2005-01-01

It is anticipated to medium term, an increase in the demand of the radioisotopes for medicine, industry and research, as well as the application of new radioisotopes derived from the development of new radiopharmaceuticals products for diagnosis and therapy applications. The personal and clinical dosimetry will have to be prepared for the new challenges. (Author)

Molecular imaging of proliferation with [{sup 18}F]FLT-PET; Molekulare Bildgebung der Proliferation mit [{sup 18}F]FLT-PET

Energy Technology Data Exchange (ETDEWEB)

Buck, A.K.; Herrmann, K.; Schwaiger, M.; Wester, H.J. [Klinikum rechts der Isar, Technische Univ. Muenchen (Germany). Nuklearmedizinische Klinik und Poliklinik; Dechow, T.; Graf, N. [Klinikum rechts der Isar, Technische Univ. Muenchen (Germany). Medizinische Klinik III, Haematologi/Onkologie

2009-06-15

An increased proliferation fraction is a hallmark of malignant cells and a specific feature of malignant tumors which potentially allows more specific tumor imaging compared to increased glucose consumption (FDG-PET). The majority of therapeutic approaches aim at inhibition of proliferation or induction of apoptosis. Accordingly, non-invasive assessment of the proliferation fraction is also of interest for monitoring response to treatment and to early detect resistance to a specific kind of therapy. In clinical studies it has been demonstrated that the radiotracer 3'-deoxy-3'-[{sup 18}F]fluorothymidine (FLT) accumulates specifically in malignant tumors. Regression analysis of tumoral FLT-uptake and immunohistochemically detected proliferation fraction (PCNA, Ki-67) resulted in a significant correlation (e.g., in lung cancer, correlation coefficient r=0.87, p<0.0001). The possibility to non-invasively assess the proliferation fraction with FLT-PET has been shown in a variety of solid cancers. Compared to the standard radiotracer FDG, superior demonstration of the proliferative activity using FLT as the tracer has been demonstrated. On the other hand, accumulation of FLT was significantly lower compared to FDG. Malignant tumors with low proliferation rates did not present with increased FLT-uptake resulting in a reduced sensitivity. In lung cancer for example, the sensitivity was 86% of FLT-PET compared to 100% of FDG-PET. Also, regarding detection of locoregional lymph node metastases or distant metastases, FDG-PET was shown to have a higher sensitivity. Due to the reduced sensitivity, there is no advantage of specific imaging of tumor proliferation regarding tumor staging. In malignant lymphoma, FLT was similar effective for tumor staging as compared to FDG-PET. In a pilot study comprising 34 patients, both tracers showed a similar sensitivity regarding detection of lymphoma. An observed specificity of 100% indicates that FLT-PET represents a diagnostic

SIDA - System for importation distribution and acquisition of radioisotope - User manual

International Nuclear Information System (INIS)

1991-01-01

The SIDA manual (system for importation, distribution and acquisition of radioisotopes) is presented. The SIDA is a system of consult and update to control importation and distribution of radioisotopes in the country. It allows to accompany processes from importation requirement to distribution of radioisotopes, executing the accountancy of I-125, which is distributed for several interprises. The system was developed in CLIPPER87 using DBASE III PLUS data base management. (M.C.K.)

Validation of Plutonium Radioisotopes Analysis Using Alpha Spectrometry

International Nuclear Information System (INIS)

Noor Fadzilah Yusof; Jalal Sharib; Mohd Tarmizi Ishak; Zulkifli Daud; Abdul Kadir Ishak

2016-01-01

This paper presents the validation of an established method used to detect plutonium (Pu) radioisotopes in marine environment samples. The separation method consists of sample digestion, anion exchange, purification, electroplating and counting by an alpha spectrometry. Applying the method on standard reference materials from marine environment, the results are validated using seven parameters, namely specificity, linearity, bias or accuracy, detection limit, precision/ repeatability, reproducibility/ ruggedness and robustness in accordance with International Organization for Standardization (ISO) guidelines. The findings were that the results obtained were in a good agreement and satisfactory compared to the provided readings from certificate of reference materials. (author)

Radioisotope camera

International Nuclear Information System (INIS)

Tausch, L.M.; Kump, R.J.

1978-01-01

The electronic ciruit corrects distortions caused by the distance between the individual photomultiplier tubes of the multiple radioisotope camera on one hand and between the tube configuration and the scintillator plate on the other. For this purpose the transmission characteristics of the nonlinear circuits are altered as a function of the energy of the incident radiation. By this means the threshold values between lower and higher amplification are adjusted to the energy level of each scintillation. The correcting circuit may be used for any number of isotopes to be measured. (DG) [de

Radioisotope Production Plan and Strategy of Kijang Research Reactor

Energy Technology Data Exchange (ETDEWEB)

Lee, Kye Hong; Lee, Jun Sig [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

2015-05-15

This reactor will be located at Kijang, Busan, Korea and be dedicated to produce mainly medical radioisotopes. Tc-99m is very important isotope for diagnosis and more than 80% of radiation diagnostic procedures in nuclear medicine depend on this isotope. There were, however, several times of insecure production of Mo-99 due to the shutdown of major production reactors worldwide. OECD/NEA is leading member countries to resolve the shortage of this isotope and trying to secure the international market of Mo-99. The radioisotope plan and strategy of Kijang Research Reactor (KJRR) should be carefully established to fit not only the domestic but also international demand on Mo-99. The implementation strategy of 6 principles of HLG-MR should be established that is appropriate to national environments. Ministry of Science, ICT and Future Planning and Ministry of Health and welfare should cooperate well to organize the national radioisotope supply structure, to set up the reasonable and competitive pricing of radioisotopes, and to cope with the international supply strategy.

Introduction of a pet food safety law in Japan

Directory of Open Access Journals (Sweden)

Katsuaki Sugiura

2009-06-01

Full Text Available In response to a growing concern among Japanese people over the safety of pet food marketed in Japan, a Pet Food Safety Law was approved by the Diet in June 2008 and will be enforced in June 2009. The law obliges manufacturers and importers of pet food to observe the standards for production methods and labelling and compositional specifications set by the Ministry of the Environment (MoE and the Ministry of Agriculture, Forestry and Fisheries (MAFF. The law also obliges manufacturers, importers and distributors (excluding retailers of pet food to keep records of the name and quantity of pet food manufactured, imported and distributed. Within the compositional specifications, maximum residue limits have been established for aflatoxin B1 and certain organophosphorus pesticides and chemical preservatives. The establishment of standards for other mycotoxins, heavy metals, organochloride pesticides and other additives is scheduled for the near future.

Clinical PET/CT Atlas: A Casebook of Imaging in Oncology

International Nuclear Information System (INIS)

2015-01-01

Integrated positron emission tomography/computed tomography (PET/CT) has evolved since its introduction into the commercial market more than a decade ago. It is now a key procedure, particularly in oncological imaging. Over the last years in routine clinical service, PET/CT has had a significant impact on diagnosis, treatment planning, staging, therapy, and monitoring of treatment response and has therefore played an important role in the care of cancer patients. The high sensitivity from the PET component and the specificity of the CT component give this hybrid imaging modality the unique characteristics that make PET/CT, even after over 10 years of clinical use, one of the fastest growing imaging modalities worldwide. This publication combines over 90 comprehensive cases covering all major indications of fluorodeoxyglucose (18F-FDG)-PET/CT as well as some cases of clinically relevant special tracers. The cases provide an overview of what the specific disease can look like in PET/CT, the typical pattern of the disease’s spread as well as likely pitfalls and teaching points. This PET/CT Atlas will allow professionals interested in PET/CT imaging to embrace the variety of oncological imaging by providing clinically relevant teaching files on the effectiveness and diagnostic quality of FDG-PET/CT imaging in routine applications

Radiation protection at radioisotope processing facilities

International Nuclear Information System (INIS)

Hillier, L.R.; Decaire, R.

2002-01-01

MDS Inc. is Canada's largest diversified health and life sciences company and provides health care services and products to prevent, diagnose and treat disease. MDS Nordion Inc. is a subsidiary of MDS Inc. and is located in Ottawa, Ontario. It provides much of the world's supply of radioisotopes used in nuclear medicine primarily to diagnose, but also to treat disease. MDS Nordion is composed of three major production divisions at its Ottawa location and serves customers in three major markets. These are primarily: radioisotopes used in nuclear medicine (Nuclear Medicine Division), radiation processing for sterilization of medical equipment and supplies, and food (Ion Technologies Division), and teletherapy equipment used in cancer treatment (Therapy Systems Division). MDS Nordion supplies customers in over 100 countries, exporting more than 95 percent of its product processed in Canada. Every year, 15 to 20 million diagnostic imaging tests are carried out in hospitals around the world, using radioisotopes supplied by MDS Nordion. In addition, 150 to 200 million cubic feet (that's enough to cover an entire CFL field - including the end zones - stacked over half a kilometer high) of single use medical products are sterilized using MDS Nordion supplied equipment. MDS Nordion receives medical isotopes from AECL, Chalk River Laboratories and processes the material to purify and quantify the radioisotope product. Sealed sources, comprised of cobalt 60, are supplied from CANDU reactors. Production processes include ventilated shielded cells with remote manipulators, gloveboxes and fumehoods, to effectively control the safety of the workplace and the environment, and to prevent contamination of the products. The facilities are highly regulated by the Canadian Nuclear Safety Commission (CNSC) for safety and environmental protection. Products are also regulated by Health Canada and the US-Food and Drug Administration (FDA). (author)

Regional specific binding of [11C]RO 15 1788 to central type benzodiazepine receptors in human brain: quantitative evaluation by PET

International Nuclear Information System (INIS)

Pappata, S.; Samson, Y.; Chavoix, C.; Prenant, C.; Maziere, M.; Baron, J.C.

1988-01-01

The central type benzodiazepine receptors were studied in 17 healthy human subjects with 11 C-RO 15 1788 and positron emission tomography (PET). The brain regional distribution of the tracer in eight control studies performed after injection of trace doses of 11 C-RO 15 1788 was consistent with that of benzodiazepine receptors. Saturation studies with co-injected cold RO 15 1788 in the remaining subjects showed a dose-dependent decrease of brain radiotracer until full inhibition of specific binding was achieved with doses above 0.1 mg/kg (four studies). Based on the results, a simple method to estimate the specifically bound 11 C-RO 15 1788 regionally in a single PET study is proposed, using the data from the full-saturation studies as a stable estimate of the nondisplaceable radioligand concentration. Using this method, it was found that quasiequilibrium between the estimated specifically bound and nondisplaceable components was achieved at times equal to or longer than 20 min after tracer administration. The validity of this method was partly supported by further results, showing a good agreement between the regional specific binding so calculated and postmortem data of receptor density

Americium-241 radioisotope thermoelectric generator development for space applications

International Nuclear Information System (INIS)

Ambrosi, Richard; Williams, Hugo; Samara-Ratna, Piyal

2013-01-01

Space nuclear power systems are under development in the UK in collaboration with European partners as part of a European Space Agency (ESA) programme. Radioisotope thermoelectric generators (RTG) are an important element of this new capability in Europe. RTG systems being developed in Europe are targeting the 10 W electric to 50 W electric power generation range adopting a modular scalable approach to the design. Radiogenic decay heat from radioisotopes can be converted to electrical power by using appropriate semiconductor based thermoelectric materials. The plan for Europe is to develop radioisotope space nuclear power systems based on both thermoelectric and Stirling power conversion systems. Although primarily focused on delivering up to 50 W of electrical power, the European radioisotope thermoelectric system development programme is targeting americium-241 as a fuel source and is maximizing the use of commercially available thermoelectric manufacturing processes in order to accelerate the development of power conversion systems. The use of americium provides an economic solution at high isotopic purity and is product of a separation process from stored plutonium produced during the reprocessing of civil nuclear fuel. A laboratory prototype that uses electrical heating as a substitute for the radioisotope was developed to validate the designs. This prototype has now been tested. This paper outlines the requirements for a European americium-241 fuelled RTG, describes the most recent updates in system design and provides further insight into recent laboratory prototype test campaigns. (author)

Americium-241 radioisotope thermoelectric generator development for space applications

Energy Technology Data Exchange (ETDEWEB)

Ambrosi, Richard; Williams, Hugo; Samara-Ratna, Piyal, E-mail: rma8@le.ac.uk [University of Leicester, (United Kingdom); and others

2013-07-01

Space nuclear power systems are under development in the UK in collaboration with European partners as part of a European Space Agency (ESA) programme. Radioisotope thermoelectric generators (RTG) are an important element of this new capability in Europe. RTG systems being developed in Europe are targeting the 10 W electric to 50 W electric power generation range adopting a modular scalable approach to the design. Radiogenic decay heat from radioisotopes can be converted to electrical power by using appropriate semiconductor based thermoelectric materials. The plan for Europe is to develop radioisotope space nuclear power systems based on both thermoelectric and Stirling power conversion systems. Although primarily focused on delivering up to 50 W of electrical power, the European radioisotope thermoelectric system development programme is targeting americium-241 as a fuel source and is maximizing the use of commercially available thermoelectric manufacturing processes in order to accelerate the development of power conversion systems. The use of americium provides an economic solution at high isotopic purity and is product of a separation process from stored plutonium produced during the reprocessing of civil nuclear fuel. A laboratory prototype that uses electrical heating as a substitute for the radioisotope was developed to validate the designs. This prototype has now been tested. This paper outlines the requirements for a European americium-241 fuelled RTG, describes the most recent updates in system design and provides further insight into recent laboratory prototype test campaigns. (author)

The radioisotopes and radiations program

International Nuclear Information System (INIS)

1982-01-01

This program of the National Atomic Energy Commission of Argentina refers to the application and production of radionuclides, their compounds and sealed sources. The applications are carried out in the medical, agricultural, cattle raising and industrial areas and in other engineering branches. The sub-program corresponding to the production of radioactive materials includes the production of radioisotopes and of sealed sources, and an engineering service for radioactive materials production and handling facilities. The sub-program of applications is performed through several groups or laboratories in charge of the biological and technological applications, intensive radiation sources, radiation dosimetry and training of personnel or of potential users of radioactive material. Furthermore, several aspects about technology transfer, technical assistance, manpower training courses and scholarships are analyzed. Finally, some legal aspects about the use of radioisotopes and radiations in Argentina are pointed out. (M.E.L.) [es

Induced radioactivity of a GSO scintillator by secondary fragments in carbon ion therapy and its effects on in-beam OpenPET imaging.

Science.gov (United States)

Hirano, Yoshiyuki; Nitta, Munetaka; Nishikido, Fumihiko; Yoshida, Eiji; Inadama, Naoko; Yamaya, Taiga

2016-07-07

The accumulation of induced radioactivity within in-beam PET scanner scintillators is of concern for its long-term clinical usage in particle therapy. To estimate the effects on OpenPET which we are developing for in-beam PET based on GSOZ (Zi doped Gd2SiO5), we measured the induced radioactivity of GSO activated by secondary fragments in a water phantom irradiation by a (12)C beam with an energy of 290 MeV u(-1). Radioisotopes of Na, Ce, Eu, Gd, Nd, Pm and Tb including positron emitters were observed in the gamma ray spectra of the activated GSO with a high purity Ge detector and their absolute radioactivities were calculated. We used the Monte Carlo simulation platform, Geant4 in which the observed radioactivity was assigned to the scintillators of a precisely reproduced OpenPET and the single and coincidence rates immediately after one treatment and after one-year usage were estimated for the most severe conditions. Comparing the highest coincidence rate originating from the activated scintillators (background) and the expected coincidence rate from an imaging object (signal), we determined the expected signal-to-noise ratio to be more than 7 within 3 min and more than 10 within 1 min from the scan start time. We concluded the effects of scintillator activation and their accumulation on the OpenPET imaging were small and clinical long-term usage of the OpenPET was feasible.

Kinetic modeling in PET imaging of hypoxia

Science.gov (United States)

Li, Fan; Joergensen, Jesper T; Hansen, Anders E; Kjaer, Andreas

2014-01-01

Tumor hypoxia is associated with increased therapeutic resistance leading to poor treatment outcome. Therefore the ability to detect and quantify intratumoral oxygenation could play an important role in future individual personalized treatment strategies. Positron Emission Tomography (PET) can be used for non-invasive mapping of tissue oxygenation in vivo and several hypoxia specific PET tracers have been developed. Evaluation of PET data in the clinic is commonly based on visual assessment together with semiquantitative measurements e.g. standard uptake value (SUV). However, dynamic PET contains additional valuable information on the temporal changes in tracer distribution. Kinetic modeling can be used to extract relevant pharmacokinetic parameters of tracer behavior in vivo that reflects relevant physiological processes. In this paper, we review the potential contribution of kinetic analysis for PET imaging of hypoxia. PMID:25250200

New Opportunities for Outer Solar System Science using Radioisotope Electric Propulsion

Energy Technology Data Exchange (ETDEWEB)

Noble, Robert J.; /SLAC; Amini, Rashied; Beauchamp, Patricia M.; /Caltech, JPL; Bennett, Gary L.; /Metaspace Enterprises; Brophy, John R.; Buratti, Bonnie J.; Ervin, Joan; /Caltech, JPL; Fernandez, Yan R.; /Central Florida U.; Grundy, Will; /Lowell Observ.; Khan, Mohammed Omair; /Caltech, JPL; King, David Q.; /Aerojet; Lang, Jared; /Caltech, JPL; Meech, Karen J.; /Hawaii U.; Newhouse, Alan; Oleson, Steven R.; Schmidt, George R.; /GRC; Spilker, Thomas; West, John L.; /Caltech, JPL

2010-05-26

Today, our questions and hypotheses about the Solar System's origin have surpassed our ability to deliver scientific instruments to deep space. The moons of the outer planets, the Trojan and Centaur minor planets, the trans-Neptunian objects (TNO), and distant Kuiper Belt objects (KBO) hold a wealth of information about the primordial conditions that led to the formation of our Solar System. Robotic missions to these objects are needed to make the discoveries, but the lack of deep-space propulsion is impeding this science. Radioisotope electric propulsion (REP) will revolutionize the way we do deep-space planetary science with robotic vehicles, giving them unprecedented mobility. Radioisotope electric generators and lightweight ion thrusters are being developed today which will make possible REP systems with specific power in the range of 5 to 10 W/kg. Studies have shown that this specific power range is sufficient to perform fast rendezvous missions from Earth to the outer Solar System and fast sample return missions. This whitepaper discusses how mobility provided by REP opens up entirely new science opportunities for robotic missions to distant primitive bodies. We also give an overview of REP technology developments and the required next steps to realize REP.

Control of the technological processes at ''Azovstal'' plant using radioisotope devices

Energy Technology Data Exchange (ETDEWEB)

Nosochenko, O V; Overchenko, Z V; Karpov, O I; Deryabina, G N

1980-05-01

Considered is the state of radioisotope control of the technological process at 'Azovstal' plant which has permitted to increase the quality of metal and of metal production. With the help of radioisotope densimeter PR-1024 carried out is the control of the density of the lime solution used for hearth spraying at pig iron casting. A system of automatic correction of skip coke supply according to indications of moisture gauges ''Neutron 3-1'' is implemented at blast furnaces. A radioisotope thickness gauge of hot rolling is positioned on the section of finishing stand of thick-sheet plant, its operation is based on the ..gamma.. radiation weakening in dependence on sheet thickness. The introduction of thickness gauges in the automatized system of rolling control is planned. A radioisotope device ''Paza 2'' for measuring of continuous ingot skin thickness is tested successively at the plant. Gamma-relay devices are used to control the level of loose materials in bunkers. Noted is the prospects of using radioisotopic means of control and automatization of technological processes in ferrous matallurgy.

PET applications in pediatrics

Energy Technology Data Exchange (ETDEWEB)

Shulkin, B. L. [Ann Arbor, Univ. of Michigan Medical Center (United States). Pediatric Nuclear Medicine Section

1997-12-01

This article summarizes the major PET studies which have been performed in pediatric patients to elucidate and characterize diseases and normal development. Issues special for the application of the technique in children, such as dosimetry, patient preparation, and image acquisition are discussed. Studies of central nervous system (CNS) development and pathology, including epilepsy, intraventricular hemorrhage, neonatal asphyxia, tumors, and effects on the CNS from treatment of other tumors are reviewed. These have contributed information fundamental to their understanding of CNS development and pathology. PET investigations into the pathophysiology of congenital heart disease have begun and hold great promise to aid their understanding of these conditions. The second major area in which PET has been applied is the study of non CNS neoplasms. Neuroblastoma has been investigated with tracers which explore basic biochemical features which characterize this tumor, as well as with tracers which explore biochemical events relatively specific for this malignancy. Other common and uncommon tumors of childhood are discussed. The PET technique has been shown useful for answering questions of clinical relevance for the management of these uncommon neoplasms. PET is likely to continue to aid their understanding of many pediatric diseases and may gain more widespread clinical acceptance as the technology continues to disseminate rapidly.

The impact of 18F-FDG PET/CT in patients with liver metastases

International Nuclear Information System (INIS)

Chua, Siew C.; Groves, Ashley M.; Kayani, Irfan; Menezes, Leon; Gacinovic, Svetislav; Du, Yong; Bomanji, Jamshed B.; Ell, Peter J.

2007-01-01

The aim of this study was to assess the performance of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) versus dedicated contrast-enhanced CT (CECT) in the detection of metastatic liver disease. All patients that presented to our Institution with suspected metastatic liver disease who underwent 18 F-FDG PET/CT and CECT within 6 weeks of each other, were retrospectively analyzed, covering a 5-year period. One hundred and thirty-one patients (67 men, 64 women; mean age 62) were identified. Seventy-five had colorectal carcinoma and 56 had other malignancies. The performance of CECT and that of 18 F-FDG-PET/CT in detecting liver metastases were compared. The ability of each to detect local recurrence, extrahepatic metastases and to alter patient management was recorded. The final diagnosis was based on histology, clinical and radiological follow-up (mean 23 months). In detecting hepatic metastases, 18 F-FDG-PET/CT yielded 96% sensitivity and 75% specificity, whilst CECT showed 88% sensitivity and 25% specificity. 18 F-FDG-PET/CT and CECT were concordant in 102 out of 131 patients (78%). In the colorectal group 18 F-FDG-PET/CT showed 94% sensitivity and 75% specificity, whilst CECT had 91% sensitivity and 25% specificity. In the noncolorectal group 18 F-FDG-PET/CT showed 98% sensitivity and 75% specificity whilst CECT had 85% sensitivity and 25% specificity. Overall, 18 F-FDG-PET/CT altered patient management over CECT in 25% of patients. CECT did not alter patient management over 18 F-FDG-PET/CT alone in any patients. 18 F-FDG-PET/CT performed better in detecting metastatic liver disease than CECT in both colorectal and noncolorectal malignancies, and frequently altered patient management. The future role of CECT in these patients may need to be re-evaluated to avoid potentially unnecessary duplication of investigation where 18 F-PET/CT is readily available. (orig.)

Quantitative Evaluation of Atlas-based Attenuation Correction for Brain PET in an Integrated Time-of-Flight PET/MR Imaging System.

Science.gov (United States)

Yang, Jaewon; Jian, Yiqiang; Jenkins, Nathaniel; Behr, Spencer C; Hope, Thomas A; Larson, Peder E Z; Vigneron, Daniel; Seo, Youngho

2017-07-01

Purpose To assess the patient-dependent accuracy of atlas-based attenuation correction (ATAC) for brain positron emission tomography (PET) in an integrated time-of-flight (TOF) PET/magnetic resonance (MR) imaging system. Materials and Methods Thirty recruited patients provided informed consent in this institutional review board-approved study. All patients underwent whole-body fluorodeoxyglucose PET/computed tomography (CT) followed by TOF PET/MR imaging. With use of TOF PET data, PET images were reconstructed with four different attenuation correction (AC) methods: PET with patient CT-based AC (CTAC), PET with ATAC (air and bone from an atlas), PET with ATAC patientBone (air and tissue from the atlas with patient bone), and PET with ATAC boneless (air and tissue from the atlas without bone). For quantitative evaluation, PET mean activity concentration values were measured in 14 1-mL volumes of interest (VOIs) distributed throughout the brain and statistical significance was tested with a paired t test. Results The mean overall difference (±standard deviation) of PET with ATAC compared with PET with CTAC was -0.69 kBq/mL ± 0.60 (-4.0% ± 3.2) (P PET with ATAC boneless (-9.4% ± 3.7) was significantly worse than that of PET with ATAC (-4.0% ± 3.2) (P PET with ATAC patientBone (-1.5% ± 1.5) improved over that of PET with ATAC (-4.0% ± 3.2) (P PET/MR imaging achieves similar quantification accuracy to that from CTAC by means of atlas-based bone compensation. However, patient-specific anatomic differences from the atlas causes bone attenuation differences and misclassified sinuses, which result in patient-dependent performance variation of ATAC. © RSNA, 2017 Online supplemental material is available for this article.

Radioisotope production in the I. Ph. P. E. cyclotron for medical application

Energy Technology Data Exchange (ETDEWEB)

Krasnov, N.N.; Dmitriyev, P.P.; Konjakhin, N.A.; Ognev, A.A. (Gosudarstvennyj Komitet po Ispol' zovaniyu Atomnoj Ehnergii SSSR, Obninsk. Fiziko-Ehnergeticheskij Inst.)

1982-01-01

The production methods for seven radioisotopes, Ga-67, Sr-85, Pd-103, In-111, Tm-167, Hg-197 and Pb-203, by using a classical 1.5m cyclotron in the Institute of Physics and Power Engineering, Obninsk, USSR, are described. At present, more than 50 cyclotrons in different countries are used for the production of radioisotopes applied to medicine. Radioisotopes are produced with the cyclotron in the I.Ph.P.E. in the form of irradiated targets, which are delivered to Moscow radiopharmaceutical factory, where radiopharmaceuticals are produced on the base of these targets. The cyclotron is operated in two regimes providing the acceleration of protons, deuterons and alpha -particles. Two types of target assemblies are used for irradiation, the one is intended for the internal beam, and the other is for the external beam. The reactions used for the production of seven radioisotopes described above, the types of targets, particle energy, respective irradiated materials, beam current, thick target yield and the amount of respective radioisotopes produced per year are reported. Metals have large heat conductivity, therefore the use of metal targets increases beam current, and increases the production rate of radioisotopes.

Radioisotope indicator, type BETA 2

International Nuclear Information System (INIS)

Duszanski, M.; Pankow, A.; Skwarczynski, B.

1975-01-01

The authors describe a radioisotope indicator, type BETA 2, constructed in the ZKMPW Works to be employed in mines for counting, checking, signalling the presence and positioning of cars, as well as monitoring the state of some other equipment. (author)